Ovarian Serous Cystadenocarcinoma: PARADIGM pathway analysis of mRNA expression data
Maintained by TCGA GDAC Team (Broad Institute/Dana-Farber Cancer Institute/Harvard Medical School)
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 69 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
FOXM1 transcription factor network 145
HIF-1-alpha transcription factor network 119
LPA receptor mediated events 101
TCGA08_retinoblastoma 98
Syndecan-1-mediated signaling events 91
Osteopontin-mediated events 90
Endothelins 88
PDGFR-alpha signaling pathway 84
Nectin adhesion pathway 74
TCGA08_p53 74
Results

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway.

Pathway.Name Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
FOXM1 transcription factor network 145 7417 51 -0.66 0.022 1000 -1000 -0.021 -1000
HIF-1-alpha transcription factor network 119 9094 76 -0.16 0.034 1000 -1000 -0.015 -1000
LPA receptor mediated events 101 10390 102 -0.086 0.023 1000 -1000 -0.021 -1000
TCGA08_retinoblastoma 98 784 8 -0.023 0.022 1000 -1000 -0.003 -1000
Syndecan-1-mediated signaling events 91 3115 34 -0.087 0.023 1000 -1000 0 -1000
Osteopontin-mediated events 90 3420 38 -0.22 0.023 1000 -1000 0 -1000
Endothelins 88 8468 96 -0.21 0.023 1000 -1000 -0.013 -1000
PDGFR-alpha signaling pathway 84 3718 44 -0.15 0.031 1000 -1000 0 -1000
Nectin adhesion pathway 74 4718 63 -0.081 0.033 1000 -1000 -0.025 -1000
TCGA08_p53 74 523 7 -0.069 0.019 1000 -1000 0 -1000
Ephrin B reverse signaling 72 3461 48 -0.2 0.051 1000 -1000 -0.03 -1000
Fc-epsilon receptor I signaling in mast cells 71 6917 97 -0.088 0.026 1000 -1000 -0.017 -1000
Thromboxane A2 receptor signaling 69 7296 105 -0.21 0.052 1000 -1000 -0.031 -1000
PLK2 and PLK4 events 68 204 3 -0.002 0.016 1000 -1000 0.018 -1000
amb2 Integrin signaling 68 5628 82 -0.13 0.034 1000 -1000 0 -1000
TRAIL signaling pathway 67 3238 48 -0.038 0.023 1000 -1000 -0.005 -1000
Cellular roles of Anthrax toxin 66 2582 39 -0.1 0.022 1000 -1000 -0.004 -1000
Syndecan-4-mediated signaling events 65 4370 67 -0.11 0.027 1000 -1000 -0.008 -1000
IL4-mediated signaling events 63 5793 91 -0.33 0.17 1000 -1000 -0.097 -1000
Noncanonical Wnt signaling pathway 60 1565 26 -0.033 0.026 1000 -1000 -0.007 -1000
BARD1 signaling events 59 3416 57 -0.035 0.027 1000 -1000 -0.035 -1000
IL1-mediated signaling events 59 3683 62 -0.074 0.045 1000 -1000 0 -1000
Nongenotropic Androgen signaling 59 3068 52 -0.13 0.066 1000 -1000 -0.014 -1000
IL23-mediated signaling events 58 3500 60 -0.27 0.025 1000 -1000 -0.011 -1000
IL6-mediated signaling events 57 4340 75 -0.12 0.025 1000 -1000 -0.019 -1000
Integrins in angiogenesis 54 4555 84 -0.056 0.033 1000 -1000 0 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 53 4581 85 -0.17 0.023 1000 -1000 -0.018 -1000
a4b1 and a4b7 Integrin signaling 50 252 5 0.004 0.019 1000 -1000 0.018 -1000
Caspase cascade in apoptosis 49 3685 74 -0.064 0.044 1000 -1000 -0.009 -1000
IFN-gamma pathway 49 3398 68 -0.053 0.034 1000 -1000 -0.02 -1000
IGF1 pathway 48 2758 57 -0.021 0.035 1000 -1000 -0.014 -1000
Signaling events mediated by the Hedgehog family 47 2489 52 -0.083 0.034 1000 -1000 -0.018 -1000
PLK1 signaling events 47 4053 85 -0.063 0.025 1000 -1000 -0.006 -1000
Ras signaling in the CD4+ TCR pathway 46 792 17 -0.026 0.024 1000 -1000 0 -1000
Signaling events mediated by PTP1B 45 3469 76 -0.094 0.075 1000 -1000 -0.012 -1000
BMP receptor signaling 45 3648 81 -0.074 0.049 1000 -1000 -0.024 -1000
Paxillin-independent events mediated by a4b1 and a4b7 45 1683 37 -0.041 0.033 1000 -1000 0 -1000
Canonical Wnt signaling pathway 45 2306 51 -0.19 0.084 1000 -1000 -0.017 -1000
EPHB forward signaling 45 3846 85 -0.028 0.036 1000 -1000 -0.019 -1000
Wnt signaling 45 319 7 -0.033 0.022 1000 -1000 0.011 -1000
IL12-mediated signaling events 43 3824 87 -0.26 0.026 1000 -1000 -0.054 -1000
TCR signaling in naïve CD8+ T cells 43 4033 93 -0.05 0.033 1000 -1000 -0.022 -1000
Stabilization and expansion of the E-cadherin adherens junction 43 3192 74 -0.059 0.035 1000 -1000 -0.028 -1000
E-cadherin signaling in keratinocytes 43 1882 43 -0.012 0.026 1000 -1000 -0.009 -1000
Syndecan-2-mediated signaling events 42 2956 69 -0.018 0.027 1000 -1000 0 -1000
BCR signaling pathway 42 4255 99 -0.057 0.032 1000 -1000 -0.017 -1000
Circadian rhythm pathway 41 910 22 -0.08 0.024 1000 -1000 -0.017 -1000
Aurora A signaling 41 2485 60 -0.064 0.037 1000 -1000 0 -1000
Reelin signaling pathway 41 2297 56 -0.018 0.055 1000 -1000 0 -1000
Paxillin-dependent events mediated by a4b1 41 1501 36 -0.032 0.035 1000 -1000 -0.03 -1000
IL2 signaling events mediated by PI3K 41 2435 58 -0.11 0.023 1000 -1000 -0.008 -1000
HIF-2-alpha transcription factor network 40 1749 43 -0.098 0.041 1000 -1000 -0.098 -1000
Ephrin A reverse signaling 39 276 7 0 0.023 1000 -1000 0 -1000
FOXA2 and FOXA3 transcription factor networks 39 1805 46 -0.17 0.042 1000 -1000 -0.002 -1000
Retinoic acid receptors-mediated signaling 39 2309 58 -0.098 0.029 1000 -1000 -0.006 -1000
ErbB2/ErbB3 signaling events 38 2483 65 -0.072 0.023 1000 -1000 -0.023 -1000
Arf6 downstream pathway 38 1668 43 -0.027 0.031 1000 -1000 -0.025 -1000
FoxO family signaling 38 2470 64 -0.27 0.041 1000 -1000 -0.006 -1000
ceramide signaling pathway 37 1819 49 -0.014 0.038 1000 -1000 -0.003 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 37 1672 45 -0.06 0.038 1000 -1000 -0.006 -1000
E-cadherin signaling in the nascent adherens junction 37 2847 76 -0.059 0.041 1000 -1000 -0.026 -1000
Signaling events mediated by PRL 36 1244 34 -0.014 0.023 1000 -1000 -0.001 -1000
Aurora B signaling 35 2362 67 -0.065 0.033 1000 -1000 -0.012 -1000
FAS signaling pathway (CD95) 33 1582 47 -0.054 0.042 1000 -1000 -0.014 -1000
Plasma membrane estrogen receptor signaling 33 2845 86 -0.055 0.051 1000 -1000 -0.027 -1000
p75(NTR)-mediated signaling 32 4008 125 -0.039 0.055 1000 -1000 -0.016 -1000
TCGA08_rtk_signaling 32 848 26 -0.014 0.028 1000 -1000 -0.018 -1000
ErbB4 signaling events 31 2207 69 -0.068 0.046 1000 -1000 -0.013 -1000
Class I PI3K signaling events 30 2205 73 -0.008 0.041 1000 -1000 -0.003 -1000
Signaling mediated by p38-gamma and p38-delta 28 430 15 -0.05 0.023 1000 -1000 0 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 27 1487 54 -0.015 0.029 1000 -1000 0 -1000
E-cadherin signaling events 27 136 5 0.018 0.025 1000 -1000 0.019 -1000
Regulation of Androgen receptor activity 27 1949 70 -0.095 0.033 1000 -1000 -0.017 -1000
RXR and RAR heterodimerization with other nuclear receptor 26 1360 52 -0.029 0.06 1000 -1000 -0.003 -1000
Regulation of Telomerase 25 2595 102 -0.13 0.046 1000 -1000 -0.003 -1000
S1P3 pathway 25 1064 42 -0.054 0.03 1000 -1000 -0.004 -1000
Nephrin/Neph1 signaling in the kidney podocyte 24 840 34 -0.023 0.049 1000 -1000 -0.022 -1000
Canonical NF-kappaB pathway 24 965 39 0 0.037 1000 -1000 0 -1000
Atypical NF-kappaB pathway 24 753 31 0 0.023 1000 -1000 0 -1000
IL2 signaling events mediated by STAT5 24 542 22 -0.077 0.032 1000 -1000 0.001 -1000
PDGFR-beta signaling pathway 24 2384 97 -0.059 0.046 1000 -1000 -0.017 -1000
S1P4 pathway 24 615 25 -0.003 0.03 1000 -1000 0 -1000
Presenilin action in Notch and Wnt signaling 23 1442 61 -0.18 0.042 1000 -1000 -0.014 -1000
LPA4-mediated signaling events 22 266 12 0 0.014 1000 -1000 0 -1000
Coregulation of Androgen receptor activity 22 1691 76 -0.01 0.033 1000 -1000 -0.019 -1000
Glucocorticoid receptor regulatory network 22 2550 114 -0.13 0.046 1000 -1000 -0.02 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 22 1514 68 -0.08 0.092 1000 -1000 -0.032 -1000
Arf6 signaling events 21 1336 62 -0.017 0.036 1000 -1000 0 -1000
EPO signaling pathway 21 1188 55 -0.006 0.058 1000 -1000 0 -1000
Neurotrophic factor-mediated Trk receptor signaling 21 2579 120 -0.058 0.056 1000 -1000 -0.021 -1000
Regulation of nuclear SMAD2/3 signaling 20 2810 136 -0.13 0.071 1000 -1000 -0.036 -1000
Glypican 1 network 20 992 48 -0.021 0.039 1000 -1000 -0.02 -1000
EGFR-dependent Endothelin signaling events 19 417 21 0 0.041 1000 -1000 0 -1000
p38 MAPK signaling pathway 19 854 44 -0.012 0.043 1000 -1000 0 -1000
S1P5 pathway 18 319 17 -0.007 0.023 1000 -1000 -0.011 -1000
Regulation of p38-alpha and p38-beta 18 977 54 -0.007 0.057 1000 -1000 0 -1000
Signaling events mediated by VEGFR1 and VEGFR2 18 2359 125 -0.019 0.055 1000 -1000 -0.026 -1000
mTOR signaling pathway 17 908 53 -0.015 0.032 1000 -1000 -0.015 -1000
Ceramide signaling pathway 17 1365 76 -0.012 0.044 1000 -1000 0 -1000
Signaling events mediated by HDAC Class III 17 687 40 -0.036 0.042 1000 -1000 -0.028 -1000
Signaling events regulated by Ret tyrosine kinase 17 1411 82 -0.008 0.056 1000 -1000 -0.022 -1000
Signaling events mediated by HDAC Class I 17 1858 104 -0.036 0.052 1000 -1000 -0.029 -1000
Syndecan-3-mediated signaling events 17 612 35 -0.009 0.034 1000 -1000 0 -1000
Signaling mediated by p38-alpha and p38-beta 17 757 44 -0.008 0.033 1000 -1000 0 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 17 563 33 -0.002 0.053 1000 -1000 0 -1000
Class IB PI3K non-lipid kinase events 17 51 3 -0.019 0.019 1000 -1000 -0.019 -1000
Arf6 trafficking events 16 1205 71 -0.025 0.033 1000 -1000 -0.018 -1000
Class I PI3K signaling events mediated by Akt 15 1030 68 -0.026 0.047 1000 -1000 -0.014 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 14 1219 83 -0.006 0.048 1000 -1000 -0.017 -1000
Hedgehog signaling events mediated by Gli proteins 13 896 65 -0.005 0.053 1000 -1000 -0.01 -1000
S1P1 pathway 13 485 36 -0.001 0.028 1000 -1000 -0.016 -1000
Calcium signaling in the CD4+ TCR pathway 13 432 31 -0.002 0.089 1000 -1000 -0.017 -1000
VEGFR1 specific signals 13 738 56 0 0.039 1000 -1000 0 -1000
JNK signaling in the CD4+ TCR pathway 12 207 17 -0.002 0.044 1000 -1000 0 -1000
Insulin-mediated glucose transport 12 389 32 0 0.033 1000 -1000 0 -1000
Effects of Botulinum toxin 12 320 26 0 0.041 1000 -1000 0 -1000
Insulin Pathway 12 890 74 -0.012 0.063 1000 -1000 -0.017 -1000
Alternative NF-kappaB pathway 12 165 13 0 0.055 1000 -1000 0 -1000
Signaling events mediated by HDAC Class II 11 886 75 -0.034 0.059 1000 -1000 -0.013 -1000
Sphingosine 1-phosphate (S1P) pathway 11 329 28 0 0.037 1000 -1000 0 -1000
Sumoylation by RanBP2 regulates transcriptional repression 11 313 27 -0.013 0.047 1000 -1000 -0.014 -1000
Angiopoietin receptor Tie2-mediated signaling 11 989 88 -0.029 0.057 1000 -1000 -0.044 -1000
Aurora C signaling 10 70 7 0 0.033 1000 -1000 0 -1000
IL27-mediated signaling events 10 540 51 -0.006 0.034 1000 -1000 -0.027 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 9 226 23 -0.013 0.043 1000 -1000 -0.001 -1000
Glypican 2 network 9 39 4 0.021 0.029 1000 -1000 0.019 -1000
Arf1 pathway 9 488 54 -0.01 0.032 1000 -1000 -0.001 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 8 664 78 -0.013 0.037 1000 -1000 -0.009 -1000
Visual signal transduction: Rods 7 390 52 0 0.065 1000 -1000 0 -1000
Rapid glucocorticoid signaling 6 136 20 0 0.025 1000 -1000 0 -1000
Visual signal transduction: Cones 1 73 38 0 0.064 1000 -1000 0 -1000
Total 4801 276456 7203 -8.1 5.2 131000 -131000 -1.5 -131000
FOXM1 transcription factor network

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 -0.43 0.59 -10000 0 -1.2 187 187
PLK1 -0.062 0.29 -10000 0 -1.3 30 30
BIRC5 -0.061 0.29 -10000 0 -1.3 29 29
HSPA1B -0.44 0.59 -10000 0 -1.1 206 206
MAP2K1 0.001 0.044 -10000 0 -0.16 3 3
BRCA2 -0.44 0.6 -10000 0 -1.2 194 194
FOXM1 -0.66 0.96 -10000 0 -1.7 203 203
XRCC1 -0.43 0.59 -10000 0 -1.2 192 192
FOXM1B/p19 -0.54 0.66 -10000 0 -1.3 210 210
Cyclin D1/CDK4 -0.44 0.55 -10000 0 -1 218 218
CDC2 -0.5 0.67 -10000 0 -1.3 199 199
TGFA -0.39 0.52 -10000 0 -0.97 205 205
SKP2 -0.44 0.6 -10000 0 -1.2 188 188
CCNE1 -0.001 0.049 -10000 0 -0.13 70 70
CKS1B -0.44 0.6 -10000 0 -1.2 194 194
RB1 -0.36 0.45 -10000 0 -0.91 190 190
FOXM1C/SP1 -0.53 0.71 -10000 0 -1.4 208 208
AURKB -0.069 0.3 -10000 0 -1.3 32 32
CENPF -0.48 0.62 -10000 0 -1.2 216 216
CDK4 0.008 0.027 -10000 0 -0.14 9 9
MYC -0.39 0.52 -10000 0 -0.98 212 212
CHEK2 -0.003 0.051 -10000 0 -0.14 26 26
ONECUT1 -0.44 0.57 -10000 0 -1.1 208 208
CDKN2A 0.013 0.023 0.093 1 -0.13 12 13
LAMA4 -0.48 0.62 -10000 0 -1.2 210 210
FOXM1B/HNF6 -0.55 0.72 -10000 0 -1.4 208 208
FOS -0.52 0.64 -10000 0 -1.2 230 230
SP1 0.021 0.011 -10000 0 -0.036 14 14
CDC25B -0.44 0.59 -10000 0 -1.1 194 194
response to radiation -0.012 0.032 -10000 0 -10000 0 0
CENPB -0.43 0.59 -10000 0 -1.2 188 188
CENPA -0.43 0.59 -10000 0 -1.1 194 194
NEK2 -0.44 0.61 -10000 0 -1.2 194 194
HIST1H2BA -0.43 0.59 -10000 0 -1.1 191 191
CCNA2 0.01 0.034 -10000 0 -0.13 29 29
EP300 0.022 0.01 -10000 0 -0.12 2 2
CCNB1/CDK1 -0.58 0.78 -10000 0 -1.5 195 195
CCNB2 -0.46 0.62 -10000 0 -1.2 205 205
CCNB1 -0.48 0.65 -10000 0 -1.3 193 193
ETV5 -0.49 0.63 -10000 0 -1.2 220 220
ESR1 -0.47 0.61 -10000 0 -1.2 213 213
CCND1 -0.44 0.56 -10000 0 -1 220 220
GSK3A 0.003 0.042 -10000 0 -0.16 10 10
Cyclin A-E1/CDK1-2 -0.037 0.1 -10000 0 -0.16 184 184
CDK2 0.015 0.025 -10000 0 -0.13 14 14
G2/M transition of mitotic cell cycle -0.015 0.038 -10000 0 -10000 0 0
FOXM1B/Cbp/p300 -0.49 0.66 -10000 0 -1.3 203 203
GAS1 -0.44 0.6 -10000 0 -1.2 195 195
MMP2 -0.53 0.64 -10000 0 -1.2 240 240
RB1/FOXM1C -0.49 0.58 -10000 0 -1.1 223 223
CREBBP 0.021 0.015 -10000 0 -0.12 6 6
HIF-1-alpha transcription factor network

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.13 0.34 -9999 0 -0.55 166 166
HDAC7 -0.001 0.006 -9999 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.067 0.34 -9999 0 -0.59 107 107
SMAD4 0.023 0.007 -9999 0 -0.12 1 1
ID2 -0.13 0.34 -9999 0 -0.55 165 165
AP1 -0.03 0.087 -9999 0 -0.15 161 161
ABCG2 -0.13 0.34 -9999 0 -0.56 165 165
HIF1A -0.017 0.091 -9999 0 -0.13 147 147
TFF3 -0.13 0.34 -9999 0 -0.55 173 173
GATA2 0.019 0.023 -9999 0 -0.1 17 17
AKT1 -0.005 0.073 -9999 0 -0.11 100 100
response to hypoxia -0.021 0.064 -9999 0 -0.11 125 125
MCL1 -0.13 0.34 -9999 0 -0.55 164 164
NDRG1 -0.14 0.35 -9999 0 -0.58 166 166
SERPINE1 -0.14 0.33 -9999 0 -0.56 165 165
FECH -0.13 0.34 -9999 0 -0.56 164 164
FURIN -0.13 0.34 -9999 0 -0.55 164 164
NCOA2 0.023 0.013 -9999 0 -0.1 5 5
EP300 0 0.089 -9999 0 -0.22 28 28
HMOX1 -0.13 0.35 -9999 0 -0.57 167 167
BHLHE40 -0.14 0.33 -9999 0 -0.56 164 164
BHLHE41 -0.14 0.33 -9999 0 -0.56 164 164
HIF1A/ARNT/SMAD3/SMAD4/SP1 0.034 0.12 -9999 0 -0.19 52 52
ENG 0.005 0.089 -9999 0 -0.19 42 42
JUN 0.014 0.033 -9999 0 -0.12 30 30
RORA -0.13 0.34 -9999 0 -0.55 164 164
ABCB1 -0.026 0.11 -9999 0 -0.78 4 4
TFRC -0.14 0.35 -9999 0 -0.57 175 175
CXCR4 -0.14 0.35 -9999 0 -0.56 179 179
TF -0.13 0.34 -9999 0 -0.55 166 166
CITED2 -0.13 0.34 -9999 0 -0.55 165 165
HIF1A/ARNT -0.084 0.44 -9999 0 -0.71 121 121
LDHA -0.09 0.3 -9999 0 -0.99 54 54
ETS1 -0.13 0.35 -9999 0 -0.57 165 165
PGK1 -0.13 0.35 -9999 0 -0.56 171 171
NOS2 -0.14 0.33 -9999 0 -0.56 164 164
ITGB2 -0.14 0.35 -9999 0 -0.57 171 171
ALDOA -0.13 0.34 -9999 0 -0.55 165 165
Cbp/p300/CITED2 -0.12 0.36 -9999 0 -0.64 131 131
FOS -0.006 0.054 -9999 0 -0.12 96 96
HK2 -0.13 0.34 -9999 0 -0.55 169 169
SP1 0.031 0.009 -9999 0 -0.11 1 1
GCK 0.002 0.12 -9999 0 -0.42 1 1
HK1 -0.13 0.34 -9999 0 -0.55 164 164
NPM1 -0.13 0.34 -9999 0 -0.55 165 165
EGLN1 -0.12 0.34 -9999 0 -0.55 165 165
CREB1 0.023 0.028 -9999 0 -0.075 42 42
PGM1 -0.13 0.34 -9999 0 -0.56 169 169
SMAD3 0.022 0.016 -9999 0 -0.12 7 7
EDN1 -0.037 0.19 -9999 0 -1.1 13 13
IGFBP1 -0.12 0.34 -9999 0 -0.55 164 164
VEGFA -0.093 0.29 -9999 0 -0.51 137 137
HIF1A/JAB1 -0.005 0.085 -9999 0 -0.18 72 72
CP -0.15 0.36 -9999 0 -0.58 176 176
CXCL12 -0.15 0.35 -9999 0 -0.57 177 177
COPS5 0.02 0.022 -9999 0 -0.11 13 13
SMAD3/SMAD4 0.029 0.032 -9999 0 -0.12 25 25
BNIP3 -0.14 0.34 -9999 0 -0.56 173 173
EGLN3 -0.15 0.35 -9999 0 -0.57 179 179
CA9 -0.15 0.34 -9999 0 -0.55 182 182
TERT -0.12 0.34 -9999 0 -0.55 164 164
ENO1 -0.13 0.34 -9999 0 -0.56 164 164
PFKL -0.13 0.34 -9999 0 -0.55 164 164
NCOA1 0.023 0.009 -9999 0 -0.12 2 2
ADM -0.14 0.34 -9999 0 -0.56 168 168
ARNT -0.009 0.07 -9999 0 -0.096 157 157
HNF4A 0.027 0.009 -9999 0 -0.12 2 2
ADFP -0.14 0.35 -9999 0 -0.57 178 178
SLC2A1 -0.097 0.29 -9999 0 -0.52 136 136
LEP -0.12 0.34 -9999 0 -0.55 164 164
HIF1A/ARNT/Cbp/p300 -0.077 0.34 -9999 0 -0.58 119 119
EPO -0.076 0.28 -9999 0 -0.57 91 91
CREBBP -0.002 0.09 -9999 0 -0.22 32 32
HIF1A/ARNT/Cbp/p300/HDAC7 -0.08 0.35 -9999 0 -0.6 117 117
PFKFB3 -0.13 0.34 -9999 0 -0.56 167 167
NT5E -0.16 0.36 -9999 0 -0.58 182 182
LPA receptor mediated events

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 -0.021 0.074 -10000 0 -0.13 138 138
NF kappa B1 p50/RelA/I kappa B alpha -0.015 0.092 -10000 0 -0.19 88 88
AP1 -0.058 0.074 -10000 0 -0.13 250 250
mol:PIP3 -0.051 0.063 -10000 0 -0.14 156 156
AKT1 -0.015 0.07 -10000 0 -0.16 54 54
PTK2B -0.028 0.066 -10000 0 -0.14 123 123
RHOA -0.009 0.054 -10000 0 -0.35 6 6
PIK3CB 0.015 0.03 -10000 0 -0.12 24 24
mol:Ca2+ -0.004 0.039 -10000 0 -0.12 31 31
MAGI3 0.018 0.026 -10000 0 -0.12 18 18
RELA 0.023 0.009 -10000 0 -0.12 2 2
apoptosis -0.035 0.07 -10000 0 -0.15 124 124
HRAS/GDP 0.017 0.008 -10000 0 -0.11 2 2
positive regulation of microtubule depolymerization -0.019 0.06 -10000 0 -0.12 125 125
NF kappa B1 p50/RelA -0.04 0.062 -10000 0 -0.13 141 141
endothelial cell migration -0.086 0.14 -10000 0 -0.23 247 247
ADCY4 -0.043 0.097 -10000 0 -0.2 135 135
ADCY5 -0.045 0.098 -10000 0 -0.2 141 141
ADCY6 -0.043 0.098 -10000 0 -0.2 134 134
ADCY7 -0.042 0.097 -10000 0 -0.2 134 134
ADCY1 -0.042 0.097 -10000 0 -0.2 134 134
ADCY2 -0.043 0.097 -10000 0 -0.2 135 135
ADCY3 -0.043 0.098 -10000 0 -0.2 135 135
ADCY8 -0.048 0.098 -10000 0 -0.2 138 138
ADCY9 -0.045 0.1 -10000 0 -0.2 141 141
GSK3B -0.024 0.064 -10000 0 -0.13 126 126
arachidonic acid secretion -0.041 0.091 -10000 0 -0.19 129 129
GNG2 0.02 0.018 -10000 0 -0.12 9 9
TRIP6 0.002 0.05 -10000 0 -0.25 19 19
GNAO1 -0.04 0.073 -10000 0 -0.11 248 248
HRAS 0.023 0.006 -10000 0 -0.12 1 1
NFKBIA -0.03 0.085 -10000 0 -0.21 69 69
GAB1 0.02 0.021 -10000 0 -0.12 12 12
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly -0.023 0.22 -10000 0 -0.87 37 37
JUN 0.014 0.033 -10000 0 -0.12 30 30
LPA/LPA2/NHERF2 -0.01 0.035 -10000 0 -0.062 140 140
TIAM1 -0.041 0.26 -10000 0 -1 37 37
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
mol:IP3 -0.004 0.039 -10000 0 -0.12 31 31
PLCB3 -0.003 0.032 -10000 0 -0.071 37 37
FOS -0.005 0.053 -10000 0 -0.12 95 95
positive regulation of mitosis -0.041 0.091 -10000 0 -0.19 129 129
LPA/LPA1-2-3 -0.037 0.061 -10000 0 -0.098 247 247
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0 -10000 0 -10000 0 0
BCAR1 0.022 0.011 -10000 0 -0.12 3 3
stress fiber formation -0.026 0.075 -10000 0 -0.15 109 109
GNAZ -0.035 0.071 -10000 0 -0.11 247 247
EGFR/PI3K-beta/Gab1 -0.053 0.065 -10000 0 -0.14 155 155
positive regulation of dendritic cell cytokine production -0.037 0.06 -10000 0 -0.098 247 247
LPA/LPA2/MAGI-3 -0.009 0.036 -10000 0 -0.063 136 136
ARHGEF1 -0.02 0.062 -10000 0 -0.12 128 128
GNAI2 -0.035 0.071 -10000 0 -0.11 247 247
GNAI3 -0.039 0.077 -10000 0 -0.11 248 248
GNAI1 -0.045 0.081 -10000 0 -0.12 247 247
LPA/LPA3 -0.021 0.031 -10000 0 -0.053 247 247
LPA/LPA2 -0.021 0.031 -10000 0 -0.052 247 247
LPA/LPA1 -0.052 0.082 -10000 0 -0.14 247 247
HB-EGF/EGFR -0.003 0.06 -10000 0 -0.12 88 88
HBEGF 0.004 0.039 -10000 0 -0.078 95 95
mol:DAG -0.004 0.039 -10000 0 -0.12 31 31
cAMP biosynthetic process -0.045 0.096 -10000 0 -0.2 135 135
NFKB1 0.021 0.013 -10000 0 -0.12 4 4
SRC 0.023 0.009 -10000 0 -0.12 2 2
GNB1 0.023 0.007 -10000 0 -0.12 1 1
LYN -0.03 0.089 -10000 0 -0.22 71 71
GNAQ -0.012 0.038 -10000 0 -0.069 125 125
LPAR2 0 0 -10000 0 -10000 0 0
LPAR3 0 0 -10000 0 -10000 0 0
LPAR1 -0.034 0.049 -10000 0 -0.084 247 247
IL8 -0.083 0.15 -10000 0 -0.36 97 97
PTK2 -0.029 0.063 -10000 0 -0.09 251 251
Rac1/GDP 0.016 0.015 -10000 0 -0.15 5 5
CASP3 -0.035 0.07 -10000 0 -0.15 124 124
EGFR 0.015 0.03 -10000 0 -0.12 25 25
PLCG1 -0.007 0.041 -10000 0 -0.069 122 122
PLD2 -0.026 0.06 -10000 0 -0.087 247 247
G12/G13 -0.019 0.073 -10000 0 -0.14 128 128
PI3K-beta -0.04 0.06 0.084 1 -0.19 49 50
cell migration -0.012 0.078 -10000 0 -0.23 50 50
SLC9A3R2 0.017 0.028 -10000 0 -0.12 22 22
PXN -0.027 0.076 -10000 0 -0.16 80 80
HRAS/GTP -0.042 0.093 -10000 0 -0.19 129 129
RAC1 0.023 0.002 -10000 0 -10000 0 0
MMP9 0 0.05 -10000 0 -0.12 81 81
PRKCE 0.021 0.017 -10000 0 -0.12 8 8
PRKCD -0.005 0.045 -10000 0 -0.13 37 37
Gi(beta/gamma) -0.043 0.096 -10000 0 -0.19 138 138
mol:LPA -0.034 0.049 -10000 0 -0.084 247 247
TRIP6/p130 Cas/FAK1/Paxillin -0.022 0.093 -10000 0 -0.16 140 140
MAPKKK cascade -0.041 0.091 -10000 0 -0.19 129 129
contractile ring contraction involved in cytokinesis -0.008 0.054 -10000 0 -0.35 6 6
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 -0.009 0.029 -10000 0 -0.057 128 128
GNA15 -0.011 0.035 -10000 0 -0.064 125 125
GNA12 0.023 0.001 -10000 0 -10000 0 0
GNA13 0.022 0.009 -10000 0 -0.12 2 2
MAPT -0.019 0.061 -10000 0 -0.12 125 125
GNA11 -0.009 0.028 -10000 0 -0.056 124 124
Rac1/GTP -0.026 0.24 -10000 0 -0.92 37 37
MMP2 -0.086 0.14 -10000 0 -0.23 247 247
TCGA08_retinoblastoma

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0.017 0.017 -10000 0 -0.085 8 8
CDKN2C 0.008 0.044 -10000 0 -0.12 56 56
CDKN2A 0.014 0.023 -10000 0 -0.12 12 12
CCND2 0.015 0.052 0.12 107 -10000 0 107
RB1 -0.023 0.061 0.091 1 -0.12 136 137
CDK4 0.022 0.068 0.13 138 -0.12 17 155
CDK6 0.014 0.073 0.13 131 -0.13 39 170
G1/S progression 0.02 0.065 0.12 138 -0.09 1 139
Syndecan-1-mediated signaling events

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.019 0.023 -9999 0 -0.12 14 14
CCL5 0.005 0.044 -9999 0 -0.12 60 60
SDCBP 0.021 0.01 -9999 0 -0.12 2 2
FGFR/FGF2/Syndecan-1 -0.083 0.12 -9999 0 -0.25 132 132
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
RP11-540L11.1 0 0 -9999 0 -10000 0 0
Syndecan-1/Laminin-5 -0.073 0.12 -9999 0 -0.24 139 139
Syndecan-1/Syntenin -0.076 0.13 -9999 0 -0.24 151 151
MAPK3 -0.06 0.12 -9999 0 -0.21 141 141
HGF/MET -0.017 0.074 -9999 0 -0.14 118 118
TGFB1/TGF beta receptor Type II 0.019 0.023 -9999 0 -0.12 14 14
BSG 0.022 0.013 -9999 0 -0.12 4 4
keratinocyte migration -0.072 0.12 -9999 0 -0.23 139 139
Syndecan-1/RANTES -0.087 0.14 -9999 0 -0.25 168 168
Syndecan-1/CD147 -0.062 0.12 -9999 0 -0.22 138 138
Syndecan-1/Syntenin/PIP2 -0.074 0.12 -9999 0 -0.23 153 153
LAMA5 0.019 0.025 -9999 0 -0.12 17 17
positive regulation of cell-cell adhesion -0.073 0.12 -9999 0 -0.22 153 153
MMP7 -0.022 0.06 -9999 0 -0.12 144 144
HGF 0.02 0.023 -9999 0 -0.12 14 14
Syndecan-1/CASK -0.079 0.12 -9999 0 -0.24 132 132
Syndecan-1/HGF/MET -0.087 0.13 -9999 0 -0.22 197 197
regulation of cell adhesion -0.058 0.11 -9999 0 -0.23 111 111
HPSE 0.014 0.034 -9999 0 -0.12 33 33
positive regulation of cell migration -0.083 0.12 -9999 0 -0.25 132 132
SDC1 -0.084 0.12 -9999 0 -0.25 132 132
Syndecan-1/Collagen -0.083 0.12 -9999 0 -0.25 132 132
PPIB 0.023 0.003 -9999 0 -10000 0 0
MET 0 0.047 -9999 0 -0.12 70 70
PRKACA 0.021 0.017 -9999 0 -0.12 8 8
MMP9 0 0.05 -9999 0 -0.12 81 81
MAPK1 -0.061 0.12 -9999 0 -0.21 139 139
homophilic cell adhesion -0.082 0.12 -9999 0 -0.25 132 132
MMP1 -0.007 0.058 -9999 0 -0.12 115 115
Osteopontin-mediated events

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.047 0.11 -9999 0 -0.22 120 120
NF kappa B1 p50/RelA/I kappa B alpha -0.067 0.17 -9999 0 -0.31 141 141
alphaV/beta3 Integrin/Osteopontin/Src -0.038 0.11 -9999 0 -0.19 164 164
AP1 -0.12 0.16 -9999 0 -0.3 184 184
ILK -0.047 0.099 -9999 0 -0.22 102 102
bone resorption -0.041 0.11 -9999 0 -0.19 151 151
PTK2B 0.023 0.009 -9999 0 -0.12 2 2
PYK2/p130Cas -0.022 0.11 -9999 0 -0.19 118 118
ITGAV 0.008 0.035 -9999 0 -0.12 30 30
mol:GTP 0 0 -9999 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 -0.001 0.07 -9999 0 -0.12 125 125
alphaV/beta3 Integrin/Osteopontin -0.042 0.12 -9999 0 -0.22 129 129
MAP3K1 -0.05 0.1 -9999 0 -0.2 131 131
JUN 0.012 0.033 -9999 0 -0.12 30 30
MAPK3 -0.064 0.12 -9999 0 -0.25 139 139
MAPK1 -0.064 0.13 -9999 0 -0.25 140 140
Rac1/GDP 0.016 0.015 -9999 0 -0.15 5 5
NFKB1 0.021 0.013 -9999 0 -0.12 4 4
MAPK8 -0.053 0.1 -9999 0 -0.2 143 143
ITGB3 -0.001 0.048 -9999 0 -0.12 71 71
NFKBIA -0.081 0.16 -9999 0 -0.32 144 144
FOS -0.007 0.054 -9999 0 -0.12 95 95
CD44 0.011 0.038 -9999 0 -0.12 41 41
CHUK 0.021 0.013 -9999 0 -0.12 4 4
PLAU -0.22 0.4 -9999 0 -1 106 106
NF kappa B1 p50/RelA -0.068 0.17 -9999 0 -0.36 123 123
BCAR1 0.022 0.011 -9999 0 -0.12 3 3
RELA 0.023 0.009 -9999 0 -0.12 2 2
alphaV beta3 Integrin -0.027 0.088 -9999 0 -0.17 117 117
mol:GDP 0 0 -9999 0 -10000 0 0
SYK -0.047 0.1 -9999 0 -0.2 130 130
VAV3 -0.055 0.11 -9999 0 -0.21 148 148
MAP3K14 -0.054 0.11 -9999 0 -0.21 145 145
ROCK2 0.019 0.021 -9999 0 -0.12 11 11
SPP1 0.008 0.034 -9999 0 -0.12 31 31
RAC1 0.023 0.002 -9999 0 -10000 0 0
Rac1/GTP -0.05 0.11 -9999 0 -0.2 147 147
MMP2 -0.13 0.16 -9999 0 -0.28 244 244
Endothelins

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.075 0.13 0.27 6 -0.25 165 171
PTK2B 0.022 0.009 -10000 0 -0.12 2 2
mol:Ca2+ -0.041 0.16 -10000 0 -0.5 37 37
EDN1 -0.057 0.11 0.2 6 -0.19 165 171
EDN3 0.02 0.023 -10000 0 -0.12 14 14
EDN2 0.018 0.027 -10000 0 -0.12 20 20
HRAS/GDP -0.068 0.14 0.21 2 -0.31 102 104
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.05 0.11 0.2 3 -0.23 106 109
ADCY4 -0.059 0.11 0.2 6 -0.2 164 170
ADCY5 -0.062 0.11 0.2 5 -0.2 169 174
ADCY6 -0.058 0.11 0.2 6 -0.2 161 167
ADCY7 -0.058 0.11 0.2 6 -0.2 161 167
ADCY1 -0.058 0.11 0.2 6 -0.2 161 167
ADCY2 -0.059 0.11 0.2 6 -0.2 163 169
ADCY3 -0.059 0.11 0.2 6 -0.2 162 168
ADCY8 -0.067 0.11 0.2 4 -0.2 174 178
ADCY9 -0.06 0.11 0.2 6 -0.2 162 168
arachidonic acid secretion -0.13 0.23 -10000 0 -0.45 150 150
ETB receptor/Endothelin-1/Gq/GTP -0.022 0.082 -10000 0 -0.2 57 57
GNAO1 0.01 0.042 -10000 0 -0.12 51 51
HRAS 0.022 0.006 -10000 0 -0.12 1 1
ETA receptor/Endothelin-1/G12/GTP -0.053 0.14 0.32 6 -0.23 149 155
ETA receptor/Endothelin-1/Gs/GTP -0.051 0.13 0.3 6 -0.21 160 166
mol:GTP -0.001 0.006 -10000 0 -10000 0 0
COL3A1 -0.13 0.19 0.28 6 -0.35 200 206
EDNRB -0.012 0.054 -10000 0 -0.089 149 149
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.074 0.14 0.28 6 -0.27 139 145
CYSLTR1 -0.084 0.15 0.28 5 -0.28 149 154
SLC9A1 -0.043 0.088 0.19 6 -0.17 130 136
mol:GDP -0.08 0.15 0.21 2 -0.33 104 106
SLC9A3 -0.059 0.16 -10000 0 -0.47 38 38
RAF1 -0.092 0.18 -10000 0 -0.38 119 119
JUN -0.081 0.27 -10000 0 -0.84 54 54
JAK2 -0.082 0.14 0.27 6 -0.26 172 178
mol:IP3 -0.053 0.12 0.18 2 -0.26 84 86
ETA receptor/Endothelin-1 -0.086 0.17 0.36 6 -0.3 163 169
PLCB1 0.011 0.034 -10000 0 -0.12 32 32
PLCB2 0.019 0.018 -10000 0 -0.12 8 8
ETA receptor/Endothelin-3 -0.02 0.077 0.16 6 -0.13 136 142
FOS -0.17 0.34 -10000 0 -0.85 106 106
Gai/GDP 0.013 0.062 -10000 0 -0.47 3 3
CRK 0.021 0.016 -10000 0 -0.12 7 7
mol:Ca ++ -0.1 0.16 0.27 3 -0.32 156 159
BCAR1 0.023 0.011 -10000 0 -0.12 3 3
PRKCB1 -0.053 0.12 -10000 0 -0.26 87 87
GNAQ 0.019 0.017 -10000 0 -0.12 6 6
GNAZ 0.022 0.011 -10000 0 -0.12 3 3
GNAL 0.021 0.018 -10000 0 -0.12 9 9
Gs family/GDP -0.067 0.14 0.2 2 -0.3 104 106
ETA receptor/Endothelin-1/Gq/GTP -0.043 0.12 0.21 4 -0.24 96 100
MAPK14 -0.028 0.086 -10000 0 -0.2 70 70
TRPC6 -0.043 0.17 -10000 0 -0.52 36 36
GNAI2 0.022 0.011 -10000 0 -0.12 3 3
GNAI3 0.021 0.008 -10000 0 -0.12 1 1
GNAI1 0.012 0.035 -10000 0 -0.12 35 35
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.032 0.09 -10000 0 -0.21 69 69
ETB receptor/Endothelin-2 0.004 0.048 -10000 0 -0.12 36 36
ETB receptor/Endothelin-3 0.007 0.043 -10000 0 -0.11 25 25
ETB receptor/Endothelin-1 -0.05 0.1 0.17 4 -0.19 158 162
MAPK3 -0.16 0.3 -10000 0 -0.74 111 111
MAPK1 -0.16 0.31 -10000 0 -0.75 111 111
Rac1/GDP -0.068 0.14 0.21 2 -0.31 103 105
cAMP biosynthetic process -0.04 0.1 0.21 5 -0.2 104 109
MAPK8 -0.058 0.19 -10000 0 -0.51 69 69
SRC 0.023 0.009 -10000 0 -0.12 2 2
ETB receptor/Endothelin-1/Gi/GTP -0.034 0.095 -10000 0 -0.25 60 60
p130Cas/CRK/Src/PYK2 -0.055 0.15 -10000 0 -0.38 66 66
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.068 0.14 0.21 2 -0.31 102 104
COL1A2 -0.14 0.23 0.28 5 -0.49 148 153
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.023 0.08 0.16 6 -0.13 146 152
mol:DAG -0.053 0.12 0.18 2 -0.26 84 86
MAP2K2 -0.12 0.23 -10000 0 -0.54 117 117
MAP2K1 -0.12 0.23 -10000 0 -0.53 116 116
EDNRA -0.05 0.1 0.2 6 -0.18 174 180
positive regulation of muscle contraction -0.06 0.12 0.24 6 -0.21 161 167
Gq family/GDP -0.046 0.14 -10000 0 -0.3 91 91
HRAS/GTP -0.07 0.14 -10000 0 -0.31 98 98
PRKCH -0.053 0.12 -10000 0 -0.26 89 89
RAC1 0.023 0.002 -10000 0 -10000 0 0
PRKCA -0.058 0.12 -10000 0 -0.26 96 96
PRKCB -0.054 0.11 -10000 0 -0.26 89 89
PRKCE -0.052 0.12 -10000 0 -0.26 87 87
PRKCD -0.056 0.12 -10000 0 -0.26 94 94
PRKCG -0.051 0.12 -10000 0 -0.26 85 85
regulation of vascular smooth muscle contraction -0.21 0.4 -10000 0 -1 106 106
PRKCQ -0.059 0.12 -10000 0 -0.26 93 93
PLA2G4A -0.14 0.25 -10000 0 -0.49 149 149
GNA14 0.018 0.022 -10000 0 -0.12 11 11
GNA15 0.019 0.019 -10000 0 -0.12 8 8
GNA12 0.023 0.001 -10000 0 -10000 0 0
GNA11 0.021 0.015 -10000 0 -0.12 5 5
Rac1/GTP -0.054 0.14 0.32 6 -0.23 151 157
MMP1 0.019 0.14 0.22 6 -0.6 12 18
PDGFR-alpha signaling pathway

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA -0.004 0.046 -10000 0 -0.13 59 59
PDGF/PDGFRA/CRKL -0.009 0.068 -10000 0 -0.13 121 121
positive regulation of JUN kinase activity 0.01 0.068 -10000 0 -0.1 115 115
CRKL 0.023 0.009 -10000 0 -0.12 2 2
PDGF/PDGFRA/Caveolin-3 -0.01 0.068 -10000 0 -0.12 157 157
AP1 -0.15 0.26 -10000 0 -0.66 107 107
mol:IP3 -0.007 0.046 -10000 0 -0.074 139 139
PLCG1 -0.007 0.046 -10000 0 -0.074 139 139
PDGF/PDGFRA/alphaV Integrin -0.037 0.094 -10000 0 -0.15 193 193
RAPGEF1 0.023 0 -10000 0 -10000 0 0
CRK 0.021 0.016 -10000 0 -0.12 7 7
mol:Ca2+ -0.011 0.053 -10000 0 -0.083 150 150
CAV3 0.022 0.011 -10000 0 -0.12 3 3
CAV1 0.012 0.039 -10000 0 -0.12 43 43
SHC/Grb2/SOS1 0.011 0.069 -10000 0 -0.1 115 115
PDGF/PDGFRA/Shf -0.009 0.068 -10000 0 -0.13 122 122
FOS -0.14 0.26 -10000 0 -0.66 107 107
JUN -0.019 0.045 0.26 4 -0.13 35 39
oligodendrocyte development -0.037 0.094 -10000 0 -0.15 193 193
GRB2 0.023 0.006 -10000 0 -0.12 1 1
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
mol:DAG -0.007 0.046 -10000 0 -0.074 139 139
PDGF/PDGFRA -0.004 0.046 -10000 0 -0.13 59 59
actin cytoskeleton reorganization -0.009 0.068 -10000 0 -0.13 122 122
SRF 0.024 0.022 -10000 0 -0.069 23 23
SHC1 0.023 0.001 -10000 0 -10000 0 0
PI3K -0.014 0.084 -10000 0 -0.13 153 153
PDGF/PDGFRA/Crk/C3G 0.007 0.061 -10000 0 -0.11 99 99
JAK1 0.003 0.032 -10000 0 -0.076 61 61
ELK1/SRF -0.011 0.066 -10000 0 -0.13 110 110
SHB 0.023 0.009 -10000 0 -0.12 2 2
SHF 0.023 0.009 -10000 0 -0.12 2 2
CSNK2A1 0.031 0.021 0.066 2 -0.1 6 8
GO:0007205 -0.023 0.072 -10000 0 -0.11 172 172
SOS1 0.017 0.027 -10000 0 -0.12 20 20
Ras protein signal transduction 0.01 0.068 -10000 0 -0.1 115 115
PDGF/PDGFRA/SHB -0.009 0.068 -10000 0 -0.13 122 122
PDGF/PDGFRA/Caveolin-1 -0.02 0.08 -10000 0 -0.13 181 181
ITGAV 0.013 0.032 -10000 0 -0.12 28 28
ELK1 -0.024 0.07 -10000 0 -0.12 146 146
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
PDGF/PDGFRA/Crk -0.01 0.068 -10000 0 -0.13 127 127
JAK-STAT cascade 0.004 0.032 -10000 0 -0.076 61 61
cell proliferation -0.009 0.067 -10000 0 -0.13 122 122
Nectin adhesion pathway

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.01 0.042 -9999 0 -0.12 52 52
alphaV beta3 Integrin -0.018 0.081 -9999 0 -0.16 107 107
PTK2 -0.073 0.15 -9999 0 -0.31 140 140
positive regulation of JNK cascade -0.052 0.11 -9999 0 -0.26 116 116
CDC42/GDP -0.044 0.17 -9999 0 -0.35 116 116
Rac1/GDP -0.043 0.17 -9999 0 -0.35 117 117
RAP1B 0.019 0.02 -9999 0 -0.12 10 10
RAP1A 0.021 0.012 -9999 0 -0.12 3 3
CTNNB1 0.022 0.008 -9999 0 -0.12 1 1
CDC42/GTP -0.044 0.15 -9999 0 -0.32 116 116
nectin-3/I-afadin -0.02 0.08 -9999 0 -0.15 119 119
RAPGEF1 -0.06 0.17 -9999 0 -0.38 115 115
mol:GTP 0 0 -9999 0 -10000 0 0
CRK -0.073 0.19 -9999 0 -0.43 115 115
PDGFB-D/PDGFRB 0.01 0.042 -9999 0 -0.12 52 52
TLN1 -0.037 0.097 -9999 0 -0.16 163 163
Rap1/GTP -0.063 0.12 -9999 0 -0.28 116 116
IQGAP1 0.02 0.017 -9999 0 -0.12 7 7
Rap1/GTP/I-afadin 0.016 0.059 -9999 0 -0.11 85 85
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin -0.02 0.08 -9999 0 -0.15 119 119
PVR 0.022 0.011 -9999 0 -0.12 3 3
Necl-5(dimer) 0.022 0.011 -9999 0 -0.12 3 3
mol:GDP -0.066 0.2 -9999 0 -0.43 116 116
MLLT4 0.014 0.032 -9999 0 -0.12 29 29
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
PI3K -0.009 0.085 -9999 0 -0.11 179 179
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.017 0.048 -9999 0 -0.14 36 36
positive regulation of lamellipodium assembly -0.059 0.12 -9999 0 -0.28 124 124
PVRL1 0.022 0.011 -9999 0 -0.12 3 3
PVRL3 0.003 0.046 -9999 0 -0.12 66 66
PVRL2 0.019 0.023 -9999 0 -0.12 15 15
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
CDH1 0.021 0.016 -9999 0 -0.12 6 6
CLDN1 -0.003 0.051 -9999 0 -0.12 87 87
JAM-A/CLDN1 -0.029 0.087 -9999 0 -0.12 216 216
SRC -0.081 0.21 -9999 0 -0.48 115 115
ITGB3 0.004 0.047 -9999 0 -0.12 68 68
nectin-1(dimer)/I-afadin/I-afadin 0.017 0.048 -9999 0 -0.14 36 36
FARP2 -0.063 0.19 -9999 0 -0.42 116 116
RAC1 0.023 0.002 -9999 0 -10000 0 0
CTNNA1 0.022 0.01 -9999 0 -0.12 2 2
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) -0.003 0.072 -9999 0 -0.12 120 120
nectin-1/I-afadin 0.017 0.048 -9999 0 -0.14 36 36
nectin-2/I-afadin 0.013 0.054 -9999 0 -0.15 43 43
RAC1/GTP/IQGAP1/filamentous actin 0.017 0.044 -9999 0 -0.11 55 55
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin -0.003 0.072 -9999 0 -0.12 119 119
CDC42/GTP/IQGAP1/filamentous actin 0.018 0.043 -9999 0 -0.11 54 54
F11R 0.023 0.007 -9999 0 -0.12 1 1
positive regulation of filopodium formation -0.052 0.11 -9999 0 -0.26 116 116
alphaV/beta3 Integrin/Talin -0.053 0.11 -9999 0 -0.21 150 150
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.013 0.054 -9999 0 -0.15 43 43
nectin-2(dimer)/I-afadin/I-afadin 0.013 0.054 -9999 0 -0.15 43 43
PIP5K1C -0.046 0.1 -9999 0 -0.17 174 174
VAV2 -0.076 0.21 -9999 0 -0.44 126 126
RAP1/GDP -0.044 0.16 -9999 0 -0.33 117 117
ITGAV 0.013 0.032 -9999 0 -0.12 28 28
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin -0.007 0.074 -9999 0 -0.12 128 128
nectin-3(dimer)/I-afadin/I-afadin -0.02 0.08 -9999 0 -0.15 119 119
Rac1/GTP -0.051 0.16 -9999 0 -0.34 124 124
PTPRM -0.056 0.11 -9999 0 -0.2 174 174
E-cadherin/beta catenin/alpha catenin 0.033 0.07 -9999 0 -0.18 25 25
adherens junction assembly 0 0 -9999 0 -10000 0 0
CDC42 0.023 0.002 -9999 0 -10000 0 0
TCGA08_p53

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A 0.007 0.013 -10000 0 -0.077 12 12
TP53 -0.051 0.11 0.18 14 -0.24 126 140
Senescence -0.069 0.12 0.18 14 -0.26 157 171
Apoptosis -0.069 0.12 0.18 14 -0.26 157 171
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 0.002 0.011 0.057 11 -0.084 4 15
MDM4 0.019 0.023 -10000 0 -0.12 14 14
Ephrin B reverse signaling

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 0.007 0.041 -10000 0 -0.12 50 50
EPHB2 0.022 0.021 -10000 0 -0.12 11 11
EFNB1 0.023 0.018 -10000 0 -0.068 19 19
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP 0.045 0.055 -10000 0 -0.15 11 11
Ephrin B2/EPHB1-2 0.011 0.062 -10000 0 -0.1 101 101
neuron projection morphogenesis 0.029 0.046 -10000 0 -0.15 11 11
Ephrin B1/EPHB1-2/Tiam1 0.04 0.056 -10000 0 -0.12 29 29
DNM1 0.022 0.019 -10000 0 -0.12 10 10
cell-cell signaling 0.002 0.004 -10000 0 -10000 0 0
MAP2K4 -0.12 0.21 -10000 0 -0.47 150 150
YES1 -0.19 0.31 -10000 0 -0.71 149 149
Ephrin B1/EPHB1-2/NCK2 0.051 0.043 -10000 0 -0.094 24 24
PI3K -0.13 0.22 -10000 0 -0.47 156 156
mol:GDP 0.038 0.055 -10000 0 -0.11 29 29
ITGA2B 0.023 0.006 -10000 0 -0.12 1 1
endothelial cell proliferation 0.001 0.058 -10000 0 -0.12 89 89
FYN -0.2 0.31 -10000 0 -0.7 154 154
MAP3K7 -0.13 0.22 -10000 0 -0.49 152 152
FGR -0.18 0.31 -10000 0 -0.69 149 149
TIAM1 0.015 0.032 -10000 0 -0.12 28 28
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
RGS3 0.023 0 -10000 0 -10000 0 0
cell adhesion -0.12 0.2 -10000 0 -0.43 160 160
LYN -0.2 0.31 -10000 0 -0.71 149 149
Ephrin B1/EPHB1-2/Src Family Kinases -0.18 0.28 -10000 0 -0.64 149 149
Ephrin B1/EPHB1-2 -0.15 0.24 -10000 0 -0.54 149 149
SRC -0.18 0.31 -10000 0 -0.69 149 149
ITGB3 0.004 0.047 -10000 0 -0.12 68 68
EPHB1 0.018 0.032 -10000 0 -0.12 28 28
EPHB4 0.022 0.009 -10000 0 -0.12 2 2
RAC1 0.023 0.002 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.001 0.058 -10000 0 -0.12 89 89
alphaIIb/beta3 Integrin 0.01 0.053 -10000 0 -0.14 38 38
BLK -0.18 0.31 -10000 0 -0.7 149 149
HCK -0.19 0.31 -10000 0 -0.69 151 151
regulation of stress fiber formation -0.049 0.042 0.093 24 -10000 0 24
MAPK8 -0.12 0.2 -10000 0 -0.44 151 151
Ephrin B1/EPHB1-2/RGS3 0.051 0.043 -10000 0 -0.096 21 21
endothelial cell migration -0.12 0.18 -10000 0 -0.4 160 160
NCK2 0.023 0.006 -10000 0 -0.12 1 1
PTPN13 -0.013 0.058 -10000 0 -0.13 112 112
regulation of focal adhesion formation -0.049 0.042 0.093 24 -10000 0 24
chemotaxis -0.049 0.042 0.095 21 -10000 0 21
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
Rac1/GTP 0.038 0.051 -10000 0 -0.15 11 11
angiogenesis -0.15 0.23 -10000 0 -0.53 149 149
LCK -0.18 0.31 -10000 0 -0.69 149 149
Fc-epsilon receptor I signaling in mast cells

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.02 0.019 -9999 0 -0.12 10 10
LAT2 -0.033 0.11 -9999 0 -0.2 138 138
AP1 -0.068 0.18 -9999 0 -0.38 107 107
mol:PIP3 -0.037 0.14 -9999 0 -0.26 128 128
IKBKB -0.014 0.082 -9999 0 -0.15 125 125
AKT1 -0.025 0.071 -9999 0 -0.14 112 112
IKBKG -0.013 0.082 -9999 0 -0.15 126 126
MS4A2 0.026 0.014 -9999 0 -0.13 3 3
mol:Sphingosine-1-phosphate 0 0 -9999 0 -10000 0 0
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
MAP3K1 -0.038 0.13 -9999 0 -0.28 98 98
mol:Ca2+ -0.026 0.11 -9999 0 -0.2 128 128
LYN 0.02 0.014 -9999 0 -0.12 4 4
CBLB -0.032 0.1 -9999 0 -0.2 131 131
SHC1 0.023 0.001 -9999 0 -10000 0 0
RasGAP/p62DOK -0.005 0.065 -9999 0 -0.1 132 132
positive regulation of cell migration 0.011 0.01 -9999 0 -0.077 7 7
INPP5D 0 0 -9999 0 -10000 0 0
PLD2 -0.008 0.051 -9999 0 -0.092 95 95
PTPN13 -0.088 0.2 -9999 0 -0.44 97 97
PTPN11 0.021 0.013 -9999 0 -0.12 3 3
GO:0007205 0 0 -9999 0 -10000 0 0
regulation of mast cell degranulation -0.035 0.11 -9999 0 -0.22 98 98
SYK 0.016 0.028 -9999 0 -0.12 20 20
GRB2 0.023 0.006 -9999 0 -0.12 1 1
LAT/PLCgamma1/GRB2/SLP76/GADs -0.062 0.12 -9999 0 -0.26 130 130
LAT -0.032 0.1 -9999 0 -0.19 137 137
PAK2 -0.043 0.14 -9999 0 -0.29 107 107
NFATC2 -0.003 0.061 -9999 0 -0.42 10 10
HRAS -0.047 0.15 -9999 0 -0.28 132 132
GAB2 0.007 0.041 -9999 0 -0.12 50 50
PLA2G1B 0.017 0.11 -9999 0 -0.92 8 8
Fc epsilon R1 0.003 0.062 -9999 0 -0.094 129 129
Antigen/IgE/Fc epsilon R1 0.006 0.055 -9999 0 -0.078 135 135
mol:GDP -0.057 0.17 -9999 0 -0.32 131 131
JUN 0.014 0.033 -9999 0 -0.12 30 30
mol:Ca++ 0 0 -9999 0 -10000 0 0
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
FOS -0.005 0.053 -9999 0 -0.12 95 95
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.037 0.11 -9999 0 -0.21 138 138
CHUK -0.017 0.085 -9999 0 -0.16 127 127
KLRG1 -0.015 0.088 -9999 0 -0.18 103 103
VAV1 -0.034 0.11 -9999 0 -0.2 132 132
calcium-dependent protein kinase C activity 0 0 -9999 0 -10000 0 0
CBL -0.032 0.1 -9999 0 -0.19 137 137
negative regulation of mast cell degranulation -0.026 0.086 -9999 0 -0.18 93 93
BTK -0.064 0.19 -9999 0 -0.44 84 84
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.035 0.1 -9999 0 -0.18 158 158
GAB2/PI3K/SHP2 -0.046 0.06 -9999 0 -0.14 117 117
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP 0.002 0.073 -9999 0 -0.23 40 40
RAF1 0.011 0.12 -9999 0 -0.99 8 8
Fc epsilon R1/FcgammaRIIB/SHIP -0.008 0.083 -9999 0 -0.12 182 182
FCER1G 0.002 0.044 -9999 0 -0.12 62 62
FCER1A 0.018 0.028 -9999 0 -0.12 20 20
Antigen/IgE/Fc epsilon R1/Fyn 0.002 0.066 -9999 0 -0.097 109 109
MAPK3 0.015 0.12 -9999 0 -0.93 8 8
MAPK1 0.014 0.12 -9999 0 -0.93 8 8
NFKB1 0.021 0.013 -9999 0 -0.12 4 4
MAPK8 -0.007 0.13 -9999 0 -0.53 26 26
DUSP1 -0.004 0.052 -9999 0 -0.12 90 90
NF-kappa-B/RelA -0.005 0.061 -9999 0 -0.12 94 94
actin cytoskeleton reorganization -0.066 0.2 -9999 0 -0.5 68 68
mol:Glucocorticoid Dexamethasone 0 0 -9999 0 -10000 0 0
PI3K -0.037 0.14 -9999 0 -0.25 137 137
FER -0.032 0.1 -9999 0 -0.2 134 134
RELA 0.023 0.009 -9999 0 -0.12 2 2
ITK -0.004 0.05 -9999 0 -0.25 12 12
SOS1 0.017 0.027 -9999 0 -0.12 20 20
PLCG1 -0.054 0.16 -9999 0 -0.3 133 133
cytokine secretion -0.005 0.044 -9999 0 -0.087 99 99
SPHK1 -0.033 0.1 -9999 0 -0.19 138 138
PTK2 -0.07 0.21 -9999 0 -0.53 68 68
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.062 0.13 -9999 0 -0.26 132 132
EDG1 0.011 0.01 -9999 0 -0.077 7 7
mol:DAG -0.035 0.14 -9999 0 -0.26 126 126
MAP2K2 0.01 0.12 -9999 0 -0.94 8 8
MAP2K1 0.013 0.11 -9999 0 -0.93 8 8
MAP2K7 0.022 0.012 -9999 0 -0.12 4 4
KLRG1/SHP2 -0.014 0.084 -9999 0 -0.17 94 94
MAP2K4 0.012 0.12 -9999 0 -0.84 11 11
Fc epsilon R1/FcgammaRIIB -0.009 0.09 -9999 0 -0.13 182 182
mol:Choline -0.008 0.05 -9999 0 -0.092 95 95
SHC/Grb2/SOS1 -0.011 0.12 -9999 0 -0.19 133 133
FYN 0.011 0.037 -9999 0 -0.12 40 40
DOK1 0.021 0.016 -9999 0 -0.12 7 7
PXN -0.06 0.19 -9999 0 -0.48 68 68
HCLS1 -0.035 0.12 -9999 0 -0.23 117 117
PRKCB -0.026 0.11 -9999 0 -0.2 128 128
FCGR2B 0.004 0.044 -9999 0 -0.12 60 60
IGHE -0.001 0.003 -9999 0 -10000 0 0
KLRG1/SHIP -0.027 0.087 -9999 0 -0.18 93 93
LCP2 0.013 0.033 -9999 0 -0.12 31 31
PLA2G4A -0.045 0.11 -9999 0 -0.22 134 134
RASA1 0.021 0.012 -9999 0 -0.12 3 3
mol:Phosphatidic acid -0.008 0.05 -9999 0 -0.092 95 95
IKK complex -0.006 0.068 -9999 0 -0.14 88 88
WIPF1 0.02 0.02 -9999 0 -0.12 11 11
Thromboxane A2 receptor signaling

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 0.005 0.046 -10000 0 -0.12 65 65
GNB1/GNG2 -0.069 0.081 -10000 0 -0.18 194 194
AKT1 -0.055 0.11 -10000 0 -0.19 195 195
EGF 0.02 0.021 -10000 0 -0.12 12 12
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR 0.026 0.029 -10000 0 -0.11 7 7
mol:Ca2+ -0.096 0.15 -10000 0 -0.29 196 196
LYN 0.024 0.031 -10000 0 -0.13 8 8
RhoA/GTP -0.036 0.069 -10000 0 -0.12 196 196
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK -0.12 0.17 -10000 0 -0.34 194 194
GNG2 0.02 0.018 -10000 0 -0.12 9 9
ARRB2 0.022 0.014 -10000 0 -0.12 5 5
TP alpha/Gq family/GDP/G beta5/gamma2 0.028 0.047 -10000 0 -0.24 12 12
G beta5/gamma2 -0.091 0.11 -10000 0 -0.23 194 194
PRKCH -0.12 0.18 -10000 0 -0.35 196 196
DNM1 0.021 0.019 -10000 0 -0.12 10 10
TXA2/TP beta/beta Arrestin3 0.017 0.014 -10000 0 -10000 0 0
mol:GTP -0.001 0.001 -10000 0 -10000 0 0
PTGDR 0.023 0.006 -10000 0 -0.12 1 1
G12 family/GTP -0.12 0.13 -10000 0 -0.29 196 196
ADRBK1 0.023 0.001 -10000 0 -10000 0 0
ADRBK2 0.015 0.032 -10000 0 -0.12 28 28
RhoA/GTP/ROCK1 0.027 0.021 -10000 0 -0.1 14 14
mol:GDP 0.05 0.12 0.23 91 -10000 0 91
mol:NADP 0.023 0 -10000 0 -10000 0 0
RAB11A 0.023 0.007 -10000 0 -0.12 1 1
PRKG1 0.018 0.026 -10000 0 -0.12 19 19
mol:IP3 -0.12 0.19 -10000 0 -0.36 196 196
cell morphogenesis 0.027 0.021 -10000 0 -0.1 14 14
PLCB2 -0.17 0.25 -10000 0 -0.49 196 196
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK 0.026 0.029 -10000 0 -0.12 6 6
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK 0.024 0.032 -10000 0 -0.14 7 7
RHOA 0.023 0.006 -10000 0 -0.12 1 1
PTGIR 0.023 0.002 -10000 0 -10000 0 0
PRKCB1 -0.13 0.19 -10000 0 -0.37 196 196
GNAQ 0.021 0.016 -10000 0 -0.12 6 6
mol:L-citrulline 0.023 0 -10000 0 -10000 0 0
TXA2/TXA2-R family -0.18 0.26 -10000 0 -0.51 194 194
LCK 0.026 0.029 -10000 0 -0.11 6 6
TXA2/TP beta/beta Arrestin3/RAB11/GDP 0.042 0.026 -10000 0 -0.12 7 7
TXA2-R family/G12 family/GDP/G beta/gamma 0.028 0.061 -10000 0 -0.43 8 8
TXA2/TP beta/beta Arrestin2/RAB11/GDP 0.041 0.028 -10000 0 -0.12 7 7
MAPK14 -0.073 0.12 -10000 0 -0.22 195 195
TGM2/GTP -0.14 0.21 -10000 0 -0.4 200 200
MAPK11 -0.072 0.12 -10000 0 -0.22 194 194
ARHGEF1 -0.053 0.094 -10000 0 -0.17 196 196
GNAI2 0.022 0.011 -10000 0 -0.12 3 3
JNK cascade -0.13 0.19 -10000 0 -0.38 195 195
RAB11/GDP 0.023 0.007 -10000 0 -0.12 1 1
ICAM1 -0.11 0.16 -10000 0 -0.32 195 195
cAMP biosynthetic process -0.11 0.17 -10000 0 -0.33 198 198
Gq family/GTP/EBP50 0.017 0.042 -10000 0 -0.14 29 29
actin cytoskeleton reorganization 0.027 0.021 -10000 0 -0.1 14 14
SRC 0.026 0.029 -10000 0 -0.11 6 6
GNB5 0.023 0.009 -10000 0 -0.12 2 2
GNB1 0.023 0.007 -10000 0 -0.12 1 1
EGF/EGFR 0.018 0.057 -10000 0 -0.13 38 38
VCAM1 -0.12 0.17 -10000 0 -0.34 195 195
TP beta/Gq family/GDP/G beta5/gamma2 0.028 0.047 -10000 0 -0.24 12 12
platelet activation -0.094 0.16 -10000 0 -0.29 195 195
PGI2/IP 0.015 0.017 -10000 0 -0.15 6 6
PRKACA 0.021 0.023 -10000 0 -0.15 8 8
Gq family/GDP/G beta5/gamma2 0.027 0.046 -10000 0 -0.22 12 12
TXA2/TP beta/beta Arrestin2 0.016 0.033 -10000 0 -0.26 5 5
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R 0.021 0.021 -10000 0 -0.14 8 8
mol:DAG -0.14 0.21 -10000 0 -0.41 196 196
EGFR 0.015 0.03 -10000 0 -0.12 25 25
TXA2/TP alpha -0.15 0.23 -10000 0 -0.45 197 197
Gq family/GTP 0.014 0.037 -10000 0 -0.14 25 25
YES1 0.024 0.032 -10000 0 -0.14 8 8
GNAI2/GTP 0.02 0.029 -10000 0 -0.12 6 6
PGD2/DP 0.017 0.004 -10000 0 -0.078 1 1
SLC9A3R1 0.016 0.031 -10000 0 -0.12 26 26
FYN 0.02 0.035 -10000 0 -0.13 13 13
mol:NO 0.023 0 -10000 0 -10000 0 0
GNA15 0.021 0.017 -10000 0 -0.12 8 8
PGK/cGMP 0.028 0.016 -10000 0 -10000 0 0
RhoA/GDP 0.023 0.006 -10000 0 -0.12 1 1
TP alpha/TGM2/GDP/G beta/gamma 0.04 0.045 -10000 0 -0.15 7 7
NOS3 0.023 0 -10000 0 -10000 0 0
RAC1 0.023 0.002 -10000 0 -10000 0 0
PRKCA -0.12 0.18 -10000 0 -0.35 197 197
PRKCB -0.12 0.18 -10000 0 -0.34 196 196
PRKCE -0.12 0.18 -10000 0 -0.36 195 195
PRKCD -0.13 0.19 -10000 0 -0.37 195 195
PRKCG -0.13 0.19 -10000 0 -0.37 196 196
muscle contraction -0.16 0.24 -10000 0 -0.47 195 195
PRKCZ -0.11 0.17 -10000 0 -0.33 195 195
ARR3 0.023 0.006 -10000 0 -0.12 1 1
TXA2/TP beta 0.033 0.035 -10000 0 -0.12 11 11
PRKCQ -0.12 0.18 -10000 0 -0.35 196 196
MAPKKK cascade -0.15 0.22 -10000 0 -0.43 196 196
SELE -0.094 0.15 -10000 0 -0.28 194 194
TP beta/GNAI2/GDP/G beta/gamma 0.052 0.035 -10000 0 -0.2 2 2
ROCK1 0.022 0.009 -10000 0 -0.12 2 2
GNA14 0.02 0.02 -10000 0 -0.12 11 11
chemotaxis -0.21 0.3 -10000 0 -0.6 194 194
GNA12 0.023 0.001 -10000 0 -10000 0 0
GNA13 0.022 0.009 -10000 0 -0.12 2 2
GNA11 0.022 0.014 -10000 0 -0.12 5 5
Rac1/GTP 0.015 0.015 -10000 0 -0.15 5 5
PLK2 and PLK4 events

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 -0.002 0.05 -9999 0 -0.12 81 81
PLK4 0.016 0.028 -9999 0 -0.12 22 22
regulation of centriole replication -0.002 0.047 -9999 0 -0.091 101 101
amb2 Integrin signaling

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.03 0.083 -9999 0 -0.13 180 180
alphaM/beta2 Integrin/GPIbA 0.022 0.059 -9999 0 -0.11 77 77
alphaM/beta2 Integrin/proMMP-9 -0.005 0.081 -9999 0 -0.13 128 128
PLAUR 0.018 0.024 -9999 0 -0.12 15 15
HMGB1 0.023 0.008 -9999 0 -0.041 1 1
alphaM/beta2 Integrin/Talin 0.015 0.069 -9999 0 -0.12 95 95
AGER 0.022 0.017 -9999 0 -0.11 7 7
RAP1A 0.021 0.012 -9999 0 -0.12 3 3
SELPLG 0.02 0.021 -9999 0 -0.12 12 12
mol:LDL 0 0 -9999 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 0.034 0.07 -9999 0 -0.15 22 22
mol:GTP 0 0 -9999 0 -10000 0 0
MMP9 0 0.05 -9999 0 -0.12 81 81
CYR61 0.002 0.047 -9999 0 -0.12 70 70
TLN1 0.021 0.012 -9999 0 -0.12 3 3
Rap1/GTP -0.099 0.15 -9999 0 -0.3 162 162
RHOA 0.023 0.006 -9999 0 -0.12 1 1
P-selectin oligomer 0.018 0.027 -9999 0 -0.12 21 21
MYH2 -0.12 0.15 -9999 0 -0.28 208 208
MST1R 0.017 0.029 -9999 0 -0.12 23 23
leukocyte activation during inflammatory response 0.027 0.052 -9999 0 -0.1 37 37
APOB 0.022 0.011 -9999 0 -0.12 3 3
mol:GDP 0 0 -9999 0 -10000 0 0
complement component iC3b receptor activity 0 0 -9999 0 -10000 0 0
MMP2 -0.015 0.059 -9999 0 -0.12 128 128
JAM3 0.02 0.02 -9999 0 -0.12 11 11
GP1BA 0.022 0.012 -9999 0 -0.12 4 4
alphaM/beta2 Integrin/CTGF 0.003 0.073 -9999 0 -0.12 118 118
alphaM/beta2 Integrin -0.12 0.16 -9999 0 -0.33 157 157
JAM3 homodimer 0.02 0.02 -9999 0 -0.12 11 11
ICAM2 0.017 0.029 -9999 0 -0.12 23 23
ICAM1 0 0.048 -9999 0 -0.12 74 74
phagocytosis triggered by activation of immune response cell surface activating receptor -0.12 0.16 -9999 0 -0.33 157 157
cell adhesion 0.021 0.059 -9999 0 -0.11 77 77
NFKB1 0.021 0.072 -9999 0 -0.25 14 14
THY1 -0.003 0.049 -9999 0 -0.12 79 79
RhoA/GDP 0.016 0.016 -9999 0 -0.14 6 6
Lipoprotein(a) 0.03 0.014 -9999 0 -0.062 12 12
alphaM/beta2 Integrin/LRP/tPA -0.016 0.087 -9999 0 -0.15 94 94
IL6 0.007 0.094 -9999 0 -0.44 10 10
ITGB2 0.013 0.032 -9999 0 -0.098 37 37
elevation of cytosolic calcium ion concentration -0.016 0.1 -9999 0 -0.15 153 153
alphaM/beta2 Integrin/JAM2/JAM3 0.027 0.063 -9999 0 -0.1 83 83
JAM2 0.014 0.035 -9999 0 -0.12 35 35
alphaM/beta2 Integrin/ICAM1 0.004 0.088 -9999 0 -0.17 66 66
alphaM/beta2 Integrin/uPA/Plg -0.006 0.088 -9999 0 -0.14 132 132
RhoA/GTP -0.13 0.16 -9999 0 -0.3 216 216
positive regulation of phagocytosis -0.078 0.14 -9999 0 -0.29 135 135
Ron/MSP 0.027 0.031 -9999 0 -0.088 36 36
alphaM/beta2 Integrin/uPAR/uPA -0.015 0.1 -9999 0 -0.15 153 153
alphaM/beta2 Integrin/uPAR 0.012 0.077 -9999 0 -0.15 88 88
PLAU -0.007 0.055 -9999 0 -0.12 102 102
PLAT -0.001 0.049 -9999 0 -0.12 76 76
actin filament polymerization -0.12 0.14 -9999 0 -0.27 208 208
MST1 0.022 0.012 -9999 0 -0.12 4 4
alphaM/beta2 Integrin/lipoprotein(a) 0.031 0.054 -9999 0 -0.1 37 37
TNF 0.015 0.076 -9999 0 -0.38 5 5
RAP1B 0.019 0.02 -9999 0 -0.12 10 10
alphaM/beta2 Integrin/uPA -0.02 0.091 -9999 0 -0.15 143 143
fibrinolysis -0.007 0.086 -9999 0 -0.14 132 132
HCK 0.019 0.024 -9999 0 -0.12 15 15
dendritic cell antigen processing and presentation -0.12 0.16 -9999 0 -0.33 157 157
VTN 0.023 0.009 -9999 0 -0.12 2 2
alphaM/beta2 Integrin/CYR61 -0.01 0.08 -9999 0 -0.13 144 144
LPA 0.021 0.019 -9999 0 -0.12 10 10
LRP1 0.014 0.032 -9999 0 -0.12 29 29
cell migration -0.044 0.086 -9999 0 -0.13 234 234
FN1 -0.013 0.056 -9999 0 -0.12 114 114
alphaM/beta2 Integrin/Thy1 -0.026 0.085 -9999 0 -0.13 197 197
MPO 0.023 0.009 -9999 0 -0.12 2 2
KNG1 0.022 0.011 -9999 0 -0.12 3 3
RAP1/GDP 0.015 0.05 -9999 0 -0.12 61 61
ROCK1 -0.12 0.15 -9999 0 -0.28 208 208
ELA2 0.022 0.011 -9999 0 -0.12 3 3
PLG 0.023 0.009 -9999 0 -0.12 2 2
CTGF 0.012 0.036 -9999 0 -0.12 37 37
alphaM/beta2 Integrin/Hck 0.017 0.07 -9999 0 -0.14 81 81
ITGAM 0.021 0.019 -9999 0 -0.11 9 9
alphaM/beta2 Integrin/P-Selectin/PSGL1 0.03 0.066 -9999 0 -0.11 80 80
HP -0.035 0.063 -9999 0 -0.12 193 193
leukocyte adhesion -0.009 0.088 -9999 0 -0.18 51 51
SELP 0.018 0.028 -9999 0 -0.12 21 21
TRAIL signaling pathway

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TNFSF10 0.001 0.046 -9999 0 -0.12 67 67
positive regulation of NF-kappaB transcription factor activity -0.021 0.079 -9999 0 -0.12 202 202
MAP2K4 -0.008 0.086 -9999 0 -0.23 34 34
IKBKB 0.022 0.015 -9999 0 -0.12 6 6
TNFRSF10B 0.022 0.014 -9999 0 -0.12 5 5
TNFRSF10A 0.019 0.021 -9999 0 -0.12 12 12
SMPD1 -0.013 0.053 -9999 0 -0.16 9 9
IKBKG 0.023 0.009 -9999 0 -0.12 2 2
mol:GTP 0 0 -9999 0 -10000 0 0
TNFRSF10D 0.019 0.023 -9999 0 -0.12 15 15
TRAIL/TRAILR2 -0.02 0.078 -9999 0 -0.12 197 197
TRAIL/TRAILR3 -0.02 0.075 -9999 0 -0.12 204 204
TRAIL/TRAILR1 -0.025 0.082 -9999 0 -0.12 213 213
TRAIL/TRAILR4 -0.021 0.08 -9999 0 -0.12 202 202
TRAIL/TRAILR1/DAP3/GTP -0.006 0.069 -9999 0 -0.11 142 142
IKK complex 0.006 0.079 -9999 0 -0.28 32 32
RIPK1 0.022 0.011 -9999 0 -0.12 3 3
response to oxidative stress 0 0 -9999 0 -10000 0 0
DAP3/GTP 0.014 0.021 -9999 0 -0.14 10 10
MAPK3 0.006 0.032 -9999 0 -0.074 71 71
MAP3K1 -0.008 0.087 -9999 0 -0.16 121 121
TRAILR4 (trimer) 0.019 0.023 -9999 0 -0.12 15 15
TRADD 0.023 0.006 -9999 0 -0.12 1 1
TRAILR1 (trimer) 0.019 0.021 -9999 0 -0.12 12 12
TRAIL/TRAILR1/FADD/TRADD/RIP/TRAF2 -0.011 0.083 -9999 0 -0.14 138 138
CFLAR 0.022 0.011 -9999 0 -0.12 3 3
MAPK1 0.005 0.034 -9999 0 -0.076 73 73
TRAIL/TRAILR1/FADD/TRADD/RIP 0.015 0.073 -9999 0 -0.094 140 140
mol:ceramide -0.013 0.053 -9999 0 -0.16 9 9
FADD 0.023 0.009 -9999 0 -0.12 2 2
MAPK8 -0.007 0.084 -9999 0 -0.22 40 40
TRAF2 0.023 0 -9999 0 -10000 0 0
TRAILR3 (trimer) 0.019 0.025 -9999 0 -0.12 18 18
CHUK 0.021 0.013 -9999 0 -0.12 4 4
TRAIL/TRAILR1/FADD -0.007 0.074 -9999 0 -0.12 137 137
DAP3 0.023 0.007 -9999 0 -0.12 1 1
CASP10 -0.038 0.098 -9999 0 -0.2 128 128
JNK cascade -0.021 0.079 -9999 0 -0.12 202 202
TRAIL (trimer) 0.001 0.046 -9999 0 -0.12 67 67
TNFRSF10C 0.019 0.026 -9999 0 -0.12 18 18
TRAIL/TRAILR1/DAP3/GTP/FADD 0.004 0.069 -9999 0 -0.098 142 142
TRAIL/TRAILR2/FADD -0.002 0.071 -9999 0 -0.12 129 129
cell death -0.013 0.052 -9999 0 -0.1 129 129
TRAIL/TRAILR2/FADD/TRADD/RIP/TRAF2 -0.007 0.079 -9999 0 -0.14 131 131
TRAILR2 (trimer) 0.022 0.014 -9999 0 -0.12 5 5
CASP8 -0.002 0.11 -9999 0 -0.66 15 15
negative regulation of caspase activity 0 0 -9999 0 -10000 0 0
TRAIL/TRAILR2/FADD/TRADD/RIP 0.019 0.071 -9999 0 -0.091 132 132
Cellular roles of Anthrax toxin

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 0.007 0.043 -10000 0 -0.12 54 54
ANTXR2 0.013 0.036 -10000 0 -0.12 36 36
negative regulation of myeloid dendritic cell antigen processing and presentation -0.007 0.013 -10000 0 -0.034 102 102
monocyte activation -0.1 0.16 -10000 0 -0.35 156 156
MAP2K2 0.006 0.052 -10000 0 -0.66 3 3
MAP2K1 0 0.015 -10000 0 -0.031 80 80
MAP2K7 0 0.014 -10000 0 -0.03 81 81
MAP2K6 -0.005 0.024 -10000 0 -0.065 55 55
CYAA -0.016 0.048 -10000 0 -0.11 102 102
MAP2K4 -0.001 0.016 -10000 0 -0.031 81 81
IL1B -0.009 0.035 -10000 0 -0.075 90 90
Channel -0.003 0.06 -10000 0 -0.12 102 102
NLRP1 -0.001 0.015 -10000 0 -0.032 81 81
CALM1 0.022 0.014 -10000 0 -0.12 5 5
negative regulation of phagocytosis 0.001 0.054 -10000 0 -0.46 7 7
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.007 0.013 0.034 102 -10000 0 102
MAPK3 -0.001 0.015 -10000 0 -0.052 19 19
MAPK1 -0.001 0.019 -10000 0 -0.036 85 85
PGR -0.011 0.027 -10000 0 -0.047 173 173
PA/Cellular Receptors -0.004 0.066 -10000 0 -0.13 102 102
apoptosis -0.007 0.013 -10000 0 -0.034 102 102
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) -0.002 0.058 -10000 0 -0.12 102 102
macrophage activation 0.003 0.018 -10000 0 -0.053 29 29
TNF 0.02 0.02 -10000 0 -0.12 11 11
VCAM1 -0.1 0.16 -10000 0 -0.36 156 156
platelet activation 0.001 0.054 -10000 0 -0.46 7 7
MAPKKK cascade 0.003 0.02 0.048 52 -10000 0 52
IL18 -0.011 0.039 -10000 0 -0.076 110 110
negative regulation of macrophage activation -0.007 0.013 -10000 0 -0.034 102 102
LEF -0.007 0.013 -10000 0 -0.034 102 102
CASP1 -0.005 0.024 -10000 0 -0.05 82 82
mol:cAMP 0.001 0.055 -10000 0 -0.46 7 7
necrosis -0.007 0.013 -10000 0 -0.034 102 102
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) -0.001 0.056 -10000 0 -0.11 102 102
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
Syndecan-4-mediated signaling events

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.11 0.2 -10000 0 -0.37 177 177
Syndecan-4/Syndesmos -0.08 0.18 -10000 0 -0.4 102 102
positive regulation of JNK cascade -0.1 0.18 -10000 0 -0.4 114 114
Syndecan-4/ADAM12 -0.094 0.18 -10000 0 -0.41 104 104
CCL5 0.005 0.044 -10000 0 -0.12 60 60
Rac1/GDP 0.016 0.015 -10000 0 -0.15 5 5
DNM2 0.02 0.022 -10000 0 -0.12 13 13
ITGA5 0.013 0.036 -10000 0 -0.12 38 38
SDCBP 0.021 0.01 -10000 0 -0.12 2 2
PLG 0.027 0.011 0.068 1 -0.1 2 3
ADAM12 -0.01 0.06 -10000 0 -0.12 127 127
mol:GTP 0 0 -10000 0 -10000 0 0
NUDT16L1 0.021 0.019 -10000 0 -0.12 10 10
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
Syndecan-4/PKC alpha -0.008 0.009 -10000 0 -0.041 4 4
Syndecan-4/Laminin alpha1 -0.088 0.18 -10000 0 -0.41 103 103
Syndecan-4/CXCL12/CXCR4 -0.11 0.19 -10000 0 -0.42 114 114
Syndecan-4/Laminin alpha3 -0.094 0.18 -10000 0 -0.42 106 106
MDK 0.021 0.014 -10000 0 -0.12 5 5
Syndecan-4/FZD7 -0.086 0.18 -10000 0 -0.41 102 102
Syndecan-4/Midkine -0.081 0.18 -10000 0 -0.4 102 102
FZD7 0.015 0.031 -10000 0 -0.12 27 27
Syndecan-4/FGFR1/FGF -0.068 0.17 -10000 0 -0.38 103 103
THBS1 -0.004 0.053 -10000 0 -0.12 92 92
integrin-mediated signaling pathway -0.098 0.18 -10000 0 -0.41 105 105
positive regulation of MAPKKK cascade -0.1 0.18 -10000 0 -0.4 114 114
Syndecan-4/TACI -0.079 0.18 -10000 0 -0.4 102 102
CXCR4 0.012 0.032 -10000 0 -0.12 29 29
cell adhesion -0.054 0.096 -10000 0 -0.19 166 166
Syndecan-4/Dynamin -0.081 0.18 -10000 0 -0.41 102 102
Syndecan-4/TSP1 -0.1 0.18 -10000 0 -0.41 110 110
Syndecan-4/GIPC -0.081 0.18 -10000 0 -0.4 102 102
Syndecan-4/RANTES -0.096 0.19 -10000 0 -0.42 105 105
ITGB1 0.021 0.015 -10000 0 -0.12 6 6
LAMA1 0 0.053 -10000 0 -0.12 89 89
LAMA3 0.006 0.043 -10000 0 -0.12 55 55
RAC1 0.023 0.002 -10000 0 -10000 0 0
PRKCA 0.001 0.052 0.079 4 -0.16 40 44
Syndecan-4/alpha-Actinin -0.082 0.18 -10000 0 -0.41 103 103
TFPI 0.018 0.026 -10000 0 -0.12 19 19
F2 0.02 0.016 -10000 0 -0.12 4 4
alpha5/beta1 Integrin 0.016 0.048 -10000 0 -0.14 34 34
positive regulation of cell adhesion -0.097 0.18 -10000 0 -0.4 111 111
ACTN1 0.022 0.011 -10000 0 -0.12 3 3
TNC -0.004 0.053 -10000 0 -0.12 93 93
Syndecan-4/CXCL12 -0.1 0.19 -10000 0 -0.43 103 103
FGF6 0.022 0.012 -10000 0 -0.12 4 4
RHOA 0.023 0.006 -10000 0 -0.12 1 1
CXCL12 -0.003 0.051 -10000 0 -0.12 86 86
TNFRSF13B 0.023 0 -10000 0 -10000 0 0
FGF2 0.023 0.009 -10000 0 -0.12 2 2
FGFR1 0.008 0.043 -10000 0 -0.12 54 54
Syndecan-4/PI-4-5-P2 -0.089 0.17 -10000 0 -0.4 102 102
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.012 0.056 -10000 0 -0.12 114 114
cell migration -0.005 0.005 -10000 0 -10000 0 0
PRKCD 0.023 0.019 -10000 0 -0.12 8 8
vasculogenesis -0.099 0.18 -10000 0 -0.4 110 110
SDC4 -0.09 0.18 -10000 0 -0.43 102 102
Syndecan-4/Tenascin C -0.1 0.18 -10000 0 -0.42 105 105
Syndecan-4/PI-4-5-P2/PKC alpha -0.006 0.007 -10000 0 -10000 0 0
Syndecan-4/Syntenin -0.085 0.18 -10000 0 -0.41 102 102
MMP9 0.001 0.051 -10000 0 -0.12 81 81
Rac1/GTP -0.054 0.098 -10000 0 -0.19 168 168
cytoskeleton organization -0.077 0.17 -10000 0 -0.39 102 102
GIPC1 0.019 0.023 -10000 0 -0.12 15 15
Syndecan-4/TFPI -0.081 0.18 -10000 0 -0.4 102 102
IL4-mediated signaling events

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.16 0.46 -10000 0 -1 88 88
STAT6 (cleaved dimer) -0.25 0.38 -10000 0 -0.94 106 106
IGHG1 -0.031 0.2 -10000 0 -0.41 36 36
IGHG3 -0.16 0.42 -10000 0 -0.93 94 94
AKT1 -0.12 0.34 -10000 0 -0.77 84 84
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.11 0.34 -10000 0 -0.81 77 77
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.13 0.37 -10000 0 -0.86 81 81
THY1 -0.33 0.62 -10000 0 -1.2 170 170
MYB 0.011 0.038 -10000 0 -0.12 41 41
HMGA1 0.012 0.037 -10000 0 -0.12 40 40
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.11 0.33 -10000 0 -0.68 99 99
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.13 0.37 -10000 0 -0.85 82 82
SP1 -0.002 0.049 -10000 0 -0.09 109 109
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.017 0.023 -10000 0 -0.088 3 3
STAT6 (dimer)/ETS1 -0.17 0.45 -10000 0 -0.96 101 101
SOCS1 -0.096 0.32 -10000 0 -0.65 93 93
SOCS3 -0.11 0.34 -10000 0 -0.83 66 66
FCER2 -0.099 0.33 -10000 0 -0.76 49 49
PARP14 0.014 0.032 -10000 0 -0.12 28 28
CCL17 -0.15 0.45 -10000 0 -0.99 85 85
GRB2 0.023 0.006 -10000 0 -0.12 1 1
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.078 0.27 -10000 0 -0.61 71 71
T cell proliferation -0.18 0.47 -10000 0 -1 99 99
IL4R/JAK1 -0.17 0.46 -10000 0 -1 96 96
EGR2 -0.15 0.45 -10000 0 -1 86 86
JAK2 0.014 0.05 -10000 0 -0.14 16 16
JAK3 0.023 0.016 -10000 0 -0.12 5 5
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
JAK1 0.024 0.021 -10000 0 -0.13 2 2
COL1A2 -0.24 0.54 -10000 0 -1.3 112 112
CCL26 -0.16 0.46 -10000 0 -1 91 91
IL4R -0.17 0.49 -10000 0 -1.1 90 90
PTPN6 0.023 0.018 -10000 0 -0.12 2 2
IL13RA2 -0.16 0.45 -10000 0 -1 86 86
IL13RA1 0.015 0.049 -10000 0 -0.13 13 13
IRF4 0.001 0.13 -10000 0 -0.85 2 2
ARG1 -0.001 0.16 -10000 0 -0.72 5 5
CBL -0.1 0.31 -10000 0 -0.64 99 99
GTF3A -0.013 0.055 -10000 0 -0.096 144 144
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
IL13RA1/JAK2 0.004 0.092 -10000 0 -0.16 75 75
IRF4/BCL6 -0.004 0.12 -10000 0 -0.84 2 2
CD40LG 0.031 0.012 -10000 0 -0.12 2 2
MAPK14 -0.11 0.33 -10000 0 -0.68 94 94
mitosis -0.11 0.32 -10000 0 -0.72 84 84
STAT6 -0.18 0.52 -10000 0 -1.1 94 94
SPI1 0.027 0.021 -10000 0 -0.12 12 12
RPS6KB1 -0.1 0.31 -10000 0 -0.69 85 85
STAT6 (dimer) -0.18 0.51 -10000 0 -1.1 94 94
STAT6 (dimer)/PARP14 -0.19 0.47 -10000 0 -1 96 96
mast cell activation 0.001 0.015 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.12 0.36 -10000 0 -0.79 88 88
FRAP1 -0.12 0.34 -10000 0 -0.77 84 84
LTA -0.15 0.45 -10000 0 -0.99 87 87
FES 0.022 0.011 -10000 0 -0.12 3 3
T-helper 1 cell differentiation 0.17 0.5 1.1 94 -10000 0 94
CCL11 -0.18 0.47 -10000 0 -1 98 98
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.12 0.35 -10000 0 -0.78 88 88
IL2RG 0 0.051 -10000 0 -0.12 82 82
IL10 -0.15 0.44 -10000 0 -0.99 86 86
IRS1 0.019 0.023 -10000 0 -0.12 14 14
IRS2 0.021 0.016 -10000 0 -0.12 7 7
IL4 0.003 0.14 -10000 0 -10000 0 0
IL5 -0.15 0.45 -10000 0 -1 79 79
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.14 0.43 -10000 0 -0.89 94 94
COL1A1 -0.3 0.6 -10000 0 -1.3 139 139
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.17 0.47 -10000 0 -1 89 89
IL2R gamma/JAK3 -0.008 0.072 -10000 0 -0.13 116 116
TFF3 -0.17 0.47 -10000 0 -1.1 86 86
ALOX15 -0.15 0.45 -10000 0 -0.99 85 85
MYBL1 0.017 0.028 -10000 0 -0.12 22 22
T-helper 2 cell differentiation -0.15 0.42 -10000 0 -0.88 99 99
SHC1 0.023 0.001 -10000 0 -10000 0 0
CEBPB 0.023 0.032 -10000 0 -0.12 29 29
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.12 0.37 -10000 0 -0.84 82 82
mol:PI-3-4-5-P3 -0.12 0.34 -10000 0 -0.77 84 84
PI3K -0.13 0.37 -10000 0 -0.84 84 84
DOK2 0.02 0.021 -10000 0 -0.12 12 12
ETS1 0.012 0.036 -10000 0 -0.12 27 27
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.074 0.26 -10000 0 -0.6 71 71
ITGB3 -0.2 0.51 -10000 0 -1.1 98 98
PIGR -0.18 0.46 -10000 0 -1 89 89
IGHE 0.001 0.06 0.16 18 -0.16 11 29
MAPKKK cascade -0.072 0.26 -10000 0 -0.59 71 71
BCL6 0.018 0.02 -10000 0 -0.12 10 10
OPRM1 -0.15 0.45 -10000 0 -0.99 85 85
RETNLB -0.15 0.45 -10000 0 -0.99 86 86
SELP -0.16 0.45 -10000 0 -0.99 86 86
AICDA -0.15 0.43 -10000 0 -0.96 86 86
Noncanonical Wnt signaling pathway

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0.02 0.019 -9999 0 -0.12 10 10
GNB1/GNG2 -0.012 0.11 -9999 0 -0.23 68 68
mol:DAG -0.018 0.095 -9999 0 -0.21 76 76
PLCG1 -0.019 0.097 -9999 0 -0.21 76 76
YES1 -0.029 0.1 -9999 0 -0.17 153 153
FZD3 0.013 0.032 -9999 0 -0.12 29 29
FZD6 0.017 0.023 -9999 0 -0.12 13 13
G protein -0.009 0.1 -9999 0 -0.22 68 68
MAP3K7 -0.014 0.084 -9999 0 -0.18 82 82
mol:Ca2+ -0.017 0.093 -9999 0 -0.2 76 76
mol:IP3 -0.018 0.095 -9999 0 -0.21 76 76
NLK 0.026 0.045 -9999 0 -0.98 1 1
GNB1 0.023 0.007 -9999 0 -0.12 1 1
CAMK2A -0.015 0.087 -9999 0 -0.19 76 76
MAP3K7IP1 0.023 0 -9999 0 -10000 0 0
Noncanonical Wnts/FZD -0.033 0.1 -9999 0 -0.18 162 162
CSNK1A1 0.022 0.007 -9999 0 -0.12 1 1
GNAS -0.028 0.098 -9999 0 -0.16 162 162
GO:0007205 -0.021 0.093 -9999 0 -0.21 76 76
WNT6 0.022 0.011 -9999 0 -0.12 3 3
WNT4 0.022 0.011 -9999 0 -0.12 3 3
NFAT1/CK1 alpha -0.01 0.11 -9999 0 -0.22 82 82
GNG2 0.02 0.018 -9999 0 -0.12 9 9
WNT5A 0.014 0.031 -9999 0 -0.12 27 27
WNT11 0.002 0.051 -9999 0 -0.12 82 82
CDC42 -0.025 0.096 -9999 0 -0.16 153 153
BARD1 signaling events

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BARD1/CSTF1 0.016 0.052 -10000 0 -0.12 70 70
ATM 0.018 0.022 -10000 0 -0.12 13 13
UBE2D3 0.023 0.001 -10000 0 -10000 0 0
PRKDC 0.021 0.015 -10000 0 -0.12 6 6
ATR 0.02 0.015 -10000 0 -0.12 5 5
UBE2L3 0.022 0.012 -10000 0 -0.12 4 4
FANCD2 -0.008 0.096 -10000 0 -0.24 69 69
protein ubiquitination -0.016 0.086 -10000 0 -0.11 211 211
XRCC5 0.021 0.01 -10000 0 -0.12 2 2
XRCC6 0.022 0.004 -10000 0 -10000 0 0
M/R/N Complex 0.023 0.065 -10000 0 -0.14 64 64
MRE11A 0.02 0.017 -10000 0 -0.12 7 7
DNA-PK 0.026 0.06 -10000 0 -0.14 60 60
FA complex/FANCD2/Ubiquitin 0.01 0.093 -10000 0 -0.32 27 27
FANCF 0.022 0.011 -10000 0 -0.12 3 3
BRCA1 0.015 0.03 -10000 0 -0.12 24 24
CCNE1 0.002 0.047 -10000 0 -0.12 70 70
CDK2/Cyclin E1 -0.016 0.075 -10000 0 -0.12 190 190
FANCG 0.021 0.016 -10000 0 -0.12 7 7
BRCA1/BACH1/BARD1 -0.001 0.071 -10000 0 -0.13 125 125
FANCE 0.023 0 -10000 0 -10000 0 0
FANCC 0.022 0.014 -10000 0 -0.12 5 5
NBN 0.02 0.015 -10000 0 -0.12 5 5
FANCA 0.021 0.019 -10000 0 -0.12 10 10
DNA repair -0.014 0.11 -10000 0 -0.3 45 45
BRCA1/BARD1/ubiquitin -0.001 0.071 -10000 0 -0.13 125 125
BARD1/DNA-PK 0.027 0.076 -10000 0 -0.14 80 80
FANCL 0.018 0.023 -10000 0 -0.12 14 14
mRNA polyadenylation -0.015 0.052 0.12 70 -10000 0 70
BRCA1/BARD1/CTIP/M/R/N Complex -0.035 0.14 -10000 0 -0.33 73 73
BRCA1/BACH1/BARD1/TopBP1 0.008 0.072 -10000 0 -0.13 104 104
BRCA1/BARD1/P53 -0.026 0.092 -10000 0 -0.12 252 252
BARD1/CSTF1/BRCA1 0.013 0.065 -10000 0 -0.12 94 94
BRCA1/BACH1 0.015 0.03 -10000 0 -0.12 24 24
BARD1 0.016 0.029 -10000 0 -0.12 23 23
PCNA 0.019 0.018 -10000 0 -0.12 8 8
BRCA1/BARD1/UbcH5C 0.015 0.063 -10000 0 -0.12 88 88
BRCA1/BARD1/UbcH7 0.013 0.065 -10000 0 -0.12 93 93
BRCA1/BARD1/RAD51/PCNA 0 0.085 -10000 0 -0.12 155 155
BARD1/DNA-PK/P53 -0.008 0.096 -10000 0 -0.2 59 59
BRCA1/BARD1/Ubiquitin -0.001 0.071 -10000 0 -0.13 125 125
BRCA1/BARD1/CTIP -0.011 0.083 -10000 0 -0.13 157 157
FA complex 0.018 0.074 -10000 0 -0.32 17 17
BARD1/EWS 0.018 0.049 -10000 0 -0.12 63 63
RBBP8 0.011 0.029 -10000 0 -0.077 47 47
TP53 0.011 0.029 -10000 0 -0.12 22 22
TOPBP1 0.021 0.016 -10000 0 -0.12 6 6
G1/S transition of mitotic cell cycle 0.027 0.091 0.12 252 -10000 0 252
BRCA1/BARD1 -0.013 0.09 -10000 0 -0.11 211 211
CSTF1 0.023 0.007 -10000 0 -0.12 1 1
BARD1/EWS-Fli1 0.002 0.045 -10000 0 -0.12 62 62
CDK2 0.018 0.023 -10000 0 -0.12 14 14
UniProt:Q9BZD1 0 0 -10000 0 -10000 0 0
RAD51 0.015 0.03 -10000 0 -0.12 25 25
RAD50 0.021 0.014 -10000 0 -0.12 5 5
BRCA1/BARD1/DNA-directed RNA polymerase II holoenzyme -0.001 0.071 -10000 0 -0.13 125 125
EWSR1 0.023 0.001 -10000 0 -10000 0 0
IL1-mediated signaling events

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.014 0.022 -10000 0 -0.14 11 11
PRKCZ 0.023 0 -10000 0 -10000 0 0
MAP3K7IP2 0.02 0.016 -10000 0 -0.12 6 6
ERC1 0.016 0.029 -10000 0 -0.12 24 24
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.063 0.15 -10000 0 -0.29 128 128
IRAK/TOLLIP 0.028 0.026 -10000 0 -0.1 15 15
IKBKB 0.022 0.015 -10000 0 -0.12 6 6
IKBKG 0.023 0.009 -10000 0 -0.12 2 2
IL1 alpha/IL1R2 0.014 0.048 -10000 0 -0.15 23 23
IL1A 0.017 0.029 -10000 0 -0.12 24 24
IL1B 0.002 0.039 -10000 0 -0.085 82 82
IRAK/TRAF6/p62/Atypical PKCs 0.036 0.059 -10000 0 -0.16 17 17
IL1R2 0.007 0.045 -10000 0 -0.12 62 62
IL1R1 0.003 0.046 -10000 0 -0.12 66 66
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.063 0.15 0.16 1 -0.28 137 138
TOLLIP 0.022 0.011 -10000 0 -0.12 3 3
TICAM2 0.021 0.014 -10000 0 -0.12 5 5
MAP3K3 0.023 0 -10000 0 -10000 0 0
TAK1/TAB1/TAB2 0.033 0.051 -10000 0 -0.14 37 37
IKK complex/ELKS 0.024 0.092 -10000 0 -0.24 50 50
JUN 0.011 0.048 -10000 0 -0.16 31 31
MAP3K7 0.021 0.014 -10000 0 -0.12 5 5
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.051 0.12 -10000 0 -0.21 142 142
IL1 alpha/IL1R1/IL1RAP/MYD88 -0.001 0.077 -10000 0 -0.11 134 134
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 -0.003 0.087 -10000 0 -0.12 162 162
IL1 beta fragment/IL1R1/IL1RAP -0.056 0.1 -10000 0 -0.15 243 243
NFKB1 0.021 0.013 -10000 0 -0.12 4 4
MAPK8 0.013 0.051 -10000 0 -0.16 32 32
IRAK1 0.016 0.023 -10000 0 -0.087 23 23
IL1RN/IL1R1 -0.007 0.07 -10000 0 -0.15 89 89
IRAK4 0.019 0.02 -10000 0 -0.12 10 10
PRKCI 0.016 0.028 -10000 0 -0.12 22 22
TRAF6 0.022 0.009 -10000 0 -0.12 2 2
PI3K 0.007 0.065 -10000 0 -0.13 96 96
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.074 0.15 -10000 0 -0.3 138 138
CHUK 0.021 0.013 -10000 0 -0.12 4 4
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.056 0.1 -10000 0 -0.15 243 243
IL1 beta/IL1R2 -0.036 0.089 -10000 0 -0.15 181 181
IRAK/TRAF6/TAK1/TAB1/TAB2 0.045 0.057 -10000 0 -0.19 18 18
NF kappa B1 p50/RelA -0.05 0.11 -10000 0 -0.2 149 149
IRAK3 0.009 0.042 -10000 0 -0.12 52 52
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.05 0.12 -10000 0 -0.22 129 129
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.03 0.11 -10000 0 -0.18 154 154
IL1 alpha/IL1R1/IL1RAP -0.014 0.078 -10000 0 -0.13 131 131
RELA 0.023 0.009 -10000 0 -0.12 2 2
MAP3K7IP1 0.023 0 -10000 0 -10000 0 0
SQSTM1 0.021 0.014 -10000 0 -0.12 5 5
MYD88 0.023 0.006 -10000 0 -0.12 1 1
IRAK/TRAF6/MEKK3 0.039 0.031 -10000 0 -0.095 23 23
IL1RAP 0.009 0.039 -10000 0 -0.12 44 44
UBE2N 0.023 0.007 -10000 0 -0.12 1 1
IRAK/TRAF6 -0.046 0.098 -10000 0 -0.19 140 140
CASP1 0.006 0.04 -10000 0 -0.12 48 48
IL1RN/IL1R2 0.011 0.053 -10000 0 -0.15 33 33
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.045 0.1 -10000 0 -0.14 243 243
TMEM189-UBE2V1 0 0 -10000 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.037 0.13 -10000 0 -0.27 106 106
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
IL1RN 0.019 0.024 -10000 0 -0.12 16 16
TRAF6/TAK1/TAB1/TAB2 0.041 0.054 -10000 0 -0.12 46 46
MAP2K6 0.014 0.051 -10000 0 -0.13 48 48
Nongenotropic Androgen signaling

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.01 0.009 -10000 0 -0.078 6 6
GNB1/GNG2 0.012 0.058 -10000 0 -0.1 94 94
regulation of S phase of mitotic cell cycle -0.018 0.085 -10000 0 -0.16 130 130
GNAO1 0.01 0.042 -10000 0 -0.12 51 51
HRAS 0.022 0.006 -10000 0 -0.12 1 1
SHBG/T-DHT 0.015 0.005 -10000 0 -0.062 2 2
PELP1 0.022 0.009 -10000 0 -0.12 2 2
AKT1 0.01 0.012 -10000 0 -0.077 10 10
MAP2K1 -0.013 0.061 -10000 0 -0.11 113 113
T-DHT/AR -0.013 0.059 -10000 0 -0.12 120 120
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.002 0.003 -10000 0 -0.007 103 103
GNAI2 0.022 0.011 -10000 0 -0.12 3 3
GNAI3 0.021 0.008 -10000 0 -0.12 1 1
GNAI1 0.012 0.035 -10000 0 -0.12 35 35
mol:GDP -0.047 0.096 -10000 0 -0.25 92 92
cell proliferation -0.063 0.16 -10000 0 -0.37 107 107
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
FOS -0.13 0.29 -10000 0 -0.7 107 107
mol:Ca2+ -0.008 0.022 -10000 0 -0.045 107 107
MAPK3 -0.042 0.11 -10000 0 -0.25 110 110
MAPK1 -0.032 0.1 -10000 0 -0.24 63 63
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
mol:IP3 -0.001 0.002 -10000 0 -0.004 103 103
cAMP biosynthetic process 0.01 0.015 0.058 17 -10000 0 17
GNG2 0.02 0.018 -10000 0 -0.12 9 9
potassium channel inhibitor activity -0.001 0.002 -10000 0 -0.004 103 103
HRAS/GTP 0.006 0.054 -10000 0 -0.092 86 86
actin cytoskeleton reorganization 0.016 0.047 -10000 0 -0.099 66 66
SRC 0.022 0.009 -10000 0 -0.13 2 2
voltage-gated calcium channel activity -0.001 0.002 -10000 0 -0.004 103 103
PI3K 0.008 0.055 -10000 0 -0.1 96 96
apoptosis 0.066 0.17 0.38 112 -10000 0 112
T-DHT/AR/PELP1 0.002 0.053 -10000 0 -0.11 87 87
HRAS/GDP -0.027 0.1 -10000 0 -0.23 94 94
CREB1 -0.072 0.18 -10000 0 -0.41 112 112
RAC1-CDC42/GTP 0.023 0.051 -10000 0 -0.1 66 66
AR 0.008 0.039 -10000 0 -0.12 43 43
GNB1 0.023 0.007 -10000 0 -0.12 1 1
RAF1 -0.008 0.053 -10000 0 -0.13 32 32
RAC1-CDC42/GDP -0.014 0.1 -10000 0 -0.22 95 95
T-DHT/AR/PELP1/Src 0.014 0.053 -10000 0 -0.098 85 85
MAP2K2 -0.015 0.062 -10000 0 -0.12 115 115
T-DHT/AR/PELP1/Src/PI3K -0.018 0.086 -10000 0 -0.16 130 130
GNAZ 0.022 0.011 -10000 0 -0.12 3 3
SHBG 0.023 0.009 -10000 0 -0.12 2 2
Gi family/GNB1/GNG2/GDP 0.002 0.076 -10000 0 -0.22 38 38
mol:T-DHT -0.001 0.001 -10000 0 -0.003 81 81
RAC1 0.023 0.002 -10000 0 -10000 0 0
GNRH1 0.011 0.009 -10000 0 -0.077 6 6
Gi family/GTP -0.018 0.07 -10000 0 -0.15 90 90
CDC42 0.023 0.002 -10000 0 -10000 0 0
IL23-mediated signaling events

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.27 0.57 -9999 0 -1.2 126 126
IL23A -0.2 0.5 -9999 0 -1.2 85 85
NF kappa B1 p50/RelA/I kappa B alpha -0.19 0.49 -9999 0 -1.1 92 92
positive regulation of T cell mediated cytotoxicity -0.22 0.56 -9999 0 -1.3 91 91
ITGA3 -0.24 0.54 -9999 0 -1.2 121 121
IL17F -0.11 0.32 -9999 0 -0.7 91 91
IL12B 0.016 0.04 -9999 0 -10000 0 0
STAT1 (dimer) -0.22 0.53 -9999 0 -1.3 93 93
CD4 -0.21 0.52 -9999 0 -1.2 101 101
IL23 -0.18 0.48 -9999 0 -1.2 85 85
IL23R 0.002 0.089 -9999 0 -10000 0 0
IL1B -0.22 0.54 -9999 0 -1.3 94 94
T-helper cell lineage commitment 0 0 -9999 0 -10000 0 0
IL24 -0.18 0.46 -9999 0 -1.1 86 86
TYK2 0.013 0.034 -9999 0 -0.14 7 7
STAT4 0.02 0.02 -9999 0 -0.12 11 11
STAT3 0.022 0.011 -9999 0 -0.12 3 3
IL18RAP 0.022 0.018 -9999 0 -0.13 8 8
IL12RB1 0.015 0.03 -9999 0 -0.15 1 1
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
IL12Rbeta1/TYK2 0.021 0.04 -9999 0 -0.11 8 8
IL23R/JAK2 -0.001 0.12 -9999 0 -10000 0 0
positive regulation of chronic inflammatory response -0.22 0.56 -9999 0 -1.3 91 91
natural killer cell activation 0 0.008 -9999 0 -10000 0 0
JAK2 0.012 0.046 -9999 0 -0.13 16 16
PIK3R1 0.016 0.031 -9999 0 -0.12 27 27
NFKB1 0.021 0.013 -9999 0 -0.12 4 4
RELA 0.022 0.01 -9999 0 -0.12 2 2
positive regulation of dendritic cell antigen processing and presentation -0.17 0.45 -9999 0 -1.1 85 85
ALOX12B -0.18 0.46 -9999 0 -1.1 87 87
CXCL1 -0.23 0.52 -9999 0 -1.1 117 117
T cell proliferation -0.22 0.56 -9999 0 -1.3 91 91
NFKBIA 0.016 0.028 -9999 0 -0.12 21 21
IL17A -0.073 0.26 -9999 0 -0.55 84 84
PI3K -0.2 0.5 -9999 0 -1.2 94 94
IFNG -0.005 0.026 -9999 0 -10000 0 0
STAT3 (dimer) -0.18 0.48 -9999 0 -1.1 92 92
IL18R1 0.021 0.022 -9999 0 -0.12 13 13
IL23/IL23R/JAK2/TYK2/SOCS3 -0.086 0.28 -9999 0 -0.62 80 80
IL18/IL18R 0.015 0.061 -9999 0 -0.11 78 78
macrophage activation -0.009 0.021 -9999 0 -0.045 78 78
TNF -0.19 0.5 -9999 0 -1.2 81 81
STAT3/STAT4 -0.19 0.51 -9999 0 -1.2 93 93
STAT4 (dimer) -0.21 0.53 -9999 0 -1.2 91 91
IL18 0.004 0.046 -9999 0 -0.12 66 66
IL19 -0.18 0.47 -9999 0 -1.1 88 88
STAT5A (dimer) -0.21 0.53 -9999 0 -1.2 92 92
STAT1 0.014 0.031 -9999 0 -0.12 26 26
SOCS3 0.015 0.032 -9999 0 -0.12 28 28
CXCL9 -0.26 0.55 -9999 0 -1.2 128 128
MPO -0.18 0.46 -9999 0 -1.1 86 86
positive regulation of humoral immune response -0.22 0.56 -9999 0 -1.3 91 91
IL23/IL23R/JAK2/TYK2 -0.24 0.61 -9999 0 -1.4 91 91
IL6 -0.2 0.48 -9999 0 -1.2 88 88
STAT5A 0.022 0.013 -9999 0 -0.12 4 4
IL2 0.025 0.014 -9999 0 -0.13 3 3
positive regulation of tyrosine phosphorylation of STAT protein 0 0.008 -9999 0 -10000 0 0
CD3E -0.2 0.5 -9999 0 -1.2 92 92
keratinocyte proliferation -0.22 0.56 -9999 0 -1.3 91 91
NOS2 -0.18 0.46 -9999 0 -1.1 91 91
IL6-mediated signaling events

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.072 0.32 -10000 0 -0.77 71 71
CRP -0.063 0.3 -10000 0 -0.73 67 67
cell cycle arrest -0.09 0.36 -10000 0 -0.79 85 85
TIMP1 -0.11 0.35 -10000 0 -0.75 105 105
IL6ST 0.016 0.03 -10000 0 -0.084 33 33
Rac1/GDP -0.019 0.17 -10000 0 -0.36 77 77
AP1 -0.06 0.21 -10000 0 -0.47 93 93
GAB2 0.01 0.042 -10000 0 -0.12 50 50
TNFSF11 -0.063 0.3 -10000 0 -0.74 65 65
HSP90B1 0.007 0.18 -10000 0 -1.2 11 11
GAB1 0.022 0.022 -10000 0 -0.12 12 12
MAPK14 -0.031 0.17 -10000 0 -0.47 55 55
AKT1 -0.018 0.15 -10000 0 -0.39 53 53
FOXO1 -0.015 0.15 -10000 0 -0.38 49 49
MAP2K6 -0.03 0.16 -10000 0 -0.37 75 75
mol:GTP 0 0.003 -10000 0 -10000 0 0
MAP2K4 -0.028 0.2 -10000 0 -0.4 92 92
MITF -0.02 0.15 -10000 0 -0.34 74 74
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.021 0.016 -10000 0 -0.12 7 7
A2M -0.12 0.39 -10000 0 -1.2 63 63
CEBPB 0.023 0.036 -10000 0 -0.11 36 36
GRB2/SOS1/GAB family/SHP2 -0.03 0.18 0.25 5 -0.38 87 92
STAT3 -0.1 0.38 -10000 0 -0.86 85 85
STAT1 -0.088 0.28 -10000 0 -0.84 68 68
CEBPD -0.071 0.31 -10000 0 -0.74 71 71
PIK3CA 0.021 0.017 -10000 0 -0.12 7 7
PI3K 0.009 0.066 -10000 0 -0.14 81 81
JUN 0.014 0.033 -10000 0 -0.12 30 30
PIAS3/MITF -0.014 0.15 -10000 0 -0.32 73 73
MAPK11 -0.03 0.17 -10000 0 -0.46 55 55
STAT3 (dimer)/FOXO1 -0.086 0.34 -10000 0 -0.69 99 99
GRB2/SOS1/GAB family 0.003 0.12 0.22 6 -0.25 65 71
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.01 0.12 -10000 0 -0.27 74 74
GRB2 0.025 0.008 -10000 0 -0.12 1 1
JAK2 0.017 0.025 -10000 0 -0.12 16 16
LBP -0.038 0.25 -10000 0 -0.57 66 66
PIK3R1 0.016 0.031 -10000 0 -0.12 27 27
JAK1 0.022 0.015 -10000 0 -0.042 19 19
MYC -0.12 0.4 -10000 0 -0.88 106 106
FGG -0.063 0.3 -10000 0 -0.72 69 69
macrophage differentiation -0.09 0.36 -10000 0 -0.79 85 85
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 0.013 0.094 -10000 0 -0.16 92 92
JUNB -0.11 0.37 -10000 0 -0.86 89 89
FOS -0.005 0.053 -10000 0 -0.12 95 95
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.023 0.16 -10000 0 -0.36 73 73
STAT1/PIAS1 -0.031 0.18 -10000 0 -0.35 94 94
GRB2/SOS1/GAB family/SHP2/PI3K -0.024 0.16 -10000 0 -0.32 86 86
STAT3 (dimer) -0.099 0.38 -10000 0 -0.84 85 85
PRKCD -0.044 0.26 -10000 0 -0.51 95 95
IL6R 0.018 0.025 -10000 0 -0.082 24 24
SOCS3 -0.047 0.22 -10000 0 -0.9 29 29
gp130 (dimer)/JAK1/JAK1/LMO4 0.02 0.08 -10000 0 -0.15 80 80
Rac1/GTP -0.024 0.18 -10000 0 -0.39 79 79
HCK 0.019 0.024 -10000 0 -0.12 15 15
MAPKKK cascade -0.049 0.22 -10000 0 -0.5 94 94
bone resorption -0.057 0.29 -10000 0 -0.69 65 65
IRF1 -0.12 0.41 -10000 0 -0.96 93 93
mol:GDP -0.025 0.16 -10000 0 -0.36 77 77
SOS1 0.019 0.028 -10000 0 -0.12 20 20
VAV1 -0.025 0.16 -10000 0 -0.36 77 77
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.03 0.18 -10000 0 -0.46 68 68
PTPN11 -0.007 0.16 -10000 0 -0.83 19 19
IL6/IL6RA 0.007 0.063 -10000 0 -0.14 64 64
gp130 (dimer)/TYK2/TYK2/LMO4 0.025 0.061 -10000 0 -0.12 65 65
gp130 (dimer)/JAK2/JAK2/LMO4 0.014 0.076 -10000 0 -0.14 88 88
IL6 0.005 0.049 -10000 0 -0.1 88 88
PIAS3 0.02 0.022 -10000 0 -0.12 13 13
PTPRE 0.022 0.018 0.08 18 -10000 0 18
PIAS1 0.022 0.009 -10000 0 -0.12 2 2
RAC1 0.023 0.003 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.013 0.097 -10000 0 -0.22 73 73
LMO4 0.021 0.023 -10000 0 -0.084 14 14
STAT3 (dimer)/PIAS3 -0.087 0.35 -10000 0 -0.78 84 84
MCL1 -0.014 0.16 -10000 0 -0.71 14 14
Integrins in angiogenesis

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.019 0.049 -9999 0 -0.15 38 38
alphaV beta3 Integrin -0.001 0.073 -9999 0 -0.13 107 107
PTK2 -0.029 0.13 -9999 0 -0.3 71 71
IGF1R 0.013 0.032 -9999 0 -0.12 28 28
PI4KB 0.022 0.014 -9999 0 -0.12 5 5
MFGE8 0.006 0.043 -9999 0 -0.12 56 56
SRC 0.023 0.009 -9999 0 -0.12 2 2
CDKN1B -0.006 0.085 -9999 0 -0.34 28 28
VEGFA 0.019 0.021 -9999 0 -0.12 11 11
ILK 0.013 0.04 -9999 0 -0.31 3 3
ROCK1 0.022 0.009 -9999 0 -0.12 2 2
AKT1 0.014 0.038 -9999 0 -0.28 3 3
PTK2B -0.011 0.063 -9999 0 -0.11 139 139
alphaV/beta3 Integrin/JAM-A 0.014 0.068 -9999 0 -0.1 114 114
CBL 0.023 0.006 -9999 0 -0.12 1 1
mol:GTP 0 0 -9999 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 -0.001 0.073 -9999 0 -0.13 107 107
IGF-1R heterotetramer/IGF1/IRS1/Shp2 0.013 0.07 -9999 0 -0.11 107 107
VEGF/Rho/ROCK/alphaV/beta3 Integrin -0.011 0.095 -9999 0 -0.25 51 51
alphaV/beta3 Integrin/Syndecan-1 -0.003 0.074 -9999 0 -0.13 113 113
PI4KA 0.021 0.016 -9999 0 -0.12 7 7
IGF-1R heterotetramer/IGF1/IRS1 -0.055 0.086 -9999 0 -0.16 152 152
PI4 Kinase 0.028 0.032 -9999 0 -0.12 24 24
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
alphaV/beta3 Integrin/Osteopontin -0.03 0.098 -9999 0 -0.16 164 164
RPS6KB1 -0.056 0.082 -9999 0 -0.16 163 163
TLN1 0.021 0.012 -9999 0 -0.12 3 3
MAPK3 -0.054 0.14 -9999 0 -0.34 102 102
GPR124 0.022 0.011 -9999 0 -0.12 3 3
MAPK1 -0.055 0.14 -9999 0 -0.34 102 102
PXN 0.022 0.014 -9999 0 -0.12 5 5
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
alphaV/beta3 Integrin/Tumstatin -0.001 0.073 -9999 0 -0.13 107 107
cell adhesion -0.03 0.097 -9999 0 -0.18 117 117
ANGPTL3 0.022 0.011 -9999 0 -0.12 3 3
VEGFR2 homodimer/VEGFA homodimer/Src 0.033 0.044 -9999 0 -0.11 38 38
IGF-1R heterotetramer 0.013 0.032 -9999 0 -0.12 28 28
Rac1/GDP 0.016 0.015 -9999 0 -0.15 5 5
TGFBR2 0.02 0.02 -9999 0 -0.12 11 11
ITGB3 0.004 0.047 -9999 0 -0.12 68 68
IGF1 0.007 0.045 -9999 0 -0.12 60 60
RAC1 0.023 0.002 -9999 0 -10000 0 0
regulation of cell-matrix adhesion -0.001 0.073 -9999 0 -0.13 107 107
apoptosis 0.013 0.032 -9999 0 -0.12 28 28
CD47 0.021 0.012 -9999 0 -0.12 3 3
alphaV/beta3 Integrin/CD47 -0.009 0.084 -9999 0 -0.14 124 124
VCL 0.021 0.013 -9999 0 -0.12 4 4
alphaV/beta3 Integrin/Del1 -0.03 0.083 -9999 0 -0.14 161 161
CSF1 0.013 0.033 -9999 0 -0.12 31 31
PIK3C2A -0.012 0.1 -9999 0 -0.36 41 41
PI4 Kinase/Pyk2 0.001 0.059 -9999 0 -0.14 49 49
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.001 0.079 -9999 0 -0.12 139 139
FAK1/Vinculin -0.016 0.12 -9999 0 -0.25 72 72
alphaV beta3/Integrin/ppsTEM5 -0.001 0.073 -9999 0 -0.13 107 107
RHOA 0.023 0.006 -9999 0 -0.12 1 1
VTN 0.023 0.009 -9999 0 -0.12 2 2
BCAR1 0.022 0.011 -9999 0 -0.12 3 3
FGF2 0.023 0.009 -9999 0 -0.12 2 2
F11R 0.022 0.012 -9999 0 -0.12 3 3
alphaV/beta3 Integrin/Lactadherin -0.028 0.088 -9999 0 -0.14 170 170
alphaV/beta3 Integrin/TGFBR2 -0.006 0.079 -9999 0 -0.14 112 112
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.015 0.075 -9999 0 -0.12 112 112
HSP90AA1 0.023 0.003 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Talin -0.005 0.074 -9999 0 -0.12 124 124
mol:GDP 0 0 -9999 0 -10000 0 0
FN1 -0.013 0.056 -9999 0 -0.12 114 114
alphaV/beta3 Integrin/Pyk2 0 0.072 -9999 0 -0.16 49 49
SDC1 0.021 0.018 -9999 0 -0.12 9 9
VAV3 -0.012 0.074 -9999 0 -0.14 118 118
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
IRS1 0.019 0.023 -9999 0 -0.12 14 14
FAK1/Paxillin -0.014 0.11 -9999 0 -0.25 66 66
cell migration -0.011 0.11 -9999 0 -0.23 71 71
ITGAV 0.013 0.032 -9999 0 -0.12 28 28
PI3K 0.006 0.083 -9999 0 -0.17 61 61
SPP1 0.012 0.032 -9999 0 -0.12 28 28
KDR 0.021 0.019 -9999 0 -0.12 10 10
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.013 0.032 -9999 0 -0.12 28 28
COL4A3 0.023 0.009 -9999 0 -0.12 2 2
angiogenesis -0.056 0.16 -9999 0 -0.37 102 102
Rac1/GTP -0.007 0.075 -9999 0 -0.18 54 54
EDIL3 -0.007 0.057 -9999 0 -0.12 109 109
cell proliferation -0.006 0.079 -9999 0 -0.14 112 112
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MET/RANBP9 -0.018 0.078 -10000 0 -0.15 124 124
CRKL -0.026 0.11 -10000 0 -0.34 32 32
mol:PIP3 -0.002 0.049 0.22 24 -10000 0 24
AKT1 0.004 0.039 0.17 23 -0.1 10 33
PTK2B 0.023 0.009 -10000 0 -0.12 2 2
RAPGEF1 -0.021 0.1 -10000 0 -0.32 31 31
RANBP10 0.023 0.009 -10000 0 -0.12 2 2
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
HGF/MET/SHIP2 -0.002 0.069 -10000 0 -0.11 122 122
MAP3K5 -0.014 0.1 -10000 0 -0.3 37 37
HGF/MET/CIN85/CBL/ENDOPHILINS 0.011 0.067 -10000 0 -0.097 126 126
AP1 -0.04 0.075 -10000 0 -0.14 166 166
mol:SU11274 0 0 -10000 0 -10000 0 0
SHC1 0.023 0.001 -10000 0 -10000 0 0
apoptosis -0.17 0.32 -10000 0 -0.75 124 124
STAT3 (dimer) -0.022 0.099 -10000 0 -0.28 38 38
GAB1/CRKL/SHP2/PI3K -0.015 0.12 -10000 0 -0.29 53 53
INPP5D 0 0 -10000 0 -10000 0 0
CBL/CRK -0.014 0.11 -10000 0 -0.31 33 33
PTPN11 0.022 0.011 -10000 0 -0.12 3 3
GO:0007205 0 0 -10000 0 -10000 0 0
PLCG1 0.019 0.024 -10000 0 -0.12 16 16
PTEN 0.022 0.008 -10000 0 -0.12 1 1
ELK1 -0.021 0.058 0.25 12 -10000 0 12
mol:SU5416 0 0 -10000 0 -10000 0 0
SHP2/GRB2/SOS1GAB1 -0.016 0.082 -10000 0 -0.2 56 56
PAK1 0.002 0.042 0.16 22 -0.1 18 40
HGF/MET/RANBP10 0 0.067 -10000 0 -0.11 118 118
HRAS -0.084 0.21 -10000 0 -0.48 122 122
DOCK1 -0.026 0.11 -10000 0 -0.31 41 41
GAB1 -0.031 0.11 -10000 0 -0.34 34 34
CRK -0.026 0.11 -10000 0 -0.33 33 33
mol:PHA665752 0 0 -10000 0 -10000 0 0
mol:GDP -0.073 0.19 -10000 0 -0.42 122 122
JUN 0.014 0.033 -10000 0 -0.12 30 30
EntrezGene:200958 0 0 -10000 0 -10000 0 0
HGF/MET -0.028 0.077 -10000 0 -0.17 119 119
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
cell morphogenesis -0.028 0.12 -10000 0 -0.27 67 67
GRB2/SHC -0.006 0.078 -10000 0 -0.14 125 125
FOS -0.005 0.053 -10000 0 -0.12 95 95
GLMN 0.004 0.013 0.076 7 -0.049 17 24
cell motility -0.021 0.058 0.25 12 -10000 0 12
HGF/MET/MUC20 -0.011 0.062 -10000 0 -0.12 118 118
cell migration -0.006 0.077 -10000 0 -0.14 125 125
GRB2 0.023 0.006 -10000 0 -0.12 1 1
CBL 0.023 0.006 -10000 0 -0.12 1 1
MET/RANBP10 -0.015 0.074 -10000 0 -0.12 187 187
HGF/MET/Paxillin/FAK1/FAK12/RasGAP -0.02 0.092 -10000 0 -0.27 30 30
MET/MUC20 -0.028 0.068 -10000 0 -0.12 186 186
RAP1B -0.019 0.1 -10000 0 -0.3 35 35
RAP1A -0.019 0.1 -10000 0 -0.3 37 37
HGF/MET/RANBP9 -0.003 0.071 -10000 0 -0.12 126 126
RAF1 -0.077 0.2 -10000 0 -0.46 122 122
STAT3 -0.02 0.098 -10000 0 -0.3 31 31
cell proliferation -0.036 0.13 -10000 0 -0.26 123 123
RPS6KB1 -0.018 0.077 -10000 0 -0.27 36 36
MAPK3 -0.025 0.075 0.69 5 -10000 0 5
MAPK1 -0.021 0.092 0.7 8 -10000 0 8
RANBP9 0.021 0.014 -10000 0 -0.12 5 5
MAPK8 -0.015 0.12 -10000 0 -0.35 46 46
SRC -0.016 0.086 -10000 0 -0.25 30 30
PI3K -0.022 0.092 -10000 0 -0.16 128 128
MET/Glomulin -0.003 0.05 -10000 0 -0.097 95 95
SOS1 0.017 0.027 -10000 0 -0.12 20 20
MAP2K1 -0.068 0.19 -10000 0 -0.42 122 122
MET 0 0.047 -10000 0 -0.12 70 70
MAP4K1 -0.014 0.1 -10000 0 -0.33 28 28
PTK2 0.021 0.016 -10000 0 -0.12 6 6
MAP2K2 -0.07 0.19 -10000 0 -0.43 122 122
BAD 0.008 0.037 0.16 23 -0.096 10 33
MAP2K4 -0.011 0.097 -10000 0 -0.26 41 41
SHP2/GRB2/SOS1/GAB1 -0.029 0.12 -10000 0 -0.23 128 128
INPPL1 0.021 0.017 -10000 0 -0.12 8 8
PXN 0.022 0.014 -10000 0 -0.12 5 5
SH3KBP1 0.02 0.019 -10000 0 -0.12 10 10
HGS -0.022 0.071 -10000 0 -0.15 119 119
PLCgamma1/PKC 0.012 0.026 -10000 0 -0.1 26 26
HGF 0.02 0.023 -10000 0 -0.12 14 14
RASA1 0.021 0.012 -10000 0 -0.12 3 3
NCK1 0.02 0.019 -10000 0 -0.12 9 9
PTPRJ 0.02 0.019 -10000 0 -0.12 9 9
NCK/PLCgamma1 -0.014 0.085 -10000 0 -0.15 131 131
PDPK1 0.001 0.043 0.19 24 -0.11 9 33
HGF/MET/SHIP -0.011 0.062 -10000 0 -0.12 118 118
a4b1 and a4b7 Integrin signaling

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ITGB1 0.021 0.015 -9999 0 -0.12 6 6
ITGB7 0.019 0.024 -9999 0 -0.12 15 15
ITGA4 0.015 0.03 -9999 0 -0.12 24 24
alpha4/beta7 Integrin 0.004 0.065 -9999 0 -0.13 106 106
alpha4/beta1 Integrin 0.006 0.063 -9999 0 -0.12 101 101
Caspase cascade in apoptosis

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 0.004 0.11 0.16 17 -0.24 59 76
ACTA1 0.023 0.073 0.15 59 -0.19 21 80
NUMA1 0.001 0.11 0.16 16 -0.25 66 82
SPTAN1 0.019 0.077 0.15 60 -0.18 28 88
LIMK1 0.025 0.072 0.15 62 -0.19 19 81
BIRC3 -0.005 0.053 -10000 0 -0.12 94 94
BIRC2 0.021 0.013 -10000 0 -0.12 4 4
BAX 0.023 0 -10000 0 -10000 0 0
CASP10 0.005 0.036 -10000 0 -0.072 89 89
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
PTK2 -0.008 0.14 0.15 30 -0.3 72 102
DIABLO 0.02 0.016 -10000 0 -0.12 6 6
apoptotic nuclear changes 0.019 0.076 0.15 60 -0.18 28 88
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.023 0.009 -10000 0 -0.12 2 2
GSN 0.021 0.074 0.15 57 -0.19 23 80
MADD 0.023 0.006 -10000 0 -0.12 1 1
TFAP2A -0.03 0.15 -10000 0 -0.48 48 48
BID 0.01 0.037 -10000 0 -0.22 5 5
MAP3K1 0.009 0.08 -10000 0 -0.36 20 20
TRADD 0.023 0.006 -10000 0 -0.12 1 1
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.025 0.041 -10000 0 -0.13 33 33
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB 0.006 0.076 0.14 36 -0.2 29 65
CASP9 0.021 0.014 -10000 0 -0.12 5 5
DNA repair -0.023 0.074 0.26 22 -0.13 74 96
neuron apoptosis -0.026 0.16 -10000 0 -0.58 39 39
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis 0.01 0.1 0.17 34 -0.22 52 86
APAF1 0.021 0.014 -10000 0 -0.12 5 5
CASP6 -0.055 0.25 -10000 0 -0.78 58 58
TRAF2 0.023 0 -10000 0 -10000 0 0
ICAD/CAD 0.028 0.069 0.15 60 -0.21 13 73
CASP7 0.044 0.077 0.19 104 -0.2 5 109
KRT18 -0.014 0.12 -10000 0 -0.56 22 22
apoptosis -0.006 0.13 0.18 30 -0.31 59 89
DFFA 0.025 0.072 0.15 60 -0.19 18 78
DFFB 0.025 0.072 0.15 62 -0.19 19 81
PARP1 0.024 0.074 0.13 74 -0.26 22 96
actin filament polymerization -0.025 0.069 0.18 18 -0.15 60 78
TNF 0.02 0.02 -10000 0 -0.12 11 11
CYCS -0.005 0.049 -10000 0 -0.19 25 25
SATB1 -0.064 0.24 -10000 0 -0.75 59 59
SLK 0.018 0.077 0.15 60 -0.18 25 85
p15 BID/BAX 0.016 0.044 -10000 0 -0.1 34 34
CASP2 0.008 0.066 -10000 0 -0.23 18 18
JNK cascade -0.009 0.079 0.36 20 -10000 0 20
CASP3 0.023 0.077 0.16 62 -0.2 19 81
LMNB2 -0.002 0.099 -10000 0 -0.26 62 62
RIPK1 0.022 0.011 -10000 0 -0.12 3 3
CASP4 0.015 0.029 -10000 0 -0.12 23 23
Mammalian IAPs/DIABLO -0.019 0.084 -10000 0 -0.13 157 157
negative regulation of DNA binding -0.03 0.15 -10000 0 -0.47 48 48
stress fiber formation 0.018 0.076 0.15 60 -0.18 25 85
GZMB 0.005 0.045 -10000 0 -0.1 79 79
CASP1 -0.064 0.14 -10000 0 -0.28 148 148
LMNB1 -0.028 0.14 -10000 0 -0.28 103 103
APP -0.026 0.16 -10000 0 -0.59 39 39
TNFRSF1A 0.021 0.016 -10000 0 -0.12 7 7
response to stress 0 0 -10000 0 -10000 0 0
CASP8 0.011 0.002 -10000 0 -10000 0 0
VIM -0.003 0.13 0.18 31 -0.31 59 90
LMNA -0.008 0.11 -10000 0 -0.27 71 71
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD 0.006 0.07 -10000 0 -0.23 21 21
LRDD 0.022 0.015 -10000 0 -0.12 6 6
SREBF1 0.024 0.074 0.15 62 -0.19 20 82
APAF-1/Caspase 9 0.027 0.11 0.26 16 -0.75 8 24
nuclear fragmentation during apoptosis 0.001 0.11 0.16 16 -0.24 66 82
CFL2 0.025 0.07 0.15 60 -0.18 18 78
GAS2 0.023 0.072 0.15 61 -0.19 20 81
positive regulation of apoptosis -0.014 0.12 -10000 0 -0.3 66 66
PRF1 0.013 0.036 -10000 0 -0.12 37 37
IFN-gamma pathway

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.007 0.08 -10000 0 -0.13 107 107
positive regulation of NF-kappaB transcription factor activity 0 0.001 -10000 0 -10000 0 0
CRKL 0.023 0.009 -10000 0 -0.12 2 2
STAT1 (dimer)/Cbp/p300 -0.019 0.13 -10000 0 -0.22 123 123
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.007 0.081 -10000 0 -0.15 100 100
antigen processing and presentation of peptide antigen via MHC class I -0.053 0.093 -10000 0 -0.2 131 131
CaM/Ca2+ 0.01 0.077 -10000 0 -0.15 72 72
RAP1A 0.021 0.012 -10000 0 -0.12 3 3
STAT1 (dimer)/SHP2 -0.018 0.093 -10000 0 -0.18 96 96
AKT1 -0.014 0.081 -10000 0 -0.18 85 85
MAP2K1 -0.007 0.068 -10000 0 -0.15 76 76
MAP3K11 -0.007 0.067 -10000 0 -0.15 72 72
IFNGR1 0.016 0.026 -10000 0 -0.12 17 17
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII 0.014 0.082 -10000 0 -0.28 28 28
Rap1/GTP -0.023 0.056 -10000 0 -0.17 54 54
CRKL/C3G 0.034 0.01 -10000 0 -0.14 1 1
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP 0.023 0.079 -10000 0 -0.13 83 83
CEBPB -0.014 0.15 -10000 0 -0.41 52 52
STAT3 0.022 0.011 -10000 0 -0.12 3 3
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 0.018 0.11 -10000 0 -0.99 3 3
STAT1 -0.019 0.087 -10000 0 -0.19 83 83
CALM1 0.022 0.014 -10000 0 -0.12 5 5
IFN-gamma (dimer) 0.01 0.039 -10000 0 -0.12 42 42
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
STAT1 (dimer)/PIAS1 -0.015 0.091 -10000 0 -0.18 95 95
CEBPB/PTGES2/Cbp/p300 -0.036 0.11 -10000 0 -0.3 63 63
mol:Ca2+ 0.005 0.078 -10000 0 -0.13 102 102
MAPK3 -0.009 0.11 -10000 0 -0.53 13 13
STAT1 (dimer) -0.041 0.15 -10000 0 -0.28 129 129
MAPK1 -0.013 0.13 -10000 0 -0.59 16 16
JAK2 0.016 0.026 -10000 0 -0.13 16 16
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
JAK1 0.02 0.012 -10000 0 -0.12 2 2
CAMK2D 0.018 0.024 -10000 0 -0.12 16 16
DAPK1 -0.015 0.16 -10000 0 -0.5 45 45
SMAD7 -0.009 0.064 -10000 0 -0.13 88 88
CBL/CRKL/C3G 0.017 0.068 -10000 0 -0.15 46 46
PI3K -0.004 0.092 -10000 0 -0.18 91 91
IFNG 0.01 0.039 -10000 0 -0.12 42 42
apoptosis -0.018 0.13 0.22 1 -0.39 47 48
CAMK2G 0.023 0.006 -10000 0 -0.12 1 1
STAT3 (dimer) 0.022 0.011 -10000 0 -0.12 3 3
CAMK2A 0.023 0.006 -10000 0 -0.12 1 1
CAMK2B 0.023 0.009 -10000 0 -0.12 2 2
FRAP1 -0.012 0.077 -10000 0 -0.17 81 81
PRKCD -0.016 0.086 -10000 0 -0.19 88 88
RAP1B 0.019 0.02 -10000 0 -0.12 10 10
negative regulation of cell growth -0.053 0.093 -10000 0 -0.2 131 131
PTPN2 0.023 0.007 -10000 0 -0.12 1 1
EP300 0.022 0.01 -10000 0 -0.12 2 2
IRF1 -0.038 0.13 -10000 0 -0.28 102 102
STAT1 (dimer)/PIASy -0.015 0.089 0.19 3 -0.18 85 88
SOCS1 0.007 0.096 -10000 0 -1.2 3 3
mol:GDP 0.015 0.065 -10000 0 -0.15 46 46
CASP1 -0.031 0.095 -10000 0 -0.18 143 143
PTGES2 0.023 0.009 -10000 0 -0.12 2 2
IRF9 0.004 0.071 -10000 0 -0.15 72 72
mol:PI-3-4-5-P3 -0.013 0.085 -10000 0 -0.18 91 91
RAP1/GDP 0.006 0.073 -10000 0 -0.18 52 52
CBL -0.006 0.066 -10000 0 -0.14 78 78
MAP3K1 -0.008 0.071 -10000 0 -0.16 76 76
PIAS1 0.022 0.009 -10000 0 -0.12 2 2
PIAS4 0.023 0.001 -10000 0 -10000 0 0
antigen processing and presentation of peptide antigen via MHC class II -0.053 0.093 -10000 0 -0.2 131 131
PTPN11 -0.01 0.067 -10000 0 -0.13 102 102
CREBBP 0.02 0.016 -10000 0 -0.12 6 6
RAPGEF1 0.023 0 -10000 0 -10000 0 0
IGF1 pathway

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0.023 0.006 -10000 0 -0.12 1 1
PTK2 0.021 0.016 -10000 0 -0.12 6 6
CRKL -0.005 0.054 -10000 0 -0.12 91 91
GRB2/SOS1/SHC 0.035 0.041 -10000 0 -0.12 30 30
HRAS 0.023 0.006 -10000 0 -0.12 1 1
IRS1/Crk -0.001 0.057 -10000 0 -0.12 88 88
IGF-1R heterotetramer/IGF1/PTP1B 0.008 0.062 -10000 0 -0.12 89 89
AKT1 -0.01 0.06 -10000 0 -0.11 108 108
BAD -0.007 0.057 -10000 0 -0.1 108 108
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.005 0.054 -10000 0 -0.12 91 91
IGF-1R heterotetramer/IGF1/IRS1/Shp2 -0.003 0.062 -10000 0 -0.12 102 102
RAF1 -0.004 0.092 -10000 0 -0.5 11 11
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos 0.01 0.07 -10000 0 -0.12 88 88
YWHAZ 0.023 0.003 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.004 0.063 -10000 0 -0.13 91 91
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
RPS6KB1 -0.011 0.063 -10000 0 -0.12 110 110
GNB2L1 0.023 0.003 -10000 0 -10000 0 0
positive regulation of MAPKKK cascade -0.007 0.079 0.2 6 -0.4 11 17
PXN 0.022 0.014 -10000 0 -0.12 5 5
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0.021 0.045 -10000 0 -0.15 29 29
HRAS/GTP -0.002 0.052 -10000 0 -0.15 24 24
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc 0.022 0.068 -10000 0 -0.15 22 22
IGF-1R heterotetramer 0.012 0.033 -10000 0 -0.12 29 29
IGF-1R heterotetramer/IGF1/IRS/Nck 0.008 0.062 -10000 0 -0.12 91 91
Crk/p130 Cas/Paxillin 0.021 0.06 -10000 0 -0.099 86 86
IGF1R 0.012 0.033 -10000 0 -0.12 29 29
IGF1 0.001 0.047 -10000 0 -0.12 62 62
IRS2/Crk 0.004 0.054 -10000 0 -0.11 86 86
PI3K 0 0.076 -10000 0 -0.12 141 141
apoptosis -0.003 0.057 0.12 57 -10000 0 57
HRAS/GDP 0.017 0.008 -10000 0 -0.11 2 2
PRKCD -0.015 0.093 -10000 0 -0.26 39 39
RAF1/14-3-3 E 0.007 0.084 -10000 0 -0.43 11 11
BAD/14-3-3 0.003 0.06 -10000 0 -0.12 57 57
PRKCZ -0.009 0.059 -10000 0 -0.11 107 107
Crk/p130 Cas/Paxillin/FAK1 0.004 0.069 -10000 0 -0.15 55 55
PTPN1 0.023 0.006 -10000 0 -0.12 1 1
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 -0.016 0.095 -10000 0 -0.21 89 89
BCAR1 0.022 0.011 -10000 0 -0.12 3 3
IGF-1R heterotetramer/IGF1/SHC/GRB10 0.019 0.061 -10000 0 -0.13 21 21
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0.017 0.027 -10000 0 -0.12 20 20
IRS1/NCK2 0.002 0.058 -10000 0 -0.12 91 91
GRB10 0.022 0.014 -10000 0 -0.12 5 5
PTPN11 -0.006 0.057 -10000 0 -0.12 92 92
IRS1 -0.011 0.058 -10000 0 -0.13 91 91
IRS2 -0.005 0.054 -10000 0 -0.12 92 92
IGF-1R heterotetramer/IGF1 -0.012 0.076 -10000 0 -0.16 91 91
GRB2 0.023 0.006 -10000 0 -0.12 1 1
PDPK1 -0.011 0.064 -10000 0 -0.12 107 107
YWHAE 0.022 0.014 -10000 0 -0.12 5 5
PRKD1 -0.021 0.097 -10000 0 -0.26 51 51
SHC1 0.023 0.001 -10000 0 -10000 0 0
Signaling events mediated by the Hedgehog family

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 -0.083 0.19 -10000 0 -0.4 135 135
IHH -0.002 0.048 -10000 0 -0.076 141 141
SHH Np/Cholesterol/GAS1 0.023 0.028 -10000 0 -0.098 16 16
LRPAP1 0.018 0.024 -10000 0 -0.12 15 15
dorsoventral neural tube patterning -0.022 0.028 0.097 16 -10000 0 16
SMO/beta Arrestin2 -0.01 0.11 -10000 0 -0.27 12 12
SMO -0.018 0.11 -10000 0 -0.3 9 9
AKT1 -0.017 0.11 -10000 0 -0.33 40 40
ARRB2 0.022 0.014 -10000 0 -0.12 5 5
BOC 0.011 0.039 -10000 0 -0.12 44 44
ADRBK1 0.023 0.001 -10000 0 -10000 0 0
heart looping -0.018 0.11 -10000 0 -0.3 9 9
STIL -0.016 0.082 -10000 0 -0.15 135 135
DHH N/PTCH2 0.034 0.011 -10000 0 -0.09 4 4
DHH N/PTCH1 -0.019 0.099 -10000 0 -0.18 135 135
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
DHH 0.022 0.011 -10000 0 -0.12 3 3
PTHLH -0.072 0.18 -10000 0 -0.38 135 135
determination of left/right symmetry -0.018 0.11 -10000 0 -0.3 9 9
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
skeletal system development -0.072 0.18 -10000 0 -0.37 135 135
IHH N/Hhip 0.016 0.039 -10000 0 -0.098 27 27
DHH N/Hhip 0.029 0.024 -10000 0 -0.14 1 1
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.018 0.11 -10000 0 -0.3 9 9
pancreas development 0.017 0.029 -10000 0 -0.12 24 24
HHAT 0.022 0.011 -10000 0 -0.12 3 3
PI3K 0.007 0.065 -10000 0 -0.13 96 96
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 0.014 0.035 -10000 0 -0.12 35 35
somite specification -0.018 0.11 -10000 0 -0.3 9 9
SHH Np/Cholesterol/PTCH1 -0.013 0.087 -10000 0 -0.15 135 135
SHH Np/Cholesterol/PTCH2 0.03 0.012 -10000 0 -0.1 3 3
SHH Np/Cholesterol/Megalin 0.007 0.039 -10000 0 -0.098 20 20
SHH 0.022 0.011 -10000 0 -0.086 5 5
catabolic process -0.033 0.11 -10000 0 -0.21 135 135
SMO/Vitamin D3 -0.01 0.097 -10000 0 -0.24 9 9
SHH Np/Cholesterol/Hhip 0.027 0.019 -10000 0 -0.099 3 3
LRP2 -0.016 0.064 -10000 0 -0.12 148 148
receptor-mediated endocytosis -0.02 0.098 -10000 0 -0.21 57 57
SHH Np/Cholesterol/BOC 0.02 0.033 -10000 0 -0.1 23 23
SHH Np/Cholesterol/CDO 0.018 0.036 -10000 0 -0.098 36 36
mesenchymal cell differentiation -0.027 0.019 0.099 3 -10000 0 3
mol:Vitamin D3 -0.011 0.088 -10000 0 -0.15 135 135
IHH N/PTCH2 0.021 0.032 -10000 0 -0.13 4 4
CDON 0.013 0.035 -10000 0 -0.12 35 35
IHH N/PTCH1 -0.028 0.11 -10000 0 -0.21 135 135
Megalin/LRPAP1 -0.011 0.065 -10000 0 -0.093 200 200
PTCH2 0.023 0.009 -10000 0 -0.12 2 2
SHH Np/Cholesterol 0.018 0.009 -10000 0 -0.068 6 6
PTCH1 -0.033 0.11 -10000 0 -0.21 135 135
HHIP 0.017 0.029 -10000 0 -0.12 24 24
PLK1 signaling events

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion 0.012 0.057 0.18 50 -10000 0 50
BUB1B -0.028 0.1 -10000 0 -0.23 87 87
PLK1 -0.009 0.049 -10000 0 -0.1 93 93
PLK1S1 -0.003 0.022 -10000 0 -0.05 78 78
KIF2A -0.006 0.047 -10000 0 -0.11 72 72
regulation of mitotic centrosome separation -0.009 0.048 -10000 0 -0.1 93 93
GOLGA2 0.023 0.006 -10000 0 -0.12 1 1
Hec1/SPC24 -0.015 0.088 -10000 0 -0.15 134 134
WEE1 -0.014 0.076 -10000 0 -0.23 34 34
cytokinesis -0.053 0.14 -10000 0 -0.29 125 125
PP2A-alpha B56 -0.036 0.24 -10000 0 -0.7 61 61
AURKA -0.025 0.09 -10000 0 -0.26 70 70
PICH/PLK1 -0.024 0.1 -10000 0 -0.18 138 138
CENPE -0.005 0.046 -10000 0 -0.11 70 70
RhoA/GTP 0.016 0.016 -10000 0 -0.14 6 6
positive regulation of microtubule depolymerization -0.006 0.047 -10000 0 -0.11 72 72
PPP2CA 0.023 0.003 -10000 0 -10000 0 0
FZR1 0.023 0 -10000 0 -10000 0 0
TPX2 -0.034 0.099 -10000 0 -0.26 90 90
PAK1 0.016 0.029 -10000 0 -0.12 23 23
SPC24 0.016 0.029 -10000 0 -0.12 24 24
FBXW11 0.023 0.003 -10000 0 -10000 0 0
CLSPN 0 0.035 -10000 0 -0.16 9 9
GORASP1 0.023 0.006 -10000 0 -0.12 1 1
metaphase -0.001 0.004 -10000 0 -0.014 31 31
mol:GTP 0 0 -10000 0 -10000 0 0
NLP -0.003 0.022 -10000 0 -0.05 78 78
G2 phase of mitotic cell cycle -0.001 0.003 -10000 0 -0.009 51 51
STAG2 0.02 0.02 -10000 0 -0.12 10 10
GRASP65/GM130/RAB1/GTP 0.017 0.031 -10000 0 -10000 0 0
spindle elongation -0.009 0.048 -10000 0 -0.1 93 93
ODF2 0.021 0.014 -10000 0 -0.12 5 5
BUB1 -0.063 0.25 -10000 0 -0.77 61 61
TPT1 0.001 0.035 -10000 0 -0.16 17 17
CDC25C -0.016 0.096 -10000 0 -0.39 32 32
CDC25B 0.015 0.025 -10000 0 -0.13 14 14
SGOL1 -0.012 0.057 -10000 0 -0.19 50 50
RHOA 0.023 0.006 -10000 0 -0.12 1 1
CCNB1/CDK1 -0.028 0.13 -10000 0 -0.24 134 134
CDC14B 0.011 0.004 -10000 0 -0.085 1 1
CDC20 0.016 0.027 -10000 0 -0.12 19 19
PLK1/PBIP1 -0.003 0.042 -10000 0 -0.096 72 72
mitosis 0.003 0.009 0.025 67 -0.011 1 68
FBXO5 -0.019 0.07 -10000 0 -0.17 78 78
CDC2 0.007 0.04 -10000 0 -0.12 46 46
NDC80 0.008 0.038 -10000 0 -0.12 43 43
metaphase plate congression 0 0.042 -10000 0 -0.17 19 19
ERCC6L -0.033 0.12 -10000 0 -0.23 132 132
NLP/gamma Tubulin -0.002 0.029 -10000 0 -0.088 39 39
microtubule cytoskeleton organization 0.001 0.035 -10000 0 -0.16 17 17
G2/M transition DNA damage checkpoint 0 0.002 0.01 16 -10000 0 16
PPP1R12A 0.022 0.008 -10000 0 -0.12 1 1
interphase 0 0.002 0.01 16 -10000 0 16
PLK1/PRC1-2 -0.015 0.095 -10000 0 -0.17 122 122
GRASP65/GM130/RAB1/GTP/PLK1 0.024 0.053 -10000 0 -0.12 49 49
RAB1A 0.023 0.004 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA -0.011 0.051 -10000 0 -0.12 86 86
mitotic prometaphase -0.001 0.003 0.02 6 -0.01 23 29
proteasomal ubiquitin-dependent protein catabolic process 0.013 0.058 -10000 0 -0.25 15 15
microtubule-based process -0.01 0.072 -10000 0 -0.14 100 100
Golgi organization -0.009 0.048 -10000 0 -0.1 93 93
Cohesin/SA2 -0.003 0.054 -10000 0 -0.12 80 80
PPP1CB/MYPT1 0.024 0.039 -10000 0 -0.15 27 27
KIF20A 0.009 0.038 -10000 0 -0.12 43 43
APC/C/CDC20 -0.005 0.069 -10000 0 -0.15 79 79
PPP2R1A 0.022 0.009 -10000 0 -0.12 2 2
chromosome segregation -0.003 0.042 -10000 0 -0.095 72 72
PRC1 0.015 0.03 -10000 0 -0.12 25 25
ECT2 -0.021 0.072 -10000 0 -0.15 102 102
C13orf34 -0.01 0.05 -10000 0 -0.11 80 80
NUDC 0 0.042 -10000 0 -0.17 19 19
regulation of attachment of spindle microtubules to kinetochore -0.028 0.099 -10000 0 -0.23 87 87
spindle assembly -0.005 0.037 -10000 0 -0.087 72 72
spindle stabilization -0.003 0.022 -10000 0 -0.05 78 78
APC/C/HCDH1 0.025 0.007 -10000 0 -0.089 2 2
MKLP2/PLK1 -0.01 0.073 -10000 0 -0.14 100 100
CCNB1 0.014 0.028 -10000 0 -0.12 21 21
PPP1CB 0.022 0.003 -10000 0 -10000 0 0
BTRC 0.023 0.002 -10000 0 -10000 0 0
ROCK2 -0.016 0.095 -10000 0 -0.33 42 42
TUBG1 0 0.039 -10000 0 -0.23 11 11
G2/M transition of mitotic cell cycle -0.043 0.12 -10000 0 -0.24 132 132
MLF1IP 0.01 0.011 -10000 0 -0.079 8 8
INCENP 0.022 0.009 -10000 0 -0.12 2 2
Ras signaling in the CD4+ TCR pathway

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.026 0.13 -9999 0 -0.25 110 110
MAP3K8 0.021 0.009 -9999 0 -0.12 2 2
FOS -0.014 0.093 -9999 0 -0.29 25 25
PRKCA 0.008 0.037 -9999 0 -0.12 40 40
PTPN7 0.017 0.013 -9999 0 -10000 0 0
HRAS 0.022 0.006 -9999 0 -0.12 1 1
PRKCB -0.003 0.006 -9999 0 -0.01 193 193
NRAS 0.021 0.012 -9999 0 -0.12 3 3
RAS family/GTP 0.024 0.043 -9999 0 -0.1 46 46
MAPK3 0.002 0.068 -9999 0 -0.49 5 5
MAP2K1 -0.017 0.091 -9999 0 -0.29 46 46
ELK1 0.015 0.02 -9999 0 -0.13 6 6
BRAF -0.016 0.086 -9999 0 -0.3 42 42
mol:GTP -0.001 0.002 -9999 0 -0.003 185 185
MAPK1 0 0.076 -9999 0 -0.47 8 8
RAF1 -0.017 0.085 -9999 0 -0.29 47 47
KRAS 0.013 0.034 -9999 0 -0.12 33 33
Signaling events mediated by PTP1B

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.01 0.042 -10000 0 -0.12 52 52
Jak2/Leptin Receptor -0.043 0.13 0.21 1 -0.37 57 58
PTP1B/AKT1 -0.06 0.1 -10000 0 -0.23 97 97
FYN 0.011 0.037 -10000 0 -0.12 40 40
p210 bcr-abl/PTP1B -0.075 0.1 -10000 0 -0.26 96 96
EGFR 0.014 0.031 -10000 0 -0.13 25 25
EGF/EGFR -0.058 0.1 -10000 0 -0.23 103 103
CSF1 0.013 0.033 -10000 0 -0.12 31 31
AKT1 0.02 0.019 -10000 0 -0.12 10 10
INSR 0.021 0.017 -10000 0 -0.12 8 8
PTP1B/N-cadherin -0.094 0.12 -10000 0 -0.24 187 187
Insulin Receptor/Insulin -0.031 0.091 -10000 0 -0.21 75 75
HCK 0.019 0.024 -10000 0 -0.12 15 15
CRK 0.021 0.016 -10000 0 -0.12 7 7
TYK2 -0.068 0.1 -10000 0 -0.25 96 96
EGF 0.018 0.022 -10000 0 -0.13 12 12
YES1 0.02 0.018 -10000 0 -0.12 8 8
CAV1 -0.056 0.096 -10000 0 -0.24 89 89
TXN 0.019 0.015 -10000 0 -0.12 5 5
PTP1B/IRS1/GRB2 -0.055 0.11 -10000 0 -0.23 104 104
cell migration 0.075 0.1 0.26 96 -10000 0 96
STAT3 0.021 0.011 -10000 0 -0.12 3 3
PRLR 0.014 0.042 -10000 0 -0.12 53 53
ITGA2B 0.022 0.006 -10000 0 -0.13 1 1
CSF1R 0.014 0.031 -10000 0 -0.12 27 27
Prolactin Receptor/Prolactin 0.035 0.035 -10000 0 -0.18 2 2
FGR 0.023 0.006 -10000 0 -0.12 1 1
PTP1B/p130 Cas -0.063 0.1 -10000 0 -0.24 96 96
Crk/p130 Cas -0.052 0.1 -10000 0 -0.23 96 96
DOK1 -0.056 0.094 -10000 0 -0.23 84 84
JAK2 -0.052 0.13 -10000 0 -0.42 50 50
Jak2/Leptin Receptor/Leptin -0.056 0.12 -10000 0 -0.25 116 116
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
PTPN1 -0.075 0.1 -10000 0 -0.26 98 98
LYN 0.021 0.013 -10000 0 -0.12 4 4
CDH2 -0.015 0.057 -10000 0 -0.12 120 120
SRC -0.008 0.054 -10000 0 -0.61 2 2
ITGB3 0.003 0.047 -10000 0 -0.12 68 68
CAT1/PTP1B -0.058 0.12 -10000 0 -0.26 103 103
CAPN1 0.02 0.013 -10000 0 -0.12 4 4
CSK 0.023 0.009 -10000 0 -0.12 2 2
PI3K -0.033 0.1 -10000 0 -0.21 95 95
mol:H2O2 0.002 0.004 -10000 0 -10000 0 0
STAT3 (dimer) -0.05 0.12 -10000 0 -0.24 116 116
negative regulation of transcription -0.05 0.13 -10000 0 -0.4 54 54
FCGR2A 0.013 0.031 -10000 0 -0.12 26 26
FER 0.019 0.018 -10000 0 -0.12 8 8
alphaIIb/beta3 Integrin 0.008 0.053 -10000 0 -0.14 38 38
BLK 0.022 0.015 -10000 0 -0.12 6 6
Insulin Receptor/Insulin/Shc 0.043 0.022 -10000 0 -0.11 7 7
RHOA 0.021 0.007 -10000 0 -0.13 1 1
LEPR 0.018 0.028 -10000 0 -0.12 21 21
BCAR1 0.022 0.011 -10000 0 -0.12 3 3
p210 bcr-abl/Grb2 0.023 0.006 -10000 0 -0.12 1 1
mol:NADPH -0.001 0.002 -10000 0 -10000 0 0
TRPV6 0 0.087 -10000 0 -0.21 48 48
PRL 0.027 0.013 -10000 0 -0.13 3 3
SOCS3 -0.031 0.23 -10000 0 -1.2 22 22
SPRY2 -0.009 0.055 -10000 0 -0.12 103 103
Insulin Receptor/Insulin/IRS1 0.039 0.03 -10000 0 -0.11 12 12
CSF1/CSF1R -0.077 0.13 -10000 0 -0.26 129 129
Ras protein signal transduction 0.029 0.034 0.099 29 -0.16 5 34
IRS1 0.019 0.023 -10000 0 -0.12 14 14
INS 0.022 0.011 -10000 0 -0.13 3 3
LEP 0.022 0.006 -10000 0 -0.12 1 1
STAT5B -0.06 0.1 -10000 0 -0.25 89 89
STAT5A -0.062 0.1 -10000 0 -0.24 102 102
GRB2 0.023 0.006 -10000 0 -0.12 1 1
PDGFB-D/PDGFRB -0.069 0.1 -10000 0 -0.24 107 107
CSN2 0.04 0.027 -10000 0 -10000 0 0
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
LAT -0.083 0.19 -10000 0 -0.5 87 87
YBX1 0.033 0.015 -10000 0 -0.18 2 2
LCK 0.022 0.015 -10000 0 -0.12 6 6
SHC1 0.023 0.001 -10000 0 -10000 0 0
NOX4 -0.021 0.062 -10000 0 -0.12 152 152
BMP receptor signaling

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS -0.035 0.091 -9999 0 -0.12 243 243
SMAD6-7/SMURF1 0.042 0.029 -9999 0 -0.13 11 11
NOG 0.017 0.029 -9999 0 -0.12 23 23
SMAD9 0.02 0.05 -9999 0 -0.54 2 2
SMAD4 0.022 0.007 -9999 0 -0.12 1 1
SMAD5 0 0.094 -9999 0 -0.29 32 32
BMP7/USAG1 -0.074 0.094 -9999 0 -0.13 369 369
SMAD5/SKI 0.011 0.094 -9999 0 -0.28 32 32
SMAD1 0.021 0.073 -9999 0 -0.28 26 26
BMP2 0.022 0.014 -9999 0 -0.12 5 5
SMAD1/SMAD1/SMAD4 -0.003 0.065 -9999 0 -0.29 18 18
BMPR1A 0.02 0.014 -9999 0 -0.12 4 4
BMPR1B 0.008 0.04 -9999 0 -0.12 48 48
BMPR1A-1B/BAMBI -0.026 0.087 -9999 0 -0.14 161 161
AHSG 0.023 0.009 -9999 0 -0.12 2 2
CER1 0.022 0.012 -9999 0 -0.12 4 4
BMP2-4/CER1 0.033 0.039 -9999 0 -0.12 16 16
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA 0.003 0.1 -9999 0 -0.25 54 54
BMP2-4 (homodimer) 0.02 0.041 -9999 0 -0.087 69 69
RGMB 0.023 0.009 -9999 0 -0.12 2 2
BMP6/BMPR2/BMPR1A-1B 0.013 0.076 -9999 0 -0.12 114 114
RGMA 0.021 0.017 -9999 0 -0.12 8 8
SMURF1 0.023 0.009 -9999 0 -0.12 2 2
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP 0.004 0.077 -9999 0 -0.17 74 74
BMP2-4/USAG1 -0.014 0.07 -9999 0 -0.12 118 118
SMAD6/SMURF1/SMAD5 0.011 0.094 -9999 0 -0.27 33 33
SOSTDC1 -0.018 0.062 -9999 0 -0.12 146 146
BMP7/BMPR2/BMPR1A-1B -0.033 0.093 -9999 0 -0.13 219 219
SKI 0.022 0.011 -9999 0 -0.12 3 3
BMP6 (homodimer) 0.02 0.023 -9999 0 -0.12 14 14
HFE2 0.023 0.009 -9999 0 -0.12 2 2
ZFYVE16 0.02 0.018 -9999 0 -0.12 8 8
MAP3K7 0.021 0.014 -9999 0 -0.12 5 5
BMP2-4/CHRD 0.033 0.038 -9999 0 -0.11 16 16
SMAD5/SMAD5/SMAD4 0.009 0.096 -9999 0 -0.28 36 36
MAPK1 0.021 0.016 -9999 0 -0.12 7 7
TAK1/TAB family 0.022 0.096 -9999 0 -0.22 50 50
BMP7 (homodimer) -0.009 0.055 -9999 0 -0.12 106 106
NUP214 0.023 0.007 -9999 0 -0.12 1 1
BMP6/FETUA 0.032 0.017 -9999 0 -0.071 16 16
SMAD1/SKI 0.033 0.072 -9999 0 -0.26 26 26
SMAD6 0.02 0.02 -9999 0 -0.12 11 11
CTDSP2 0.022 0.01 -9999 0 -0.12 2 2
BMP2-4/FETUA 0.033 0.039 -9999 0 -0.066 70 70
MAP3K7IP1 0.023 0 -9999 0 -10000 0 0
GREM1 0.008 0.044 -9999 0 -0.12 58 58
BMPR2 (homodimer) 0.021 0.014 -9999 0 -0.12 5 5
GADD34/PP1CA 0.03 0.047 -9999 0 -0.12 46 46
BMPR1A-1B (homodimer) -0.011 0.081 -9999 0 -0.13 154 154
CHRDL1 -0.008 0.055 -9999 0 -0.12 103 103
ENDOFIN/SMAD1 0.03 0.076 -9999 0 -0.27 27 27
SMAD6-7/SMURF1/SMAD1 0.049 0.076 -9999 0 -0.25 26 26
SMAD6/SMURF1 0.023 0.009 -9999 0 -0.12 2 2
BAMBI -0.004 0.054 -9999 0 -0.12 95 95
SMURF2 0.022 0.013 -9999 0 -0.12 4 4
BMP2-4/CHRDL1 -0.014 0.072 -9999 0 -0.12 135 135
BMP2-4/GREM1 0.023 0.049 -9999 0 -0.12 30 30
SMAD7 0.023 0.003 -9999 0 -10000 0 0
SMAD8A/SMAD8A/SMAD4 0.028 0.052 -9999 0 -0.41 3 3
SMAD1/SMAD6 0.033 0.073 -9999 0 -0.26 26 26
TAK1/SMAD6 0.027 0.035 -9999 0 -0.14 21 21
BMP7 -0.009 0.055 -9999 0 -0.12 106 106
BMP6 0.02 0.023 -9999 0 -0.12 14 14
MAP3K7IP2 0.02 0.016 -9999 0 -0.12 6 6
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 0.003 0.083 -9999 0 -0.22 44 44
PPM1A 0.023 0.001 -9999 0 -10000 0 0
SMAD1/SMURF2 0.031 0.075 -9999 0 -0.27 26 26
SMAD7/SMURF1 0.031 0.023 -9999 0 -0.14 9 9
CTDSPL 0.023 0.006 -9999 0 -0.12 1 1
PPP1CA 0.023 0.002 -9999 0 -10000 0 0
XIAP 0 0 -9999 0 -10000 0 0
CTDSP1 0.022 0.011 -9999 0 -0.12 3 3
PPP1R15A 0.019 0.025 -9999 0 -0.12 17 17
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS 0.002 0.08 -9999 0 -0.21 51 51
CHRD 0.023 0.006 -9999 0 -0.12 1 1
BMPR2 0.021 0.014 -9999 0 -0.12 5 5
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.005 0.088 -9999 0 -0.24 43 43
BMP4 0.009 0.042 -9999 0 -0.12 52 52
FST 0.004 0.049 -9999 0 -0.12 73 73
BMP2-4/NOG 0.027 0.047 -9999 0 -0.12 33 33
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 -0.023 0.091 -9999 0 -0.12 220 220
Paxillin-independent events mediated by a4b1 and a4b7

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.003 0.076 -9999 0 -0.17 89 89
CRKL 0.023 0.009 -9999 0 -0.12 2 2
Rac1/GDP 0.016 0.015 -9999 0 -0.15 5 5
DOCK1 0.019 0.02 -9999 0 -0.12 10 10
ITGA4 0.015 0.03 -9999 0 -0.12 24 24
alpha4/beta7 Integrin/MAdCAM1 0.032 0.059 -9999 0 -0.1 78 78
EPO 0.023 0.006 -9999 0 -0.12 1 1
alpha4/beta7 Integrin 0.004 0.065 -9999 0 -0.13 106 106
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.021 0.016 -9999 0 -0.12 7 7
alpha4/beta1 Integrin 0.006 0.063 -9999 0 -0.12 101 101
EPO/EPOR (dimer) 0.032 0.019 -9999 0 -0.08 15 15
lamellipodium assembly 0.004 0.087 -9999 0 -0.25 35 35
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
PI3K 0.007 0.065 -9999 0 -0.13 96 96
ARF6 0.023 0.003 -9999 0 -10000 0 0
JAK2 0.003 0.081 -9999 0 -0.18 73 73
PXN 0.022 0.014 -9999 0 -0.12 5 5
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
MADCAM1 0.023 0.006 -9999 0 -0.12 1 1
cell adhesion 0.03 0.058 -9999 0 -0.1 78 78
CRKL/CBL 0.033 0.013 -9999 0 -0.14 2 2
ITGB1 0.021 0.015 -9999 0 -0.12 6 6
SRC -0.038 0.074 -9999 0 -0.13 186 186
ITGB7 0.019 0.024 -9999 0 -0.12 15 15
RAC1 0.023 0.002 -9999 0 -10000 0 0
alpha4/beta1 Integrin/VCAM1 -0.041 0.09 -9999 0 -0.15 186 186
p130Cas/Crk/Dock1 -0.021 0.075 -9999 0 -0.16 77 77
VCAM1 -0.019 0.06 -9999 0 -0.12 139 139
RHOA 0.023 0.006 -9999 0 -0.12 1 1
alpha4/beta1 Integrin/Paxillin/GIT1 0.033 0.057 -9999 0 -0.098 74 74
BCAR1 -0.033 0.068 -9999 0 -0.11 186 186
EPOR 0.02 0.021 -9999 0 -0.12 12 12
mol:GDP 0 0 -9999 0 -10000 0 0
CBL 0.023 0.006 -9999 0 -0.12 1 1
GIT1 0.022 0.012 -9999 0 -0.12 4 4
Rac1/GTP 0.004 0.09 -9999 0 -0.26 34 34
Canonical Wnt signaling pathway

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.037 0.047 0.11 128 -0.089 10 138
AES 0.036 0.042 0.099 124 -0.11 10 134
FBXW11 0.023 0.003 -10000 0 -10000 0 0
mol:GTP 0.001 0.002 -10000 0 -10000 0 0
LRP6/FZD1 0.018 0.047 -10000 0 -0.11 66 66
SMAD4 0.022 0.007 -10000 0 -0.12 1 1
DKK2 0.023 0.011 -10000 0 -0.12 3 3
TLE1 0.033 0.038 0.097 100 -0.11 8 108
MACF1 0.016 0.026 -10000 0 -0.12 18 18
CTNNB1 0.021 0.098 0.18 8 -0.34 23 31
WIF1 0.02 0.022 -10000 0 -0.12 13 13
beta catenin/RanBP3 0.084 0.19 0.38 135 -0.35 13 148
KREMEN2 0.022 0.012 -10000 0 -0.12 4 4
DKK1 0.015 0.034 -10000 0 -0.12 33 33
beta catenin/beta TrCP1 0.033 0.096 0.19 8 -0.35 20 28
FZD1 0.023 0.006 -10000 0 -0.12 1 1
AXIN2 -0.037 0.16 -10000 0 -0.77 13 13
AXIN1 0.023 0.011 -10000 0 -0.12 3 3
RAN 0.024 0.002 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.036 0.083 -10000 0 -0.5 9 9
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.024 0.11 0.23 9 -0.28 42 51
Axin1/APC/GSK3 0.027 0.06 -10000 0 -0.25 16 16
Axin1/APC/GSK3/beta catenin/Macf1 0.03 0.068 -10000 0 -0.26 16 16
HNF1A 0.037 0.038 0.1 112 -0.12 3 115
CTBP1 0.037 0.04 0.1 107 -0.11 7 114
MYC -0.17 0.44 -10000 0 -1.3 74 74
RANBP3 0.023 0.009 -10000 0 -0.12 2 2
DKK2/LRP6/Kremen 2 0.032 0.043 -10000 0 -0.11 32 32
NKD1 0.022 0.012 -10000 0 -0.12 4 4
TCF4 0.036 0.042 0.1 120 -0.093 8 128
TCF3 0.037 0.039 0.1 108 -0.12 5 113
WNT1/LRP6/FZD1/Axin1 0.044 0.044 -10000 0 -0.097 36 36
Ran/GTP 0.018 0.012 -10000 0 -0.14 3 3
CtBP/CBP/TCF/TLE1/AES 0.08 0.23 0.45 128 -0.36 12 140
LEF1 0.011 0.057 0.097 78 -0.11 75 153
DVL1 0.027 0.076 -10000 0 -0.33 18 18
CSNK2A1 0.022 0.015 -10000 0 -0.12 6 6
beta catenin/TCF/CtBP/CBP/TLE1/AES -0.025 0.14 -10000 0 -0.3 74 74
DKK1/LRP6/Kremen 2 0.027 0.047 -10000 0 -0.11 34 34
LRP6 0.014 0.034 -10000 0 -0.12 32 32
CSNK1A1 0.04 0.044 0.11 125 -0.13 1 126
NLK 0.017 0.022 -10000 0 -0.13 11 11
CCND1 -0.19 0.45 -10000 0 -1.3 83 83
WNT1 0.023 0.009 -10000 0 -0.12 2 2
GSK3A 0.021 0.019 -10000 0 -0.12 10 10
GSK3B 0.022 0.011 -10000 0 -0.12 3 3
FRAT1 0.023 0.006 -10000 0 -0.12 1 1
PPP2R5D 0.018 0.044 -10000 0 -0.2 16 16
APC 0.022 0.033 -10000 0 -0.085 38 38
WNT1/LRP6/FZD1 0.018 0.056 -10000 0 -0.24 10 10
CREBBP 0.035 0.037 0.1 89 -0.1 5 94
EPHB forward signaling

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 0.011 0.049 -10000 0 -0.12 54 54
cell-cell adhesion 0.023 0.039 0.14 38 -10000 0 38
Ephrin B/EPHB2/RasGAP 0.016 0.076 -10000 0 -0.15 36 36
ITSN1 0.022 0.011 -10000 0 -0.12 3 3
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
SHC1 0.023 0.001 -10000 0 -10000 0 0
Ephrin B1/EPHB3 0.022 0.034 -10000 0 -0.12 24 24
Ephrin B1/EPHB1 0.024 0.027 -10000 0 -0.068 43 43
HRAS/GDP -0.002 0.07 -10000 0 -0.14 85 85
Ephrin B/EPHB1/GRB7 0.018 0.071 -10000 0 -0.14 29 29
Endophilin/SYNJ1 -0.001 0.052 -10000 0 -0.087 124 124
KRAS 0.014 0.034 -10000 0 -0.12 33 33
Ephrin B/EPHB1/Src 0.024 0.067 -10000 0 -0.091 108 108
endothelial cell migration 0.001 0.071 -10000 0 -0.11 145 145
GRB2 0.023 0.006 -10000 0 -0.12 1 1
GRB7 0.018 0.026 -10000 0 -0.12 18 18
PAK1 -0.003 0.057 -10000 0 -0.16 28 28
HRAS 0.023 0.006 -10000 0 -0.12 1 1
RRAS -0.006 0.056 -10000 0 -0.095 127 127
DNM1 0.021 0.019 -10000 0 -0.12 10 10
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK 0 0.049 -10000 0 -0.087 109 109
lamellipodium assembly -0.023 0.039 -10000 0 -0.14 38 38
Ephrin B/EPHB1/Src/p52 SHC/GRB2 0.019 0.051 -10000 0 -0.22 13 13
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
EPHB2 0.02 0.02 -10000 0 -0.12 11 11
EPHB3 0.019 0.024 -10000 0 -0.12 15 15
EPHB1 0.016 0.032 -10000 0 -0.12 28 28
EPHB4 0.022 0.009 -10000 0 -0.12 2 2
mol:GDP -0.01 0.079 -10000 0 -0.17 97 97
Ephrin B/EPHB2 0.012 0.066 -10000 0 -0.097 123 123
Ephrin B/EPHB3 0.011 0.065 -10000 0 -0.095 123 123
JNK cascade 0.015 0.045 -10000 0 -0.1 56 56
Ephrin B/EPHB1 0.013 0.063 -10000 0 -0.095 108 108
RAP1/GDP 0.001 0.084 -10000 0 -0.16 97 97
EFNB2 0.007 0.041 -10000 0 -0.12 50 50
EFNB3 0.018 0.026 -10000 0 -0.12 19 19
EFNB1 0.021 0.018 -10000 0 -0.12 9 9
Ephrin B2/EPHB1-2 0.006 0.061 -10000 0 -0.1 101 101
RAP1B 0.019 0.02 -10000 0 -0.12 10 10
RAP1A 0.021 0.012 -10000 0 -0.12 3 3
CDC42/GTP 0.008 0.077 -10000 0 -0.18 30 30
Rap1/GTP -0.028 0.045 -10000 0 -0.14 59 59
axon guidance 0.011 0.049 -10000 0 -0.12 54 54
MAPK3 0.008 0.063 -10000 0 -0.19 17 17
MAPK1 0.008 0.063 -10000 0 -0.19 18 18
Rac1/GDP 0.001 0.079 -10000 0 -0.16 85 85
actin cytoskeleton reorganization -0.025 0.045 -10000 0 -0.14 43 43
CDC42/GDP 0.001 0.079 -10000 0 -0.16 85 85
PI3K 0.004 0.074 -10000 0 -0.11 145 145
EFNA5 0.014 0.033 -10000 0 -0.12 30 30
Ephrin B2/EPHB4 0 0.058 -10000 0 -0.12 89 89
Ephrin B/EPHB2/Intersectin/N-WASP -0.005 0.08 -10000 0 -0.26 17 17
CDC42 0.023 0.002 -10000 0 -10000 0 0
RAS family/GTP -0.026 0.042 -10000 0 -0.13 53 53
PTK2 -0.001 0.051 -10000 0 -0.2 33 33
MAP4K4 0.015 0.045 -10000 0 -0.1 56 56
SRC 0.023 0.009 -10000 0 -0.12 2 2
KALRN 0.015 0.033 -10000 0 -0.12 30 30
Intersectin/N-WASP 0.031 0.022 -10000 0 -0.11 12 12
neuron projection morphogenesis 0.005 0.07 -10000 0 -0.16 42 42
MAP2K1 0.005 0.066 -10000 0 -0.2 15 15
WASL 0.023 0.009 -10000 0 -0.12 2 2
Ephrin B1/EPHB1-2/NCK1 0.036 0.056 -10000 0 -0.11 55 55
cell migration 0.002 0.077 -10000 0 -0.2 27 27
NRAS 0.022 0.011 -10000 0 -0.12 3 3
SYNJ1 -0.001 0.052 -10000 0 -0.088 124 124
PXN 0.022 0.014 -10000 0 -0.12 5 5
TF -0.001 0.049 -10000 0 -0.12 33 33
HRAS/GTP 0.01 0.063 -10000 0 -0.15 29 29
Ephrin B1/EPHB1-2 0.032 0.039 -10000 0 -0.11 26 26
cell adhesion mediated by integrin 0.014 0.047 0.1 100 -10000 0 100
RAC1 0.023 0.002 -10000 0 -10000 0 0
mol:GTP 0.011 0.069 -10000 0 -0.16 29 29
RAC1-CDC42/GTP -0.024 0.039 -10000 0 -0.13 39 39
RASA1 0.021 0.012 -10000 0 -0.12 3 3
RAC1-CDC42/GDP 0.009 0.08 -10000 0 -0.15 85 85
ruffle organization 0.004 0.057 -10000 0 -0.14 40 40
NCK1 0.02 0.019 -10000 0 -0.12 9 9
receptor internalization 0 0.049 -10000 0 -0.082 125 125
Ephrin B/EPHB2/KALRN 0.019 0.073 -10000 0 -0.13 39 39
ROCK1 0.017 0.028 -10000 0 -0.097 24 24
RAS family/GDP -0.028 0.049 -10000 0 -0.16 43 43
Rac1/GTP -0.024 0.041 -10000 0 -0.14 38 38
Ephrin B/EPHB1/Src/Paxillin 0 0.071 -10000 0 -0.14 100 100
Wnt signaling

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.033 0.1 -9999 0 -0.18 162 162
FZD6 0.017 0.023 -9999 0 -0.12 13 13
WNT6 0.022 0.011 -9999 0 -0.12 3 3
WNT4 0.022 0.011 -9999 0 -0.12 3 3
FZD3 0.013 0.032 -9999 0 -0.12 29 29
WNT5A 0.014 0.031 -9999 0 -0.12 27 27
WNT11 0.002 0.051 -9999 0 -0.12 82 82
IL12-mediated signaling events

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 -0.001 0.094 -10000 0 -0.22 49 49
TBX21 -0.081 0.27 -10000 0 -0.71 60 60
B2M 0.024 0.006 -10000 0 -10000 0 0
TYK2 0.015 0.029 -10000 0 -0.088 13 13
IL12RB1 0.017 0.024 -10000 0 -0.12 1 1
GADD45B -0.09 0.32 -10000 0 -0.84 62 62
IL12RB2 0.014 0.033 -10000 0 -0.12 16 16
GADD45G -0.079 0.28 -10000 0 -0.78 50 50
natural killer cell activation -0.003 0.018 -10000 0 -0.039 46 46
RELB 0.022 0.011 -10000 0 -0.12 3 3
RELA 0.023 0.009 -10000 0 -0.12 2 2
IL18 0.004 0.047 -10000 0 -0.12 66 66
IL2RA 0.021 0.017 -10000 0 -0.12 8 8
IFNG 0.013 0.038 -10000 0 -0.12 41 41
STAT3 (dimer) -0.073 0.27 -10000 0 -0.58 88 88
HLA-DRB5 -0.014 0.058 -10000 0 -0.12 119 119
FASLG -0.083 0.28 -10000 0 -0.71 61 61
NF kappa B2 p52/RelB -0.077 0.27 -10000 0 -0.6 89 89
CD4 0.012 0.029 -10000 0 -0.13 21 21
SOCS1 0.016 0.031 -10000 0 -0.12 27 27
EntrezGene:6955 -0.002 0.008 -10000 0 -10000 0 0
CD3D 0.004 0.045 -10000 0 -0.13 56 56
CD3E 0.012 0.034 -10000 0 -0.12 29 29
CD3G -0.001 0.051 -10000 0 -0.13 78 78
IL12Rbeta2/JAK2 0.009 0.063 -10000 0 -0.15 52 52
CCL3 -0.1 0.32 -10000 0 -0.86 62 62
CCL4 -0.09 0.27 -10000 0 -0.61 89 89
HLA-A 0.021 0.018 -10000 0 -0.12 8 8
IL18/IL18R 0.025 0.076 -10000 0 -0.12 81 81
NOS2 -0.082 0.26 -10000 0 -0.56 93 93
IL12/IL12R/TYK2/JAK2/SPHK2 0.002 0.091 -10000 0 -0.23 41 41
IL1R1 -0.17 0.42 -10000 0 -1 98 98
IL4 0.026 0.021 0.073 3 -0.11 3 6
JAK2 0.012 0.033 -10000 0 -0.12 17 17
EntrezGene:6957 -0.001 0.007 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.01 0.12 -10000 0 -0.4 32 32
RAB7A -0.063 0.26 -10000 0 -0.7 52 52
lysosomal transport -0.058 0.25 -10000 0 -0.66 54 54
FOS -0.26 0.48 -10000 0 -1.1 125 125
STAT4 (dimer) -0.073 0.28 -10000 0 -0.62 84 84
STAT5A (dimer) -0.082 0.28 -10000 0 -0.6 93 93
GZMA -0.11 0.34 -10000 0 -0.87 70 70
GZMB -0.1 0.31 -10000 0 -0.77 69 69
HLX 0.023 0.006 -10000 0 -0.12 1 1
LCK -0.092 0.29 -10000 0 -0.64 88 88
TCR/CD3/MHC II/CD4 -0.11 0.21 -10000 0 -0.35 193 193
IL2/IL2R 0.013 0.068 -10000 0 -0.1 114 114
MAPK14 -0.084 0.3 -10000 0 -0.72 73 73
CCR5 -0.063 0.25 -10000 0 -0.65 51 51
IL1B 0.005 0.044 -10000 0 -0.12 45 45
STAT6 -0.025 0.14 -10000 0 -0.36 41 41
STAT4 0.02 0.02 -10000 0 -0.12 11 11
STAT3 0.022 0.011 -10000 0 -0.12 3 3
STAT1 0.014 0.031 -10000 0 -0.12 26 26
NFKB1 0.021 0.013 -10000 0 -0.12 4 4
NFKB2 0.023 0.009 -10000 0 -0.12 2 2
IL12B 0.018 0.023 -10000 0 -0.038 2 2
CD8A 0.024 0.011 -10000 0 -0.12 3 3
CD8B 0.024 0.015 -10000 0 -0.12 6 6
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity 0.001 0.093 0.22 49 -10000 0 49
IL2RB 0.019 0.024 -10000 0 -0.12 16 16
proteasomal ubiquitin-dependent protein catabolic process -0.065 0.26 -10000 0 -0.57 84 84
IL2RG -0.002 0.05 -10000 0 -0.12 82 82
IL12 0.004 0.063 -10000 0 -0.14 48 48
STAT5A 0.022 0.013 -10000 0 -0.12 4 4
CD247 0.021 0.01 -10000 0 -10000 0 0
IL2 0.022 0.011 -10000 0 -0.12 3 3
SPHK2 0.022 0.011 -10000 0 -0.12 3 3
FRAP1 0.022 0.013 -10000 0 -0.12 4 4
IL12A -0.001 0.051 -10000 0 -0.12 70 70
IL12/IL12R/TYK2/JAK2 -0.099 0.3 -10000 0 -0.68 89 89
MAP2K3 -0.078 0.29 -10000 0 -0.67 81 81
RIPK2 0.013 0.034 -10000 0 -0.12 32 32
MAP2K6 -0.096 0.3 -10000 0 -0.67 86 86
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA 0.008 0.032 -10000 0 -0.13 24 24
IL18RAP 0.022 0.02 -10000 0 -0.12 8 8
IL12Rbeta1/TYK2 0.024 0.037 -10000 0 -0.15 3 3
EOMES 0.018 0.031 -10000 0 -10000 0 0
STAT1 (dimer) -0.097 0.28 -10000 0 -0.58 103 103
T cell proliferation -0.06 0.22 -10000 0 -0.49 85 85
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0.021 0.024 -10000 0 -0.12 13 13
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.11 0.2 -10000 0 -0.52 87 87
ATF2 -0.076 0.28 -10000 0 -0.66 76 76
TCR signaling in naïve CD8+ T cells

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC -0.004 0.14 -10000 0 -0.34 60 60
FYN -0.047 0.18 -10000 0 -0.4 86 86
LAT/GRAP2/SLP76 -0.009 0.15 -10000 0 -0.34 72 72
IKBKB 0.022 0.015 -10000 0 -0.12 6 6
AKT1 -0.009 0.13 -10000 0 -0.3 75 75
B2M 0.022 0.007 -10000 0 -10000 0 0
IKBKG 0.008 0.044 -10000 0 -0.092 63 63
MAP3K8 0.023 0.009 -10000 0 -0.12 2 2
mol:Ca2+ -0.004 0.011 -10000 0 -0.034 45 45
integrin-mediated signaling pathway 0.021 0.035 -10000 0 -0.096 44 44
LAT/GRAP2/SLP76/VAV1/PI3K Class IA -0.023 0.18 -10000 0 -0.42 75 75
TRPV6 0.003 0.017 -10000 0 -0.13 6 6
CD28 0.022 0.011 -10000 0 -0.12 3 3
SHC1 -0.019 0.16 -10000 0 -0.4 62 62
receptor internalization -0.014 0.14 -10000 0 -0.35 63 63
PRF1 -0.019 0.18 -10000 0 -0.81 19 19
KRAS 0.014 0.034 -10000 0 -0.12 33 33
GRB2 0.023 0.006 -10000 0 -0.12 1 1
COT/AKT1 0.004 0.11 -10000 0 -0.24 74 74
LAT -0.019 0.16 -10000 0 -0.4 62 62
EntrezGene:6955 0 0.003 -10000 0 -0.022 3 3
CD3D 0.008 0.044 -10000 0 -0.12 56 56
CD3E 0.015 0.033 -10000 0 -0.13 29 29
CD3G 0.002 0.051 -10000 0 -0.12 78 78
RASGRP2 0.007 0.015 -10000 0 -0.049 1 1
RASGRP1 -0.017 0.14 -10000 0 -0.29 87 87
HLA-A 0.02 0.019 -10000 0 -0.13 8 8
RASSF5 0.02 0.022 -10000 0 -0.12 13 13
RAP1A/GTP/RAPL 0.022 0.035 -10000 0 -0.096 44 44
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.009 0.05 -10000 0 -0.094 66 66
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.026 0.054 -10000 0 -0.15 78 78
PRKCA -0.005 0.08 -10000 0 -0.18 72 72
GRAP2 0.022 0.012 -10000 0 -0.12 4 4
mol:IP3 -0.044 0.098 0.098 3 -0.27 73 76
EntrezGene:6957 0 0.004 -10000 0 -0.023 2 2
TCR/CD3/MHC I/CD8 -0.014 0.13 -10000 0 -0.36 50 50
ORAI1 0 0.023 0.091 6 -0.15 7 13
CSK -0.019 0.16 -10000 0 -0.4 63 63
B7 family/CD28 -0.007 0.16 -10000 0 -0.35 73 73
CHUK 0.021 0.013 -10000 0 -0.12 4 4
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.026 0.17 -10000 0 -0.45 62 62
PTPN6 -0.023 0.16 -10000 0 -0.4 64 64
VAV1 -0.023 0.16 -10000 0 -0.4 68 68
Monovalent TCR/CD3 -0.015 0.095 -10000 0 -0.2 96 96
CBL 0.023 0.006 -10000 0 -0.12 1 1
LCK -0.036 0.17 -10000 0 -0.4 78 78
PAG1 -0.019 0.16 -10000 0 -0.4 62 62
RAP1A 0.021 0.012 -10000 0 -0.12 3 3
TCR/CD3/MHC I/CD8/LCK -0.028 0.17 -10000 0 -0.42 68 68
CD80 0.019 0.024 -10000 0 -0.12 15 15
CD86 0.013 0.034 -10000 0 -0.12 32 32
PDK1/CARD11/BCL10/MALT1 -0.027 0.066 -10000 0 -0.18 73 73
HRAS 0.023 0.006 -10000 0 -0.12 1 1
GO:0035030 -0.016 0.13 -10000 0 -0.3 73 73
CD8A 0.022 0.012 -10000 0 -0.13 3 3
CD8B 0.021 0.016 -10000 0 -0.13 6 6
PTPRC -0.004 0.051 -10000 0 -0.12 86 86
PDK1/PKC theta -0.016 0.15 -10000 0 -0.35 74 74
CSK/PAG1 -0.014 0.15 -10000 0 -0.39 62 62
SOS1 0.017 0.027 -10000 0 -0.12 20 20
peptide-MHC class I 0.012 0.073 -10000 0 -0.19 59 59
GRAP2/SLP76 -0.015 0.17 -10000 0 -0.38 76 76
STIM1 -0.002 0.032 -10000 0 -0.17 18 18
RAS family/GTP 0.007 0.07 -10000 0 -0.14 73 73
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.014 0.15 -10000 0 -0.37 63 63
mol:DAG -0.041 0.088 -10000 0 -0.24 76 76
RAP1A/GDP 0.005 0.026 -10000 0 -0.053 54 54
PLCG1 0.019 0.024 -10000 0 -0.12 16 16
CD247 0.023 0.004 -10000 0 -10000 0 0
cytotoxic T cell degranulation -0.017 0.18 -10000 0 -0.72 22 22
RAP1A/GTP -0.002 0.009 -10000 0 -0.037 25 25
mol:PI-3-4-5-P3 -0.015 0.15 -10000 0 -0.35 75 75
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.05 0.12 -10000 0 -0.34 70 70
NRAS 0.022 0.011 -10000 0 -0.12 3 3
ZAP70 0.023 0.006 -10000 0 -0.12 1 1
GRB2/SOS1 0.021 0.045 -10000 0 -0.15 29 29
LAT/GRAP2/SLP76/VAV1 -0.013 0.14 -10000 0 -0.33 75 75
MALT1 0.017 0.026 -10000 0 -0.12 19 19
TRAF6 0.022 0.009 -10000 0 -0.12 2 2
CD8 heterodimer 0.033 0.016 -10000 0 -0.083 6 6
CARD11 0.017 0.028 -10000 0 -0.12 22 22
PRKCB -0.03 0.063 -10000 0 -0.17 76 76
PRKCE 0 0.079 -10000 0 -0.18 71 71
PRKCQ -0.023 0.17 -10000 0 -0.39 75 75
LCP2 0.013 0.033 -10000 0 -0.12 31 31
BCL10 0.023 0.001 -10000 0 -10000 0 0
regulation of survival gene product expression -0.005 0.11 -10000 0 -0.26 75 75
IKK complex 0.007 0.044 -10000 0 -0.083 53 53
RAS family/GDP -0.006 0.01 -10000 0 -0.034 40 40
MAP3K14 0.008 0.087 -10000 0 -0.19 71 71
PDPK1 -0.007 0.12 -10000 0 -0.29 74 74
TCR/CD3/MHC I/CD8/Fyn -0.03 0.19 -10000 0 -0.48 65 65
Stabilization and expansion of the E-cadherin adherens junction

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization 0 0.088 -10000 0 -0.18 86 86
epithelial cell differentiation 0.029 0.059 -10000 0 -0.12 67 67
CYFIP2 0.02 0.018 -10000 0 -0.12 8 8
ENAH 0.009 0.056 -10000 0 -0.13 51 51
EGFR 0.015 0.03 -10000 0 -0.12 25 25
EPHA2 0.02 0.022 -10000 0 -0.12 13 13
MYO6 0.01 0.057 -10000 0 -0.12 67 67
CTNNB1 0.022 0.008 -10000 0 -0.12 1 1
ABI1/Sra1/Nap1 0.03 0.05 -10000 0 -0.11 62 62
AQP5 -0.059 0.15 -10000 0 -0.32 119 119
CTNND1 0.023 0.004 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.015 0.049 -10000 0 -0.11 67 67
regulation of calcium-dependent cell-cell adhesion 0.014 0.05 -10000 0 -0.11 67 67
EGF 0.02 0.021 -10000 0 -0.12 12 12
NCKAP1 0.023 0.004 -10000 0 -10000 0 0
AQP3 0.012 0.076 -10000 0 -0.3 21 21
cortical microtubule organization 0.029 0.059 -10000 0 -0.12 67 67
GO:0000145 0.008 0.045 -10000 0 -0.1 67 67
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.033 0.061 -10000 0 -0.12 67 67
MLLT4 0.014 0.032 -10000 0 -0.12 29 29
ARF6/GDP -0.022 0.05 -10000 0 -0.17 43 43
ARF6 0.023 0.003 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.029 0.062 -10000 0 -0.11 75 75
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP 0.015 0.058 -10000 0 -0.18 30 30
PVRL2 0.019 0.023 -10000 0 -0.12 15 15
ZYX 0.011 0.054 -10000 0 -0.12 67 67
ARF6/GTP 0.035 0.063 -10000 0 -0.17 18 18
CDH1 0.021 0.016 -10000 0 -0.12 6 6
EGFR/EGFR/EGF/EGF 0.015 0.062 -10000 0 -0.19 24 24
RhoA/GDP 0.03 0.058 -10000 0 -0.11 71 71
actin cytoskeleton organization 0.009 0.059 -10000 0 -0.13 67 67
IGF-1R heterotetramer 0.013 0.032 -10000 0 -0.12 28 28
GIT1 0.022 0.012 -10000 0 -0.12 4 4
IGF1R 0.013 0.032 -10000 0 -0.12 28 28
IGF1 0.007 0.045 -10000 0 -0.12 60 60
DIAPH1 -0.022 0.2 -10000 0 -0.56 70 70
Wnt receptor signaling pathway -0.029 0.059 0.12 67 -10000 0 67
RHOA 0.023 0.006 -10000 0 -0.12 1 1
RhoA/GTP -0.022 0.049 -10000 0 -0.17 42 42
CTNNA1 0.022 0.01 -10000 0 -0.12 2 2
VCL 0.009 0.061 -10000 0 -0.13 67 67
EFNA1 0.014 0.031 -10000 0 -0.12 26 26
LPP 0.012 0.054 -10000 0 -0.11 69 69
Ephrin A1/EPHA2 0.012 0.064 -10000 0 -0.19 28 28
SEC6/SEC8 -0.02 0.049 -10000 0 -0.19 32 32
MGAT3 0.014 0.051 -10000 0 -0.11 67 67
HGF/MET -0.006 0.071 -10000 0 -0.18 45 45
HGF 0.02 0.023 -10000 0 -0.12 14 14
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN 0 0.089 -10000 0 -0.18 86 86
actin cable formation 0.012 0.08 -10000 0 -0.2 48 48
KIAA1543 0.013 0.05 -10000 0 -0.11 67 67
KIFC3 0.015 0.05 -10000 0 -0.11 67 67
NCK1 0.02 0.019 -10000 0 -0.12 9 9
EXOC3 0.023 0.009 -10000 0 -0.12 2 2
ACTN1 0.013 0.057 -10000 0 -0.12 67 67
NCK1/GIT1 0.022 0.043 -10000 0 -0.14 32 32
mol:GDP 0.029 0.059 -10000 0 -0.12 67 67
EXOC4 0.022 0.007 -10000 0 -0.12 1 1
STX4 0.014 0.052 -10000 0 -0.11 67 67
PIP5K1C 0.015 0.05 -10000 0 -0.11 67 67
LIMA1 0.019 0.023 -10000 0 -0.12 14 14
ABI1 0.022 0.009 -10000 0 -0.12 2 2
ROCK1 0.011 0.06 -10000 0 -0.16 39 39
adherens junction assembly 0.022 0.059 -10000 0 -0.2 20 20
IGF-1R heterotetramer/IGF1 0 0.071 -10000 0 -0.17 47 47
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.013 0.054 -10000 0 -0.15 43 43
MET 0 0.047 -10000 0 -0.12 70 70
PLEKHA7 0.013 0.052 -10000 0 -0.11 67 67
mol:GTP 0.028 0.061 -10000 0 -0.11 75 75
establishment of epithelial cell apical/basal polarity 0.013 0.062 -10000 0 -0.18 34 34
cortical actin cytoskeleton stabilization 0 0.088 -10000 0 -0.18 86 86
regulation of cell-cell adhesion 0.009 0.059 -10000 0 -0.13 67 67
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton 0 0.089 -10000 0 -0.18 86 86
E-cadherin signaling in keratinocytes

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation -0.005 0.1 -10000 0 -0.27 51 51
adherens junction organization -0.007 0.12 -10000 0 -0.26 68 68
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP 0.002 0.098 -10000 0 -0.25 49 49
FMN1 -0.002 0.11 -10000 0 -0.24 69 69
mol:IP3 -0.002 0.092 -10000 0 -0.21 63 63
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin -0.004 0.11 -10000 0 -0.26 67 67
CTNNB1 0.022 0.008 -10000 0 -0.12 1 1
AKT1 0.001 0.097 -10000 0 -0.25 48 48
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin 0.007 0.13 -10000 0 -0.36 47 47
CTNND1 0.023 0.004 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.001 0.1 -10000 0 -0.24 68 68
VASP -0.001 0.11 -10000 0 -0.25 68 68
ZYX -0.004 0.11 -10000 0 -0.25 69 69
JUB -0.005 0.11 -10000 0 -0.25 69 69
EGFR(dimer) -0.001 0.11 -10000 0 -0.25 71 71
E-cadherin/beta catenin-gamma catenin 0.026 0.052 -10000 0 -0.11 63 63
mol:PI-3-4-5-P3 0.003 0.1 -10000 0 -0.26 50 50
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
PI3K 0.004 0.11 -10000 0 -0.26 50 50
FYN -0.012 0.11 -10000 0 -0.27 69 69
mol:Ca2+ -0.002 0.09 -10000 0 -0.21 63 63
JUP 0.019 0.021 -10000 0 -0.12 12 12
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
mol:DAG -0.002 0.092 -10000 0 -0.21 63 63
CDH1 0.02 0.016 -10000 0 -0.12 6 6
RhoA/GDP 0.002 0.097 -10000 0 -0.24 49 49
establishment of polarity of embryonic epithelium -0.001 0.1 -10000 0 -0.24 68 68
SRC 0.023 0.009 -10000 0 -0.12 2 2
RAC1 0.023 0.002 -10000 0 -10000 0 0
RHOA 0.023 0.006 -10000 0 -0.12 1 1
EGFR 0.015 0.03 -10000 0 -0.12 25 25
CASR 0.001 0.086 -10000 0 -0.24 42 42
RhoA/GTP 0.006 0.089 -10000 0 -0.25 40 40
AKT2 0 0.097 -10000 0 -0.24 52 52
actin cable formation 0.001 0.1 -10000 0 -0.24 68 68
apoptosis 0.004 0.099 0.24 57 -10000 0 57
CTNNA1 0.022 0.01 -10000 0 -0.12 2 2
mol:GDP -0.006 0.097 -10000 0 -0.24 57 57
PIP5K1A -0.001 0.11 -10000 0 -0.25 68 68
PLCG1 -0.003 0.094 -10000 0 -0.21 63 63
Rac1/GTP 0.004 0.11 -10000 0 -0.24 70 70
homophilic cell adhesion 0 0.003 -10000 0 -10000 0 0
Syndecan-2-mediated signaling events

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.018 0.069 -9999 0 -0.16 81 81
EPHB2 0.02 0.02 -9999 0 -0.12 11 11
Syndecan-2/TACI 0.014 0.043 -9999 0 -0.11 47 47
LAMA1 0 0.053 -9999 0 -0.12 89 89
Syndecan-2/alpha2 ITGB1 -0.007 0.08 -9999 0 -0.15 76 76
HRAS 0.023 0.006 -9999 0 -0.12 1 1
Syndecan-2/CASK -0.001 0.039 -9999 0 -0.11 47 47
ITGA5 0.013 0.036 -9999 0 -0.12 38 38
BAX 0.025 0.021 -9999 0 -10000 0 0
EPB41 0.02 0.019 -9999 0 -0.12 9 9
positive regulation of cell-cell adhesion 0.004 0.05 -9999 0 -0.1 84 84
LAMA3 0.006 0.043 -9999 0 -0.12 55 55
EZR 0 0 -9999 0 -10000 0 0
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
CAV2 0.01 0.039 -9999 0 -0.12 45 45
Syndecan-2/MMP2 -0.016 0.066 -9999 0 -0.16 68 68
RP11-540L11.1 0 0 -9999 0 -10000 0 0
alpha2 ITGB1 0.007 0.061 -9999 0 -0.15 60 60
dendrite morphogenesis 0.01 0.049 -9999 0 -0.12 49 49
Syndecan-2/GM-CSF 0.014 0.043 -9999 0 -0.11 48 48
determination of left/right symmetry 0.011 0.025 -9999 0 -0.067 50 50
Syndecan-2/PKC delta 0.01 0.049 -9999 0 -0.12 54 54
GNB2L1 0.023 0.003 -9999 0 -10000 0 0
MAPK3 0.014 0.039 -9999 0 -0.094 48 48
MAPK1 0.013 0.039 -9999 0 -0.096 48 48
Syndecan-2/RACK1 0.024 0.043 -9999 0 -0.087 54 54
NF1 0.018 0.02 -9999 0 -0.12 10 10
FGFR/FGF/Syndecan-2 0.011 0.025 -9999 0 -0.067 50 50
ITGA2 0.011 0.038 -9999 0 -0.12 41 41
MAPK8 0.02 0.023 -9999 0 -0.11 1 1
Syndecan-2/alpha2/beta1 Integrin 0.005 0.07 -9999 0 -0.11 121 121
Syndecan-2/Kininogen 0.014 0.043 -9999 0 -0.11 47 47
ITGB1 0.021 0.015 -9999 0 -0.12 6 6
SRC 0.017 0.036 -9999 0 -0.078 54 54
Syndecan-2/CASK/Protein 4.1 0.009 0.045 -9999 0 -0.1 61 61
extracellular matrix organization 0.01 0.049 -9999 0 -0.12 53 53
actin cytoskeleton reorganization -0.018 0.069 -9999 0 -0.16 81 81
Syndecan-2/Caveolin-2/Ras 0.009 0.062 -9999 0 -0.11 95 95
Syndecan-2/Laminin alpha3 -0.001 0.06 -9999 0 -0.14 62 62
Syndecan-2/RasGAP 0.027 0.051 -9999 0 -0.082 80 80
alpha5/beta1 Integrin 0.016 0.048 -9999 0 -0.14 34 34
PRKCD 0.02 0.018 -9999 0 -0.12 8 8
Syndecan-2 dimer 0.011 0.049 -9999 0 -0.12 49 49
GO:0007205 0.004 0 -9999 0 -10000 0 0
DNA mediated transformation 0 0 -9999 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.026 0.047 -9999 0 -0.14 7 7
RHOA 0.023 0.006 -9999 0 -0.12 1 1
SDCBP 0.021 0.01 -9999 0 -0.12 2 2
TNFRSF13B 0.023 0 -9999 0 -10000 0 0
RASA1 0.021 0.012 -9999 0 -0.12 3 3
alpha2/beta1 Integrin 0.007 0.061 -9999 0 -0.15 60 60
Syndecan-2/Synbindin 0.006 0.05 -9999 0 -0.12 56 56
TGFB1 0.019 0.023 -9999 0 -0.12 14 14
CASP3 0.01 0.043 -9999 0 -0.1 54 54
FN1 -0.013 0.056 -9999 0 -0.12 114 114
Syndecan-2/IL8 0.001 0.055 -9999 0 -0.13 61 61
SDC2 0.011 0.025 -9999 0 -0.067 50 50
KNG1 0.022 0.011 -9999 0 -0.12 3 3
Syndecan-2/Neurofibromin 0.007 0.051 -9999 0 -0.13 52 52
TRAPPC4 0.016 0.025 -9999 0 -0.12 16 16
CSF2 0.023 0.009 -9999 0 -0.12 2 2
Syndecan-2/TGFB1 0.01 0.049 -9999 0 -0.12 53 53
Syndecan-2/Syntenin/PI-4-5-P2 0.004 0.05 -9999 0 -0.1 84 84
Syndecan-2/Ezrin 0.012 0.04 -9999 0 -0.097 51 51
PRKACA 0.008 0.045 -9999 0 -0.11 53 53
angiogenesis 0.001 0.055 -9999 0 -0.13 61 61
MMP2 -0.015 0.059 -9999 0 -0.12 128 128
IL8 0.004 0.047 -9999 0 -0.12 69 69
calcineurin-NFAT signaling pathway 0.014 0.043 -9999 0 -0.11 47 47
BCR signaling pathway

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN -0.024 0.11 -10000 0 -0.25 76 76
IKBKB 0.013 0.077 0.19 14 -0.23 27 41
AKT1 -0.008 0.06 0.14 12 -0.15 49 61
IKBKG 0.012 0.068 0.16 1 -0.22 26 27
CALM1 -0.008 0.1 0.16 4 -0.28 52 56
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
MAP3K1 -0.029 0.13 -10000 0 -0.33 63 63
MAP3K7 0.021 0.014 -10000 0 -0.12 5 5
mol:Ca2+ -0.012 0.11 0.16 4 -0.29 53 57
DOK1 0.021 0.016 -10000 0 -0.12 7 7
AP-1 -0.014 0.077 0.14 1 -0.18 73 74
LYN 0.02 0.013 -10000 0 -0.12 4 4
BLNK 0.014 0.033 -10000 0 -0.12 31 31
SHC1 0.023 0.001 -10000 0 -10000 0 0
BCR complex 0.028 0.026 -10000 0 -0.077 32 32
CD22 -0.04 0.1 -10000 0 -0.21 108 108
CAMK2G -0.003 0.099 0.15 4 -0.26 50 54
CSNK2A1 0.021 0.015 -10000 0 -0.12 6 6
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.001 0.052 -10000 0 -0.14 37 37
GO:0007205 -0.012 0.11 0.16 4 -0.3 53 57
SYK 0.016 0.027 -10000 0 -0.12 20 20
ELK1 -0.008 0.1 0.16 4 -0.28 51 55
NFATC1 -0.014 0.084 0.16 1 -0.22 58 59
B-cell antigen/BCR complex 0.028 0.026 -10000 0 -0.077 32 32
PAG1/CSK 0.032 0.02 -10000 0 -0.1 12 12
NFKBIB 0.008 0.045 -10000 0 -0.13 46 46
HRAS -0.001 0.087 0.13 3 -0.25 44 47
NFKBIA 0.011 0.041 -10000 0 -0.12 36 36
NF-kappa-B/RelA/I kappa B beta 0.014 0.043 -10000 0 -0.12 41 41
RasGAP/Csk 0.023 0.067 -10000 0 -0.087 127 127
mol:GDP -0.011 0.11 0.15 4 -0.29 52 56
PTEN 0.022 0.008 -10000 0 -0.12 1 1
CD79B 0.023 0.006 -10000 0 -0.12 1 1
NF-kappa-B/RelA/I kappa B alpha 0.014 0.04 -10000 0 -0.11 41 41
GRB2 0.023 0.006 -10000 0 -0.12 1 1
PI3K/BCAP/CD19 -0.029 0.13 -10000 0 -0.36 60 60
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
mol:IP3 -0.012 0.11 0.16 4 -0.3 53 57
CSK 0.023 0.009 -10000 0 -0.12 2 2
FOS -0.023 0.11 0.15 2 -0.29 56 58
CHUK -0.004 0.096 0.16 1 -0.26 55 56
IBTK 0.02 0.016 -10000 0 -0.12 6 6
CARD11/BCL10/MALT1/TAK1 0.006 0.1 0.19 1 -0.24 54 55
PTPN6 -0.036 0.095 -10000 0 -0.2 108 108
RELA 0.023 0.009 -10000 0 -0.12 2 2
BCL2A1 0.009 0.034 -10000 0 -0.079 53 53
VAV2 -0.031 0.11 -10000 0 -0.31 56 56
ubiquitin-dependent protein catabolic process 0.012 0.045 -10000 0 -0.12 46 46
BTK -0.05 0.25 -10000 0 -1.1 32 32
CD19 -0.032 0.095 -10000 0 -0.21 94 94
MAP4K1 0.02 0.023 -10000 0 -0.12 14 14
CD72 0.023 0.006 -10000 0 -0.12 1 1
PAG1 0.022 0.014 -10000 0 -0.12 5 5
MAPK14 -0.021 0.11 -10000 0 -0.28 63 63
SH3BP5 0.021 0.015 -10000 0 -0.12 6 6
PIK3AP1 -0.009 0.11 0.17 4 -0.33 46 50
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.012 0.13 -10000 0 -0.29 85 85
RAF1 0.002 0.083 0.13 3 -0.24 42 45
RasGAP/p62DOK/SHIP 0.015 0.062 -10000 0 -0.084 131 131
CD79A 0.016 0.032 -10000 0 -0.12 28 28
re-entry into mitotic cell cycle -0.014 0.076 0.14 1 -0.18 73 74
RASA1 0.021 0.012 -10000 0 -0.12 3 3
MAPK3 0.009 0.074 0.13 3 -0.21 36 39
MAPK1 0.008 0.074 0.13 3 -0.22 36 39
CD72/SHP1 -0.026 0.095 -10000 0 -0.22 71 71
NFKB1 0.021 0.013 -10000 0 -0.12 4 4
MAPK8 -0.022 0.11 -10000 0 -0.29 63 63
actin cytoskeleton organization -0.024 0.098 -10000 0 -0.28 56 56
NF-kappa-B/RelA 0.022 0.096 -10000 0 -0.23 54 54
Calcineurin 0.014 0.098 -10000 0 -0.25 48 48
PI3K -0.038 0.075 -10000 0 -0.22 60 60
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.012 0.11 0.17 4 -0.34 42 46
SOS1 0.017 0.027 -10000 0 -0.12 20 20
Bam32/HPK1 -0.042 0.18 -10000 0 -0.55 46 46
DAPP1 -0.057 0.19 -10000 0 -0.61 46 46
cytokine secretion -0.012 0.08 0.16 1 -0.21 58 59
mol:DAG -0.012 0.11 0.16 4 -0.3 53 57
PLCG2 0.02 0.02 -10000 0 -0.12 11 11
MAP2K1 0.006 0.079 0.13 3 -0.22 39 42
B-cell antigen/BCR complex/FcgammaRIIB 0.009 0.063 -10000 0 -0.11 99 99
mol:PI-3-4-5-P3 -0.034 0.057 0.095 1 -0.17 56 57
ETS1 -0.006 0.098 0.15 2 -0.27 50 52
B-cell antigen/BCR complex/LYN/SYK/BLNK 0.029 0.069 -10000 0 -0.1 96 96
B-cell antigen/BCR complex/LYN -0.037 0.1 -10000 0 -0.22 94 94
MALT1 0.017 0.026 -10000 0 -0.12 19 19
TRAF6 0.022 0.009 -10000 0 -0.12 2 2
RAC1 -0.026 0.1 -10000 0 -0.29 56 56
B-cell antigen/BCR complex/LYN/SYK -0.004 0.091 -10000 0 -0.22 54 54
CARD11 -0.009 0.11 0.16 4 -0.28 52 56
FCGR2B 0.004 0.044 -10000 0 -0.12 60 60
PPP3CA 0.021 0.014 -10000 0 -0.12 5 5
BCL10 0.023 0.001 -10000 0 -10000 0 0
IKK complex 0.012 0.039 0.1 16 -0.096 26 42
PTPRC -0.004 0.051 -10000 0 -0.12 86 86
PDPK1 -0.01 0.054 0.13 13 -0.13 52 65
PPP3CB 0.023 0.003 -10000 0 -10000 0 0
PPP3CC 0.022 0.011 -10000 0 -0.12 3 3
POU2F2 0.012 0.033 -10000 0 -0.075 53 53
Circadian rhythm pathway

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
chromatin modification -0.068 0.31 -10000 0 -1 50 50
CLOCK 0.017 0.024 -10000 0 -0.056 40 40
TIMELESS/CRY2 -0.064 0.31 -10000 0 -1 50 50
DEC1/BMAL1 0.024 0.039 -10000 0 -0.13 30 30
ATR 0.02 0.015 -10000 0 -0.12 5 5
NR1D1 -0.01 0.11 -10000 0 -0.53 2 2
ARNTL 0.018 0.023 -10000 0 -0.051 37 37
TIMELESS -0.08 0.33 -10000 0 -1.1 50 50
NPAS2 0.002 0.049 -10000 0 -0.097 94 94
CRY2 0.023 0 -10000 0 -10000 0 0
mol:CO 0.001 0.042 0.13 50 -10000 0 50
CHEK1 0.012 0.035 -10000 0 -0.12 34 34
mol:HEME -0.001 0.042 -10000 0 -0.13 50 50
PER1 0.022 0.014 -10000 0 -0.12 5 5
BMAL/CLOCK/NPAS2 0 0.087 -10000 0 -0.12 155 155
BMAL1/CLOCK -0.033 0.19 -10000 0 -0.56 55 55
S phase of mitotic cell cycle -0.068 0.31 -10000 0 -1 50 50
TIMELESS/CHEK1/ATR -0.071 0.32 -10000 0 -1.1 50 50
mol:NADPH -0.001 0.042 -10000 0 -0.13 50 50
PER1/TIMELESS -0.064 0.31 -10000 0 -1.1 50 50
PER1-2 / CRY1-2 0 0 -10000 0 -10000 0 0
DEC1 0.022 0.011 -10000 0 -0.12 3 3
Aurora A signaling

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A 0.001 0.074 -10000 0 -0.18 70 70
BIRC5 0.018 0.023 -10000 0 -0.12 14 14
NFKBIA 0.013 0.039 0.11 8 -0.13 24 32
CPEB1 0.02 0.023 -10000 0 -0.12 14 14
AKT1 0.018 0.027 0.11 8 -0.1 12 20
NDEL1 0.023 0.006 -10000 0 -0.12 1 1
Aurora A/BRCA1 -0.006 0.069 -10000 0 -0.16 69 69
NDEL1/TACC3 0.006 0.075 -10000 0 -0.16 74 74
GADD45A 0.014 0.032 -10000 0 -0.12 29 29
GSK3B 0.021 0.013 0.071 9 -0.12 3 12
PAK1/Aurora A 0.003 0.071 -10000 0 -0.17 67 67
MDM2 0.02 0.02 -10000 0 -0.12 11 11
JUB 0.018 0.024 -10000 0 -0.12 15 15
TPX2 0.017 0.017 -10000 0 -0.071 16 16
TP53 -0.064 0.13 -10000 0 -0.25 179 179
DLG7 0.012 0.026 0.11 2 -0.059 40 42
AURKAIP1 0.02 0.021 -10000 0 -0.12 12 12
ARHGEF7 0.023 0.006 -10000 0 -0.12 1 1
G2 phase of mitotic cell cycle 0 0 -10000 0 -10000 0 0
Aurora A/NDEL1/TACC3 0.006 0.08 -10000 0 -0.17 74 74
G2/M transition of mitotic cell cycle -0.006 0.069 -10000 0 -0.15 69 69
AURKA -0.004 0.078 0.14 8 -0.2 67 75
AURKB 0.003 0.064 -10000 0 -0.27 23 23
CDC25B 0.006 0.067 -10000 0 -0.25 29 29
G2/M transition checkpoint -0.001 0.067 -10000 0 -0.15 75 75
mRNA polyadenylation 0.006 0.061 -10000 0 -0.15 67 67
Aurora A/CPEB 0.006 0.061 -10000 0 -0.15 67 67
Aurora A/TACC1/TRAP/chTOG 0.006 0.091 -10000 0 -0.18 76 76
BRCA1 0.015 0.03 -10000 0 -0.12 24 24
centrosome duplication 0.003 0.071 -10000 0 -0.17 67 67
regulation of centrosome cycle 0.005 0.074 -10000 0 -0.16 74 74
spindle assembly 0.005 0.09 -10000 0 -0.18 76 76
TDRD7 0.014 0.031 -10000 0 -0.12 27 27
Aurora A/RasGAP/Survivin 0.005 0.082 -10000 0 -0.16 81 81
CENPA 0.012 0.044 -10000 0 -0.24 13 13
Aurora A/PP2A 0.007 0.068 -10000 0 -0.16 67 67
meiosis 0 0 -10000 0 -10000 0 0
protein catabolic process -0.025 0.096 -10000 0 -0.25 67 67
negative regulation of DNA binding -0.063 0.13 -10000 0 -0.25 179 179
prophase 0 0 -10000 0 -10000 0 0
GIT1/beta-PIX 0.034 0.01 -10000 0 -0.071 5 5
RASA1 0.021 0.012 -10000 0 -0.12 3 3
Ajuba/Aurora A -0.001 0.068 -10000 0 -0.15 75 75
mitotic prometaphase 0.002 0.018 0.073 32 -10000 0 32
proteasomal ubiquitin-dependent protein catabolic process -0.004 0.077 0.14 8 -0.2 67 75
TACC1 0.014 0.035 -10000 0 -0.12 34 34
TACC3 0.014 0.032 -10000 0 -0.12 29 29
Aurora A/Antizyme1 0.005 0.077 -10000 0 -0.16 76 76
Aurora A/RasGAP 0.005 0.073 -10000 0 -0.18 67 67
OAZ1 0.017 0.025 -10000 0 -0.12 17 17
RAN 0.023 0.002 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
PRKACA 0.02 0.019 0.071 9 -0.12 8 17
GIT1 0.022 0.012 -10000 0 -0.12 4 4
GIT1/beta-PIX/PAK1 0.037 0.036 -10000 0 -0.11 21 21
Importin alpha/Importin beta/TPX2 0.017 0.017 -10000 0 -0.071 16 16
PPP2R5D 0.022 0.014 -10000 0 -0.12 5 5
Aurora A/TPX2 -0.003 0.082 -10000 0 -0.2 74 74
PAK1 0.016 0.029 -10000 0 -0.12 23 23
CKAP5 0.021 0.013 -10000 0 -0.12 4 4
Reelin signaling pathway

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.022 0.042 -9999 0 -0.1 52 52
VLDLR 0.01 0.038 -9999 0 -0.12 41 41
CRKL 0.023 0.009 -9999 0 -0.12 2 2
LRPAP1 0.018 0.024 -9999 0 -0.12 15 15
FYN 0.011 0.037 -9999 0 -0.12 40 40
ITGA3 0.012 0.034 -9999 0 -0.12 33 33
RELN/VLDLR/Fyn -0.006 0.073 -9999 0 -0.13 102 102
MAPK8IP1/MKK7/MAP3K11/JNK1 0.055 0.042 -9999 0 -0.093 31 31
AKT1 -0.015 0.078 -9999 0 -0.15 112 112
MAP2K7 0.022 0.012 -9999 0 -0.12 4 4
RAPGEF1 0.023 0 -9999 0 -10000 0 0
DAB1 0.022 0.011 -9999 0 -0.12 3 3
RELN/LRP8/DAB1 0.025 0.042 -9999 0 -0.11 21 21
LRPAP1/LRP8 0.015 0.054 -9999 0 -0.12 72 72
RELN/LRP8/DAB1/Fyn 0.02 0.056 -9999 0 -0.096 63 63
DAB1/alpha3/beta1 Integrin -0.006 0.069 -9999 0 -0.14 60 60
long-term memory 0.016 0.062 -9999 0 -0.13 20 20
DAB1/LIS1 0.016 0.067 -9999 0 -0.14 25 25
DAB1/CRLK/C3G 0.012 0.057 -9999 0 -0.13 21 21
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
DAB1/NCK2 0.019 0.067 -9999 0 -0.14 22 22
ARHGEF2 0.022 0.009 -9999 0 -0.12 2 2
mol:Src family inhibitors PP1 and PP2 0 0 -9999 0 -10000 0 0
GRIN2A 0.001 0.052 -9999 0 -0.12 86 86
CDK5R1 0.023 0.006 -9999 0 -0.12 1 1
RELN 0.001 0.053 -9999 0 -0.12 88 88
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
RELN/LRP8/Fyn 0.009 0.061 -9999 0 -0.12 62 62
GRIN2A/RELN/LRP8/DAB1/Fyn 0.015 0.066 -9999 0 -0.096 89 89
MAPK8 0.021 0.015 -9999 0 -0.12 6 6
RELN/VLDLR/DAB1 0.011 0.055 -9999 0 -0.1 69 69
ITGB1 0.021 0.015 -9999 0 -0.12 6 6
MAP1B -0.006 0.056 -9999 0 -0.11 96 96
RELN/LRP8 0.015 0.058 -9999 0 -0.12 53 53
GRIN2B/RELN/LRP8/DAB1/Fyn 0.029 0.061 -9999 0 -0.093 65 65
PI3K 0.007 0.065 -9999 0 -0.13 96 96
mol:PP2 0 0 -9999 0 -10000 0 0
alpha3/beta1 Integrin 0.004 0.063 -9999 0 -0.14 72 72
RAP1A 0.005 0.05 -9999 0 -0.13 26 26
PAFAH1B1 0.021 0.018 -9999 0 -0.12 9 9
MAPK8IP1 0.017 0.029 -9999 0 -0.12 24 24
CRLK/C3G 0.034 0.01 -9999 0 -0.14 1 1
GRIN2B 0.021 0.019 -9999 0 -0.12 10 10
NCK2 0.023 0.006 -9999 0 -0.12 1 1
neuron differentiation 0.017 0.057 -9999 0 -0.18 23 23
neuron adhesion -0.004 0.061 -9999 0 -0.13 67 67
LRP8 0.02 0.021 -9999 0 -0.12 12 12
GSK3B -0.011 0.074 -9999 0 -0.14 113 113
RELN/VLDLR/DAB1/Fyn 0.006 0.066 -9999 0 -0.1 103 103
MAP3K11 0.022 0.014 -9999 0 -0.12 5 5
RELN/VLDLR/DAB1/P13K -0.018 0.083 -9999 0 -0.16 112 112
CDK5 0.015 0.032 -9999 0 -0.12 28 28
MAPT 0.01 0.016 -9999 0 -0.094 5 5
neuron migration -0.014 0.079 -9999 0 -0.19 52 52
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 0.017 0.057 -9999 0 -0.18 23 23
RELN/VLDLR 0.007 0.071 -9999 0 -0.11 119 119
Paxillin-dependent events mediated by a4b1

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.023 0.009 -10000 0 -0.12 2 2
Rac1/GDP 0.021 0.007 -10000 0 -10000 0 0
DOCK1 0.019 0.02 -10000 0 -0.12 10 10
ITGA4 0.015 0.03 -10000 0 -0.12 24 24
RAC1 0.023 0.002 -10000 0 -10000 0 0
alpha4/beta7 Integrin 0.004 0.065 -10000 0 -0.13 106 106
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.021 0.016 -10000 0 -0.12 7 7
alpha4/beta1 Integrin 0.02 0.059 -10000 0 -0.12 75 75
alpha4/beta7 Integrin/Paxillin 0.021 0.055 -10000 0 -0.1 79 79
lamellipodium assembly 0.001 0.12 -10000 0 -0.3 63 63
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
PI3K 0.007 0.065 -10000 0 -0.13 96 96
ARF6 0.023 0.003 -10000 0 -10000 0 0
TLN1 0.021 0.012 -10000 0 -0.12 3 3
PXN 0.021 0.014 -10000 0 -0.071 13 13
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
ARF6/GTP 0.031 0.051 -10000 0 -0.13 11 11
cell adhesion 0.026 0.062 -10000 0 -0.098 96 96
CRKL/CBL 0.033 0.013 -10000 0 -0.14 2 2
alpha4/beta1 Integrin/Paxillin 0.022 0.053 -10000 0 -0.1 76 76
ITGB1 0.021 0.015 -10000 0 -0.12 6 6
ITGB7 0.019 0.024 -10000 0 -0.12 15 15
ARF6/GDP 0.02 0.008 -10000 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/VCAM1 -0.022 0.082 -10000 0 -0.12 187 187
p130Cas/Crk/Dock1 0.035 0.04 -10000 0 -0.11 34 34
VCAM1 -0.019 0.06 -10000 0 -0.12 139 139
alpha4/beta1 Integrin/Paxillin/Talin 0.027 0.063 -10000 0 -0.098 96 96
alpha4/beta1 Integrin/Paxillin/GIT1 0.034 0.055 -10000 0 -0.09 76 76
BCAR1 0.022 0.011 -10000 0 -0.12 3 3
mol:GDP -0.032 0.054 0.09 76 -10000 0 76
CBL 0.023 0.006 -10000 0 -0.12 1 1
PRKACA 0.021 0.017 -10000 0 -0.12 8 8
GIT1 0.022 0.012 -10000 0 -0.12 4 4
alpha4/beta1 Integrin/Paxillin/Talin/Actin Cytoskeleton 0.027 0.063 -10000 0 -0.098 96 96
Rac1/GTP -0.001 0.13 -10000 0 -0.33 63 63
IL2 signaling events mediated by PI3K

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.02 0.16 -10000 0 -0.69 21 21
UGCG -0.001 0.079 -10000 0 -0.73 5 5
AKT1/mTOR/p70S6K/Hsp90/TERT -0.031 0.16 -10000 0 -0.31 104 104
mol:GTP 0 0.001 -10000 0 -10000 0 0
mol:glucosylceramide -0.001 0.078 -10000 0 -0.71 5 5
mol:DAG -0.043 0.2 -10000 0 -0.89 29 29
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.04 0.18 -10000 0 -0.37 104 104
FRAP1 -0.053 0.2 -10000 0 -0.42 104 104
FOXO3 -0.053 0.2 -10000 0 -0.41 108 108
AKT1 -0.058 0.21 -10000 0 -0.44 106 106
GAB2 0.007 0.041 -10000 0 -0.12 50 50
SMPD1 0.006 0.042 -10000 0 -0.52 1 1
SGMS1 -0.029 0.16 -10000 0 -0.68 29 29
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP -0.005 0.05 -10000 0 -0.13 67 67
CALM1 0.022 0.014 -10000 0 -0.12 5 5
cell proliferation -0.039 0.16 -10000 0 -0.32 96 96
EIF3A 0.022 0.004 -10000 0 -10000 0 0
PI3K 0.008 0.067 -10000 0 -0.15 67 67
RPS6KB1 -0.031 0.18 -10000 0 -0.85 22 22
mol:sphingomyelin -0.043 0.2 -10000 0 -0.89 29 29
natural killer cell activation -0.001 0.003 -10000 0 -0.011 30 30
JAK3 0.022 0.016 -10000 0 -0.066 13 13
PIK3R1 0.015 0.033 -10000 0 -0.12 27 27
JAK1 0.022 0.013 -10000 0 -0.05 10 10
NFKB1 0.021 0.013 -10000 0 -0.12 4 4
MYC -0.11 0.32 -10000 0 -0.83 84 84
MYB -0.064 0.29 -10000 0 -1.1 42 42
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K -0.039 0.16 -10000 0 -0.32 104 104
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 -0.008 0.17 -10000 0 -0.78 22 22
mol:PI-3-4-5-P3 -0.037 0.15 -10000 0 -0.31 104 104
Rac1/GDP 0.008 0.051 -10000 0 -0.12 66 66
T cell proliferation -0.032 0.14 -10000 0 -0.29 104 104
SHC1 0.022 0.004 -10000 0 -10000 0 0
RAC1 0.023 0.002 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity -0.001 0.019 -10000 0 -0.042 80 80
PRKCZ -0.033 0.15 -10000 0 -0.3 104 104
NF kappa B1 p50/RelA -0.035 0.19 -10000 0 -0.37 109 109
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K -0.016 0.12 -10000 0 -0.33 50 50
HSP90AA1 0.023 0.003 -10000 0 -10000 0 0
RELA 0.023 0.009 -10000 0 -0.12 2 2
IL2RA 0.02 0.018 -10000 0 -0.12 8 8
IL2RB 0.019 0.025 -10000 0 -0.091 24 24
TERT 0.023 0 -10000 0 -10000 0 0
E2F1 -0.016 0.13 -10000 0 -0.42 44 44
SOS1 0.016 0.027 -10000 0 -0.12 20 20
RPS6 0.023 0.002 -10000 0 -10000 0 0
mol:cAMP 0 0.009 0.02 77 -10000 0 77
PTPN11 0.021 0.012 -10000 0 -0.12 3 3
IL2RG -0.002 0.051 -10000 0 -0.12 82 82
actin cytoskeleton organization -0.032 0.14 -10000 0 -0.29 104 104
GRB2 0.022 0.007 -10000 0 -0.12 1 1
IL2 0.023 0.014 -10000 0 -0.054 13 13
PIK3CA 0.02 0.019 -10000 0 -0.068 17 17
Rac1/GTP 0.02 0.057 -10000 0 -0.11 66 66
LCK 0.022 0.017 -10000 0 -0.091 9 9
BCL2 -0.033 0.17 -10000 0 -0.41 60 60
HIF-2-alpha transcription factor network

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MMP14 -0.098 0.3 -10000 0 -0.93 63 63
oxygen homeostasis 0.001 0.01 -10000 0 -10000 0 0
TCEB2 0.023 0.006 -10000 0 -0.12 1 1
TCEB1 0.022 0.011 -10000 0 -0.12 3 3
VHL/Elongin B/Elongin C/HIF2A 0.008 0.11 -10000 0 -0.2 68 68
EPO 0.004 0.19 -10000 0 -0.37 53 53
FIH (dimer) 0.023 0.013 -10000 0 -0.12 1 1
APEX1 0.02 0.026 -10000 0 -0.12 11 11
SERPINE1 -0.015 0.19 -10000 0 -0.38 57 57
FLT1 -0.027 0.23 -10000 0 -0.76 46 46
ADORA2A -0.01 0.17 -10000 0 -0.37 55 55
germ cell development -0.018 0.2 -10000 0 -0.36 83 83
SLC11A2 -0.011 0.19 -10000 0 -0.38 66 66
BHLHE40 -0.013 0.18 -10000 0 -0.36 68 68
HIF1AN 0.023 0.013 -10000 0 -0.12 1 1
HIF2A/ARNT/SIRT1 0.012 0.14 -10000 0 -0.26 57 57
ETS1 0.027 0.037 -10000 0 -0.11 33 33
CITED2 0.025 0.079 -10000 0 -0.86 3 3
KDR -0.027 0.22 -10000 0 -0.74 46 46
PGK1 -0.013 0.2 -10000 0 -0.38 77 77
SIRT1 0.023 0.003 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF2A/ARNT 0.022 0.23 -10000 0 -0.4 66 66
EPAS1 -0.009 0.11 -10000 0 -0.21 91 91
SP1 0.016 0.034 -10000 0 -0.077 59 59
ABCG2 -0.007 0.19 -10000 0 -0.39 58 58
EFNA1 -0.019 0.2 -10000 0 -0.4 79 79
FXN -0.011 0.17 -10000 0 -0.37 55 55
POU5F1 -0.02 0.2 -10000 0 -0.37 83 83
neuron apoptosis -0.021 0.23 0.4 66 -10000 0 66
EP300 0.022 0.01 -10000 0 -0.12 2 2
EGLN3 -0.001 0.051 -10000 0 -0.12 84 84
EGLN2 0.023 0.014 -10000 0 -0.12 2 2
EGLN1 0.023 0.014 -10000 0 -0.12 2 2
VHL/Elongin B/Elongin C 0.041 0.029 -10000 0 -0.12 15 15
VHL 0.021 0.016 -10000 0 -0.12 7 7
ARNT 0.023 0.021 -10000 0 -0.12 4 4
SLC2A1 -0.024 0.19 -10000 0 -0.38 77 77
TWIST1 -0.011 0.17 -10000 0 -0.35 67 67
ELK1 0.028 0.019 -10000 0 -0.1 9 9
HIF2A/ARNT/Cbp/p300 0.008 0.15 -10000 0 -0.28 59 59
VEGFA -0.013 0.2 -10000 0 -0.4 66 66
CREBBP 0.021 0.015 -10000 0 -0.12 6 6
Ephrin A reverse signaling

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAPKKK cascade 0.017 0.04 -9999 0 -0.089 68 68
EFNA5 0.014 0.033 -9999 0 -0.12 30 30
FYN 0.007 0.043 -9999 0 -0.12 40 40
neuron projection morphogenesis 0.017 0.04 -9999 0 -0.089 68 68
cell-cell signaling 0 0 -9999 0 -10000 0 0
Ephrin A5/EPHA5 0.017 0.041 -9999 0 -0.089 68 68
EPHA5 0.023 0.009 -9999 0 -0.12 2 2
FOXA2 and FOXA3 transcription factor networks

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL -0.056 0.28 -10000 0 -0.62 64 64
PCK1 -0.16 0.41 -10000 0 -1 85 85
HNF4A -0.11 0.36 -10000 0 -0.73 112 112
KCNJ11 -0.012 0.27 -10000 0 -0.6 47 47
AKT1 -0.004 0.16 -10000 0 -0.31 51 51
response to starvation -0.019 0.045 -10000 0 -0.13 69 69
DLK1 -0.028 0.28 -10000 0 -0.63 52 52
NKX2-1 -0.01 0.15 -10000 0 -0.54 1 1
ACADM -0.069 0.3 -10000 0 -0.66 75 75
TAT -0.025 0.2 -10000 0 -0.6 14 14
CEBPB 0.021 0.032 -10000 0 -0.12 29 29
CEBPA 0.029 0.015 -10000 0 -0.12 5 5
TTR 0.011 0.16 -10000 0 -0.83 4 4
PKLR -0.045 0.27 -10000 0 -0.62 51 51
APOA1 -0.17 0.49 -10000 0 -1 115 115
CPT1C -0.052 0.27 -10000 0 -0.61 58 58
ALAS1 -0.012 0.19 -10000 0 -0.62 14 14
TFRC -0.1 0.4 -10000 0 -0.94 85 85
FOXF1 0.015 0.012 -10000 0 -0.11 5 5
NF1 0.024 0.026 -10000 0 -0.13 12 12
HNF1A (dimer) 0.042 0.019 -10000 0 -0.13 5 5
CPT1A -0.064 0.29 -10000 0 -0.63 77 77
HMGCS1 -0.059 0.29 -10000 0 -0.64 64 64
NR3C1 0.035 0.017 -10000 0 -0.11 5 5
CPT1B -0.047 0.27 -10000 0 -0.61 56 56
chromatin remodeling 0 0 -10000 0 -10000 0 0
SP1 0.029 0.013 -10000 0 -0.14 2 2
GCK -0.045 0.27 -10000 0 -0.6 54 54
CREB1 -0.009 0.07 -10000 0 -0.17 76 76
IGFBP1 -0.014 0.16 -10000 0 -0.52 8 8
PDX1 0.028 0.17 -10000 0 -0.7 5 5
UCP2 -0.093 0.33 -10000 0 -0.68 95 95
ALDOB -0.012 0.27 -10000 0 -0.61 44 44
AFP 0.017 0.051 -10000 0 -0.34 1 1
BDH1 -0.07 0.3 -10000 0 -0.64 77 77
HADH -0.021 0.28 -10000 0 -0.63 49 49
F2 -0.066 0.34 -10000 0 -0.8 49 49
HNF1A 0.042 0.019 -10000 0 -0.13 5 5
G6PC 0.025 0.076 -10000 0 -0.42 1 1
SLC2A2 0.021 0.18 -10000 0 -0.66 2 2
INS 0.009 0.012 0.16 1 -0.14 2 3
FOXA1 0.035 0.03 -10000 0 -0.21 2 2
FOXA3 0.002 0.097 -10000 0 -0.19 76 76
FOXA2 -0.008 0.32 -10000 0 -0.67 54 54
ABCC8 -0.012 0.27 -10000 0 -0.61 44 44
ALB 0.017 0.051 -10000 0 -0.3 3 3
Retinoic acid receptors-mediated signaling

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.019 0.02 -10000 0 -0.12 10 10
HDAC3 0.023 0.002 -10000 0 -10000 0 0
VDR 0.019 0.022 -10000 0 -0.12 13 13
Cbp/p300/PCAF 0.02 0.043 -10000 0 -0.13 41 41
EP300 0.022 0.01 -10000 0 -0.12 2 2
RARs/AIB1/Cbp/p300/PCAF/9cRA -0.001 0.095 -10000 0 -0.26 48 48
KAT2B 0 0 -10000 0 -10000 0 0
MAPK14 0.023 0.007 -10000 0 -0.12 1 1
AKT1 0.019 0.089 0.17 78 -0.18 45 123
RAR alpha/9cRA/Cyclin H -0.016 0.12 -10000 0 -0.22 106 106
mol:9cRA 0 0 -10000 0 -10000 0 0
RARs/Src-1/Cbp/p300/PCAF/9cRA 0.002 0.081 -10000 0 -0.2 55 55
CDC2 0.006 0.04 -10000 0 -0.12 46 46
response to UV -0.001 0.008 -10000 0 -10000 0 0
RAR alpha/Jnk1 0.006 0.062 -10000 0 -0.15 52 52
NCOR2 0.019 0.023 -10000 0 -0.12 15 15
VDR/VDR/Vit D3 0.008 0.035 -10000 0 -0.12 36 36
RXRs/RARs/NRIP1/9cRA -0.044 0.19 -10000 0 -0.48 72 72
NCOA2 0.021 0.013 -10000 0 -0.12 4 4
NCOA3 0.021 0.012 -10000 0 -0.12 3 3
NCOA1 0.022 0.009 -10000 0 -0.12 2 2
VDR/VDR/DNA 0.019 0.022 -10000 0 -0.12 13 13
RARG 0.02 0.016 -10000 0 -0.12 6 6
RAR gamma1/9cRA 0.024 0.028 -10000 0 -0.11 18 18
MAPK3 0.02 0.015 -10000 0 -0.12 5 5
MAPK1 0.021 0.016 -10000 0 -0.12 7 7
MAPK8 0.019 0.018 -10000 0 -0.12 6 6
mol:Vit D3 0 0 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 -0.036 0.14 -10000 0 -0.31 96 96
RARA 0.01 0.056 -10000 0 -0.12 63 63
negative regulation of phosphoinositide 3-kinase cascade 0 0 -10000 0 -10000 0 0
RARs/TIF2/Cbp/p300/PCAF/9cRA 0 0.086 -10000 0 -0.21 56 56
PRKCA 0.008 0.043 -10000 0 -0.088 78 78
RXRs/RARs/NRIP1/9cRA/HDAC1 -0.063 0.21 -10000 0 -0.54 74 74
RXRG -0.006 0.07 -10000 0 -0.19 56 56
RXRA -0.034 0.11 -10000 0 -0.21 98 98
RXRB 0.003 0.064 -10000 0 -0.19 43 43
VDR/Vit D3/DNA 0.008 0.035 -10000 0 -0.12 36 36
RBP1 0.01 0.035 -10000 0 -0.12 35 35
CRBP1/9-cic-RA -0.019 0.065 -10000 0 -0.13 138 138
RARB 0.012 0.036 -10000 0 -0.12 33 33
PRKCG 0.018 0.025 -10000 0 -0.052 52 52
MNAT1 0.023 0.007 -10000 0 -0.12 1 1
RAR alpha/RXRs -0.021 0.16 -10000 0 -0.36 81 81
RXRs/RARs/SMRT(N-CoR2)/9cRA -0.016 0.13 -10000 0 -0.28 79 79
proteasomal ubiquitin-dependent protein catabolic process -0.01 0.099 -10000 0 -0.25 51 51
RXRs/RARs/NRIP1/9cRA/HDAC3 -0.06 0.21 -10000 0 -0.54 73 73
positive regulation of DNA binding -0.02 0.11 -10000 0 -0.2 106 106
NRIP1 -0.098 0.32 -10000 0 -0.98 59 59
RXRs/RARs -0.048 0.17 -10000 0 -0.4 93 93
RXRs/RXRs/DNA/9cRA -0.042 0.14 -10000 0 -0.32 95 95
PRKACA 0.021 0.017 -10000 0 -0.12 8 8
CDK7 0.018 0.023 -10000 0 -0.12 14 14
TFIIH 0.029 0.053 -10000 0 -0.13 46 46
RAR alpha/9cRA 0.023 0.071 -10000 0 -0.2 26 26
CCNH 0.02 0.022 -10000 0 -0.12 13 13
CREBBP 0.021 0.015 -10000 0 -0.12 6 6
RAR gamma2/9cRA 0.025 0.05 -10000 0 -0.18 16 16
ErbB2/ErbB3 signaling events

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 0.012 0.012 -10000 0 -0.057 15 15
RAS family/GTP 0.004 0.084 -10000 0 -0.18 52 52
NFATC4 0.001 0.053 0.18 6 -0.12 40 46
ERBB2IP 0.021 0.019 -10000 0 -0.12 9 9
HSP90 (dimer) 0.023 0.003 -10000 0 -10000 0 0
mammary gland morphogenesis 0 0.066 0.19 7 -0.12 85 92
JUN 0.004 0.07 -10000 0 -10000 0 0
HRAS 0.023 0.006 -10000 0 -0.12 1 1
DOCK7 -0.005 0.066 0.19 6 -0.13 91 97
ErbB2/ErbB3/neuregulin 1 beta/SHC 0.017 0.061 0.21 7 -0.1 88 95
AKT1 0.01 0.012 -10000 0 -0.078 10 10
BAD 0.013 0.011 -10000 0 -0.057 13 13
MAPK10 0.002 0.045 0.14 6 -0.1 43 49
mol:GTP -0.001 0.001 -10000 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta 0.001 0.071 0.2 7 -0.13 85 92
RAF1 -0.005 0.085 -10000 0 -0.18 57 57
ErbB2/ErbB3/neuregulin 2 0.004 0.054 -10000 0 -0.11 88 88
STAT3 -0.003 0.17 -10000 0 -0.93 19 19
cell migration 0.001 0.053 0.16 5 -0.12 43 48
mol:PI-3-4-5-P3 0 0.001 -10000 0 -10000 0 0
cell proliferation -0.063 0.21 -10000 0 -0.52 66 66
FOS -0.072 0.2 -10000 0 -0.41 127 127
NRAS 0.021 0.011 -10000 0 -0.12 3 3
mol:Ca2+ 0 0.066 0.19 7 -0.12 85 92
MAPK3 -0.04 0.17 -10000 0 -0.47 47 47
MAPK1 -0.042 0.17 -10000 0 -0.47 50 50
JAK2 -0.005 0.065 0.19 6 -0.13 88 94
NF2 0.013 0.046 -10000 0 -0.73 2 2
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 0.012 0.051 0.13 8 -0.16 28 36
NRG1 0.02 0.017 -10000 0 -0.12 8 8
GRB2/SOS1 0.021 0.045 -10000 0 -0.15 29 29
MAPK8 -0.012 0.092 0.18 6 -0.19 98 104
MAPK9 0.003 0.044 0.14 5 -0.11 36 41
ERBB2 0 0.048 0.27 15 -10000 0 15
ERBB3 0.013 0.031 -10000 0 -0.12 26 26
SHC1 0.023 0.001 -10000 0 -10000 0 0
RAC1 0.023 0.002 -10000 0 -10000 0 0
apoptosis -0.009 0.017 0.084 12 -10000 0 12
STAT3 (dimer) -0.002 0.17 -10000 0 -0.91 19 19
RNF41 0.013 0.012 -10000 0 -0.047 17 17
FRAP1 0.013 0.011 -10000 0 -0.057 14 14
RAC1-CDC42/GTP -0.006 0.05 -10000 0 -0.11 57 57
ErbB2/ErbB2/HSP90 (dimer) 0.012 0.028 -10000 0 -0.1 25 25
CHRNA1 -0.025 0.14 -10000 0 -0.34 50 50
myelination 0 0.053 0.18 6 -0.14 22 28
PPP3CB -0.001 0.058 0.18 6 -0.11 86 92
KRAS 0.014 0.034 -10000 0 -0.12 33 33
RAC1-CDC42/GDP 0.017 0.074 -10000 0 -0.13 83 83
NRG2 0.023 0.006 -10000 0 -0.12 1 1
mol:GDP 0.012 0.051 0.13 8 -0.16 28 36
SOS1 0.017 0.027 -10000 0 -0.12 20 20
MAP2K2 -0.01 0.09 -10000 0 -0.18 75 75
SRC 0.023 0.009 -10000 0 -0.12 2 2
mol:cAMP 0 0.001 -10000 0 -10000 0 0
PTPN11 -0.002 0.063 0.19 5 -0.12 86 91
MAP2K1 -0.043 0.16 -10000 0 -0.39 60 60
heart morphogenesis 0 0.066 0.19 7 -0.12 85 92
RAS family/GDP 0.012 0.085 -10000 0 -0.18 48 48
GRB2 0.023 0.006 -10000 0 -0.12 1 1
PRKACA 0.01 0.048 -10000 0 -0.77 2 2
CHRNE 0.01 0.019 -10000 0 -10000 0 0
HSP90AA1 0.023 0.003 -10000 0 -10000 0 0
activation of caspase activity -0.01 0.012 0.078 10 -10000 0 10
nervous system development 0 0.066 0.19 7 -0.12 85 92
CDC42 0.023 0.002 -10000 0 -10000 0 0
Arf6 downstream pathway

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR -0.027 0.22 -10000 0 -0.83 37 37
regulation of axonogenesis -0.005 0.059 0.18 43 -10000 0 43
myoblast fusion 0 0.1 0.38 37 -10000 0 37
mol:GTP 0 0.065 -10000 0 -0.22 44 44
regulation of calcium-dependent cell-cell adhesion -0.007 0.087 0.16 100 -10000 0 100
ARF1/GTP 0.013 0.055 -10000 0 -0.16 45 45
mol:GM1 -0.002 0.048 -10000 0 -0.16 44 44
mol:Choline 0.004 0.051 -10000 0 -0.15 45 45
lamellipodium assembly -0.006 0.12 -10000 0 -0.41 44 44
MAPK3 0.005 0.085 -10000 0 -0.28 44 44
ARF6/GTP/NME1/Tiam1 0.008 0.088 -10000 0 -0.16 100 100
ARF1 0.018 0.028 -10000 0 -0.12 21 21
ARF6/GDP 0 0.1 -10000 0 -0.38 37 37
ARF1/GDP 0.005 0.1 -10000 0 -0.33 44 44
ARF6 0.016 0.035 -10000 0 -0.12 35 35
RAB11A 0.023 0.007 -10000 0 -0.12 1 1
TIAM1 0.014 0.034 -10000 0 -0.13 28 28
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 0.004 0.087 -10000 0 -0.28 45 45
actin filament bundle formation -0.007 0.1 0.34 44 -10000 0 44
KALRN 0.002 0.08 -10000 0 -0.29 37 37
RAB11FIP3/RAB11A 0.031 0.023 -10000 0 -0.13 11 11
RhoA/GDP 0.007 0.1 -10000 0 -0.34 44 44
NME1 0.014 0.031 -10000 0 -0.12 24 24
Rac1/GDP 0.007 0.1 -10000 0 -0.34 44 44
substrate adhesion-dependent cell spreading 0 0.065 -10000 0 -0.22 44 44
cortical actin cytoskeleton organization -0.007 0.12 -10000 0 -0.41 44 44
RAC1 0.023 0.002 -10000 0 -10000 0 0
liver development 0 0.065 -10000 0 -0.22 44 44
ARF6/GTP 0 0.065 -10000 0 -0.22 44 44
RhoA/GTP 0.016 0.056 -10000 0 -0.17 44 44
mol:GDP -0.005 0.11 -10000 0 -0.36 44 44
ARF6/GTP/RAB11FIP3/RAB11A 0.029 0.052 -10000 0 -0.13 50 50
RHOA 0.023 0.006 -10000 0 -0.12 1 1
PLD1 0 0.059 -10000 0 -0.18 44 44
RAB11FIP3 0.022 0.011 -10000 0 -0.12 3 3
tube morphogenesis -0.006 0.12 -10000 0 -0.41 44 44
ruffle organization 0.005 0.059 -10000 0 -0.18 43 43
regulation of epithelial cell migration 0 0.065 -10000 0 -0.22 44 44
PLD2 0.01 0.05 -10000 0 -0.16 45 45
PIP5K1A 0.005 0.059 -10000 0 -0.18 43 43
mol:Phosphatidic acid 0.004 0.051 -10000 0 -0.15 45 45
Rac1/GTP -0.007 0.12 -10000 0 -0.41 44 44
FoxO family signaling

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G6PC 0.023 0.06 -9999 0 -0.41 1 1
PLK1 -0.15 0.36 -9999 0 -0.85 85 85
CDKN1B -0.05 0.19 -9999 0 -0.35 111 111
FOXO3 -0.13 0.32 -9999 0 -0.6 133 133
KAT2B -0.011 0.027 -9999 0 -0.045 193 193
FOXO1/SIRT1 0.025 0.065 -9999 0 -0.24 15 15
CAT -0.16 0.38 -9999 0 -0.92 82 82
CTNNB1 0.022 0.008 -9999 0 -0.12 1 1
AKT1 0.009 0.038 -9999 0 -0.072 39 39
FOXO1 0.016 0.066 -9999 0 -0.27 11 11
MAPK10 0.013 0.042 -9999 0 -0.1 39 39
mol:GTP 0 0.003 -9999 0 -10000 0 0
FOXO4 0.011 0.13 -9999 0 -0.34 41 41
response to oxidative stress -0.008 0.029 -9999 0 -0.052 106 106
FOXO3A/SIRT1 -0.14 0.3 -9999 0 -0.48 202 202
XPO1 0.022 0.01 -9999 0 -0.12 2 2
EP300 0.024 0.01 -9999 0 -0.12 2 2
BCL2L11 0.005 0.086 -9999 0 -1.3 2 2
FOXO1/SKP2 0.022 0.069 -9999 0 -0.25 17 17
mol:GDP -0.008 0.029 -9999 0 -0.052 106 106
RAN 0.024 0.003 -9999 0 -10000 0 0
GADD45A -0.081 0.27 -9999 0 -0.72 61 61
YWHAQ 0.023 0.003 -9999 0 -10000 0 0
FOXO1/14-3-3 family 0.041 0.086 -9999 0 -0.27 21 21
MST1 0.007 0.034 -9999 0 -0.068 19 19
CSNK1D 0.023 0.001 -9999 0 -10000 0 0
CSNK1E 0.022 0.015 -9999 0 -0.12 6 6
FOXO4/14-3-3 family 0.013 0.12 -9999 0 -0.35 29 29
YWHAB 0.023 0.007 -9999 0 -0.12 1 1
MAPK8 0.016 0.042 -9999 0 -0.11 31 31
MAPK9 0.015 0.042 -9999 0 -0.12 28 28
YWHAG 0.02 0.022 -9999 0 -0.12 13 13
YWHAE 0.022 0.014 -9999 0 -0.12 5 5
YWHAZ 0.023 0.003 -9999 0 -10000 0 0
SIRT1 0.02 0.008 -9999 0 -10000 0 0
SOD2 -0.092 0.3 -9999 0 -0.69 84 84
RBL2 -0.083 0.27 -9999 0 -0.69 54 54
RAL/GDP 0.019 0.043 -9999 0 -0.13 26 26
CHUK 0.007 0.034 -9999 0 -0.056 50 50
Ran/GTP 0.017 0.014 -9999 0 -0.14 3 3
CSNK1G2 0.022 0.011 -9999 0 -0.12 3 3
RAL/GTP 0.022 0.044 -9999 0 -0.12 26 26
CSNK1G1 0.023 0.009 -9999 0 -0.12 2 2
FASLG 0.007 0.068 -9999 0 -1.2 1 1
SKP2 0.018 0.024 -9999 0 -0.12 16 16
USP7 0.02 0.02 -9999 0 -0.12 10 10
IKBKB 0.007 0.036 -9999 0 -0.06 48 48
CCNB1 -0.18 0.42 -9999 0 -0.98 97 97
FOXO1-3a-4/beta catenin -0.036 0.21 -9999 0 -0.39 95 95
proteasomal ubiquitin-dependent protein catabolic process 0.022 0.068 -9999 0 -0.25 17 17
CSNK1A1 0.022 0.007 -9999 0 -0.12 1 1
SGK1 -0.011 0.027 -9999 0 -0.045 193 193
CSNK1G3 0.022 0.007 -9999 0 -0.12 1 1
Ran/GTP/Exportin 1 0.027 0.032 -9999 0 -0.12 25 25
ZFAND5 0.019 0.12 -9999 0 -0.54 9 9
SFN 0.014 0.032 -9999 0 -0.12 29 29
CDK2 0.022 0.023 -9999 0 -0.12 14 14
FOXO3A/14-3-3 -0.005 0.13 -9999 0 -0.33 47 47
CREBBP 0.025 0.016 -9999 0 -0.12 6 6
FBXO32 -0.27 0.5 -9999 0 -1.1 148 148
BCL6 -0.12 0.34 -9999 0 -0.96 55 55
RALB 0.023 0.008 -9999 0 -0.12 1 1
RALA 0.023 0.009 -9999 0 -0.12 2 2
YWHAH 0.021 0.014 -9999 0 -0.12 5 5
ceramide signaling pathway

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K4 -0.012 0.11 -10000 0 -0.21 118 118
BAG4 0.022 0.012 -10000 0 -0.12 4 4
BAD 0.007 0.036 -10000 0 -0.11 20 20
NFKBIA 0.016 0.028 -10000 0 -0.12 21 21
BIRC3 -0.005 0.053 -10000 0 -0.12 94 94
BAX 0.007 0.036 -10000 0 -0.11 19 19
EnzymeConsortium:3.1.4.12 0 0.027 -10000 0 -0.063 41 41
IKBKB -0.009 0.11 -10000 0 -0.2 119 119
MAP2K2 0.013 0.036 -10000 0 -0.1 23 23
MAP2K1 0.015 0.033 -10000 0 -0.099 20 20
SMPD1 0.005 0.028 -10000 0 -0.094 16 16
GO:0005551 0 0 -10000 0 -10000 0 0
FADD/Caspase 8 -0.005 0.12 -10000 0 -0.2 119 119
MAP2K4 0.008 0.039 -10000 0 -0.11 30 30
protein ubiquitination -0.012 0.11 -10000 0 -0.2 119 119
EnzymeConsortium:2.7.1.37 0.017 0.034 -10000 0 -0.11 12 12
response to UV 0 0 -10000 0 -0.001 8 8
RAF1 0.011 0.035 -10000 0 -0.11 21 21
CRADD 0.023 0.009 -10000 0 -0.12 2 2
mol:ceramide 0.003 0.038 -10000 0 -0.12 20 20
I-kappa-B-alpha/RELA/p50/ubiquitin 0.018 0.041 -10000 0 -0.097 61 61
MADD 0.023 0.006 -10000 0 -0.12 1 1
MAP3K1 0.004 0.04 -10000 0 -0.12 30 30
TRADD 0.023 0.006 -10000 0 -0.12 1 1
RELA/p50 0.023 0.009 -10000 0 -0.12 2 2
MAPK3 0.017 0.035 -10000 0 -0.12 11 11
MAPK1 0.016 0.037 -10000 0 -0.12 16 16
p50/RELA/I-kappa-B-alpha 0.018 0.049 -10000 0 -0.14 40 40
FADD -0.01 0.11 -10000 0 -0.2 118 118
KSR1 0.008 0.036 -10000 0 -0.11 20 20
MAPK8 0.008 0.042 -10000 0 -0.11 35 35
TRAF2 0.024 0.001 -10000 0 -10000 0 0
response to radiation 0 0 -10000 0 -10000 0 0
CHUK -0.013 0.11 -10000 0 -0.2 119 119
TNF R/SODD 0.027 0.034 -10000 0 -0.11 29 29
TNF 0.02 0.02 -10000 0 -0.12 11 11
CYCS 0.006 0.038 0.097 1 -0.11 22 23
IKBKG -0.009 0.11 -10000 0 -0.19 119 119
TNF/TNF R/TRADD/MADD/cIAP/RIP/TRAF2/RAIDD -0.014 0.12 -10000 0 -0.22 118 118
RELA 0.023 0.009 -10000 0 -0.12 2 2
RIPK1 0.022 0.011 -10000 0 -0.12 3 3
AIFM1 0.001 0.044 0.097 1 -0.12 36 37
TNF/TNF R/SODD 0.038 0.034 -10000 0 -0.11 20 20
TNFRSF1A 0.021 0.016 -10000 0 -0.12 7 7
response to heat 0 0 -10000 0 -10000 0 0
CASP8 0.005 0.13 -10000 0 -0.67 17 17
NSMAF -0.011 0.11 -10000 0 -0.21 118 118
response to hydrogen peroxide 0 0 -10000 0 -0.001 8 8
BCL2 0.016 0.031 -10000 0 -0.12 27 27
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.022 0.012 -9999 0 -0.12 4 4
Caspase 8 (4 units) 0.023 0.084 -9999 0 -0.25 33 33
NEF 0.005 0.007 -9999 0 -0.066 5 5
NFKBIA -0.001 0.039 -9999 0 -0.074 88 88
BIRC3 -0.058 0.13 -9999 0 -0.21 206 206
CYCS 0.013 0.071 -9999 0 -0.23 29 29
RIPK1 0.022 0.011 -9999 0 -0.12 3 3
CD247 0.028 0.008 -9999 0 -0.11 1 1
MAP2K7 0.018 0.091 -9999 0 -0.36 19 19
protein ubiquitination 0.021 0.067 -9999 0 -0.19 28 28
CRADD 0.023 0.009 -9999 0 -0.12 2 2
DAXX 0.022 0.012 -9999 0 -0.12 4 4
FAS 0.016 0.025 -9999 0 -0.12 17 17
BID 0.021 0.065 -9999 0 -0.24 28 28
NF-kappa-B/RelA/I kappa B alpha -0.021 0.11 -9999 0 -0.18 146 146
TRADD 0.023 0.006 -9999 0 -0.12 1 1
MAP3K5 0.018 0.025 -9999 0 -0.12 17 17
CFLAR 0.022 0.011 -9999 0 -0.12 3 3
FADD 0.023 0.009 -9999 0 -0.12 2 2
NF-kappa-B/RelA/I kappa B alpha/ubiquitin -0.021 0.11 -9999 0 -0.18 146 146
MAPK8 0.02 0.09 -9999 0 -0.35 19 19
APAF1 0.021 0.014 -9999 0 -0.12 5 5
TRAF1 0.023 0.001 -9999 0 -10000 0 0
TRAF2 0.023 0 -9999 0 -10000 0 0
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG 0.019 0.068 -9999 0 -0.26 27 27
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD 0.019 0.075 -9999 0 -0.22 29 29
CHUK 0.021 0.071 -9999 0 -0.2 28 28
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0.038 0.068 -9999 0 -0.18 27 27
TCRz/NEF 0.028 0.014 -9999 0 -0.16 2 2
TNF 0.02 0.02 -9999 0 -0.12 11 11
FASLG 0.029 0.021 -9999 0 -0.16 5 5
NFKB1 0.004 0.031 -9999 0 -0.055 86 86
TNFR1A/BAG4/TNF-alpha 0.038 0.034 -9999 0 -0.11 20 20
CASP6 -0.041 0.21 -9999 0 -0.53 78 78
CASP7 -0.058 0.19 -9999 0 -0.41 117 117
RELA 0.003 0.032 -9999 0 -0.05 102 102
CASP2 0.022 0.009 -9999 0 -0.12 2 2
CASP3 -0.06 0.2 -9999 0 -0.41 118 118
TNFRSF1A 0.021 0.016 -9999 0 -0.12 7 7
TNFR1A/BAG4 0.027 0.034 -9999 0 -0.11 29 29
CASP8 0.023 0.004 -9999 0 -10000 0 0
CASP9 0.022 0.014 -9999 0 -0.12 5 5
MAP3K14 0.022 0.071 -9999 0 -0.2 28 28
APAF-1/Caspase 9 -0.028 0.12 -9999 0 -0.22 123 123
BCL2 0.02 0.087 -9999 0 -0.31 22 22
E-cadherin signaling in the nascent adherens junction

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN -0.009 0.13 -9999 0 -0.41 49 49
KLHL20 -0.012 0.085 -9999 0 -0.19 68 68
CYFIP2 0.02 0.018 -9999 0 -0.12 8 8
Rac1/GDP 0.012 0.091 -9999 0 -0.22 55 55
ENAH -0.01 0.13 -9999 0 -0.4 50 50
AP1M1 0.021 0.017 -9999 0 -0.12 8 8
RAP1B 0.019 0.02 -9999 0 -0.12 10 10
RAP1A 0.021 0.012 -9999 0 -0.12 3 3
CTNNB1 0.022 0.008 -9999 0 -0.12 1 1
CDC42/GTP 0.011 0.07 -9999 0 -0.2 34 34
ABI1/Sra1/Nap1 -0.028 0.049 -9999 0 -0.14 74 74
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin 0.038 0.055 -9999 0 -0.1 63 63
RAPGEF1 0 0.11 -9999 0 -0.34 49 49
CTNND1 0.023 0.004 -9999 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion -0.01 0.13 -9999 0 -0.41 49 49
CRK -0.005 0.12 -9999 0 -0.37 49 49
E-cadherin/gamma catenin/alpha catenin 0.025 0.06 -9999 0 -0.13 61 61
alphaE/beta7 Integrin 0.026 0.035 -9999 0 -0.11 33 33
IQGAP1 0.02 0.017 -9999 0 -0.12 7 7
NCKAP1 0.023 0.004 -9999 0 -10000 0 0
Rap1/GTP/I-afadin 0.015 0.059 -9999 0 -0.11 85 85
DLG1 -0.01 0.13 -9999 0 -0.41 49 49
ChemicalAbstracts:7440-70-2 0 0 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 -0.022 0.05 -9999 0 -0.16 53 53
MLLT4 0.014 0.032 -9999 0 -0.12 29 29
ARF6/GTP/NME1/Tiam1 0.018 0.056 -9999 0 -0.11 71 71
PI3K -0.028 0.065 -9999 0 -0.2 53 53
ARF6 0.023 0.003 -9999 0 -10000 0 0
mol:Ca2+ 0 0 -9999 0 -10000 0 0
E-cadherin/gamma catenin 0.017 0.054 -9999 0 -0.13 61 61
TIAM1 0.015 0.032 -9999 0 -0.12 28 28
E-cadherin(dimer)/Ca2+ 0.033 0.061 -9999 0 -0.12 67 67
AKT1 0.005 0.049 -9999 0 -0.12 50 50
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
CDH1 0.02 0.016 -9999 0 -0.12 6 6
RhoA/GDP 0.013 0.091 -9999 0 -0.22 55 55
actin cytoskeleton organization -0.007 0.064 -9999 0 -0.14 69 69
CDC42/GDP 0.013 0.091 -9999 0 -0.22 54 54
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin 0.001 0.08 -9999 0 -0.19 66 66
ITGB7 0.019 0.024 -9999 0 -0.12 15 15
RAC1 0.023 0.002 -9999 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin 0.036 0.065 -9999 0 -0.13 67 67
E-cadherin/Ca2+/beta catenin/alpha catenin 0.023 0.049 -9999 0 -0.11 64 64
mol:GDP 0.001 0.1 -9999 0 -0.26 54 54
CDC42/GTP/IQGAP1 0.018 0.043 -9999 0 -0.11 54 54
JUP 0.019 0.021 -9999 0 -0.12 12 12
p120 catenin/RhoA/GDP 0.017 0.094 -9999 0 -0.23 53 53
RAC1/GTP/IQGAP1 0.017 0.044 -9999 0 -0.11 55 55
PIP5K1C/AP1M1 0.033 0.014 -9999 0 -0.14 1 1
RHOA 0.023 0.006 -9999 0 -0.12 1 1
CDC42 0.023 0.002 -9999 0 -10000 0 0
CTNNA1 0.022 0.01 -9999 0 -0.12 2 2
positive regulation of S phase of mitotic cell cycle -0.014 0.063 -9999 0 -0.12 119 119
NME1 0.015 0.03 -9999 0 -0.12 24 24
clathrin coat assembly 0 0 -9999 0 -10000 0 0
TJP1 -0.011 0.14 -9999 0 -0.42 51 51
regulation of cell-cell adhesion -0.018 0.05 -9999 0 -0.18 34 34
WASF2 -0.002 0.036 -9999 0 -0.073 79 79
Rap1/GTP 0.013 0.08 -9999 0 -0.23 33 33
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.041 0.064 -9999 0 -0.1 76 76
CCND1 -0.018 0.076 -9999 0 -0.15 119 119
VAV2 -0.019 0.17 -9999 0 -0.46 65 65
RAP1/GDP 0.016 0.087 -9999 0 -0.24 36 36
adherens junction assembly -0.01 0.13 -9999 0 -0.4 51 51
homophilic cell adhesion 0 0 -9999 0 -10000 0 0
ABI1 0.022 0.009 -9999 0 -0.12 2 2
PIP5K1C 0.023 0 -9999 0 -10000 0 0
regulation of heterotypic cell-cell adhesion 0.033 0.064 -9999 0 -0.17 23 23
E-cadherin/beta catenin 0.008 0.056 -9999 0 -0.23 28 28
mol:GTP 0 0 -9999 0 -10000 0 0
SRC -0.008 0.13 -9999 0 -0.4 49 49
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
Rac1/GTP -0.059 0.11 -9999 0 -0.32 66 66
E-cadherin/beta catenin/alpha catenin 0.026 0.058 -9999 0 -0.13 64 64
ITGAE 0.023 0 -9999 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.011 0.14 -9999 0 -0.42 49 49
Signaling events mediated by PRL

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 0.002 0.047 -10000 0 -0.12 70 70
mol:Halofuginone 0.003 0.025 -10000 0 -0.18 10 10
ITGA1 0.014 0.03 -10000 0 -0.12 24 24
CDKN1A 0.014 0.059 -10000 0 -0.29 18 18
PRL-3/alpha Tubulin 0.014 0.051 -10000 0 -0.1 83 83
mol:Ca2+ 0.018 0.076 0.28 41 -0.09 9 50
AGT 0.02 0.02 -10000 0 -0.12 11 11
CCNA2 -0.001 0.094 -10000 0 -0.59 12 12
TUBA1B 0.023 0 -10000 0 -10000 0 0
EGR1 -0.002 0.06 -10000 0 -0.34 12 12
CDK2/Cyclin E1 0.006 0.074 -10000 0 -0.26 23 23
MAPK3 0.014 0.027 -10000 0 -0.072 46 46
PRL-2 /Rab GGTase beta 0.009 0.063 -10000 0 -0.13 87 87
MAPK1 0.013 0.031 -10000 0 -0.083 47 47
PTP4A1 0.001 0.092 -10000 0 -0.57 12 12
PTP4A3 0.011 0.038 -10000 0 -0.12 42 42
PTP4A2 0.022 0.009 -10000 0 -0.12 2 2
ITGB1 0.013 0.028 -10000 0 -0.074 48 48
SRC 0.023 0.009 -10000 0 -0.12 2 2
RAC1 -0.014 0.11 -10000 0 -0.34 54 54
Rab GGTase beta/Rab GGTase alpha 0.012 0.058 -10000 0 -0.13 79 79
PRL-1/ATF-5 -0.003 0.095 -10000 0 -0.54 12 12
RABGGTA 0.023 0.006 -10000 0 -0.12 1 1
BCAR1 0.02 0.076 0.28 41 -0.09 2 43
RHOC -0.013 0.11 -10000 0 -0.35 51 51
RHOA -0.014 0.11 -10000 0 -0.34 54 54
cell motility -0.011 0.11 -10000 0 -0.31 60 60
PRL-1/alpha Tubulin 0 0.094 -10000 0 -0.54 12 12
PRL-3/alpha1 Integrin -0.012 0.08 -10000 0 -0.13 161 161
ROCK1 -0.012 0.11 -10000 0 -0.31 60 60
RABGGTB 0.017 0.022 -10000 0 -0.12 12 12
CDK2 0.018 0.023 -10000 0 -0.12 14 14
mitosis 0.001 0.091 -10000 0 -0.57 12 12
ATF5 0.018 0.027 -10000 0 -0.12 20 20
Aurora B signaling

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex -0.05 0.17 -9999 0 -0.35 99 99
STMN1 0.019 0.019 -9999 0 -0.069 23 23
Aurora B/RasGAP/Survivin 0.018 0.072 -9999 0 -0.16 70 70
Chromosomal passenger complex/Cul3 protein complex -0.001 0.087 -9999 0 -0.23 53 53
BIRC5 0.018 0.023 -9999 0 -0.12 14 14
DES -0.029 0.23 -9999 0 -0.95 32 32
Aurora C/Aurora B/INCENP 0.033 0.039 -9999 0 -0.11 32 32
Aurora B/TACC1 0.014 0.048 -9999 0 -0.13 45 45
Aurora B/PP2A 0.02 0.048 -9999 0 -0.12 51 51
mol:GTP 0 0 -9999 0 -10000 0 0
CBX5 -0.005 0.061 -9999 0 -0.2 49 49
mitotic metaphase/anaphase transition 0.002 0.005 -9999 0 -10000 0 0
NDC80 0.009 0.032 -9999 0 -0.081 55 55
Cul3 protein complex 0.016 0.056 -9999 0 -0.11 58 58
KIF2C -0.065 0.21 -9999 0 -0.5 87 87
PEBP1 0.022 0.008 -9999 0 -0.12 1 1
KIF20A 0.009 0.038 -9999 0 -0.12 43 43
mol:GDP 0 0 -9999 0 -10000 0 0
Aurora B/RasGAP 0.012 0.058 -9999 0 -0.14 69 69
SEPT1 0.022 0.014 -9999 0 -0.12 5 5
SMC2 0.015 0.03 -9999 0 -0.12 25 25
SMC4 0.018 0.025 -9999 0 -0.12 17 17
NSUN2/NPM1/Nucleolin -0.024 0.17 -9999 0 -0.66 33 33
PSMA3 0.019 0.021 -9999 0 -0.12 11 11
G2/M transition of mitotic cell cycle 0 0.003 -9999 0 -10000 0 0
H3F3B -0.001 0.065 -9999 0 -0.21 47 47
AURKB 0.018 0.027 -9999 0 -0.12 19 19
AURKC 0.023 0.006 -9999 0 -0.12 1 1
CDCA8 0.019 0.021 -9999 0 -0.11 12 12
cytokinesis -0.04 0.2 -9999 0 -0.45 76 76
Aurora B/Septin1 -0.022 0.19 -9999 0 -0.43 73 73
AURKA 0.015 0.028 -9999 0 -0.12 21 21
INCENP 0.021 0.011 -9999 0 -0.12 2 2
KLHL13 -0.001 0.053 -9999 0 -0.12 89 89
BUB1 0.017 0.026 -9999 0 -0.12 17 17
hSgo1/Aurora B/Survivin 0.011 0.078 -9999 0 -0.16 77 77
EVI5 0.021 0.016 -9999 0 -0.12 6 6
RhoA/GTP -0.022 0.18 -9999 0 -0.36 86 86
SGOL1 0.016 0.028 -9999 0 -0.12 22 22
CENPA -0.036 0.17 -9999 0 -0.35 88 88
NCAPG 0.01 0.037 -9999 0 -0.12 39 39
Aurora B/HC8 Proteasome 0.009 0.063 -9999 0 -0.14 75 75
NCAPD2 0.015 0.03 -9999 0 -0.12 25 25
Aurora B/PP1-gamma 0.012 0.059 -9999 0 -0.15 61 61
RHOA 0.023 0.006 -9999 0 -0.12 1 1
NCAPH 0.019 0.02 -9999 0 -0.12 10 10
NPM1 -0.01 0.12 -9999 0 -0.41 39 39
RASA1 0.021 0.012 -9999 0 -0.12 3 3
KLHL9 0.023 0.007 -9999 0 -0.12 1 1
mitotic prometaphase -0.001 0.004 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.008 0.063 -9999 0 -0.14 75 75
PPP1CC 0.022 0.005 -9999 0 -10000 0 0
Centraspindlin -0.032 0.19 -9999 0 -0.38 90 90
RhoA/GDP 0.016 0.016 -9999 0 -0.14 6 6
NSUN2 -0.01 0.11 -9999 0 -0.39 40 40
MYLK -0.005 0.066 -9999 0 -0.21 50 50
KIF23 0.013 0.034 -9999 0 -0.12 32 32
VIM 0.016 0.028 -9999 0 -0.09 28 28
RACGAP1 0.017 0.025 -9999 0 -0.12 16 16
mitosis 0 0 -9999 0 -10000 0 0
NCL -0.02 0.12 -9999 0 -0.37 57 57
Chromosomal passenger complex -0.035 0.17 -9999 0 -0.33 94 94
Chromosomal passenger complex/EVI5 0.032 0.084 -9999 0 -0.16 73 73
TACC1 0.014 0.035 -9999 0 -0.12 34 34
PPP2R5D 0.022 0.014 -9999 0 -0.12 5 5
CUL3 0.023 0.004 -9999 0 -10000 0 0
response to DNA damage stimulus 0 0 -9999 0 -10000 0 0
FAS signaling pathway (CD95)

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.003 0.039 0.15 3 -0.26 10 13
RFC1 0.003 0.04 0.16 4 -0.26 10 14
PRKDC 0.003 0.039 0.16 4 -0.25 10 14
RIPK1 0.022 0.011 -10000 0 -0.12 3 3
CASP7 0.002 0.091 -10000 0 -0.45 16 16
FASLG/FAS/FADD/FAF1 0.036 0.085 0.16 118 -0.17 42 160
MAP2K4 -0.001 0.11 -10000 0 -0.31 37 37
mol:ceramide 0.005 0.094 -10000 0 -0.28 33 33
GSN 0.002 0.038 0.16 1 -0.26 10 11
FASLG/FAS/FADD/FAF1/Caspase 8 0.042 0.09 0.16 111 -0.25 18 129
FAS 0.016 0.026 -10000 0 -0.12 17 17
BID 0.005 0.017 0.25 2 -10000 0 2
MAP3K1 0.001 0.093 0.17 2 -0.33 26 28
MAP3K7 0.021 0.014 -10000 0 -0.12 5 5
RB1 0.001 0.041 0.16 4 -0.25 11 15
CFLAR 0.022 0.011 -10000 0 -0.12 3 3
HGF/MET -0.054 0.089 -10000 0 -0.14 247 247
ARHGDIB -0.002 0.043 0.16 3 -0.28 10 13
FADD 0.022 0.01 -10000 0 -0.12 2 2
actin filament polymerization -0.002 0.038 0.25 10 -0.16 1 11
NFKB1 -0.037 0.2 -10000 0 -0.74 38 38
MAPK8 -0.001 0.12 -10000 0 -0.36 34 34
DFFA 0.003 0.04 0.16 4 -0.25 11 15
DNA fragmentation during apoptosis 0.003 0.04 0.16 4 -0.25 11 15
FAS/FADD/MET -0.014 0.082 -10000 0 -0.13 163 163
CFLAR/RIP1 0.03 0.027 -10000 0 -0.12 16 16
FAIM3 0.022 0.012 -10000 0 -0.12 4 4
FAF1 0.021 0.015 -10000 0 -0.12 5 5
PARP1 0.004 0.037 0.16 4 -0.24 10 14
DFFB 0.003 0.04 0.16 4 -0.25 11 15
CHUK -0.034 0.19 -10000 0 -0.71 38 38
FASLG 0.022 0.014 -10000 0 -0.13 4 4
FAS/FADD 0.012 0.056 -10000 0 -0.13 67 67
HGF 0.02 0.023 -10000 0 -0.12 14 14
LMNA 0 0.047 0.14 4 -0.25 14 18
CASP6 -0.003 0.05 0.16 4 -0.29 12 16
CASP10 0.018 0.02 -10000 0 -0.12 10 10
CASP3 -0.002 0.046 0.18 4 -0.28 11 15
PTPN13 -0.012 0.056 -10000 0 -0.12 112 112
CASP8 -0.005 0.018 0.28 2 -10000 0 2
IL6 -0.038 0.21 -10000 0 -0.77 33 33
MET 0 0.047 -10000 0 -0.12 70 70
ICAD/CAD 0.007 0.038 0.15 2 -0.22 12 14
FASLG/FAS/FADD/FAF1/Caspase 10 0.005 0.095 -10000 0 -0.28 33 33
activation of caspase activity by cytochrome c 0.005 0.017 0.25 2 -10000 0 2
PAK2 0.003 0.04 0.16 4 -0.25 11 15
BCL2 0.016 0.031 -10000 0 -0.12 27 27
Plasma membrane estrogen receptor signaling

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.036 0.049 -10000 0 -0.094 62 62
ER alpha/Gai/GDP/Gbeta gamma 0.006 0.094 -10000 0 -0.26 53 53
AKT1 -0.054 0.23 -10000 0 -0.6 78 78
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.055 0.23 -10000 0 -0.61 78 78
mol:Ca2+ 0.011 0.069 -10000 0 -0.25 30 30
IGF1R 0.013 0.032 -10000 0 -0.12 28 28
E2/ER alpha (dimer)/Striatin 0.014 0.047 -10000 0 -0.12 54 54
SHC1 0.023 0.001 -10000 0 -10000 0 0
apoptosis 0.051 0.22 0.57 78 -10000 0 78
RhoA/GTP -0.016 0.034 -10000 0 -0.15 17 17
E2/ER alpha (dimer)/PELP1/Src/p130 Cas 0.008 0.1 -10000 0 -0.26 58 58
regulation of stress fiber formation -0.007 0.049 0.14 38 -10000 0 38
E2/ERA-ERB (dimer) 0.018 0.041 -10000 0 -0.099 59 59
KRAS 0.014 0.034 -10000 0 -0.12 33 33
G13/GTP 0.014 0.041 -10000 0 -0.1 55 55
pseudopodium formation 0.007 0.049 -10000 0 -0.14 38 38
E2/ER alpha (dimer)/PELP1 0.018 0.041 -10000 0 -0.12 43 43
GRB2 0.023 0.006 -10000 0 -0.12 1 1
GNG2 0.02 0.018 -10000 0 -0.12 9 9
GNAO1 0.01 0.042 -10000 0 -0.12 51 51
HRAS 0.023 0.006 -10000 0 -0.12 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.012 0.13 -10000 0 -0.33 66 66
E2/ER beta (dimer) 0.017 0.004 -10000 0 -0.077 1 1
mol:GDP 0.002 0.075 -10000 0 -0.24 44 44
mol:NADP -0.012 0.13 -10000 0 -0.33 66 66
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
mol:IP3 0.01 0.071 -10000 0 -0.26 30 30
IGF-1R heterotetramer 0.013 0.032 -10000 0 -0.12 28 28
PLCB1 0.009 0.072 -10000 0 -0.26 30 30
PLCB2 0.016 0.069 -10000 0 -0.26 28 28
IGF1 0.007 0.045 -10000 0 -0.12 60 60
mol:L-citrulline -0.012 0.13 -10000 0 -0.33 66 66
RHOA 0.023 0.006 -10000 0 -0.12 1 1
Gai/GDP 0.023 0.057 -10000 0 -0.53 2 2
JNK cascade 0.017 0.004 -10000 0 -0.077 1 1
BCAR1 0.022 0.011 -10000 0 -0.12 3 3
ESR2 0.023 0.006 -10000 0 -0.12 1 1
GNAQ 0.021 0.016 -10000 0 -0.12 6 6
ESR1 0.018 0.024 -10000 0 -0.12 15 15
Gq family/GDP/Gbeta gamma 0.031 0.062 -10000 0 -0.3 16 16
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 0.017 0.086 -10000 0 -0.51 8 8
E2/ER alpha (dimer)/PELP1/Src/p52 SHC 0.008 0.1 -10000 0 -0.25 58 58
GNAZ 0.022 0.011 -10000 0 -0.12 3 3
E2/ER alpha (dimer) 0.002 0.045 -10000 0 -0.13 58 58
STRN 0.022 0.013 -10000 0 -0.12 4 4
GNAL 0.021 0.018 -10000 0 -0.12 9 9
PELP1 0.023 0.009 -10000 0 -0.12 2 2
MAPK11 0.021 0.003 -10000 0 -0.057 1 1
GNAI2 0.022 0.011 -10000 0 -0.12 3 3
GNAI3 0.021 0.008 -10000 0 -0.12 1 1
GNAI1 0.012 0.035 -10000 0 -0.12 35 35
HBEGF -0.025 0.1 -10000 0 -0.25 65 65
cAMP biosynthetic process 0.016 0.032 -10000 0 -0.086 44 44
SRC 0.004 0.096 -10000 0 -0.25 62 62
PI3K 0.007 0.065 -10000 0 -0.13 96 96
GNB1 0.023 0.007 -10000 0 -0.12 1 1
G13/GDP/Gbeta gamma 0.023 0.076 -10000 0 -0.2 46 46
SOS1 0.017 0.027 -10000 0 -0.12 20 20
IGF-1R heterotetramer/IGF1 -0.038 0.072 -10000 0 -0.22 62 62
Gs family/GTP 0.022 0.035 -10000 0 -0.087 44 44
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.03 0.043 -10000 0 -0.11 38 38
vasodilation -0.011 0.12 -10000 0 -0.31 68 68
mol:DAG 0.01 0.071 -10000 0 -0.26 30 30
Gs family/GDP/Gbeta gamma 0.005 0.068 -10000 0 -0.2 45 45
MSN 0.007 0.051 -10000 0 -0.15 38 38
Gq family/GTP 0.015 0.073 -10000 0 -0.27 28 28
mol:PI-3-4-5-P3 -0.053 0.22 -10000 0 -0.59 78 78
NRAS 0.022 0.011 -10000 0 -0.12 3 3
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.011 0.12 0.31 68 -10000 0 68
GRB2/SOS1 0.021 0.045 -10000 0 -0.15 29 29
RhoA/GDP 0.014 0.076 -10000 0 -0.22 46 46
NOS3 -0.013 0.13 -10000 0 -0.34 66 66
GNA11 0.022 0.014 -10000 0 -0.12 5 5
MAPKKK cascade -0.005 0.15 -10000 0 -0.44 53 53
E2/ER alpha (dimer)/PELP1/Src 0.003 0.1 -10000 0 -0.26 59 59
ruffle organization 0.007 0.049 -10000 0 -0.14 38 38
ROCK2 0.01 0.049 -10000 0 -0.15 23 23
GNA14 0.02 0.02 -10000 0 -0.12 11 11
GNA15 0.021 0.017 -10000 0 -0.12 8 8
GNA13 0.022 0.009 -10000 0 -0.12 2 2
MMP9 -0.012 0.099 -10000 0 -0.26 60 60
MMP2 -0.018 0.1 -10000 0 -0.26 65 65
p75(NTR)-mediated signaling

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.02 0.048 -10000 0 -0.13 49 49
Necdin/E2F1 0.016 0.046 -10000 0 -0.15 20 20
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E 0.039 0.048 -10000 0 -0.098 51 51
NGF (dimer)/p75(NTR)/BEX1 -0.008 0.054 -10000 0 -0.075 210 210
NT-4/5 (dimer)/p75(NTR) 0.016 0.013 -10000 0 -0.085 9 9
IKBKB 0.022 0.015 -10000 0 -0.12 6 6
AKT1 0.009 0.045 -10000 0 -0.1 63 63
IKBKG 0.023 0.009 -10000 0 -0.12 2 2
BDNF 0.022 0.011 -10000 0 -0.12 3 3
MGDIs/NGR/p75(NTR)/LINGO1 0.04 0.031 -10000 0 -0.12 13 13
FURIN 0.02 0.02 -10000 0 -0.12 11 11
proBDNF (dimer)/p75(NTR)/Sortilin 0.035 0.042 -10000 0 -0.12 33 33
LINGO1 0.018 0.026 -10000 0 -0.12 19 19
Sortilin/TRAF6/NRIF 0.003 0.054 -10000 0 -0.17 24 24
proBDNF (dimer) 0.022 0.011 -10000 0 -0.12 3 3
NTRK1 0.023 0.006 -10000 0 -0.12 1 1
RTN4R 0.021 0.018 -10000 0 -0.12 9 9
neuron apoptosis -0.039 0.12 -10000 0 -0.36 34 34
IRAK1 0.019 0.023 -10000 0 -0.12 14 14
SHC1 0.019 0.011 -10000 0 -0.063 9 9
ARHGDIA 0.016 0.032 -10000 0 -0.12 29 29
RhoA/GTP 0.016 0.016 -10000 0 -0.14 6 6
Gamma Secretase 0.034 0.067 -10000 0 -0.097 89 89
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 0.025 0.05 -10000 0 -0.11 59 59
MAGEH1 0.018 0.024 -10000 0 -0.12 16 16
proNGF (dimer)/p75(NTR)/Sortilin/Necdin 0.021 0.051 -10000 0 -0.11 53 53
Mammalian IAPs/DIABLO -0.019 0.083 -10000 0 -0.13 157 157
proNGF (dimer) 0 0 -10000 0 -10000 0 0
MAGED1 0.02 0.019 -10000 0 -0.12 10 10
APP 0.022 0.008 -10000 0 -0.12 1 1
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
ZNF274 0.023 0 -10000 0 -10000 0 0
RhoA/GDP/RHOGDI 0.029 0.028 -10000 0 -0.1 12 12
NGF 0 0 -10000 0 -10000 0 0
cell cycle arrest 0.023 0.042 0.098 60 -0.091 39 99
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK 0.01 0.063 -10000 0 -0.16 60 60
NT-4/5 (dimer)/p75(NTR)/TRAF6 0.027 0.023 -10000 0 -0.091 19 19
NCSTN 0.022 0.012 -10000 0 -0.12 4 4
mol:GTP 0.022 0.034 -10000 0 -0.094 42 42
PSENEN 0.016 0.03 -10000 0 -0.12 24 24
mol:ceramide 0.016 0.034 -10000 0 -0.11 33 33
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs -0.004 0.091 -10000 0 -0.3 31 31
p75(NTR)/beta APP 0.023 0.043 -10000 0 -0.13 41 41
BEX1 -0.017 0.062 -10000 0 -0.12 145 145
mol:GDP 0.006 0.01 -10000 0 -0.068 9 9
NGF (dimer) -0.028 0.064 -10000 0 -0.1 197 197
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI 0.046 0.041 -10000 0 -0.11 21 21
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
RAC1/GTP 0.025 0.016 -10000 0 -0.073 13 13
MYD88 0.023 0.006 -10000 0 -0.12 1 1
CHUK 0.021 0.013 -10000 0 -0.12 4 4
NGF (dimer)/p75(NTR)/PKA 0.022 0.034 -10000 0 -0.094 42 42
RHOB 0.022 0.014 -10000 0 -0.12 5 5
RHOA 0.023 0.006 -10000 0 -0.12 1 1
MAGE-G1/E2F1 0.032 0.018 -10000 0 -0.088 12 12
NT3 (dimer) -0.003 0.056 -10000 0 -0.12 101 101
TP53 0.011 0.047 -10000 0 -0.18 23 23
PRDM4 0.017 0.032 -10000 0 -0.1 33 33
BDNF (dimer) -0.021 0.069 -10000 0 -0.096 203 203
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
SORT1 0.02 0.018 -10000 0 -0.12 8 8
activation of caspase activity 0.034 0.046 -10000 0 -0.098 51 51
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 0.032 0.042 -10000 0 -0.11 40 40
RHOC 0.023 0.002 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
MAPK10 0.022 0.054 -10000 0 -0.18 20 20
DIABLO 0.02 0.016 -10000 0 -0.12 6 6
SMPD2 0.016 0.034 -10000 0 -0.11 33 33
APH1B 0.014 0.032 -10000 0 -0.12 29 29
APH1A 0.023 0.009 -10000 0 -0.12 2 2
proNGF (dimer)/p75(NTR)/Sortilin 0.021 0.038 -10000 0 -0.1 45 45
PSEN1 0.022 0.008 -10000 0 -0.12 1 1
APAF-1/Pro-Caspase 9 0.025 0.041 -10000 0 -0.13 33 33
NT3 (dimer)/p75(NTR) 0.011 0.048 -10000 0 -0.078 118 118
MAPK8 0.022 0.058 -10000 0 -0.2 21 21
MAPK9 0.022 0.054 -10000 0 -0.18 20 20
APAF1 0.021 0.014 -10000 0 -0.12 5 5
NTF3 -0.003 0.056 -10000 0 -0.12 101 101
NTF4 0 0 -10000 0 -10000 0 0
NDN 0.007 0.044 -10000 0 -0.12 59 59
RAC1/GDP 0.016 0.015 -10000 0 -0.15 5 5
RhoA-B-C/GDP 0.04 0.035 -10000 0 -0.084 34 34
p75 CTF/Sortilin/TRAF6/NRIF 0.037 0.059 -10000 0 -0.12 62 62
RhoA-B-C/GTP 0.022 0.034 -10000 0 -0.094 42 42
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.055 0.045 -10000 0 -0.18 5 5
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 0.045 0.046 -10000 0 -0.1 40 40
PRKACB 0.019 0.02 -10000 0 -0.12 11 11
proBDNF (dimer)/p75 ECD 0.022 0.045 -10000 0 -0.15 33 33
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
BIRC3 -0.005 0.053 -10000 0 -0.12 94 94
BIRC2 0.021 0.013 -10000 0 -0.12 4 4
neuron projection morphogenesis 0.003 0.055 0.099 47 -0.13 45 92
BAD 0.021 0.06 -10000 0 -0.2 20 20
RIPK2 0.013 0.034 -10000 0 -0.12 32 32
NGFR 0.021 0.017 -10000 0 -0.12 8 8
CYCS 0.015 0.042 -10000 0 -0.11 47 47
ADAM17 0.019 0.021 -10000 0 -0.12 11 11
NGF (dimer)/p75(NTR)/TRAF6/RIP2 0.024 0.05 -10000 0 -0.11 54 54
BCL2L11 0.021 0.06 -10000 0 -0.19 21 21
BDNF (dimer)/p75(NTR) 0.032 0.017 -10000 0 -0.14 2 2
PI3K 0.021 0.054 -10000 0 -0.11 63 63
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 0.033 0.038 -10000 0 -0.1 35 35
NDNL2 0.023 0.009 -10000 0 -0.12 2 2
YWHAE 0.022 0.014 -10000 0 -0.12 5 5
PRKCI 0.016 0.028 -10000 0 -0.12 22 22
NGF (dimer)/p75(NTR) 0.016 0.013 -10000 0 -0.085 9 9
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE 0.029 0.046 -10000 0 -0.11 47 47
TRAF6 0.022 0.009 -10000 0 -0.12 2 2
RAC1 0.023 0.002 -10000 0 -10000 0 0
PRKCZ 0.023 0 -10000 0 -10000 0 0
PLG 0.023 0.009 -10000 0 -0.12 2 2
oligodendrocyte cell fate commitment 0 0 -10000 0 -10000 0 0
CASP6 0.013 0.05 -10000 0 -0.16 33 33
SQSTM1 0.021 0.014 -10000 0 -0.12 5 5
NGFRAP1 0.022 0.009 -10000 0 -0.12 2 2
CASP3 0.021 0.059 -10000 0 -0.19 20 20
E2F1 0.021 0.016 -10000 0 -0.12 7 7
CASP9 0.022 0.014 -10000 0 -0.12 5 5
IKK complex 0.021 0.08 -10000 0 -0.22 34 34
NGF (dimer)/TRKA 0.017 0.004 -10000 0 -0.077 1 1
MMP7 -0.022 0.06 -10000 0 -0.12 144 144
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.042 0.042 -10000 0 -0.097 40 40
MMP3 0.017 0.029 -10000 0 -0.12 23 23
APAF-1/Caspase 9 -0.037 0.061 -10000 0 -0.16 86 86
TCGA08_rtk_signaling

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA 0.004 0.044 -10000 0 -0.12 59 59
HRAS 0.023 0.006 -10000 0 -0.12 1 1
EGFR 0.015 0.03 -10000 0 -0.12 25 25
AKT 0 0.065 0.14 5 -0.12 83 88
FOXO3 0.021 0.017 -10000 0 -0.12 8 8
AKT1 0.021 0.019 -10000 0 -0.12 10 10
FOXO1 0.023 0.009 -10000 0 -0.12 2 2
AKT3 -0.004 0.056 -10000 0 -0.12 102 102
FOXO4 0.023 0 -10000 0 -10000 0 0
MET 0 0.047 -10000 0 -0.12 70 70
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
PIK3CB 0.015 0.03 -10000 0 -0.12 24 24
NRAS 0.022 0.011 -10000 0 -0.12 3 3
PIK3CG 0.011 0.037 -10000 0 -0.12 39 39
PIK3R3 0.012 0.036 -10000 0 -0.12 37 37
PIK3R2 0.017 0.03 -10000 0 -0.12 25 25
NF1 0.018 0.02 -10000 0 -0.12 10 10
RAS 0.005 0.061 0.15 33 -0.15 43 76
ERBB2 0.02 0.021 -10000 0 -0.12 12 12
proliferation/survival/translation 0.002 0.074 0.23 36 -10000 0 36
PI3K -0.014 0.075 0.13 9 -0.14 105 114
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
KRAS 0.014 0.034 -10000 0 -0.12 33 33
FOXO 0.028 0.037 0.14 9 -0.033 13 22
AKT2 0.019 0.025 -10000 0 -0.12 17 17
PTEN 0.022 0.008 -10000 0 -0.12 1 1
ErbB4 signaling events

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF -0.046 0.2 -10000 0 -0.79 33 33
epithelial cell differentiation -0.037 0.19 -10000 0 -0.65 40 40
ITCH 0.027 0.027 0.085 4 -0.072 28 32
WWP1 -0.051 0.28 -10000 0 -1.2 33 33
FYN 0.011 0.037 -10000 0 -0.12 40 40
EGFR 0.015 0.03 -10000 0 -0.12 25 25
PRL 0.022 0.011 -10000 0 -0.12 3 3
neuron projection morphogenesis -0.015 0.16 -10000 0 -0.57 35 35
PTPRZ1 0.021 0.018 -10000 0 -0.12 9 9
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC -0.007 0.18 -10000 0 -0.59 39 39
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta -0.035 0.18 -10000 0 -0.66 39 39
ADAM17 0.023 0.031 0.085 1 -0.087 33 34
ErbB4/ErbB4 -0.035 0.21 -10000 0 -0.8 37 37
ErbB4/ErbB4/neuregulin 3/neuregulin 3 -0.053 0.2 -10000 0 -0.8 33 33
NCOR1 0.022 0.009 -10000 0 -0.12 2 2
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn -0.037 0.18 -10000 0 -0.62 42 42
GRIN2B -0.035 0.17 -10000 0 -0.59 42 42
ErbB4/ErbB2/betacellulin -0.04 0.18 -10000 0 -0.64 40 40
STAT1 0.014 0.031 -10000 0 -0.12 26 26
HBEGF 0.018 0.026 -10000 0 -0.12 19 19
PRLR 0.01 0.042 -10000 0 -0.12 53 53
E4ICDs/ETO2 -0.044 0.2 -10000 0 -0.79 33 33
axon guidance -0.06 0.23 -10000 0 -0.81 40 40
NEDD4 0.024 0.034 0.085 6 -0.082 41 47
Prolactin receptor/Prolactin receptor/Prolactin 0.024 0.032 -10000 0 -0.074 54 54
CBFA2T3 0.023 0.006 -10000 0 -0.12 1 1
ErbB4/ErbB2/HBEGF -0.031 0.18 -10000 0 -0.64 38 38
MAPK3 -0.016 0.16 -10000 0 -0.55 39 39
STAT1 (dimer) -0.056 0.21 -10000 0 -0.75 38 38
MAPK1 -0.016 0.16 -10000 0 -0.55 39 39
JAK2 0.017 0.025 -10000 0 -0.12 16 16
ErbB4/ErbB2/neuregulin 1 beta -0.03 0.18 -10000 0 -0.64 39 39
NRG1 0.021 0.027 -10000 0 -0.07 30 30
NRG3 0.005 0.048 -10000 0 -0.12 72 72
NRG2 0.023 0.006 -10000 0 -0.12 1 1
NRG4 0.001 0.047 -10000 0 -0.12 70 70
heart development -0.06 0.23 -10000 0 -0.81 40 40
neural crest cell migration -0.03 0.18 -10000 0 -0.62 39 39
ERBB2 0.021 0.027 -10000 0 -0.059 41 41
WWOX/E4ICDs -0.044 0.2 -10000 0 -0.79 33 33
SHC1 0.023 0.001 -10000 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 -0.068 0.2 -10000 0 -0.63 46 46
apoptosis 0.046 0.19 0.7 38 -10000 0 38
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta -0.044 0.2 -10000 0 -0.79 33 33
ErbB4/ErbB2/epiregulin -0.03 0.18 -10000 0 -0.64 39 39
ErbB4/ErbB4/betacellulin/betacellulin -0.054 0.2 -10000 0 -0.79 34 34
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 -0.027 0.19 -10000 0 -0.64 39 39
MDM2 -0.032 0.2 -10000 0 -0.8 33 33
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta -0.024 0.17 -10000 0 -0.59 39 39
STAT5A -0.055 0.22 -10000 0 -0.78 40 40
ErbB4/EGFR/neuregulin 1 beta -0.035 0.18 -10000 0 -0.65 38 38
DLG4 0.023 0.009 -10000 0 -0.12 2 2
GRB2/SHC 0.033 0.019 -10000 0 -0.14 6 6
E4ICDs/TAB2/NCoR1 -0.04 0.2 -10000 0 -0.72 37 37
STAT5A (dimer) -0.037 0.21 -10000 0 -0.73 40 40
MAP3K7IP2 0.02 0.016 -10000 0 -0.12 6 6
STAT5B (dimer) -0.05 0.22 -10000 0 -0.78 40 40
LRIG1 0.01 0.037 -10000 0 -0.12 40 40
EREG 0.021 0.017 -10000 0 -0.12 8 8
BTC 0.01 0.039 -10000 0 -0.12 43 43
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta -0.06 0.23 -10000 0 -0.82 40 40
ERBB4 -0.033 0.21 -10000 0 -0.8 37 37
STAT5B 0.023 0.006 -10000 0 -0.12 1 1
YAP1 0.002 0.077 -10000 0 -0.5 11 11
GRB2 0.023 0.006 -10000 0 -0.12 1 1
ErbB4/ErbB2/neuregulin 4 -0.049 0.18 -10000 0 -0.55 51 51
glial cell differentiation 0.039 0.2 0.71 37 -10000 0 37
WWOX 0.023 0.006 -10000 0 -0.12 1 1
cell proliferation -0.068 0.21 -10000 0 -0.58 61 61
Class I PI3K signaling events

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP 0.005 0.042 -10000 0 -0.11 49 49
DAPP1 0.005 0.08 -10000 0 -0.25 27 27
Src family/SYK family/BLNK-LAT/BTK-ITK 0 0.12 -10000 0 -0.3 53 53
mol:DAG 0.015 0.066 0.16 14 -0.14 44 58
HRAS 0.023 0.008 -10000 0 -0.13 1 1
RAP1A 0.022 0.012 -10000 0 -0.12 3 3
ARF5/GDP 0.003 0.086 -10000 0 -0.2 62 62
PLCG2 0.02 0.02 -10000 0 -0.12 11 11
PLCG1 0.019 0.024 -10000 0 -0.12 16 16
ARF5 0.02 0.018 -10000 0 -0.12 9 9
mol:GTP -0.006 0.038 -10000 0 -0.11 54 54
ARF1/GTP 0.003 0.05 0.16 21 -0.12 41 62
RHOA 0.023 0.006 -10000 0 -0.12 1 1
YES1 0.02 0.018 -10000 0 -0.12 8 8
RAP1A/GTP 0.012 0.05 0.17 22 -0.12 38 60
ADAP1 -0.005 0.036 -10000 0 -0.1 54 54
ARAP3 -0.006 0.038 -10000 0 -0.11 54 54
INPPL1 0.021 0.017 -10000 0 -0.12 8 8
PREX1 0.021 0.017 -10000 0 -0.12 8 8
ARHGEF6 0.014 0.032 -10000 0 -0.12 28 28
ARHGEF7 0.023 0.006 -10000 0 -0.12 1 1
ARF1 0.018 0.028 -10000 0 -0.12 21 21
NRAS 0.022 0.012 -10000 0 -0.12 3 3
FYN 0.011 0.037 -10000 0 -0.12 40 40
ARF6 0.023 0.003 -10000 0 -10000 0 0
FGR 0.023 0.006 -10000 0 -0.12 1 1
mol:Ca2+ 0.012 0.038 0.092 14 -0.077 38 52
mol:IP4 0 0 -10000 0 -10000 0 0
TIAM1 0.015 0.032 -10000 0 -0.12 28 28
ZAP70 0.023 0.006 -10000 0 -0.12 1 1
mol:IP3 0.013 0.05 0.11 14 -0.1 42 56
LYN 0.021 0.013 -10000 0 -0.12 4 4
ARF1/GDP 0.002 0.088 -10000 0 -0.21 59 59
RhoA/GDP 0.014 0.067 0.17 19 -0.15 46 65
PDK1/Src/Hsp90 0.041 0.032 -10000 0 -0.12 19 19
BLNK 0.014 0.033 -10000 0 -0.12 31 31
actin cytoskeleton reorganization 0.005 0.087 0.19 17 -0.22 45 62
SRC 0.023 0.009 -10000 0 -0.12 2 2
PLEKHA2 0.013 0.011 -10000 0 -0.057 12 12
RAC1 0.023 0.002 -10000 0 -10000 0 0
PTEN 0.022 0.009 -10000 0 -0.12 1 1
HSP90AA1 0.023 0.003 -10000 0 -10000 0 0
ARF6/GTP 0.006 0.042 -10000 0 -0.11 47 47
RhoA/GTP 0.013 0.052 0.17 22 -0.11 41 63
Src family/SYK family/BLNK-LAT 0.006 0.097 -10000 0 -0.27 37 37
BLK 0.022 0.015 -10000 0 -0.12 6 6
PDPK1 0.023 0.007 -10000 0 -0.12 1 1
CYTH1 -0.005 0.036 -10000 0 -0.1 54 54
HCK 0.019 0.024 -10000 0 -0.12 15 15
CYTH3 -0.005 0.036 -10000 0 -0.1 54 54
CYTH2 -0.005 0.036 -10000 0 -0.1 54 54
KRAS 0.014 0.035 -10000 0 -0.12 33 33
GO:0030676 0 0 -10000 0 -10000 0 0
FOXO3 0.015 0.054 0.13 22 -0.21 20 42
SGK1 0.008 0.05 -10000 0 -0.22 19 19
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP -0.008 0.086 -10000 0 -0.22 58 58
SOS1 0.017 0.027 -10000 0 -0.12 20 20
SYK 0.016 0.027 -10000 0 -0.12 20 20
ARF6/GDP 0.008 0.064 0.17 19 -0.15 47 66
mol:PI-3-4-5-P3 -0.004 0.039 0.085 1 -0.11 54 55
ARAP3/RAP1A/GTP 0.012 0.05 0.17 22 -0.12 38 60
VAV1 0.02 0.02 -10000 0 -0.12 10 10
mol:PI-3-4-P2 0.01 0.011 -10000 0 -0.077 8 8
RAS family/GTP/PI3K Class I 0.026 0.058 0.19 22 -0.11 54 76
PLEKHA1 0.013 0.012 -10000 0 -0.057 15 15
Rac1/GDP 0.004 0.087 -10000 0 -0.2 60 60
LAT 0.022 0.011 -10000 0 -0.12 3 3
Rac1/GTP -0.001 0.1 -10000 0 -0.25 67 67
ITK -0.002 0.04 -10000 0 -0.1 58 58
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma 0.014 0.083 0.19 14 -0.19 44 58
LCK 0.022 0.015 -10000 0 -0.12 6 6
BTK -0.003 0.043 -10000 0 -0.11 56 56
Signaling mediated by p38-gamma and p38-delta

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K 0.019 0.016 -9999 0 -0.058 18 18
SNTA1 0.023 0.009 -9999 0 -0.12 2 2
response to hypoxia 0 0 -9999 0 -10000 0 0
STMN1 0.017 0.021 -9999 0 -0.074 21 21
MAPK12 0.01 0.027 -9999 0 -0.059 36 36
CCND1 -0.05 0.14 -9999 0 -0.36 89 89
p38 gamma/SNTA1 0.005 0.057 -9999 0 -0.16 40 40
MAP2K3 0.023 0.006 -9999 0 -0.12 1 1
PKN1 0.016 0.031 -9999 0 -0.12 26 26
G2/M transition checkpoint 0.003 0.044 -9999 0 -0.15 36 36
MAP2K6 0.008 0.028 -9999 0 -0.05 79 79
MAPT 0.007 0.039 -9999 0 -0.13 28 28
MAPK13 0.019 0.019 -9999 0 -0.079 17 17
hyperosmotic response 0 0 -9999 0 -10000 0 0
ZAK -0.001 0.058 -9999 0 -0.21 37 37
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.021 0.014 -10000 0 -0.12 5 5
VLDLR 0.01 0.038 -10000 0 -0.12 41 41
LRPAP1 0.018 0.024 -10000 0 -0.12 15 15
NUDC 0.022 0.011 -10000 0 -0.12 3 3
RELN/LRP8 0.015 0.058 -10000 0 -0.12 53 53
CaM/Ca2+ 0.014 0.02 -10000 0 -0.12 12 12
KATNA1 0.02 0.02 -10000 0 -0.12 10 10
GO:0030286 0 0 -10000 0 -10000 0 0
ABL1 0.006 0.047 -10000 0 -0.11 53 53
IQGAP1/CaM 0.016 0.054 -10000 0 -0.13 63 63
DAB1 0.022 0.011 -10000 0 -0.12 3 3
IQGAP1 0.02 0.017 -10000 0 -0.12 7 7
PLA2G7 0.004 0.045 -10000 0 -0.12 61 61
CALM1 0.022 0.014 -10000 0 -0.12 5 5
DYNLT1 0.018 0.023 -10000 0 -0.12 14 14
mol:Ca2+ 0 0 -10000 0 -10000 0 0
LRPAP1/LRP8 0.015 0.054 -10000 0 -0.12 72 72
UniProt:Q4QZ09 0 0 -10000 0 -10000 0 0
CLIP1 0.023 0.009 -10000 0 -0.12 2 2
CDK5R1 0.023 0.006 -10000 0 -0.12 1 1
LIS1/Poliovirus Protein 3A 0.012 0.023 -10000 0 -0.086 26 26
CDK5R2 0.022 0.011 -10000 0 -0.12 3 3
mol:PP1 0 0 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 0.01 0.06 -10000 0 -0.12 69 69
YWHAE 0.022 0.014 -10000 0 -0.12 5 5
NDEL1/14-3-3 E 0.023 0.055 -10000 0 -0.15 24 24
MAP1B -0.015 0.059 0.2 3 -0.19 47 50
RAC1 0.014 0.048 -10000 0 -0.36 7 7
p35/CDK5 0.008 0.054 -10000 0 -0.12 33 33
RELN 0.001 0.053 -10000 0 -0.12 88 88
PAFAH/LIS1 0.015 0.038 -10000 0 -0.13 14 14
LIS1/CLIP170 0.029 0.028 -10000 0 -0.13 11 11
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain 0.016 0.063 -10000 0 -0.15 39 39
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.014 0.098 -10000 0 -0.21 93 93
GO:0005869 0 0 -10000 0 -10000 0 0
NDEL1 0.011 0.052 -10000 0 -0.15 22 22
LIS1/IQGAP1 0.025 0.034 -10000 0 -0.16 13 13
RHOA 0.014 0.048 -10000 0 -0.3 9 9
PAFAH1B1 0.02 0.015 -10000 0 -0.071 15 15
PAFAH1B3 0.014 0.032 -10000 0 -0.12 29 29
PAFAH1B2 0.022 0.013 -10000 0 -0.12 4 4
MAP1B/LIS1/Dynein heavy chain 0.009 0.054 0.13 3 -0.13 53 56
NDEL1/Katanin 60/Dynein heavy chain 0.025 0.065 -10000 0 -0.17 25 25
LRP8 0.02 0.021 -10000 0 -0.12 12 12
NDEL1/Katanin 60 0.021 0.056 -10000 0 -0.14 30 30
P39/CDK5 0.008 0.053 -10000 0 -0.09 94 94
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.028 0.029 -10000 0 -0.13 11 11
CDK5 0.004 0.043 -10000 0 -0.099 56 56
PPP2R5D 0.022 0.014 -10000 0 -0.12 5 5
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.025 0.023 -10000 0 -0.11 11 11
CSNK2A1 0.021 0.015 -10000 0 -0.12 6 6
RELN/VLDLR/DAB1/LIS1 0.021 0.059 -10000 0 -0.092 81 81
RELN/VLDLR 0.007 0.071 -10000 0 -0.11 119 119
CDC42 0.015 0.04 -10000 0 -0.27 7 7
E-cadherin signaling events

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
E-cadherin/beta catenin-gamma catenin 0.025 0.057 -9999 0 -0.12 63 63
E-cadherin/beta catenin 0.018 0.053 -9999 0 -0.14 54 54
CTNNB1 0.022 0.008 -9999 0 -0.12 1 1
JUP 0.019 0.021 -9999 0 -0.12 12 12
CDH1 0.021 0.016 -9999 0 -0.12 6 6
Regulation of Androgen receptor activity

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.02 0.015 -9999 0 -0.07 13 13
SMARCC1 0 0.17 -9999 0 -1.1 13 13
REL 0.021 0.014 -9999 0 -0.12 5 5
HDAC7 -0.018 0.096 -9999 0 -0.17 120 120
JUN 0.014 0.033 -9999 0 -0.12 30 30
EP300 0.022 0.01 -9999 0 -0.12 2 2
KAT2B 0 0 -9999 0 -10000 0 0
KAT5 0 0 -9999 0 -10000 0 0
MAPK14 0.013 0.025 -9999 0 -0.071 34 34
FOXO1 0.023 0.009 -9999 0 -0.12 2 2
T-DHT/AR -0.001 0.11 -9999 0 -0.18 119 119
MAP2K6 0.012 0.035 -9999 0 -0.12 33 33
BRM/BAF57 0.007 0.062 -9999 0 -0.12 110 110
MAP2K4 0.022 0.012 -9999 0 -0.12 3 3
SMARCA2 0.012 0.036 -9999 0 -0.12 36 36
PDE9A -0.095 0.31 -9999 0 -0.86 79 79
NCOA2 0.022 0.013 -9999 0 -0.12 4 4
CEBPA 0.022 0.014 -9999 0 -0.12 5 5
EHMT2 0.023 0.009 -9999 0 -0.12 2 2
cell proliferation -0.011 0.11 -9999 0 -0.25 60 60
NR0B1 0.013 0.038 -9999 0 -0.12 41 41
EGR1 -0.005 0.054 -9999 0 -0.12 99 99
RXRs/9cRA 0.033 0.033 -9999 0 -0.096 4 4
AR/RACK1/Src 0.011 0.073 -9999 0 -0.17 47 47
AR/GR -0.013 0.085 -9999 0 -0.17 101 101
GNB2L1 0.023 0.003 -9999 0 -10000 0 0
PKN1 0.016 0.031 -9999 0 -0.12 26 26
RCHY1 0.018 0.022 -9999 0 -0.12 13 13
epidermal growth factor receptor activity 0 0 -9999 0 -10000 0 0
MAPK8 0.018 0.018 -9999 0 -0.074 9 9
T-DHT/AR/TIF2/CARM1 0.01 0.084 -9999 0 -0.16 66 66
SRC 0.015 0.027 -9999 0 -0.066 16 16
NR3C1 0.021 0.015 -9999 0 -0.12 5 5
KLK3 0.004 0.047 -9999 0 -10000 0 0
APPBP2 0.019 0.017 -9999 0 -0.12 6 6
TRIM24 0.023 0.014 -9999 0 -0.12 5 5
T-DHT/AR/TIP60 -0.014 0.071 -9999 0 -0.15 87 87
TMPRSS2 0.002 0.092 -9999 0 -0.68 4 4
RXRG 0.006 0.047 -9999 0 -0.12 68 68
mol:9cRA 0 0 -9999 0 -10000 0 0
RXRA 0.021 0.017 -9999 0 -0.12 8 8
RXRB 0.023 0 -9999 0 -10000 0 0
CARM1 0.019 0.026 -9999 0 -0.12 19 19
NR2C2 0.023 0.006 -9999 0 -0.12 1 1
KLK2 0.019 0.072 -9999 0 -0.25 13 13
AR -0.01 0.074 -9999 0 -0.16 94 94
SENP1 0.022 0.011 -9999 0 -0.12 3 3
HSP90AA1 0.023 0.003 -9999 0 -10000 0 0
MDM2 0.018 0.02 -9999 0 -0.12 11 11
SRY 0.021 0.008 -9999 0 -0.11 2 2
GATA2 0.02 0.022 -9999 0 -0.12 13 13
MYST2 0.022 0.011 -9999 0 -0.12 3 3
HOXB13 0.02 0.026 -9999 0 -0.12 19 19
T-DHT/AR/RACK1/Src 0.006 0.074 -9999 0 -0.17 52 52
positive regulation of transcription 0.02 0.022 -9999 0 -0.12 13 13
DNAJA1 0.02 0.012 -9999 0 -0.13 2 2
proteasomal ubiquitin-dependent protein catabolic process -0.001 0.09 -9999 0 -0.28 48 48
NCOA1 0.025 0.032 -9999 0 -0.16 15 15
SPDEF 0.012 0.042 -9999 0 -0.12 50 50
T-DHT/AR/TIF2 -0.006 0.088 -9999 0 -0.22 57 57
T-DHT/AR/Hsp90 -0.003 0.078 -9999 0 -0.18 60 60
GSK3B 0.022 0.011 -9999 0 -0.12 3 3
NR2C1 0.021 0.01 -9999 0 -0.12 2 2
mol:T-DHT 0.013 0.028 -9999 0 -0.07 16 16
SIRT1 0.023 0.003 -9999 0 -10000 0 0
ZMIZ2 0.02 0.014 -9999 0 -0.12 5 5
POU2F1 0.017 0.041 -9999 0 -0.077 78 78
T-DHT/AR/DAX-1 -0.007 0.077 -9999 0 -0.15 86 86
CREBBP 0.021 0.015 -9999 0 -0.12 6 6
SMARCE1 0.023 0.011 -9999 0 -0.12 3 3
RXR and RAR heterodimerization with other nuclear receptor

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 -0.021 0.2 -10000 0 -0.97 24 24
VDR 0.019 0.022 -10000 0 -0.12 13 13
FAM120B 0.022 0.011 -10000 0 -0.12 3 3
RXRs/LXRs/DNA/9cRA 0.025 0.095 -10000 0 -0.24 54 54
RXRs/LXRs/DNA/Oxysterols 0.019 0.13 -10000 0 -0.35 59 59
MED1 0.021 0.014 -10000 0 -0.12 5 5
mol:9cRA 0.002 0.016 -10000 0 -0.047 49 49
RARs/THRs/DNA/Src-1 -0.003 0.087 -10000 0 -0.29 24 24
RXRs/NUR77 0.033 0.067 0.18 8 -0.13 27 35
RXRs/PPAR 0.032 0.039 -10000 0 -0.16 5 5
NCOR2 0.019 0.023 -10000 0 -0.12 15 15
VDR/VDR/Vit D3 0.008 0.035 -10000 0 -0.12 36 36
RARs/VDR/DNA/Vit D3 0.029 0.056 -10000 0 -0.1 66 66
RARA 0.023 0 -10000 0 -10000 0 0
NCOA1 0.022 0.009 -10000 0 -0.12 2 2
VDR/VDR/DNA 0.019 0.022 -10000 0 -0.12 13 13
RARs/RARs/DNA/9cRA 0.025 0.045 -10000 0 -0.097 52 52
RARG 0.021 0.015 -10000 0 -0.12 6 6
RPS6KB1 -0.004 0.091 -10000 0 -0.32 39 39
RARs/THRs/DNA/SMRT -0.002 0.083 -10000 0 -0.27 24 24
THRA 0.022 0.015 -10000 0 -0.12 6 6
mol:Bile acids 0 0 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.008 0.035 -10000 0 -0.12 36 36
RXRs/PPAR/9cRA/PGJ2/DNA 0.041 0.074 0.27 14 -0.16 15 29
NR1H4 0.021 0.017 -10000 0 -0.12 8 8
RXRs/LXRs/DNA 0.06 0.085 -10000 0 -0.16 53 53
NR1H2 0.021 0.027 -10000 0 -0.12 11 11
NR1H3 0.02 0.029 -10000 0 -0.052 64 64
RXRs/VDR/DNA/Vit D3 0.039 0.059 0.17 6 -0.13 23 29
NR4A1 0.003 0.049 -10000 0 -0.12 74 74
mol:ATRA 0 0 -10000 0 -10000 0 0
RXRs/FXR/9cRA/MED1 0.022 0.049 -10000 0 -0.17 15 15
RXRG 0.006 0.05 -10000 0 -0.12 68 68
RXR alpha/CCPG 0.031 0.026 -10000 0 -0.12 9 9
RXRA 0.021 0.025 -10000 0 -0.11 10 10
RXRB 0.024 0.02 -10000 0 -0.045 2 2
THRB 0.011 0.036 -10000 0 -0.12 36 36
PPARG 0.018 0.028 -10000 0 -0.12 22 22
PPARD 0.023 0.009 -10000 0 -0.12 2 2
TNF 0.022 0.13 -10000 0 -0.59 5 5
mol:Oxysterols 0.001 0.015 -10000 0 -0.041 56 56
cholesterol transport 0.02 0.13 -10000 0 -0.34 59 59
PPARA 0.022 0.012 -10000 0 -0.12 4 4
mol:Vit D3 0 0 -10000 0 -10000 0 0
RARB 0.013 0.034 -10000 0 -0.12 33 33
RXRs/NUR77/BCL2 0.013 0.045 -10000 0 -0.15 23 23
SREBF1 0.022 0.13 -10000 0 -0.41 20 20
RXRs/RXRs/DNA/9cRA 0.041 0.073 0.26 14 -0.16 15 29
ABCA1 -0.029 0.27 -10000 0 -0.84 55 55
RARs/THRs 0.027 0.072 -10000 0 -0.16 28 28
RXRs/FXR 0.049 0.057 0.18 8 -0.12 15 23
BCL2 0.016 0.031 -10000 0 -0.12 27 27
Regulation of Telomerase

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex -0.047 0.18 -10000 0 -0.45 59 59
RAD9A 0.023 0 -10000 0 -10000 0 0
AP1 -0.031 0.087 -10000 0 -0.16 150 150
IFNAR2 0.018 0.02 -10000 0 -0.13 8 8
AKT1 0.012 0.041 -10000 0 -0.17 7 7
ER alpha/Oestrogen 0.002 0.046 -10000 0 -0.13 58 58
NFX1/SIN3/HDAC complex 0.009 0.089 -10000 0 -0.27 35 35
EGF 0.02 0.022 -10000 0 -0.13 12 12
SMG5 0.022 0.011 -10000 0 -0.12 3 3
SMG6 0.022 0.011 -10000 0 -0.12 3 3
SP3/HDAC2 0.026 0.031 -10000 0 -0.13 13 13
TERT/c-Abl -0.042 0.17 -10000 0 -0.42 60 60
SAP18 0.023 0.003 -10000 0 -10000 0 0
MRN complex 0.023 0.065 -10000 0 -0.14 64 64
WT1 0.019 0.016 -10000 0 -0.12 5 5
WRN 0.019 0.02 -10000 0 -0.12 10 10
SP1 0.02 0.015 -10000 0 -0.14 1 1
SP3 0.023 0.003 -10000 0 -10000 0 0
TERF2IP 0.023 0.009 -10000 0 -0.12 2 2
Telomerase/Nucleolin -0.033 0.17 -10000 0 -0.39 66 66
Mad/Max 0.032 0.015 -10000 0 -0.079 4 4
TERT -0.048 0.18 -10000 0 -0.46 58 58
CCND1 -0.13 0.37 -10000 0 -0.98 83 83
MAX 0.023 0.004 -10000 0 -10000 0 0
RBBP7 0.021 0.012 -10000 0 -0.12 3 3
RBBP4 0.021 0.014 -10000 0 -0.12 5 5
TERF2 0.025 0.017 0.082 38 -0.12 1 39
PTGES3 0.014 0.036 -10000 0 -0.12 36 36
SIN3A 0.021 0.014 -10000 0 -0.12 5 5
Telomerase/911 0.017 0.096 -10000 0 -0.34 27 27
CDKN1B -0.015 0.095 -10000 0 -0.25 51 51
RAD1 0.02 0.021 -10000 0 -0.12 12 12
XRCC5 0.021 0.01 -10000 0 -0.12 2 2
XRCC6 0.022 0.004 -10000 0 -10000 0 0
SAP30 0.023 0.001 -10000 0 -10000 0 0
TRF2/PARP2 0.03 0.032 -10000 0 -0.09 30 30
UBE3A 0.023 0.004 -10000 0 -10000 0 0
JUN 0.014 0.033 -10000 0 -0.12 30 30
E6 -0.001 0.003 -10000 0 -10000 0 0
HPV-16 E6/E6AP 0.013 0.021 -10000 0 -0.15 8 8
FOS -0.006 0.053 -10000 0 -0.12 95 95
IFN-gamma/IRF1 -0.007 0.086 -10000 0 -0.16 112 112
PARP2 0.018 0.026 -10000 0 -0.12 18 18
BLM 0.015 0.032 -10000 0 -0.12 28 28
Telomerase 0.013 0.1 -10000 0 -0.41 23 23
IRF1 0.004 0.058 -10000 0 -0.13 70 70
ESR1 0.017 0.024 -10000 0 -0.12 15 15
KU/TER 0.018 0.058 -10000 0 -0.17 44 44
ATM/TRF2 0.02 0.049 -10000 0 -0.13 51 51
ubiquitin-dependent protein catabolic process 0.013 0.088 -10000 0 -0.26 33 33
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.013 0.09 -10000 0 -0.26 33 33
HDAC1 0.019 0.02 -10000 0 -0.12 10 10
HDAC2 0.017 0.024 -10000 0 -0.12 12 12
ATM -0.012 0.067 0.14 1 -0.26 38 39
SMAD3 0.019 0.019 -10000 0 -0.072 21 21
ABL1 0.022 0.007 -10000 0 -0.12 1 1
MXD1 0.021 0.018 -10000 0 -0.12 8 8
MRE11A 0.02 0.017 -10000 0 -0.12 7 7
HUS1 0.023 0 -10000 0 -10000 0 0
RPS6KB1 0.021 0.014 -10000 0 -0.12 5 5
TERT/NF kappa B1/14-3-3 -0.024 0.17 -10000 0 -0.4 53 53
NR2F2 0.023 0.014 -10000 0 -0.12 4 4
MAPK3 0.021 0.016 -10000 0 -0.091 8 8
MAPK1 0.02 0.017 -10000 0 -0.087 10 10
TGFB1/TGF beta receptor Type II 0.019 0.023 -10000 0 -0.12 14 14
NFKB1 0.021 0.013 -10000 0 -0.12 4 4
HNRNPC 0.022 0.012 -10000 0 -0.12 4 4
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis -0.012 0.067 0.14 1 -0.26 38 39
NBN 0.02 0.015 -10000 0 -0.12 5 5
EGFR 0.015 0.03 -10000 0 -0.12 25 25
mol:Oestrogen 0 0.002 -10000 0 -10000 0 0
EGF/EGFR 0.015 0.051 -10000 0 -0.14 46 46
MYC 0.015 0.028 -10000 0 -0.12 20 20
IL2 0.02 0.017 -10000 0 -0.12 3 3
KU 0.018 0.058 -10000 0 -0.17 44 44
RAD50 0.021 0.014 -10000 0 -0.12 5 5
HSP90AA1 0.023 0.003 -10000 0 -10000 0 0
TGFB1 0.019 0.023 -10000 0 -0.12 14 14
TRF2/BLM 0.024 0.043 -10000 0 -0.095 57 57
FRAP1 0.022 0.013 -10000 0 -0.12 4 4
KU/TERT -0.035 0.18 -10000 0 -0.42 62 62
SP1/HDAC2 0.025 0.038 -10000 0 -0.14 19 19
PINX1 0.021 0.017 -10000 0 -0.12 8 8
Telomerase/EST1A -0.029 0.17 -10000 0 -0.38 64 64
Smad3/Myc 0.016 0.046 -10000 0 -0.15 29 29
911 complex 0.043 0.024 -10000 0 -0.11 9 9
IFNG 0.009 0.047 -10000 0 -0.1 76 76
Telomerase/PinX1 -0.032 0.17 -10000 0 -0.38 65 65
Telomerase/AKT1/mTOR/p70S6K 0.004 0.11 -10000 0 -0.37 26 26
SIN3B 0.022 0.015 -10000 0 -0.12 6 6
YWHAE 0.022 0.014 -10000 0 -0.12 5 5
Telomerase/EST1B -0.03 0.17 -10000 0 -0.38 65 65
response to DNA damage stimulus -0.004 0.03 0.052 1 -0.12 38 39
MRN complex/TRF2/Rap1 0.046 0.06 -10000 0 -0.11 54 54
TRF2/WRN 0.024 0.042 -10000 0 -0.11 47 47
Telomerase/hnRNP C1/C2 -0.029 0.17 -10000 0 -0.38 64 64
E2F1 0.02 0.018 -10000 0 -0.12 7 7
ZNFX1 0.018 0.022 -10000 0 -0.12 12 12
PIF1 0.023 0.006 -10000 0 -0.12 1 1
NCL 0.022 0.008 -10000 0 -0.12 1 1
DKC1 0.022 0.011 -10000 0 -0.12 3 3
telomeric DNA binding 0 0 -10000 0 -10000 0 0
S1P3 pathway

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.01 0.042 -9999 0 -0.12 52 52
mol:S1P -0.002 0.007 -9999 0 -0.029 24 24
S1P1/S1P/Gi 0.008 0.065 -9999 0 -0.22 31 31
GNAO1 0.008 0.043 -9999 0 -0.12 51 51
S1P/S1P3/G12/G13 0.024 0.024 -9999 0 -0.1 14 14
AKT1 0.006 0.059 -9999 0 -0.36 7 7
AKT3 -0.054 0.23 -9999 0 -1 24 24
mol:GTP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB 0.01 0.042 -9999 0 -0.12 52 52
GNAI2 0.02 0.014 -9999 0 -0.12 3 3
GNAI3 0.02 0.012 -9999 0 -0.027 13 13
GNAI1 0.01 0.036 -9999 0 -0.12 35 35
mol:GDP 0 0 -9999 0 -10000 0 0
S1PR3 -0.002 0.008 -9999 0 -0.031 24 24
S1PR2 0 0 -9999 0 -10000 0 0
EDG1 0.021 0.016 -9999 0 -0.12 7 7
mol:Ca2+ -0.016 0.088 -9999 0 -0.25 45 45
MAPK3 -0.012 0.084 -9999 0 -0.23 48 48
MAPK1 -0.013 0.085 -9999 0 -0.23 47 47
JAK2 -0.023 0.1 -9999 0 -0.27 60 60
CXCR4 -0.021 0.092 -9999 0 -0.24 58 58
FLT1 0.019 0.019 -9999 0 -0.052 24 24
RhoA/GDP 0.016 0.016 -9999 0 -0.14 6 6
Rac1/GDP 0.016 0.015 -9999 0 -0.15 5 5
SRC -0.012 0.083 -9999 0 -0.23 45 45
S1P/S1P3/Gi -0.016 0.089 -9999 0 -0.25 45 45
RAC1 0.023 0.002 -9999 0 -10000 0 0
RhoA/GTP -0.005 0.085 -9999 0 -0.22 46 46
VEGFA 0.017 0.024 -9999 0 -0.073 24 24
S1P/S1P2/Gi -0.011 0.076 -9999 0 -0.15 100 100
VEGFR1 homodimer/VEGFA homodimer 0.016 0.055 -9999 0 -0.15 44 44
RHOA 0.023 0.006 -9999 0 -0.12 1 1
S1P/S1P3/Gq 0.014 0.045 -9999 0 -0.15 34 34
GNAQ 0.021 0.016 -9999 0 -0.12 6 6
GNAZ 0.02 0.014 -9999 0 -0.12 3 3
G12/G13 0.03 0.028 -9999 0 -0.14 14 14
GNA14 0.02 0.02 -9999 0 -0.12 11 11
GNA15 0.021 0.017 -9999 0 -0.12 8 8
GNA12 0.023 0.001 -9999 0 -10000 0 0
GNA13 0.022 0.009 -9999 0 -0.12 2 2
GNA11 0.022 0.014 -9999 0 -0.12 5 5
Rac1/GTP -0.005 0.085 -9999 0 -0.22 46 46
Nephrin/Neph1 signaling in the kidney podocyte

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
positive regulation of NF-kappaB transcription factor activity -0.023 0.042 0.11 47 -10000 0 47
KIRREL 0.018 0.028 -10000 0 -0.12 20 20
Nephrin/NEPH1Par3/Par6/Atypical PKCs 0.023 0.043 -10000 0 -0.11 47 47
PLCG1 0.019 0.024 -10000 0 -0.12 16 16
ARRB2 0.022 0.014 -10000 0 -0.12 5 5
WASL 0.023 0.009 -10000 0 -0.12 2 2
Nephrin/NEPH1/podocin/CD2AP 0.036 0.056 -10000 0 -0.11 64 64
ChemicalAbstracts:57-88-5 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2/N-WASP 0.021 0.053 -10000 0 -0.14 34 34
FYN 0.014 0.034 -10000 0 -0.11 26 26
mol:Ca2+ 0.041 0.047 -10000 0 -0.11 38 38
mol:DAG 0.042 0.048 -10000 0 -0.11 38 38
NPHS2 0.022 0.014 -10000 0 -0.12 4 4
mol:IP3 0.042 0.048 -10000 0 -0.11 38 38
regulation of endocytosis 0.031 0.045 -10000 0 -0.098 32 32
Nephrin/NEPH1/podocin/Cholesterol 0.034 0.035 -10000 0 -0.1 27 27
establishment of cell polarity 0.023 0.042 -10000 0 -0.11 47 47
Nephrin/NEPH1/podocin/NCK1-2 0.049 0.054 -10000 0 -0.1 39 39
Nephrin/NEPH1/beta Arrestin2 0.033 0.046 -10000 0 -0.099 32 32
NPHS1 0.021 0.02 -10000 0 -0.1 12 12
Nephrin/NEPH1/podocin 0.025 0.045 -10000 0 -0.11 28 28
TJP1 0.021 0.01 -10000 0 -0.12 2 2
NCK1 0.02 0.019 -10000 0 -0.12 9 9
NCK2 0.023 0.006 -10000 0 -0.12 1 1
heterophilic cell adhesion 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/PLCgamma1 0.043 0.048 -10000 0 -0.11 38 38
CD2AP 0.02 0.017 -10000 0 -0.12 7 7
Nephrin/NEPH1/podocin/GRB2 0.047 0.042 -10000 0 -0.11 28 28
GRB2 0.023 0.006 -10000 0 -0.12 1 1
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
TRPC6 0.019 0.029 -10000 0 -0.089 25 25
cytoskeleton organization 0.022 0.047 -10000 0 -0.13 30 30
Nephrin/NEPH1 0.022 0.029 -10000 0 -0.072 47 47
Nephrin/NEPH1/ZO-1 0.027 0.055 -10000 0 -0.13 56 56
Canonical NF-kappaB pathway

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FBXW11 0.019 0.02 -9999 0 -0.055 27 27
mol:GTP 0 0 -9999 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.013 0.11 -9999 0 -0.26 53 53
ERC1 0.016 0.029 -9999 0 -0.12 24 24
RIP2/NOD2 0.013 0.053 -9999 0 -0.11 81 81
NFKBIA 0.001 0.087 -9999 0 -0.22 60 60
BIRC2 0.021 0.013 -9999 0 -0.12 4 4
IKBKB 0.022 0.015 -9999 0 -0.12 6 6
RIPK2 0.013 0.034 -9999 0 -0.12 32 32
IKBKG 0.012 0.091 -9999 0 -0.32 29 29
IKK complex/A20 0.037 0.096 -9999 0 -0.31 26 26
NEMO/A20/RIP2 0.013 0.034 -9999 0 -0.12 32 32
XPO1 0.022 0.01 -9999 0 -0.12 2 2
NEMO/ATM 0.017 0.1 -9999 0 -0.3 39 39
tumor necrosis factor receptor activity 0 0 -9999 0 -10000 0 0
RAN 0.023 0.002 -9999 0 -10000 0 0
Exportin 1/RanGTP 0.025 0.03 -9999 0 -0.11 26 26
IKK complex/ELKS 0.021 0.094 -9999 0 -0.33 25 25
BCL10/MALT1/TRAF6 0.034 0.043 -9999 0 -0.12 31 31
NOD2 0.023 0.006 -9999 0 -0.12 1 1
NFKB1 0.017 0.023 -9999 0 -0.062 33 33
RELA 0.019 0.022 -9999 0 -0.055 37 37
MALT1 0.017 0.026 -9999 0 -0.12 19 19
cIAP1/UbcH5C 0.021 0.047 -9999 0 -0.14 45 45
ATM 0.018 0.022 -9999 0 -0.12 13 13
TNF/TNFR1A 0.025 0.036 -9999 0 -0.11 37 37
TRAF6 0.022 0.009 -9999 0 -0.12 2 2
PRKCA 0.011 0.037 -9999 0 -0.12 40 40
CHUK 0.021 0.013 -9999 0 -0.12 4 4
UBE2D3 0.023 0.001 -9999 0 -10000 0 0
TNF 0.02 0.02 -9999 0 -0.12 11 11
NF kappa B1 p50/RelA 0.029 0.075 -9999 0 -0.15 75 75
BCL10 0.023 0.001 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.001 0.086 -9999 0 -0.22 60 60
beta TrCP1/SCF ubiquitin ligase complex 0.019 0.02 -9999 0 -0.056 27 27
TNFRSF1A 0.021 0.016 -9999 0 -0.12 7 7
IKK complex 0.029 0.098 -9999 0 -0.31 30 30
CYLD 0.023 0.007 -9999 0 -0.12 1 1
IKK complex/PKC alpha 0.024 0.1 -9999 0 -0.33 26 26
Atypical NF-kappaB pathway

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL3/RelA 0.03 0.026 -9999 0 -0.094 21 21
FBXW11 0.023 0.003 -9999 0 -10000 0 0
NF kappa B1 p50/c-Rel 0.022 0.04 -9999 0 -0.11 41 41
NF kappa B1 p50/RelA/I kappa B alpha 0.018 0.073 -9999 0 -0.21 28 28
NFKBIA 0.001 0.066 -9999 0 -0.15 78 78
MAPK14 0.023 0.007 -9999 0 -0.12 1 1
NF kappa B1 p105/p50 0.022 0.042 -9999 0 -0.12 40 40
ARRB2 0.014 0.035 -9999 0 -0.2 14 14
REL 0.022 0.014 -9999 0 -0.12 5 5
response to oxidative stress 0 0 -9999 0 -10000 0 0
BCL3/NF kappa B1 p50 0.02 0.042 -9999 0 -0.12 40 40
response to UV 0 0 -9999 0 -10000 0 0
NF kappa B1 p105/RelA 0.022 0.04 -9999 0 -0.11 40 40
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
NF kappa B1 p50 dimer 0.012 0.044 -9999 0 -0.13 48 48
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
NFKB1 0.02 0.014 -9999 0 -0.071 10 10
RELA 0.023 0.009 -9999 0 -0.12 2 2
positive regulation of anti-apoptosis 0.013 0.051 -9999 0 -0.2 9 9
NF kappa B1 p50/RelA/I kappa B alpha/beta Arrestin2 0.02 0.075 -9999 0 -0.2 35 35
SRC 0.023 0.009 -9999 0 -0.12 2 2
PI3K 0.007 0.065 -9999 0 -0.13 96 96
NF kappa B1 p50/RelA 0.013 0.052 -9999 0 -0.2 9 9
IKBKB 0.022 0.015 -9999 0 -0.12 6 6
beta TrCP1/SCF ubiquitin ligase complex 0.023 0.003 -9999 0 -10000 0 0
SYK 0.016 0.027 -9999 0 -0.12 20 20
I kappa B alpha/PIK3R1 0.008 0.069 -9999 0 -0.14 78 78
cell death 0.02 0.072 -9999 0 -0.19 35 35
NF kappa B1 p105/c-Rel 0.022 0.04 -9999 0 -0.11 41 41
LCK 0.022 0.015 -9999 0 -0.12 6 6
BCL3 0.02 0.023 -9999 0 -0.12 14 14
IL2 signaling events mediated by STAT5

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.008 0.041 -9999 0 -0.12 50 50
ELF1 0.032 0.023 -9999 0 -0.2 3 3
CCNA2 0.013 0.032 -9999 0 -0.12 29 29
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
JAK3 0.022 0.014 -9999 0 -0.12 5 5
PIK3R1 0.016 0.031 -9999 0 -0.12 27 27
JAK1 0.022 0.01 -9999 0 -0.12 2 2
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K -0.006 0.13 -9999 0 -0.31 53 53
SHC1 0.024 0.002 -9999 0 -10000 0 0
SP1 0.012 0.055 -9999 0 -0.25 11 11
IL2RA 0.03 0.037 -9999 0 -0.49 2 2
IL2RB 0.019 0.024 -9999 0 -0.12 16 16
SOS1 0.018 0.027 -9999 0 -0.12 20 20
IL2RG -0.001 0.05 -9999 0 -0.12 82 82
G1/S transition of mitotic cell cycle -0.077 0.17 -9999 0 -0.31 154 154
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
CCND2 -0.001 0.088 -9999 0 -0.48 10 10
LCK 0.022 0.015 -9999 0 -0.12 6 6
GRB2 0.023 0.007 -9999 0 -0.12 1 1
IL2 0.023 0.011 -9999 0 -0.12 3 3
CDK6 0.008 0.04 -9999 0 -0.12 46 46
CCND3 -0.004 0.14 -9999 0 -0.6 12 12
PDGFR-beta signaling pathway

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
S1P1/Sphingosine-1-phosphate 0.025 0.07 -9999 0 -0.22 17 17
PDGFB-D/PDGFRB/SLAP 0.02 0.039 -9999 0 -0.08 72 72
PDGFB-D/PDGFRB/APS/CBL 0.022 0.028 -9999 0 -0.06 57 57
AKT1 0.008 0.053 -9999 0 -0.12 45 45
mol:PI-4-5-P2 0 0 -9999 0 -10000 0 0
mol:Sphingosine-1-phosphate 0.019 0.068 -9999 0 -0.24 17 17
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
FGR 0.014 0.04 -9999 0 -0.2 2 2
mol:Ca2+ 0.011 0.065 -9999 0 -0.28 13 13
MYC -0.059 0.26 -9999 0 -0.7 76 76
SHC1 0.023 0.001 -9999 0 -10000 0 0
HRAS/GDP 0.026 0.038 -9999 0 -0.086 38 38
LRP1/PDGFRB/PDGFB 0.024 0.053 -9999 0 -0.11 57 57
GRB10 0.022 0.014 -9999 0 -0.12 5 5
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
GO:0007205 0.011 0.066 -9999 0 -0.28 13 13
PTEN 0.022 0.008 -9999 0 -0.12 1 1
GRB2 0.023 0.006 -9999 0 -0.12 1 1
GRB7 0.018 0.026 -9999 0 -0.12 18 18
PDGFB-D/PDGFRB/SHP2 0.017 0.045 -9999 0 -0.091 77 77
PDGFB-D/PDGFRB/GRB10 0.021 0.039 -9999 0 -0.082 66 66
cell cycle arrest 0.02 0.039 -9999 0 -0.08 72 72
HRAS 0.023 0.006 -9999 0 -0.12 1 1
HIF1A 0.007 0.054 -9999 0 -0.13 52 52
GAB1 0.006 0.08 -9999 0 -0.24 24 24
mol:GTP 0 0 -9999 0 -10000 0 0
DNM2 0.006 0.078 -9999 0 -0.21 34 34
PDGFB-D/PDGFRB 0.032 0.039 -9999 0 -0.11 14 14
mol:GDP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB/LMW-PTP 0.016 0.047 -9999 0 -0.097 77 77
S1P1/Sphingosine-1-phosphate/PDGFB-D/PDGFRB 0.018 0.086 -9999 0 -0.2 45 45
positive regulation of MAPKKK cascade 0.017 0.045 -9999 0 -0.091 77 77
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
mol:IP3 0.011 0.066 -9999 0 -0.29 13 13
E5 0 0.001 -9999 0 -10000 0 0
CSK 0.023 0.009 -9999 0 -0.12 2 2
PDGFB-D/PDGFRB/GRB7 0.017 0.046 -9999 0 -0.088 82 82
SHB 0.023 0.009 -9999 0 -0.12 2 2
BLK 0.014 0.039 -9999 0 -0.19 5 5
PTPN2 0.022 0.008 -9999 0 -0.13 1 1
PDGFB-D/PDGFRB/SNX15 0.024 0.033 -9999 0 -0.074 55 55
BCAR1 0.022 0.011 -9999 0 -0.12 3 3
VAV2 -0.004 0.11 -9999 0 -0.24 80 80
CBL 0.023 0.006 -9999 0 -0.12 1 1
PDGFB-D/PDGFRB/DEP1 0.017 0.046 -9999 0 -0.09 81 81
LCK 0.014 0.039 -9999 0 -0.18 5 5
PDGFRB 0.01 0.043 -9999 0 -0.12 52 52
ACP1 0.021 0.014 -9999 0 -0.12 5 5
HCK -0.001 0.091 -9999 0 -0.42 19 19
ABL1 0.007 0.068 -9999 0 -0.21 22 22
PDGFB-D/PDGFRB/CBL 0.007 0.082 -9999 0 -0.26 20 20
PTPN1 0.022 0.007 -9999 0 -0.13 1 1
SNX15 0.023 0 -9999 0 -10000 0 0
STAT3 0.022 0.011 -9999 0 -0.12 3 3
STAT1 0.014 0.031 -9999 0 -0.12 26 26
cell proliferation -0.049 0.23 -9999 0 -0.61 77 77
SLA 0.02 0.019 -9999 0 -0.12 10 10
actin cytoskeleton reorganization 0.031 0.041 -9999 0 -0.15 7 7
SRC 0.015 0.038 -9999 0 -0.18 5 5
PI3K -0.021 0.04 -9999 0 -0.14 43 43
PDGFB-D/PDGFRB/GRB7/SHC 0.03 0.042 -9999 0 -0.13 17 17
SH2B2 0 0 -9999 0 -10000 0 0
PLCgamma1/SPHK1 0.019 0.07 -9999 0 -0.24 17 17
LYN -0.021 0.13 -9999 0 -0.44 44 44
LRP1 0.014 0.032 -9999 0 -0.12 29 29
SOS1 0.017 0.027 -9999 0 -0.12 20 20
STAT5B 0.023 0.006 -9999 0 -0.12 1 1
STAT5A 0.022 0.013 -9999 0 -0.12 4 4
NCK1-2/p130 Cas 0.046 0.052 -9999 0 -0.12 15 15
SPHK1 0.022 0.015 -9999 0 -0.12 6 6
EDG1 0.022 0.016 -9999 0 -0.12 7 7
mol:DAG 0.011 0.066 -9999 0 -0.29 13 13
PLCG1 0.011 0.068 -9999 0 -0.29 13 13
NHERF/PDGFRB 0.024 0.049 -9999 0 -0.12 28 28
YES1 -0.011 0.12 -9999 0 -0.44 34 34
cell migration 0.024 0.049 -9999 0 -0.12 28 28
SHC/Grb2/SOS1 0.044 0.051 -9999 0 -0.16 8 8
SLC9A3R2 0.017 0.028 -9999 0 -0.12 22 22
SLC9A3R1 0.016 0.031 -9999 0 -0.12 26 26
NHERF1-2/PDGFRB/PTEN 0.031 0.056 -9999 0 -0.1 50 50
FYN -0.021 0.12 -9999 0 -0.38 46 46
DOK1 0.021 0.029 -9999 0 -0.11 10 10
HRAS/GTP 0.017 0.008 -9999 0 -0.11 2 2
PDGFB 0.022 0.011 -9999 0 -0.12 3 3
RAC1 -0.022 0.16 -9999 0 -0.4 82 82
PRKCD 0.019 0.031 -9999 0 -0.12 11 11
FER 0.02 0.03 -9999 0 -0.11 11 11
MAPKKK cascade -0.007 0.028 -9999 0 -0.15 8 8
RASA1 0.02 0.03 -9999 0 -0.12 10 10
NCK1 0.02 0.019 -9999 0 -0.12 9 9
NCK2 0.023 0.006 -9999 0 -0.12 1 1
p62DOK/Csk 0.032 0.033 -9999 0 -0.093 16 16
PDGFB-D/PDGFRB/SHB 0.023 0.033 -9999 0 -0.074 57 57
chemotaxis 0.007 0.067 -9999 0 -0.2 22 22
STAT1-3-5/STAT1-3-5 0.021 0.058 -9999 0 -0.14 22 22
Bovine Papilomavirus E5/PDGFRB 0.007 0.03 -9999 0 -0.081 55 55
PTPRJ 0.02 0.019 -9999 0 -0.12 9 9
S1P4 pathway

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -9999 0 -10000 0 0
GNAO1 0.01 0.042 -9999 0 -0.12 51 51
CDC42/GTP 0.008 0.067 -9999 0 -0.21 22 22
PLCG1 -0.001 0.065 -9999 0 -0.14 86 86
mol:GTP 0 0 -9999 0 -10000 0 0
GNAI2 0.022 0.011 -9999 0 -0.12 3 3
GNAI3 0.021 0.008 -9999 0 -0.12 1 1
G12/G13 0.03 0.028 -9999 0 -0.14 14 14
cell migration 0.007 0.065 -9999 0 -0.21 22 22
S1PR5 0 0 -9999 0 -10000 0 0
S1PR4 0 0 -9999 0 -10000 0 0
MAPK3 0 0.066 -9999 0 -0.14 86 86
MAPK1 0 0.066 -9999 0 -0.14 86 86
S1P/S1P5/Gi -0.003 0.069 -9999 0 -0.15 86 86
GNAI1 0.012 0.035 -9999 0 -0.12 35 35
CDC42/GDP 0.016 0.012 -9999 0 -0.15 3 3
S1P/S1P5/G12 0.016 0.006 -9999 0 -0.12 1 1
RHOA 0.021 0.02 -9999 0 -0.1 14 14
S1P/S1P4/Gi -0.003 0.069 -9999 0 -0.15 86 86
mol:GDP 0 0 -9999 0 -10000 0 0
GNAZ 0.022 0.011 -9999 0 -0.12 3 3
S1P/S1P4/G12/G13 0.026 0.021 -9999 0 -0.1 14 14
GNA12 0.023 0.001 -9999 0 -10000 0 0
GNA13 0.022 0.009 -9999 0 -0.12 2 2
CDC42 0.023 0.002 -9999 0 -10000 0 0
Presenilin action in Notch and Wnt signaling

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.015 0.12 -10000 0 -0.48 29 29
HDAC1 0.027 0.027 0.087 22 -0.1 10 32
AES 0.023 0.021 0.065 1 -0.12 10 11
FBXW11 0.023 0.003 -10000 0 -10000 0 0
DTX1 0.023 0.009 -10000 0 -0.12 2 2
LRP6/FZD1 0.018 0.047 -10000 0 -0.11 66 66
TLE1 0.022 0.02 0.075 1 -0.11 10 11
AP1 -0.004 0.071 -10000 0 -0.2 45 45
NCSTN 0.022 0.012 -10000 0 -0.12 4 4
ADAM10 0.022 0.013 -10000 0 -0.12 4 4
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 -0.056 0.18 -10000 0 -0.48 52 52
NICD/RBPSUH 0.013 0.12 -10000 0 -0.48 29 29
WIF1 0.02 0.022 -10000 0 -0.12 13 13
NOTCH1 0.001 0.12 -10000 0 -0.51 29 29
PSENEN 0.016 0.03 -10000 0 -0.12 24 24
KREMEN2 0.022 0.012 -10000 0 -0.12 4 4
DKK1 0.015 0.034 -10000 0 -0.12 33 33
beta catenin/beta TrCP1 -0.005 0.081 -10000 0 -0.28 30 30
APH1B 0.014 0.032 -10000 0 -0.12 29 29
APH1A 0.023 0.009 -10000 0 -0.12 2 2
AXIN1 -0.001 0.046 0.19 4 -0.2 10 14
CtBP/CBP/TCF1/TLE1/AES 0.038 0.094 0.18 107 -0.2 22 129
PSEN1 0.022 0.008 -10000 0 -0.12 1 1
FOS -0.005 0.053 -10000 0 -0.12 95 95
JUN 0.014 0.033 -10000 0 -0.12 30 30
MAP3K7 0.024 0.017 -10000 0 -0.12 5 5
CTNNB1 -0.016 0.078 -10000 0 -0.28 29 29
MAPK3 0.022 0.014 -10000 0 -0.12 5 5
DKK2/LRP6/Kremen 2 0.032 0.043 -10000 0 -0.11 32 32
HNF1A 0.024 0.014 0.063 2 -0.12 4 6
CTBP1 0.024 0.018 -10000 0 -0.12 7 7
MYC -0.15 0.42 -10000 0 -1.2 73 73
NKD1 0.023 0.012 -10000 0 -0.12 4 4
FZD1 0.023 0.006 -10000 0 -0.12 1 1
NOTCH1 precursor/Deltex homolog 1 0.014 0.12 -10000 0 -0.48 29 29
apoptosis -0.004 0.071 -10000 0 -0.2 45 45
Delta 1/NOTCHprecursor 0.013 0.12 -10000 0 -0.48 29 29
DLL1 0.022 0.012 -10000 0 -0.12 4 4
PPARD 0.001 0.045 -10000 0 -10000 0 0
Gamma Secretase 0.033 0.067 -10000 0 -0.098 89 89
APC -0.004 0.057 0.19 4 -0.28 11 15
DVL1 0.017 0.066 -10000 0 -0.3 20 20
CSNK2A1 0.021 0.015 -10000 0 -0.12 6 6
MAP3K7IP1 0.026 0.008 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 0.027 0.047 -10000 0 -0.11 34 34
LRP6 0.014 0.034 -10000 0 -0.12 32 32
CSNK1A1 0.022 0.007 -10000 0 -0.12 1 1
NLK 0.029 0.042 -10000 0 -0.22 11 11
CCND1 -0.18 0.43 -10000 0 -1.2 82 82
WNT1 0.023 0.009 -10000 0 -0.12 2 2
Axin1/APC/beta catenin -0.001 0.086 0.2 3 -0.28 27 30
DKK2 0.022 0.011 -10000 0 -0.12 3 3
NOTCH1 precursor/DVL1 0.014 0.13 -10000 0 -0.44 34 34
GSK3B 0.023 0.011 -10000 0 -0.12 3 3
FRAT1 0.024 0.007 -10000 0 -0.12 1 1
NOTCH/Deltex homolog 1 0.016 0.12 -10000 0 -0.48 29 29
PPP2R5D 0.009 0.041 -10000 0 -0.21 12 12
MAPK1 0.021 0.016 -10000 0 -0.12 7 7
WNT1/LRP6/FZD1 0.042 0.045 -10000 0 -0.096 37 37
RBPJ 0.023 0.006 -10000 0 -0.12 1 1
CREBBP 0.017 0.018 -10000 0 -0.12 6 6
LPA4-mediated signaling events

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ADCY4 0.012 0.014 -9999 0 -0.057 22 22
ADCY5 0.009 0.02 -9999 0 -0.06 42 42
ADCY6 0.013 0.01 -9999 0 -0.057 11 11
ADCY7 0.014 0.009 -9999 0 -0.057 8 8
ADCY1 0.013 0.013 -9999 0 -0.067 12 12
ADCY2 0.012 0.013 -9999 0 -0.057 18 18
ADCY3 0.012 0.013 -9999 0 -0.057 18 18
ADCY8 0.002 0.03 -9999 0 -0.061 99 99
PRKCE 0.01 0.011 -9999 0 -0.077 8 8
ADCY9 0.012 0.015 -9999 0 -0.064 17 17
mol:DAG 0 0 -9999 0 -10000 0 0
cAMP biosynthetic process 0.012 0.032 -9999 0 -0.18 11 11
Coregulation of Androgen receptor activity

Figure S85.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S85.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 0.014 0.035 -9999 0 -0.12 35 35
SVIL 0.016 0.031 -9999 0 -0.12 26 26
ZNF318 0.018 0.014 -9999 0 -0.12 5 5
JMJD2C 0.029 0.016 -9999 0 -0.12 6 6
T-DHT/AR/Ubc9 0.017 0.057 -9999 0 -0.11 84 84
CARM1 0.018 0.026 -9999 0 -0.12 19 19
PRDX1 0.022 0.004 -9999 0 -10000 0 0
PELP1 0.022 0.009 -9999 0 -0.12 2 2
CTNNB1 0.023 0.008 -9999 0 -0.12 1 1
AKT1 0.02 0.019 -9999 0 -0.12 10 10
PTK2B 0.023 0.009 -9999 0 -0.12 2 2
MED1 0.02 0.014 -9999 0 -0.12 5 5
MAK 0.008 0.04 -9999 0 -0.12 47 47
response to oxidative stress 0 0 -9999 0 -10000 0 0
HIP1 0.022 0.019 -9999 0 -0.12 9 9
GSN 0.023 0.012 -9999 0 -0.12 3 3
NCOA2 0.021 0.013 -9999 0 -0.12 4 4
NCOA6 0.023 0.014 -9999 0 -0.12 5 5
DNA-PK 0.023 0.06 -9999 0 -0.14 60 60
NCOA4 0.023 0.004 -9999 0 -10000 0 0
PIAS3 0.021 0.022 -9999 0 -0.12 13 13
cell proliferation 0.004 0.045 -9999 0 -0.5 2 2
XRCC5 0.021 0.01 -9999 0 -0.12 2 2
UBE3A 0.025 0.003 -9999 0 -10000 0 0
T-DHT/AR/SNURF 0.016 0.058 -9999 0 -0.11 84 84
FHL2 0.018 0.078 -9999 0 -0.67 5 5
RANBP9 0.023 0.014 -9999 0 -0.12 5 5
JMJD1A 0.033 0.024 -9999 0 -0.12 6 6
CDK6 0.008 0.04 -9999 0 -0.12 46 46
TGFB1I1 0.024 0.012 -9999 0 -0.12 4 4
T-DHT/AR/CyclinD1 -0.01 0.079 -9999 0 -0.13 140 140
XRCC6 0.022 0.004 -9999 0 -10000 0 0
T-DHT/AR 0.027 0.076 -9999 0 -0.18 20 20
CTDSP1 0.023 0.011 -9999 0 -0.12 3 3
CTDSP2 0.02 0.009 -9999 0 -0.12 2 2
BRCA1 0.016 0.03 -9999 0 -0.12 24 24
TCF4 0.019 0.017 -9999 0 -0.12 8 8
CDKN2A 0.013 0.022 -9999 0 -0.12 12 12
SRF 0.024 0.03 -9999 0 -0.12 23 23
NKX3-1 0.013 0.086 -9999 0 -0.29 34 34
KLK3 0.013 0.04 -9999 0 -10000 0 0
TMF1 0.022 0.012 -9999 0 -0.12 3 3
HNRNPA1 0.022 0.002 -9999 0 -10000 0 0
AOF2 0.024 0.009 -9999 0 -0.12 2 2
APPL1 0.019 0.014 -9999 0 -0.073 12 12
T-DHT/AR/Caspase 8 0.012 0.061 -9999 0 -0.11 96 96
AR 0.015 0.039 -9999 0 -0.11 44 44
UBA3 0.001 0 -9999 0 -10000 0 0
PATZ1 0.021 0.012 -9999 0 -0.12 4 4
PAWR 0.023 0.009 -9999 0 -0.12 2 2
PRKDC 0.02 0.015 -9999 0 -0.12 6 6
PA2G4 0.021 0.009 -9999 0 -0.12 2 2
UBE2I 0.023 0.001 -9999 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 0.015 0.054 -9999 0 -0.1 81 81
RPS6KA3 0.019 0.023 -9999 0 -0.12 13 13
T-DHT/AR/ARA70 0.014 0.062 -9999 0 -0.11 99 99
LATS2 0.022 0.006 -9999 0 -0.12 1 1
T-DHT/AR/PRX1 0.012 0.055 -9999 0 -0.097 100 100
Cyclin D3/CDK11 p58 0.014 0.019 -9999 0 -0.1 14 14
VAV3 0.011 0.038 -9999 0 -0.12 41 41
KLK2 0.016 0.072 -9999 0 -0.29 23 23
CASP8 0.022 0.004 -9999 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 0.023 0.065 -9999 0 -0.1 101 101
TMPRSS2 0.005 0.099 -9999 0 -0.3 36 36
CCND1 0.006 0.042 -9999 0 -0.12 54 54
PIAS1 0.025 0.009 -9999 0 -0.12 2 2
mol:T-DHT 0.006 0.007 -9999 0 -0.055 2 2
CDC2L1 0 0 -9999 0 -10000 0 0
PIAS4 0.026 0.002 -9999 0 -10000 0 0
T-DHT/AR/CDK6 -0.008 0.078 -9999 0 -0.12 143 143
CMTM2 0.023 0.006 -9999 0 -0.12 1 1
SNURF 0.021 0.017 -9999 0 -0.12 8 8
ZMIZ1 0.022 0.031 -9999 0 -0.11 26 26
CCND3 0.021 0.018 -9999 0 -0.12 9 9
TGIF1 0.022 0.001 -9999 0 -10000 0 0
FKBP4 0.022 0.02 -9999 0 -0.12 10 10
Glucocorticoid receptor regulatory network

Figure S86.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S86.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 -0.011 0.059 -10000 0 -0.7 2 2
SMARCC2 0.022 0.012 -10000 0 -0.12 4 4
SMARCC1 0.023 0.003 -10000 0 -10000 0 0
TBX21 0.042 0.047 -10000 0 -0.27 2 2
SUMO2 0.021 0.005 -10000 0 -10000 0 0
STAT1 (dimer) -0.007 0.08 -10000 0 -0.17 92 92
FKBP4 0.02 0.02 -10000 0 -0.12 10 10
FKBP5 0.006 0.043 -10000 0 -0.12 56 56
GR alpha/HSP90/FKBP51/HSP90 -0.013 0.082 0.24 1 -0.2 44 45
PRL 0.045 0.057 -10000 0 -0.5 1 1
cortisol/GR alpha (dimer)/TIF2 -0.02 0.11 0.43 3 -0.33 4 7
RELA -0.02 0.075 -10000 0 -0.15 116 116
FGG -0.016 0.1 0.45 1 -0.32 3 4
GR beta/TIF2 -0.006 0.07 0.23 2 -0.2 23 25
IFNG -0.003 0.12 -10000 0 -0.45 4 4
apoptosis -0.052 0.16 -10000 0 -0.45 34 34
CREB1 0.033 0.008 -10000 0 -10000 0 0
histone acetylation 0.028 0.081 0.27 8 -0.28 20 28
BGLAP 0.042 0.075 -10000 0 -0.87 2 2
GR/PKAc 0.028 0.063 0.23 2 -0.15 21 23
NF kappa B1 p50/RelA -0.044 0.14 -10000 0 -0.27 132 132
SMARCD1 0.021 0.018 -10000 0 -0.12 9 9
MDM2 -0.003 0.047 0.14 1 -0.22 9 10
GATA3 0.037 0.022 -10000 0 -0.12 11 11
AKT1 0.015 0.022 0.15 2 -0.13 10 12
CSF2 0.03 0.055 -10000 0 -10000 0 0
GSK3B 0.02 0.012 -10000 0 -0.13 3 3
NR1I3 -0.038 0.15 -10000 0 -0.49 8 8
CSN2 -0.015 0.093 0.32 2 -0.29 3 5
BRG1/BAF155/BAF170/BAF60A 0.041 0.052 -10000 0 -0.11 45 45
NFATC1 0.033 0.013 -10000 0 -10000 0 0
POU2F1 0.031 0.008 -10000 0 -0.11 1 1
CDKN1A -0.041 0.12 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
response to UV -0.002 0.004 -10000 0 -10000 0 0
SFN 0.014 0.032 -10000 0 -0.12 29 29
GR alpha/HSP90/FKBP51/HSP90/14-3-3 -0.007 0.086 0.24 1 -0.18 62 63
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.11 0.28 -10000 0 -0.72 92 92
JUN 0.021 0.089 -10000 0 -0.3 7 7
IL4 0.046 0.048 -10000 0 -10000 0 0
CDK5R1 0.022 0.007 -10000 0 -0.12 1 1
PRKACA 0.021 0.017 -10000 0 -0.12 8 8
cortisol/GR alpha (monomer)/AP-1 -0.043 0.079 0.19 12 -0.2 62 74
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.006 0.079 0.24 1 -0.17 46 47
cortisol/GR alpha (monomer) -0.039 0.12 0.48 3 -0.38 3 6
NCOA2 0.021 0.013 -10000 0 -0.12 4 4
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.014 0.079 -10000 0 -0.14 130 130
AP-1/NFAT1-c-4 -0.012 0.15 -10000 0 -0.4 25 25
AFP 0.017 0.083 -10000 0 -0.56 1 1
SUV420H1 0.021 0.015 -10000 0 -0.12 6 6
IRF1 -0.095 0.24 -10000 0 -0.6 86 86
TP53 0.026 0.033 -10000 0 -10000 0 0
PPP5C 0.022 0.014 -10000 0 -0.12 5 5
KRT17 -0.011 0.15 -10000 0 -0.78 10 10
KRT14 -0.006 0.2 0.46 9 -1.1 15 24
TBP 0.031 0.026 -10000 0 -0.2 5 5
CREBBP 0.023 0.052 0.3 15 -0.13 5 20
HDAC1 0.013 0.02 -10000 0 -0.13 10 10
HDAC2 0.018 0.021 -10000 0 -0.12 12 12
AP-1 -0.012 0.15 -10000 0 -0.4 25 25
MAPK14 0.02 0.008 -10000 0 -0.13 1 1
MAPK10 0.011 0.037 -10000 0 -0.13 38 38
MAPK11 0.021 0.004 -10000 0 -10000 0 0
KRT5 -0.07 0.26 -10000 0 -0.89 46 46
interleukin-1 receptor activity -0.002 0.001 -10000 0 -10000 0 0
NCOA1 0.024 0.01 -10000 0 -0.08 4 4
STAT1 -0.007 0.08 -10000 0 -0.17 92 92
CGA 0.043 0.059 -10000 0 -0.41 2 2
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 -0.046 0.11 0.27 10 -0.34 37 47
MAPK3 0.019 0.015 -10000 0 -0.13 5 5
MAPK1 0.019 0.017 -10000 0 -0.12 7 7
ICAM1 -0.13 0.32 -10000 0 -0.8 101 101
NFKB1 -0.031 0.097 -10000 0 -0.18 133 133
MAPK8 0.033 0.076 -10000 0 -0.26 6 6
MAPK9 0.019 0.012 -10000 0 -0.12 3 3
cortisol/GR alpha (dimer) -0.055 0.17 -10000 0 -0.46 35 35
BAX -0.039 0.12 -10000 0 -10000 0 0
POMC 0.029 0.082 -10000 0 -10000 0 0
EP300 0.023 0.047 0.29 14 -0.13 1 15
cortisol/GR alpha (dimer)/p53 -0.045 0.12 0.5 1 -0.36 5 6
proteasomal ubiquitin-dependent protein catabolic process -0.006 0.058 0.26 15 -0.2 8 23
SGK1 0.001 0.1 0.34 14 -0.32 31 45
IL13 0.021 0.089 -10000 0 -0.52 1 1
IL6 -0.028 0.15 -10000 0 -0.72 12 12
PRKACG 0.023 0.009 -10000 0 -0.12 2 2
IL5 0.025 0.089 -10000 0 -10000 0 0
IL2 0.004 0.11 -10000 0 -0.46 2 2
CDK5 0.014 0.032 -10000 0 -0.12 28 28
PRKACB 0.019 0.02 -10000 0 -0.12 11 11
HSP90AA1 0.023 0.003 -10000 0 -10000 0 0
IL8 -0.055 0.22 -10000 0 -0.76 40 40
CDK5R1/CDK5 0.019 0.042 -10000 0 -0.11 52 52
NF kappa B1 p50/RelA/PKAc -0.002 0.12 -10000 0 -0.19 112 112
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 -0.01 0.11 0.4 2 -0.31 4 6
SMARCA4 0.015 0.031 -10000 0 -0.12 27 27
chromatin remodeling -0.009 0.092 0.27 2 -0.32 14 16
NF kappa B1 p50/RelA/Cbp -0.02 0.13 0.34 8 -0.25 80 88
JUN (dimer) 0.021 0.089 -10000 0 -0.3 7 7
YWHAH 0.021 0.014 -10000 0 -0.12 5 5
VIPR1 0.043 0.045 -10000 0 -0.22 2 2
NR3C1 -0.015 0.081 0.32 2 -0.33 10 12
NR4A1 0.01 0.048 -10000 0 -10000 0 0
TIF2/SUV420H1 0.02 0.048 -10000 0 -0.13 50 50
MAPKKK cascade -0.052 0.16 -10000 0 -0.45 34 34
cortisol/GR alpha (dimer)/Src-1 -0.013 0.11 0.44 3 -0.32 2 5
PBX1 0.029 0.014 -10000 0 -0.11 4 4
POU1F1 0.03 0.014 -10000 0 -0.13 4 4
SELE -0.006 0.11 -10000 0 -0.41 3 3
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A -0.009 0.092 0.27 2 -0.32 14 16
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 -0.01 0.11 0.4 2 -0.31 4 6
mol:cortisol -0.027 0.065 0.26 3 -10000 0 3
MMP1 -0.038 0.16 -10000 0 -0.95 12 12
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S87.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S87.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.028 0.018 -10000 0 -0.1 6 6
NFATC2 0.016 0.19 -10000 0 -0.4 55 55
NFATC3 0.06 0.059 0.26 28 -0.24 2 30
CD40LG 0.043 0.14 -10000 0 -0.53 5 5
ITCH 0.026 0.064 -10000 0 -0.28 17 17
CBLB 0.023 0.073 -10000 0 -0.31 19 19
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment 0.038 0.15 -10000 0 -0.5 12 12
JUNB 0.007 0.042 -10000 0 -0.12 52 52
CaM/Ca2+/Calcineurin A alpha-beta B1 0.034 0.059 -10000 0 -0.19 30 30
T cell anergy 0.012 0.087 -10000 0 -0.31 29 29
TLE4 -0.016 0.18 -10000 0 -0.44 62 62
Jun/NFAT1-c-4/p21SNFT 0.08 0.15 -10000 0 -0.56 4 4
AP-1/NFAT1-c-4 0.08 0.2 -10000 0 -0.62 4 4
IKZF1 0.019 0.13 -10000 0 -0.27 49 49
T-helper 2 cell differentiation 0.023 0.14 -10000 0 -0.49 4 4
AP-1/NFAT1 0.007 0.15 -10000 0 -0.27 68 68
CALM1 0.027 0.037 -10000 0 -0.11 32 32
EGR2 0.067 0.15 0.51 15 -0.76 4 19
EGR3 0.068 0.14 -10000 0 -0.52 1 1
NFAT1/FOXP3 0.038 0.14 -10000 0 -0.27 51 51
EGR1 -0.005 0.054 -10000 0 -0.12 99 99
JUN 0.019 0.035 -10000 0 -0.12 31 31
EGR4 0.023 0.014 -10000 0 -0.13 5 5
mol:Ca2+ 0.006 0.03 -10000 0 -0.12 26 26
GBP3 -0.06 0.23 -10000 0 -0.46 123 123
FOSL1 0.021 0.018 -10000 0 -0.12 9 9
NFAT1-c-4/MAF/IRF4 0.092 0.14 -10000 0 -0.53 4 4
DGKA 0.012 0.14 -10000 0 -0.31 56 56
CREM 0.021 0.012 -10000 0 -0.12 4 4
NFAT1-c-4/PPARG 0.081 0.14 -10000 0 -0.57 4 4
CTLA4 0.018 0.11 -10000 0 -0.28 23 23
NFAT1-c-4 (dimer)/EGR1 0.053 0.15 -10000 0 -0.56 5 5
NFAT1-c-4 (dimer)/EGR4 0.088 0.14 -10000 0 -0.56 4 4
FOS 0 0.053 -10000 0 -0.11 96 96
IFNG 0.017 0.14 -10000 0 -0.43 8 8
T cell activation 0.027 0.11 -10000 0 -0.46 1 1
MAF 0.023 0.012 -10000 0 -0.12 4 4
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells -0.07 0.13 0.61 3 -0.49 25 28
TNF 0.037 0.14 -10000 0 -0.51 6 6
FASLG 0.056 0.15 -10000 0 -0.98 3 3
TBX21 0.026 0.018 -10000 0 -0.13 3 3
BATF3 0 0 -10000 0 -10000 0 0
PRKCQ 0.019 0.03 -10000 0 -0.12 25 25
PTPN1 0.019 0.13 -10000 0 -0.31 31 31
NFAT1-c-4/ICER1 0.081 0.14 -10000 0 -0.56 4 4
GATA3 0.024 0.021 -10000 0 -0.12 11 11
T-helper 1 cell differentiation 0.017 0.14 -10000 0 -0.43 8 8
IL2RA 0.04 0.15 -10000 0 -0.44 16 16
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 0.015 0.14 -10000 0 -0.35 35 35
E2F1 0.017 0.045 -10000 0 -0.15 36 36
PPARG 0.018 0.028 -10000 0 -0.12 22 22
SLC3A2 0.013 0.14 -10000 0 -0.3 57 57
IRF4 0.019 0.025 -10000 0 -0.12 17 17
PTGS2 0.035 0.15 -10000 0 -0.56 5 5
CSF2 0.043 0.14 -10000 0 -0.53 5 5
JunB/Fra1/NFAT1-c-4 0.071 0.15 -10000 0 -0.5 6 6
IL4 0.022 0.14 -10000 0 -0.52 3 3
IL5 0.042 0.14 -10000 0 -0.53 5 5
IL2 0.027 0.11 -10000 0 -0.47 1 1
IL3 0.012 0.04 -10000 0 -0.38 3 3
RNF128 0.026 0.051 -10000 0 -0.25 7 7
NFATC1 0.071 0.13 0.49 25 -0.62 3 28
CDK4 -0.08 0.28 0.46 1 -1.2 29 30
PTPRK -0.007 0.18 -10000 0 -0.43 59 59
IL8 0.029 0.15 -10000 0 -0.5 8 8
POU2F1 0.031 0.007 -10000 0 -0.12 1 1
Arf6 signaling events

Figure S88.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S88.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.013 0.017 -9999 0 -0.078 18 18
ARNO/beta Arrestin1-2 0.029 0.019 -9999 0 -0.077 11 11
EGFR 0.015 0.03 -9999 0 -0.12 25 25
EPHA2 0.02 0.022 -9999 0 -0.12 13 13
USP6 0.023 0.006 -9999 0 -0.12 1 1
IQSEC1 0.023 0.006 -9999 0 -0.12 1 1
EGFR/EGFR/EGF/EGF 0.016 0.05 -9999 0 -0.14 40 40
ARRB2 0.017 0.018 -9999 0 -0.2 3 3
mol:GTP 0.003 0.006 -9999 0 -0.04 1 1
ARRB1 0.02 0.022 -9999 0 -0.12 13 13
FBXO8 0.022 0.011 -9999 0 -0.12 3 3
TSHR 0.013 0.038 -9999 0 -0.12 41 41
EGF 0.02 0.021 -9999 0 -0.12 12 12
somatostatin receptor activity 0 0 -9999 0 0 27 27
ARAP2 0 0 -9999 0 0 26 26
mol:GDP 0.015 0.046 -9999 0 -0.17 22 22
mol:PI-3-4-5-P3 0 0 -9999 0 0 27 27
ITGA2B 0.023 0.006 -9999 0 -0.12 1 1
ARF6 0.023 0.003 -9999 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.029 0.062 -9999 0 -0.11 75 75
ADAP1 0 0 -9999 0 0 26 26
KIF13B 0.02 0.022 -9999 0 -0.12 13 13
HGF/MET -0.017 0.074 -9999 0 -0.14 118 118
PXN 0.022 0.014 -9999 0 -0.12 5 5
ARF6/GTP 0.022 0.059 -9999 0 -0.21 26 26
EGFR/EGFR/EGF/EGF/ARFGEP100 0.03 0.046 -9999 0 -0.11 40 40
ADRB2 0.023 0.006 -9999 0 -0.12 1 1
receptor agonist activity 0 0 -9999 0 0 27 27
actin filament binding 0 0 -9999 0 0 27 27
SRC 0.023 0.009 -9999 0 -0.12 2 2
ITGB3 0.004 0.047 -9999 0 -0.12 68 68
GNAQ 0.021 0.016 -9999 0 -0.12 6 6
EFA6/PI-4-5-P2 0 0 -9999 0 -0.001 26 26
ARF6/GDP 0.021 0.05 -9999 0 -0.25 11 11
ARF6/GDP/GULP/ACAP1 0.017 0.061 -9999 0 -0.16 29 29
alphaIIb/beta3 Integrin/paxillin/GIT1 0.036 0.05 -9999 0 -0.096 39 39
ACAP1 0 0 -9999 0 0 4 4
ACAP2 0 0 -9999 0 0 26 26
LHCGR/beta Arrestin2 0.023 0.016 -9999 0 -0.14 3 3
EFNA1 0.014 0.031 -9999 0 -0.12 26 26
HGF 0.02 0.023 -9999 0 -0.12 14 14
CYTH3 0 0 -9999 0 -0.001 27 27
CYTH2 0 0.001 -9999 0 -0.004 27 27
NCK1 0.02 0.019 -9999 0 -0.12 9 9
fibronectin binding 0 0 -9999 0 0 28 28
endosomal lumen acidification 0 0 -9999 0 0 16 16
microtubule-based process 0 0 -9999 0 -10000 0 0
GULP1 0.005 0.045 -9999 0 -0.12 63 63
GNAQ/ARNO 0.015 0.007 -9999 0 -0.047 6 6
mol:Phosphatidic acid 0 0 -9999 0 0 26 26
PIP3-E 0.018 0.028 -9999 0 -0.12 22 22
MET 0 0.047 -9999 0 -0.12 70 70
GNA14 0.02 0.02 -9999 0 -0.12 11 11
GNA15 0.021 0.017 -9999 0 -0.12 8 8
GIT1 0.022 0.012 -9999 0 -0.12 4 4
mol:PI-4-5-P2 0 0 -9999 0 -0.001 26 26
GNA11 0.022 0.014 -9999 0 -0.12 5 5
LHCGR 0.022 0.014 -9999 0 -0.12 5 5
AGTR1 0.022 0.012 -9999 0 -0.12 4 4
desensitization of G-protein coupled receptor protein signaling pathway 0.023 0.016 -9999 0 -0.14 3 3
IPCEF1/ARNO 0.026 0.038 -9999 0 -0.084 41 41
alphaIIb/beta3 Integrin 0.01 0.053 -9999 0 -0.14 38 38
EPO signaling pathway

Figure S89.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S89.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.015 0.15 -9999 0 -0.51 27 27
CRKL 0.029 0.037 -9999 0 -0.1 8 8
mol:DAG 0.026 0.075 -9999 0 -0.2 44 44
HRAS 0.032 0.045 -9999 0 -0.14 10 10
MAPK8 0.021 0.041 -9999 0 -0.11 43 43
RAP1A 0.026 0.045 -9999 0 -0.17 14 14
GAB1 0.027 0.038 -9999 0 -0.11 10 10
MAPK14 0.022 0.041 -9999 0 -0.11 44 44
EPO 0.025 0.008 -9999 0 -0.12 1 1
PLCG1 0.026 0.076 -9999 0 -0.2 44 44
EPOR/TRPC2/IP3 Receptors 0.022 0.022 -9999 0 -0.12 12 12
RAPGEF1 0.023 0 -9999 0 -10000 0 0
EPO/EPOR (dimer)/SOCS3 0.035 0.043 -9999 0 -0.11 32 32
GAB1/SHC/GRB2/SOS1 0.042 0.052 -9999 0 -0.14 11 11
EPO/EPOR (dimer) 0.034 0.022 -9999 0 -0.088 11 11
IRS2 0.028 0.038 -9999 0 -0.11 9 9
STAT1 0.02 0.1 -9999 0 -0.26 53 53
STAT5B 0.032 0.076 -9999 0 -0.2 40 40
cell proliferation 0.02 0.038 -9999 0 -0.1 44 44
GAB1/SHIP/PIK3R1/SHP2/SHC 0.022 0.046 -9999 0 -0.13 13 13
TEC 0.02 0.045 -9999 0 -0.13 22 22
SOCS3 0.015 0.032 -9999 0 -0.12 28 28
STAT1 (dimer) 0.021 0.098 -9999 0 -0.25 53 53
JAK2 0.019 0.025 -9999 0 -0.12 16 16
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
EPO/EPOR (dimer)/JAK2 0.058 0.054 -9999 0 -0.12 8 8
EPO/EPOR 0.034 0.022 -9999 0 -0.088 11 11
LYN 0.022 0.014 -9999 0 -0.12 4 4
TEC/VAV2 0.021 0.059 -9999 0 -0.13 29 29
elevation of cytosolic calcium ion concentration 0.022 0.022 -9999 0 -0.12 12 12
SHC1 0.023 0.001 -9999 0 -10000 0 0
EPO/EPOR (dimer)/LYN 0.039 0.052 -9999 0 -0.13 43 43
mol:IP3 0.026 0.075 -9999 0 -0.2 44 44
PI3K regualtory subunit polypeptide 1/IRS2/SHIP 0.029 0.047 -9999 0 -0.14 15 15
SH2B3 0.024 0.004 -9999 0 -10000 0 0
NFKB1 0.018 0.053 -9999 0 -0.15 43 43
EPO/EPOR (dimer)/JAK2/SOCS3 -0.006 0.06 -9999 0 -0.17 64 64
PTPN6 0.025 0.038 -9999 0 -0.11 10 10
TEC/VAV2/GRB2 0.029 0.062 -9999 0 -0.13 23 23
EPOR 0.022 0.022 -9999 0 -0.12 12 12
INPP5D 0 0 -9999 0 -10000 0 0
mol:GDP 0.042 0.053 -9999 0 -0.14 11 11
SOS1 0.017 0.027 -9999 0 -0.12 20 20
PLCG2 0.02 0.02 -9999 0 -0.12 11 11
CRKL/CBL/C3G 0.053 0.042 -9999 0 -0.13 4 4
VAV2 0.027 0.037 -9999 0 -0.1 8 8
CBL 0.029 0.038 -9999 0 -0.12 8 8
SHC/Grb2/SOS1 0.03 0.045 -9999 0 -0.13 16 16
STAT5A 0.03 0.079 -9999 0 -0.23 33 33
GRB2 0.023 0.006 -9999 0 -0.12 1 1
STAT5 (dimer) 0.049 0.088 -9999 0 -0.24 31 31
LYN/PLCgamma2 0.02 0.05 -9999 0 -0.13 54 54
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
BTK 0.022 0.047 -9999 0 -0.15 20 20
BCL2 0.019 0.12 -9999 0 -0.37 34 34
Neurotrophic factor-mediated Trk receptor signaling

Figure S90.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S90.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.023 0.009 -10000 0 -0.12 2 2
RAS family/GTP/Tiam1 0 0.066 -10000 0 -0.16 64 64
NT3 (dimer)/TRKC 0.007 0.051 -10000 0 -0.15 19 19
NT3 (dimer)/TRKB 0.023 0.047 -10000 0 -0.12 19 19
SHC/Grb2/SOS1/GAB1/PI3K 0.003 0.087 -10000 0 -0.31 22 22
RAPGEF1 0.023 0 -10000 0 -10000 0 0
BDNF 0.022 0.011 -10000 0 -0.12 3 3
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
DYNLT1 0.018 0.023 -10000 0 -0.12 14 14
NTRK1 0.023 0.006 -10000 0 -0.12 1 1
NTRK2 0.019 0.026 -10000 0 -0.12 18 18
NTRK3 0.015 0.033 -10000 0 -0.12 31 31
NT-4/5 (dimer)/TRKB 0.027 0.02 -10000 0 -0.064 25 25
neuron apoptosis -0.043 0.036 -10000 0 -10000 0 0
SHC 2-3/Grb2 0.045 0.038 -10000 0 -10000 0 0
SHC1 0.023 0.001 -10000 0 -10000 0 0
SHC2 0.027 0.034 -10000 0 -10000 0 0
SHC3 0.027 0.034 -10000 0 -10000 0 0
STAT3 (dimer) -0.02 0.1 -10000 0 -0.25 86 86
NT3 (dimer)/TRKA 0.025 0.044 -10000 0 -0.13 11 11
RIN/GDP 0.03 0.061 -10000 0 -0.19 26 26
GIPC1 0.019 0.023 -10000 0 -0.12 15 15
KRAS 0.014 0.034 -10000 0 -0.12 33 33
DNAJA3 0.009 0.042 0.16 13 -0.14 8 21
RIN/GTP 0.017 0.007 -10000 0 -0.077 3 3
CCND1 -0.058 0.18 -10000 0 -0.48 85 85
MAGED1 0.02 0.019 -10000 0 -0.12 10 10
PTPN11 0.022 0.011 -10000 0 -0.12 3 3
RICS 0.017 0.027 -10000 0 -0.12 20 20
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.035 0.041 -10000 0 -0.12 30 30
GRB2 0.023 0.006 -10000 0 -0.12 1 1
NGF (dimer)/TRKA/MATK 0.031 0.01 -10000 0 -0.07 5 5
TRKA/NEDD4-2 0.022 0.043 -10000 0 -0.11 50 50
ELMO1 0.01 0.041 -10000 0 -0.12 49 49
RhoG/GTP/ELMO1/DOCK1 0.009 0.049 -10000 0 -0.088 108 108
NGF 0 0 -10000 0 -10000 0 0
HRAS 0.023 0.006 -10000 0 -0.12 1 1
DOCK1 0.019 0.02 -10000 0 -0.12 10 10
GAB2 0.007 0.041 -10000 0 -0.12 50 50
RIT2 0.022 0.011 -10000 0 -0.12 3 3
RIT1 0.021 0.014 -10000 0 -0.12 5 5
FRS2 0.019 0.024 -10000 0 -0.12 15 15
DNM1 0.021 0.019 -10000 0 -0.12 10 10
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.021 0.016 -10000 0 -0.12 7 7
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP 0.006 0.044 0.13 3 -0.14 12 15
mol:GDP 0.027 0.083 -10000 0 -0.28 26 26
NGF (dimer) 0 0 -10000 0 -10000 0 0
RhoG/GDP 0.003 0.039 -10000 0 -0.097 69 69
RIT1/GDP 0.029 0.064 -10000 0 -0.2 26 26
TIAM1 0.015 0.032 -10000 0 -0.12 28 28
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
BDNF (dimer)/TRKB 0.043 0.021 -10000 0 -0.11 3 3
KIDINS220/CRKL/C3G 0.034 0.01 -10000 0 -0.14 1 1
SHC/RasGAP 0.025 0.039 -10000 0 -0.14 29 29
FRS2 family/SHP2 0.035 0.041 -10000 0 -0.12 30 30
SHC/GRB2/SOS1/GAB1 0.043 0.047 -10000 0 -0.1 41 41
RIT1/GTP 0.012 0.028 -10000 0 -0.13 20 20
NT3 (dimer) -0.003 0.056 -10000 0 -0.12 101 101
RAP1/GDP 0.017 0.056 -10000 0 -0.17 28 28
KIDINS220/CRKL 0.023 0.009 -10000 0 -0.12 2 2
BDNF (dimer) 0.022 0.011 -10000 0 -0.12 3 3
ubiquitin-dependent protein catabolic process 0.02 0.035 -10000 0 -0.09 50 50
Schwann cell development -0.004 0.009 -10000 0 -0.057 2 2
EHD4 0.023 0.001 -10000 0 -10000 0 0
FRS2 family/GRB2/SOS1 0.042 0.05 -10000 0 -0.11 38 38
FRS2 family/SHP2/CRK family/C3G/GAB2 0.012 0.065 -10000 0 -0.21 19 19
RAP1B 0.019 0.02 -10000 0 -0.12 10 10
RAP1A 0.021 0.012 -10000 0 -0.12 3 3
CDC42/GTP 0.031 0.04 -10000 0 -0.15 4 4
ABL1 0.022 0.007 -10000 0 -0.12 1 1
SH2B family/GRB2/SOS1 0.021 0.045 -10000 0 -0.15 29 29
Rap1/GTP 0.023 0.081 -10000 0 -0.26 34 34
STAT3 -0.02 0.1 -10000 0 -0.25 86 86
axon guidance 0.02 0.034 -10000 0 -0.15 4 4
MAPK3 0.024 0.013 -10000 0 -0.21 1 1
MAPK1 0.024 0.014 -10000 0 -0.21 1 1
CDC42/GDP 0.03 0.062 -10000 0 -0.19 26 26
NTF3 -0.003 0.056 -10000 0 -0.12 101 101
NTF4 0 0 -10000 0 -10000 0 0
NGF (dimer)/TRKA/FAIM 0.03 0.012 -10000 0 -0.073 7 7
PI3K 0.007 0.065 -10000 0 -0.13 96 96
FRS3 0.023 0.009 -10000 0 -0.12 2 2
FAIM 0.022 0.012 -10000 0 -0.12 4 4
GAB1 0.02 0.021 -10000 0 -0.12 12 12
RASGRF1 0.01 0.041 0.16 13 -0.14 8 21
SOS1 0.017 0.027 -10000 0 -0.12 20 20
MCF2L 0.008 0.039 -10000 0 -0.12 19 19
RGS19 0.023 0 -10000 0 -10000 0 0
CDC42 0.023 0.002 -10000 0 -10000 0 0
RAS family/GTP 0.018 0.11 -10000 0 -0.32 46 46
Rac1/GDP 0.03 0.062 -10000 0 -0.19 26 26
NGF (dimer)/TRKA/GRIT 0.022 0.034 -10000 0 -0.12 26 26
neuron projection morphogenesis -0.04 0.18 -10000 0 -0.82 20 20
NGF (dimer)/TRKA/NEDD4-2 0.021 0.036 -10000 0 -0.09 50 50
MAP2K1 0.022 0.035 -10000 0 -0.089 41 41
NGFR 0.021 0.017 -10000 0 -0.12 8 8
NGF (dimer)/TRKA/GIPC/GAIP 0.019 0.048 -10000 0 -0.14 42 42
RAS family/GTP/PI3K -0.003 0.084 -10000 0 -0.18 87 87
FRS2 family/SHP2/GRB2/SOS1 0.047 0.058 -10000 0 -0.2 12 12
NRAS 0.022 0.011 -10000 0 -0.12 3 3
GRB2/SOS1 0.021 0.045 -10000 0 -0.15 29 29
PRKCI 0.016 0.028 -10000 0 -0.12 22 22
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0.023 0.002 -10000 0 -10000 0 0
PRKCZ 0.023 0 -10000 0 -10000 0 0
MAPKKK cascade 0.027 0.033 -10000 0 -0.4 2 2
RASA1 0.021 0.012 -10000 0 -0.12 3 3
TRKA/c-Abl 0.029 0.031 -10000 0 -0.14 18 18
SQSTM1 0.021 0.014 -10000 0 -0.12 5 5
BDNF (dimer)/TRKB/GIPC 0.041 0.049 -10000 0 -0.1 42 42
NGF (dimer)/TRKA/p62/Atypical PKCs 0.033 0.053 -10000 0 -0.097 67 67
MATK 0.022 0.014 -10000 0 -0.12 5 5
NEDD4L 0.017 0.027 -10000 0 -0.12 20 20
RAS family/GDP -0.013 0.034 -10000 0 -0.14 28 28
NGF (dimer)/TRKA 0.003 0.036 -10000 0 -0.15 8 8
Rac1/GTP -0.017 0.041 -10000 0 -0.13 42 42
FRS2 family/SHP2/CRK family 0.056 0.042 -10000 0 -0.13 6 6
Regulation of nuclear SMAD2/3 signaling

Figure S91.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S91.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.02 0.011 -10000 0 -0.12 2 2
HSPA8 0.023 0.003 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha 0.061 0.084 0.2 44 -0.14 29 73
AKT1 0.023 0.021 -10000 0 -0.1 15 15
GSC 0.024 0.078 -10000 0 -1.2 2 2
NKX2-5 0.022 0.015 -10000 0 -0.047 19 19
muscle cell differentiation -0.039 0.08 0.28 19 -10000 0 19
SMAD2-3/SMAD4/SP1 0.048 0.094 -10000 0 -0.23 19 19
SMAD4 0.024 0.039 -10000 0 -0.14 13 13
CBFB 0.022 0.009 -10000 0 -0.12 2 2
SAP18 0.023 0.003 -10000 0 -10000 0 0
Cbp/p300/MSG1 0.026 0.052 -10000 0 -0.14 37 37
SMAD3/SMAD4/VDR 0.047 0.073 -10000 0 -0.16 31 31
MYC 0.013 0.029 0.098 5 -0.13 20 25
CDKN2B 0.03 0.12 -10000 0 -1.2 5 5
AP1 0.005 0.1 -10000 0 -0.22 68 68
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.006 0.12 -10000 0 -0.32 48 48
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 0.039 0.055 -10000 0 -0.28 10 10
SP3 0.02 0.015 -10000 0 -0.042 8 8
CREB1 0.023 0.003 -10000 0 -10000 0 0
FOXH1 0.024 0.018 -10000 0 -0.11 6 6
SMAD3/SMAD4/GR 0.036 0.07 0.18 1 -0.15 36 37
GATA3 0.026 0.021 -10000 0 -0.12 11 11
SKI/SIN3/HDAC complex/NCoR1 0.02 0.078 -10000 0 -0.25 27 27
MEF2C/TIF2 0.042 0.064 -10000 0 -0.2 24 24
endothelial cell migration 0.014 0.11 1.2 3 -10000 0 3
MAX 0.023 0.006 0.076 2 -10000 0 2
RBBP7 0.022 0.012 -10000 0 -0.12 3 3
RBBP4 0.021 0.014 -10000 0 -0.12 5 5
RUNX2 0.019 0.023 -10000 0 -0.12 15 15
RUNX3 0.018 0.028 -10000 0 -0.12 22 22
RUNX1 0.019 0.022 -10000 0 -0.12 13 13
CTBP1 0.021 0.016 -10000 0 -0.12 7 7
NR3C1 0.021 0.016 0.074 3 -0.13 5 8
VDR 0.019 0.022 -10000 0 -0.12 13 13
CDKN1A 0.017 0.065 -10000 0 -0.53 1 1
KAT2B -0.001 0.002 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.055 0.053 -10000 0 -0.2 10 10
DCP1A 0.023 0.001 -10000 0 -10000 0 0
SKI 0.023 0.011 -10000 0 -0.12 3 3
SERPINE1 -0.014 0.11 -10000 0 -1.2 3 3
SMAD3/SMAD4/ATF2 0.041 0.064 -10000 0 -0.17 22 22
SMAD3/SMAD4/ATF3 0.035 0.062 -10000 0 -0.13 25 25
SAP30 0.023 0.001 -10000 0 -10000 0 0
Cbp/p300/PIAS3 0.027 0.051 0.14 2 -0.14 38 40
JUN -0.008 0.098 -10000 0 -0.22 67 67
SMAD3/SMAD4/IRF7 0.051 0.058 -10000 0 -0.17 13 13
TFE3 0.018 0.032 -10000 0 -0.082 44 44
COL1A2 -0.13 0.26 -10000 0 -0.64 112 112
mesenchymal cell differentiation -0.041 0.057 0.15 15 -10000 0 15
DLX1 0.021 0.017 -10000 0 -0.12 8 8
TCF3 0.022 0.014 -10000 0 -0.12 5 5
FOS -0.004 0.055 -10000 0 -0.11 105 105
SMAD3/SMAD4/Max 0.046 0.056 0.18 1 -0.16 9 10
Cbp/p300/SNIP1 0.033 0.047 -10000 0 -0.13 36 36
ZBTB17 0.022 0.006 0.081 5 -10000 0 5
LAMC1 0.021 0.083 -10000 0 -0.26 38 38
TGIF2/HDAC complex/SMAD3/SMAD4 0.04 0.061 -10000 0 -0.15 23 23
IRF7 0.024 0.017 -10000 0 -0.12 7 7
ESR1 0.033 0.037 0.099 99 -0.13 10 109
HNF4A 0.023 0.009 -10000 0 -0.12 2 2
MEF2C 0.034 0.061 -10000 0 -0.22 23 23
SMAD2-3/SMAD4 0.05 0.063 -10000 0 -0.19 11 11
Cbp/p300/Src-1 0.029 0.053 -10000 0 -0.14 46 46
IGHV3OR16-13 0.005 0.075 -10000 0 -0.49 12 12
TGIF2/HDAC complex 0.021 0.013 -10000 0 -0.12 4 4
CREBBP 0.02 0.016 -10000 0 -0.13 6 6
SKIL 0.011 0.035 -10000 0 -0.12 35 35
HDAC1 0.02 0.02 -10000 0 -0.12 10 10
HDAC2 0.02 0.021 -10000 0 -0.12 12 12
SNIP1 0.023 0.011 -10000 0 -0.12 3 3
GCN5L2 0.021 0.013 -10000 0 -0.12 4 4
SMAD3/SMAD4/TFE3 0.047 0.072 -10000 0 -0.16 37 37
MSG1/HSC70 0.027 0.032 -10000 0 -0.082 42 42
SMAD2 0.027 0.015 -10000 0 -0.068 7 7
SMAD3 0.022 0.036 -10000 0 -0.1 21 21
SMAD3/E2F4-5/DP1/p107/SMAD4 0.024 0.067 -10000 0 -0.18 33 33
SMAD2/SMAD2/SMAD4 -0.001 0.043 0.12 2 -0.2 16 18
NCOR1 0.022 0.009 -10000 0 -0.12 2 2
NCOA2 0.021 0.013 -10000 0 -0.12 4 4
NCOA1 0.022 0.009 -10000 0 -0.12 2 2
MYOD/E2A 0.032 0.016 -10000 0 -0.077 12 12
SMAD2-3/SMAD4/SP1/MIZ-1 0.061 0.091 -10000 0 -0.22 17 17
IFNB1 0.035 0.044 -10000 0 -0.17 8 8
SMAD3/SMAD4/MEF2C 0.059 0.076 -10000 0 -0.22 20 20
CITED1 0.014 0.035 -10000 0 -0.12 35 35
SMAD2-3/SMAD4/ARC105 0.062 0.061 -10000 0 -0.17 10 10
RBL1 0.019 0.022 -10000 0 -0.12 13 13
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB 0.042 0.067 -10000 0 -0.4 8 8
RUNX1-3/PEBPB2 0.035 0.04 -10000 0 -0.12 27 27
SMAD7 -0.003 0.14 -10000 0 -0.42 28 28
MYC/MIZ-1 0.003 0.063 0.17 5 -0.13 93 98
SMAD3/SMAD4 -0.018 0.098 0.29 2 -0.3 37 39
IL10 0.039 0.044 -10000 0 -0.18 7 7
PIASy/HDAC complex 0.024 0.004 -10000 0 -10000 0 0
PIAS3 0.019 0.022 -10000 0 -0.12 13 13
CDK2 0.017 0.023 -10000 0 -0.12 14 14
IL5 0.039 0.044 -10000 0 -0.2 6 6
CDK4 0.018 0.019 -10000 0 -0.12 9 9
PIAS4 0.024 0.004 -10000 0 -10000 0 0
ATF3 0.011 0.04 -10000 0 -0.12 47 47
SMAD3/SMAD4/SP1 0.027 0.09 -10000 0 -0.21 30 30
FOXG1 0.02 0.019 -10000 0 -0.12 10 10
FOXO3 0.023 0.02 -10000 0 -0.07 23 23
FOXO1 0.025 0.017 -10000 0 -0.071 17 17
FOXO4 0.025 0.016 -10000 0 -0.072 15 15
heart looping 0.034 0.06 -10000 0 -0.22 23 23
CEBPB 0.017 0.033 -10000 0 -0.11 34 34
SMAD3/SMAD4/DLX1 0.044 0.055 -10000 0 -0.16 13 13
MYOD1 0.022 0.015 -10000 0 -0.12 6 6
SMAD3/SMAD4/HNF4 0.045 0.053 -10000 0 -0.14 14 14
SMAD3/SMAD4/GATA3 0.059 0.059 -10000 0 -0.2 7 7
SnoN/SIN3/HDAC complex/NCoR1 0.011 0.035 -10000 0 -0.12 35 35
SMAD3/SMAD4/RUNX1-3/PEBPB2 0.058 0.062 -10000 0 -0.13 18 18
SMAD3/SMAD4/SP1-3 0.042 0.097 -10000 0 -0.21 34 34
MED15 0.022 0.012 -10000 0 -0.12 4 4
SP1 -0.004 0.053 -10000 0 -0.093 113 113
SIN3B 0.022 0.015 -10000 0 -0.12 6 6
SIN3A 0.022 0.014 -10000 0 -0.12 5 5
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.071 0.061 -10000 0 -0.16 21 21
ITGB5 0.007 0.094 -10000 0 -0.28 39 39
TGIF/SIN3/HDAC complex/CtBP 0.022 0.078 -10000 0 -0.27 22 22
SMAD3/SMAD4/AR 0.016 0.077 -10000 0 -0.14 61 61
AR 0.009 0.038 -10000 0 -0.12 43 43
negative regulation of cell growth 0.026 0.073 -10000 0 -0.22 32 32
SMAD3/SMAD4/MYOD 0.044 0.055 -10000 0 -0.17 12 12
E2F5 0.02 0.02 -10000 0 -0.12 11 11
E2F4 0.022 0.012 -10000 0 -0.12 4 4
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.069 0.058 -10000 0 -0.16 12 12
SMAD2-3/SMAD4/FOXO1-3a-4 0.041 0.061 -10000 0 -0.31 10 10
TFDP1 0.019 0.023 -10000 0 -0.12 14 14
SMAD3/SMAD4/AP1 0.012 0.11 -10000 0 -0.23 65 65
SMAD3/SMAD4/RUNX2 0.041 0.057 -10000 0 -0.15 15 15
TGIF2 0.021 0.013 -10000 0 -0.12 4 4
TGIF1 0.023 0 -10000 0 -10000 0 0
ATF2 0.022 0.004 -10000 0 -10000 0 0
Glypican 1 network

Figure S92.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S92.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer 0.029 0.045 -10000 0 -0.11 31 31
fibroblast growth factor receptor signaling pathway 0.028 0.044 -10000 0 -0.11 31 31
LAMA1 0 0.053 -10000 0 -0.12 89 89
PRNP 0.021 0.015 -10000 0 -0.12 5 5
GPC1/SLIT2 -0.011 0.07 -10000 0 -0.14 101 101
SMAD2 0.024 0.028 -10000 0 -0.1 18 18
GPC1/PrPc/Cu2+ 0.021 0.036 -10000 0 -0.12 33 33
GPC1/Laminin alpha1 0.015 0.043 -10000 0 -0.076 101 101
TDGF1 0.022 0.015 -10000 0 -0.12 6 6
CRIPTO/GPC1 0.032 0.017 -10000 0 -0.076 14 14
APP/GPC1 0.023 0.043 -10000 0 -0.13 41 41
mol:NO 0 0 -10000 0 -10000 0 0
YES1 0.024 0.016 -10000 0 -0.11 1 1
FLT1 0.022 0.014 -10000 0 -0.12 5 5
GPC1/TGFB/TGFBR1/TGFBR2 0.039 0.033 -10000 0 -0.11 18 18
SERPINC1 0.023 0.009 -10000 0 -0.12 2 2
FYN 0.019 0.024 -10000 0 -0.11 1 1
FGR 0.026 0.014 -10000 0 -0.11 1 1
positive regulation of MAPKKK cascade 0.016 0.052 -10000 0 -0.18 17 17
SLIT2 0.001 0.047 -10000 0 -0.12 71 71
GPC1/NRG 0.031 0.019 -10000 0 -0.14 2 2
NRG1 0.021 0.017 -10000 0 -0.12 8 8
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.032 0.046 -10000 0 -0.12 41 41
LYN 0.024 0.015 -10000 0 -0.11 1 1
mol:Spermine 0.011 0.01 -10000 0 -0.077 7 7
cell growth 0.028 0.044 -10000 0 -0.11 31 31
BMP signaling pathway -0.021 0.016 0.12 7 -10000 0 7
SRC 0.026 0.015 -10000 0 -0.11 2 2
TGFBR1 0.022 0.011 -10000 0 -0.12 3 3
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A 0.011 0.041 -10000 0 -0.12 48 48
GPC1 0.021 0.016 -10000 0 -0.12 7 7
TGFBR1 (dimer) 0.022 0.011 -10000 0 -0.12 3 3
VEGFA 0.019 0.021 -10000 0 -0.12 11 11
BLK 0.025 0.016 -10000 0 -0.11 2 2
HCK 0.023 0.019 -10000 0 -0.17 1 1
FGF2 0.023 0.009 -10000 0 -0.12 2 2
FGFR1 0.008 0.043 -10000 0 -0.12 54 54
VEGFR1 homodimer 0.022 0.014 -10000 0 -0.12 5 5
TGFBR2 0.02 0.02 -10000 0 -0.12 11 11
cell death 0.023 0.043 -10000 0 -0.13 41 41
ATIII/GPC1 0.033 0.015 -10000 0 -0.078 10 10
PLA2G2A/GPC1 0.023 0.034 -10000 0 -0.076 57 57
LCK 0.025 0.016 -10000 0 -0.17 1 1
neuron differentiation 0.031 0.019 -10000 0 -0.14 2 2
PrPc/Cu2+ 0.007 0.039 -10000 0 -0.14 37 37
APP 0.022 0.008 -10000 0 -0.12 1 1
TGFBR2 (dimer) 0.02 0.02 -10000 0 -0.12 11 11
EGFR-dependent Endothelin signaling events

Figure S93.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S93.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.023 0.006 -9999 0 -0.12 1 1
EGFR 0.015 0.03 -9999 0 -0.12 25 25
EGF/EGFR 0.013 0.053 -9999 0 -0.092 80 80
EGF/EGFR dimer/SHC/GRB2/SOS1 0.041 0.058 -9999 0 -0.17 9 9
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA 0.014 0.035 -9999 0 -0.12 34 34
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF 0.02 0.021 -9999 0 -0.12 12 12
EGF/EGFR dimer/SHC 0.03 0.046 -9999 0 -0.11 40 40
mol:GDP 0.036 0.056 -9999 0 -0.17 9 9
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 0.009 0.043 -9999 0 -0.12 54 54
GRB2/SOS1 0.021 0.045 -9999 0 -0.15 29 29
HRAS/GTP 0.023 0.045 -9999 0 -0.16 9 9
SHC1 0.023 0.001 -9999 0 -10000 0 0
HRAS/GDP 0.036 0.052 -9999 0 -0.16 9 9
FRAP1 0.016 0.044 -9999 0 -0.16 11 11
EGF/EGFR dimer 0.016 0.05 -9999 0 -0.14 40 40
SOS1 0.017 0.027 -9999 0 -0.12 20 20
GRB2 0.023 0.006 -9999 0 -0.12 1 1
ETA receptor/Endothelin-1 0.008 0.056 -9999 0 -0.16 34 34
p38 MAPK signaling pathway

Figure S94.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S94.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TRAF6/ASK1 0.008 0.054 -9999 0 -0.15 53 53
TRAF2/ASK1 0.022 0.033 -9999 0 -0.091 42 42
ATM 0.018 0.022 -9999 0 -0.12 13 13
MAP2K3 -0.002 0.12 -9999 0 -0.32 63 63
response to stress 0 0 -9999 0 -10000 0 0
MAP2K6 -0.012 0.12 -9999 0 -0.27 70 70
hyperosmotic response 0 0 -9999 0 -10000 0 0
response to oxidative stress 0 0 -9999 0 -10000 0 0
GADD45G 0.015 0.033 -9999 0 -0.12 30 30
TXN -0.003 0.051 -9999 0 -0.21 33 33
CALM1 0.022 0.014 -9999 0 -0.12 5 5
GADD45A 0.014 0.032 -9999 0 -0.12 29 29
GADD45B 0.016 0.029 -9999 0 -0.12 24 24
MAP3K1 0.021 0.015 -9999 0 -0.12 6 6
MAP3K6 0.022 0.012 -9999 0 -0.12 4 4
MAP3K7 0.021 0.014 -9999 0 -0.12 5 5
MAP3K4 0.023 0 -9999 0 -10000 0 0
mol:Ca2+ 0 0 -9999 0 -10000 0 0
ASK1/ASK2 0.023 0.041 -9999 0 -0.14 26 26
TAK1/TAB family -0.002 0.072 -9999 0 -0.32 25 25
RAC1/OSM/MEKK3 0.043 0.015 -9999 0 -0.097 6 6
TRAF2 0.023 0 -9999 0 -10000 0 0
RAC1/OSM/MEKK3/MKK3 0.016 0.1 -9999 0 -0.25 63 63
TRAF6 0.004 0.058 -9999 0 -0.21 36 36
RAC1 0.023 0.002 -9999 0 -10000 0 0
mol:LPS 0 0 -9999 0 -10000 0 0
CAMK2B 0.023 0.009 -9999 0 -0.12 2 2
CCM2 0.023 0.001 -9999 0 -10000 0 0
CaM/Ca2+/CAMKIIB 0.029 0.019 -9999 0 -0.093 13 13
MAPK11 0.023 0 -9999 0 -10000 0 0
response to DNA damage stimulus 0 0 -9999 0 -10000 0 0
CaM/Ca2+/CAMKIIB/ASK1 0.033 0.037 -9999 0 -0.1 32 32
OSM/MEKK3 0.034 0.007 -9999 0 -0.14 1 1
TAOK1 -0.001 0.067 -9999 0 -0.22 43 43
TAOK2 0.003 0.056 -9999 0 -0.2 38 38
TAOK3 -0.003 0.067 -9999 0 -0.21 50 50
MAP3K7IP1 0.023 0 -9999 0 -10000 0 0
MAPK14 0.023 0.007 -9999 0 -0.12 1 1
MAP3K7IP2 0.02 0.016 -9999 0 -0.12 6 6
MAP3K5 0.018 0.025 -9999 0 -0.12 17 17
MAP3K10 0.022 0.015 -9999 0 -0.12 6 6
MAP3K3 0.023 0 -9999 0 -10000 0 0
TRX/ASK1 0.009 0.051 -9999 0 -0.18 33 33
GADD45/MTK1/MTK1 0.025 0.057 -9999 0 -0.095 79 79
S1P5 pathway

Figure S95.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S95.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
telencephalon oligodendrocyte cell migration -0.007 0.066 0.21 23 -10000 0 23
GNAI2 0.022 0.011 -10000 0 -0.12 3 3
S1P/S1P5/G12 0.016 0.006 -10000 0 -0.12 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
GNAO1 0.01 0.042 -10000 0 -0.12 51 51
RhoA/GTP 0.007 0.067 -10000 0 -0.21 23 23
negative regulation of cAMP metabolic process -0.003 0.068 -10000 0 -0.15 86 86
GNAZ 0.022 0.011 -10000 0 -0.12 3 3
GNAI3 0.021 0.008 -10000 0 -0.12 1 1
GNA12 0.023 0.001 -10000 0 -10000 0 0
S1PR5 0 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
S1P/S1P5/Gi -0.003 0.069 -10000 0 -0.15 86 86
RhoA/GDP 0.016 0.016 -10000 0 -0.14 6 6
RHOA 0.023 0.006 -10000 0 -0.12 1 1
GNAI1 0.012 0.035 -10000 0 -0.12 35 35
Regulation of p38-alpha and p38-beta

Figure S96.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S96.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
RIP1/MEKK3 0.03 0.016 -9999 0 -0.095 9 9
response to insulin stimulus 0 0 -9999 0 -10000 0 0
RIPK1 0.022 0.011 -9999 0 -0.12 3 3
response to stress 0 0 -9999 0 -10000 0 0
MAP2K6 0.013 0.034 -9999 0 -0.12 33 33
mol:GTP 0 0 -9999 0 -10000 0 0
MAP2K4 0.022 0.011 -9999 0 -0.12 3 3
RAC1-CDC42/GTP/PAK family 0.007 0.055 -9999 0 -0.15 50 50
response to UV 0 0 -9999 0 -10000 0 0
YES1 0.02 0.018 -9999 0 -0.12 8 8
interleukin-1 receptor activity 0 0 -9999 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -9999 0 -10000 0 0
MAP3K3 0.023 0 -9999 0 -10000 0 0
FYN 0.011 0.037 -9999 0 -0.12 40 40
MAP3K12 0.022 0.011 -9999 0 -0.12 3 3
FGR 0.023 0.006 -9999 0 -0.12 1 1
p38 alpha/TAB1 0.019 0.083 -9999 0 -0.2 45 45
PRKG1 0.018 0.026 -9999 0 -0.12 19 19
DUSP8 0.023 0.006 -9999 0 -0.12 1 1
PGK/cGMP/p38 alpha 0.013 0.08 -9999 0 -0.2 45 45
apoptosis 0.018 0.08 -9999 0 -0.19 45 45
RAL/GTP 0.024 0.033 -9999 0 -0.11 29 29
LYN 0.021 0.013 -9999 0 -0.12 4 4
DUSP1 -0.004 0.052 -9999 0 -0.12 90 90
PAK1 0.016 0.029 -9999 0 -0.12 23 23
SRC 0.023 0.009 -9999 0 -0.12 2 2
RAC1/OSM/MEKK3/MKK3 0.057 0.021 -9999 0 -0.093 11 11
TRAF6 0.022 0.009 -9999 0 -0.12 2 2
RAC1 0.023 0.002 -9999 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -9999 0 -10000 0 0
mol:LPS 0 0 -9999 0 -10000 0 0
mol:cGMP 0 0 -9999 0 -10000 0 0
CCM2 0.023 0.001 -9999 0 -10000 0 0
RAC1-CDC42/GTP 0.03 0.019 -9999 0 -0.13 7 7
MAPK11 0.004 0.1 -9999 0 -0.24 54 54
BLK 0.022 0.015 -9999 0 -0.12 6 6
HCK 0.019 0.024 -9999 0 -0.12 15 15
MAP2K3 0.023 0.006 -9999 0 -0.12 1 1
DUSP16 0.018 0.026 -9999 0 -0.12 18 18
DUSP10 0.012 0.036 -9999 0 -0.12 36 36
TRAF6/MEKK3 0.028 0.017 -9999 0 -0.093 11 11
MAP3K7IP1 0.023 0 -9999 0 -10000 0 0
MAPK14 0.01 0.087 -9999 0 -0.22 47 47
positive regulation of innate immune response 0.007 0.11 -9999 0 -0.27 52 52
LCK 0.022 0.015 -9999 0 -0.12 6 6
p38alpha-beta/MKP7 0.013 0.11 -9999 0 -0.27 48 48
p38alpha-beta/MKP5 0.005 0.12 -9999 0 -0.26 59 59
PGK/cGMP 0.014 0.017 -9999 0 -0.077 19 19
PAK2 0.022 0.011 -9999 0 -0.12 3 3
p38alpha-beta/MKP1 -0.007 0.12 -9999 0 -0.27 67 67
CDC42 0.023 0.002 -9999 0 -10000 0 0
RALB 0.022 0.007 -9999 0 -0.12 1 1
RALA 0.022 0.009 -9999 0 -0.12 2 2
PAK3 0.008 0.044 -9999 0 -0.12 59 59
Signaling events mediated by VEGFR1 and VEGFR2

Figure S97.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S97.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaV beta3 Integrin -0.018 0.081 -9999 0 -0.16 107 107
AKT1 0.019 0.12 -9999 0 -0.32 32 32
PTK2B -0.005 0.081 -9999 0 -0.2 49 49
VEGFR2 homodimer/Frs2 0.025 0.058 -9999 0 -0.29 7 7
CAV1 0.012 0.039 -9999 0 -0.12 43 43
CALM1 0.022 0.014 -9999 0 -0.12 5 5
VEGFR2 homodimer/VEGFA homodimer/Frs2 0.03 0.073 -9999 0 -0.24 17 17
endothelial cell proliferation 0.026 0.1 -9999 0 -0.31 23 23
mol:Ca2+ 0.027 0.068 -9999 0 -0.23 18 18
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Rac 0.036 0.083 -9999 0 -0.22 28 28
RP11-342D11.1 0.019 0.062 -9999 0 -0.23 17 17
CDH5 0.022 0.014 -9999 0 -0.12 5 5
VEGFA homodimer 0.038 0.057 -9999 0 -0.1 69 69
SHC1 0.023 0.001 -9999 0 -10000 0 0
SHC2 0.023 0.009 -9999 0 -0.12 2 2
HRAS/GDP 0.03 0.061 -9999 0 -0.25 11 11
SH2D2A 0.023 0.009 -9999 0 -0.12 2 2
VEGFR2 homodimer/VEGFA homodimer/SHP1/eNOS 0.054 0.083 -9999 0 -0.32 9 9
VEGFR2 homodimer/VEGFA homodimer/TsAd 0.036 0.07 -9999 0 -0.24 16 16
VEGFR1 homodimer 0.022 0.014 -9999 0 -0.12 5 5
SHC/GRB2/SOS1 0.055 0.078 -9999 0 -0.26 12 12
GRB10 0.029 0.073 -9999 0 -0.34 11 11
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
GRB2 0.023 0.006 -9999 0 -0.12 1 1
PAK1 0.016 0.029 -9999 0 -0.12 23 23
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Cadherin/beta catenin 0.04 0.087 -9999 0 -0.21 31 31
HRAS 0.023 0.006 -9999 0 -0.12 1 1
VEGF/Rho/ROCK1/Integrin Complex -0.019 0.12 -9999 0 -0.3 64 64
HIF1A 0.022 0.01 -9999 0 -0.12 2 2
FRS2 0.019 0.024 -9999 0 -0.12 15 15
oxygen and reactive oxygen species metabolic process 0.034 0.081 -9999 0 -0.22 28 28
mol:GTP 0 0 -9999 0 -10000 0 0
FLT4 0.023 0.009 -9999 0 -0.12 2 2
Nck/Pak 0.013 0.056 -9999 0 -0.15 50 50
VEGFR2 homodimer/VEGFA homodimer/Fyn 0.021 0.08 -9999 0 -0.22 24 24
mol:GDP 0.041 0.071 -9999 0 -0.25 12 12
mol:NADP 0.037 0.071 -9999 0 -0.29 9 9
eNOS/Hsp90 0.045 0.071 -9999 0 -0.27 9 9
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
mol:IP3 0.027 0.068 -9999 0 -0.24 18 18
HIF1A/ARNT 0.024 0.042 -9999 0 -0.14 34 34
SHB 0.023 0.009 -9999 0 -0.12 2 2
VEGFA 0.022 0.021 -9999 0 -0.099 14 14
VEGFC 0.018 0.028 -9999 0 -0.12 21 21
FAK1/Vinculin -0.007 0.13 -9999 0 -0.39 33 33
mol:Ca ++ 0 0 -9999 0 -10000 0 0
RHOA 0.023 0.006 -9999 0 -0.12 1 1
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.007 0.095 -9999 0 -0.21 47 47
PTPN6 0.023 0.009 -9999 0 -0.12 2 2
EPAS1 0.025 0.04 -9999 0 -0.13 27 27
mol:L-citrulline 0.037 0.071 -9999 0 -0.29 9 9
ITGAV 0.013 0.032 -9999 0 -0.12 28 28
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
VEGFR2 homodimer/VEGFA homodimer/Frs2/GRB2 0.042 0.074 -9999 0 -0.21 20 20
VEGFR2 homodimer/VEGFA homodimer 0.047 0.079 -9999 0 -0.25 17 17
VEGFR2/3 heterodimer 0.028 0.057 -9999 0 -0.28 7 7
VEGFB 0.015 0.033 -9999 0 -0.12 30 30
MAPK11 0.022 0.069 -9999 0 -0.25 17 17
VEGFR2 homodimer 0.028 0.052 -9999 0 -0.34 7 7
FLT1 0.022 0.014 -9999 0 -0.12 5 5
NEDD4 0.023 0.022 -9999 0 -0.12 12 12
MAPK3 0.014 0.064 -9999 0 -0.23 17 17
MAPK1 0.013 0.065 -9999 0 -0.24 17 17
VEGFA145/NRP2 0.001 0.072 -9999 0 -0.15 85 85
VEGFR1/2 heterodimer 0.027 0.059 -9999 0 -0.27 9 9
KDR 0.028 0.052 -9999 0 -0.34 7 7
VEGFA165/NRP1/VEGFR2 homodimer 0.032 0.084 -9999 0 -0.21 29 29
SRC 0.023 0.009 -9999 0 -0.12 2 2
platelet activating factor biosynthetic process 0.014 0.066 -9999 0 -0.24 16 16
PI3K 0.034 0.099 -9999 0 -0.3 22 22
VEGFR2 homodimer/VEGFA homodimer/NCK1 0.027 0.076 -9999 0 -0.22 21 21
FES 0.029 0.066 -9999 0 -0.23 17 17
GAB1 0.026 0.095 -9999 0 -0.3 25 25
VEGFR2 homodimer/VEGFA homodimer/Src 0.036 0.07 -9999 0 -0.24 16 16
CTNNB1 0.022 0.008 -9999 0 -0.12 1 1
SOS1 0.017 0.027 -9999 0 -0.12 20 20
ARNT 0.022 0.012 -9999 0 -0.12 4 4
eNOS/Caveolin-1 0.039 0.075 -9999 0 -0.28 10 10
VEGFR2 homodimer/VEGFA homodimer/Yes 0.028 0.076 -9999 0 -0.22 22 22
PI3K/GAB1 0.027 0.12 -9999 0 -0.34 30 30
VEGFR2 homodimer/VEGFA homodimer/Frs2/Nck/Pak 0.035 0.083 -9999 0 -0.19 29 29
PRKACA 0.021 0.017 -9999 0 -0.12 8 8
VEGFR2/3 heterodimer/VEGFC homodimer 0.036 0.06 -9999 0 -0.32 6 6
HSP90AA1 0.023 0.003 -9999 0 -10000 0 0
CDC42 0.029 0.066 -9999 0 -0.23 17 17
actin cytoskeleton reorganization 0.035 0.07 -9999 0 -0.23 16 16
PTK2 -0.016 0.13 -9999 0 -0.4 32 32
EDG1 0.03 0.068 -9999 0 -0.28 11 11
mol:DAG 0.027 0.068 -9999 0 -0.24 18 18
CaM/Ca2+ 0.033 0.068 -9999 0 -0.26 12 12
MAP2K3 0.023 0.065 -9999 0 -0.24 14 14
VEGFR2 homodimer/VEGFA homodimer/GRB10/NEDD4 0.052 0.084 -9999 0 -0.35 11 11
PLCG1 0.027 0.069 -9999 0 -0.24 18 18
VEGFR2 homodimer/VEGFA homodimer/Src/Shb 0.048 0.069 -9999 0 -0.22 16 16
IQGAP1 0.02 0.017 -9999 0 -0.12 7 7
YES1 0.02 0.018 -9999 0 -0.12 8 8
VEGFR2 homodimer/VEGFA homodimer/SHP2 0.031 0.075 -9999 0 -0.24 20 20
VEGFR2 homodimer/VEGFA homodimer/SHP1 0.035 0.071 -9999 0 -0.24 16 16
cell migration -0.002 0.14 -9999 0 -0.37 47 47
mol:PI-3-4-5-P3 0.034 0.095 -9999 0 -0.28 22 22
FYN 0.011 0.037 -9999 0 -0.12 40 40
VEGFB/NRP1 0.026 0.064 -9999 0 -0.21 19 19
mol:NO 0.037 0.071 -9999 0 -0.29 9 9
PXN 0.022 0.014 -9999 0 -0.12 5 5
HRAS/GTP -0.013 0.043 -9999 0 -0.24 11 11
VEGFR2 homodimer/VEGFA homodimer/GRB10 0.048 0.078 -9999 0 -0.35 11 11
VHL 0.021 0.016 -9999 0 -0.12 7 7
ITGB3 0.004 0.047 -9999 0 -0.12 68 68
NOS3 0.037 0.076 -9999 0 -0.32 9 9
VEGFR2 homodimer/VEGFA homodimer/Sck 0.036 0.07 -9999 0 -0.24 16 16
RAC1 0.023 0.002 -9999 0 -10000 0 0
PRKCA 0.02 0.063 -9999 0 -0.22 20 20
PRKCB 0.02 0.062 -9999 0 -0.22 18 18
VCL 0.021 0.013 -9999 0 -0.12 4 4
VEGFA165/NRP1 0.033 0.065 -9999 0 -0.23 17 17
VEGFR1/2 heterodimer/VEGFA homodimer 0.034 0.073 -9999 0 -0.24 18 18
VEGFA165/NRP2 0.001 0.072 -9999 0 -0.15 85 85
MAPKKK cascade 0.048 0.074 -9999 0 -0.28 13 13
NRP2 0.011 0.036 -9999 0 -0.12 38 38
VEGFC homodimer 0.018 0.027 -9999 0 -0.12 21 21
NCK1 0.02 0.019 -9999 0 -0.12 9 9
ROCK1 0.022 0.009 -9999 0 -0.12 2 2
FAK1/Paxillin -0.005 0.13 -9999 0 -0.38 33 33
MAP3K13 0.024 0.069 -9999 0 -0.23 19 19
PDPK1 0.029 0.085 -9999 0 -0.26 22 22
mTOR signaling pathway

Figure S98.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S98.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GBL 0.023 0.009 -10000 0 -0.12 2 2
MKNK1 0.023 0.006 -10000 0 -0.12 1 1
mol:PIP3 -0.005 0.043 -10000 0 -0.14 28 28
FRAP1 0.01 0.072 -10000 0 -0.42 13 13
AKT1 0.006 0.057 0.18 19 -0.14 34 53
INSR 0.021 0.017 -10000 0 -0.12 8 8
Insulin Receptor/Insulin 0.028 0.019 -10000 0 -0.12 6 6
mol:GTP 0.022 0.057 0.18 18 -0.13 26 44
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA/eIF3/40s Ribosomal subunit -0.015 0.045 -10000 0 -0.17 33 33
TSC2 0.021 0.017 -10000 0 -0.12 8 8
RHEB/GDP 0.008 0.047 -10000 0 -0.13 33 33
TSC1 0.023 0.006 -10000 0 -0.12 1 1
Insulin Receptor/IRS1 0.02 0.029 -10000 0 -0.22 6 6
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA 0.01 0.061 -10000 0 -0.2 31 31
mol:GDP 0 0 -10000 0 -10000 0 0
EIF3A 0.022 0.004 -10000 0 -10000 0 0
RPS6KB1 0.006 0.085 0.16 14 -0.3 29 43
MAP3K5 -0.004 0.058 -10000 0 -0.27 25 25
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
apoptosis -0.004 0.058 -10000 0 -0.27 25 25
mol:LY294002 0 0 0 6 -0.001 6 12
EIF4B 0.008 0.079 0.16 14 -0.26 31 45
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.021 0.078 0.16 12 -0.24 31 43
eIF4E/eIF4G1/eIF4A1 -0.007 0.042 -10000 0 -0.24 15 15
KIAA1303 0.023 0.009 -10000 0 -0.12 2 2
PI3K 0.016 0.053 -10000 0 -0.16 24 24
mTOR/RHEB/GTP/Raptor/GBL 0.026 0.054 0.16 16 -0.15 26 42
FKBP1A 0.022 0.012 -10000 0 -0.12 4 4
RHEB/GTP 0.019 0.053 0.14 3 -0.13 33 36
mol:Amino Acids 0 0 0 6 -0.001 6 12
FKBP12/Rapamycin 0.016 0.014 -10000 0 -0.11 7 7
PDPK1 0.005 0.052 0.18 17 -0.15 20 37
EIF4E 0.023 0.001 -10000 0 -10000 0 0
ASK1/PP5C 0.005 0.14 -10000 0 -0.49 38 38
mTOR/RHEB/GTP/Raptor/GBL/eIF4E 0.032 0.061 -10000 0 -10000 0 0
TSC1/TSC2 0.025 0.061 0.19 18 -0.14 26 44
tumor necrosis factor receptor activity 0 0 0.001 6 0 6 12
RPS6 0.023 0.002 -10000 0 -10000 0 0
PPP5C 0.022 0.014 -10000 0 -0.12 5 5
EIF4G1 0.023 0.004 -10000 0 -10000 0 0
IRS1 0.006 0.028 -10000 0 -0.27 5 5
INS 0.022 0.011 -10000 0 -0.12 3 3
PTEN 0.022 0.008 -10000 0 -0.12 1 1
PDK2 0.004 0.054 0.18 17 -0.16 24 41
EIF4EBP1 0.011 0.1 -10000 0 -1.1 5 5
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
PPP2R5D 0.014 0.066 -10000 0 -0.37 13 13
peptide biosynthetic process 0.022 0.018 -10000 0 -0.11 6 6
RHEB 0.019 0.022 -10000 0 -0.12 13 13
EIF4A1 0.023 0.007 -10000 0 -0.12 1 1
mol:Rapamycin 0 0.001 0.003 20 -0.002 17 37
EEF2 0.023 0.018 -10000 0 -0.12 6 6
eIF4E/4E-BP1 0.023 0.098 -10000 0 -1 5 5
Ceramide signaling pathway

Figure S99.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S99.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.02 0.016 -10000 0 -0.076 15 15
MAP4K4 0.003 0.068 -10000 0 -0.22 21 21
BAG4 0.022 0.012 -10000 0 -0.12 4 4
PKC zeta/ceramide 0.013 0.009 0.075 5 -10000 0 5
NFKBIA 0.016 0.028 -10000 0 -0.12 21 21
BIRC3 -0.005 0.053 -10000 0 -0.12 94 94
BAX 0.01 0.005 -10000 0 -10000 0 0
RIPK1 0.022 0.011 -10000 0 -0.12 3 3
AKT1 0.007 0.021 -10000 0 -0.13 12 12
BAD 0.001 0.01 0.068 5 -0.055 3 8
SMPD1 0.009 0.036 -10000 0 -0.14 17 17
RB1 -0.012 0.033 0.068 3 -0.092 78 81
FADD/Caspase 8 0.003 0.095 -10000 0 -0.3 29 29
MAP2K4 0 0.023 0.069 5 -0.093 27 32
NSMAF 0.021 0.014 -10000 0 -0.12 5 5
response to UV 0 0 -10000 0 -10000 0 0
RAF1 0.004 0.015 0.069 5 -0.097 7 12
EGF 0.02 0.021 -10000 0 -0.12 12 12
mol:ceramide -0.004 0.01 0.063 7 -10000 0 7
MADD 0.023 0.006 -10000 0 -0.12 1 1
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid 0.018 0.022 -10000 0 -0.085 20 20
ASAH1 0.021 0.017 -10000 0 -0.12 7 7
negative regulation of cell cycle -0.012 0.033 0.068 3 -0.091 78 81
cell proliferation 0.017 0.041 -10000 0 -0.12 14 14
BID 0.009 0.079 -10000 0 -0.6 4 4
MAP3K1 -0.003 0.021 0.068 5 -0.1 18 23
EIF2A -0.007 0.043 -10000 0 -0.11 59 59
TRADD 0.023 0.006 -10000 0 -0.12 1 1
CRADD 0.023 0.009 -10000 0 -0.12 2 2
MAPK3 0.009 0.021 -10000 0 -0.1 12 12
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 0.008 0.024 -10000 0 -0.12 13 13
Cathepsin D/ceramide 0.011 0.013 0.076 4 -0.056 9 13
FADD 0.004 0.068 -10000 0 -0.22 20 20
KSR1 0.001 0.01 0.068 5 -10000 0 5
MAPK8 0.005 0.039 -10000 0 -0.19 17 17
PRKRA -0.002 0.02 0.068 5 -0.099 17 22
PDGFA 0.02 0.022 -10000 0 -0.12 13 13
TRAF2 0.023 0 -10000 0 -10000 0 0
IGF1 0.007 0.045 -10000 0 -0.12 60 60
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.004 0.01 0.063 7 -10000 0 7
CTSD 0.02 0.02 -10000 0 -0.12 11 11
regulation of nitric oxide biosynthetic process 0.021 0.046 -10000 0 -0.13 47 47
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta 0.019 0.043 -10000 0 -0.13 14 14
PRKCD 0.02 0.018 -10000 0 -0.12 8 8
PRKCZ 0.023 0 -10000 0 -10000 0 0
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine 0.018 0.022 -10000 0 -0.085 20 20
RelA/NF kappa B1 0.021 0.047 -10000 0 -0.13 47 47
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0.023 0.009 -10000 0 -0.12 2 2
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD 0.001 0.073 -10000 0 -0.24 19 19
TNFR1A/BAG4/TNF-alpha 0.038 0.034 -10000 0 -0.11 20 20
mol:Sphingosine-1-phosphate 0.02 0.016 -10000 0 -0.076 15 15
MAP2K1 0.007 0.016 0.071 1 -0.094 9 10
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.023 0.009 -10000 0 -0.12 2 2
CYCS 0.004 0.024 0.13 2 -0.12 14 16
TNFRSF1A 0.021 0.016 -10000 0 -0.12 7 7
NFKB1 0.021 0.013 -10000 0 -0.12 4 4
TNFR1A/BAG4 0.027 0.034 -10000 0 -0.11 29 29
EIF2AK2 -0.008 0.036 0.069 5 -0.1 53 58
TNF-alpha/TNFR1A/FAN 0.033 0.047 -10000 0 -0.13 34 34
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 -0.003 0.12 -10000 0 -0.4 39 39
MAP2K2 0.005 0.019 0.071 1 -0.094 11 12
SMPD3 0.011 0.041 -10000 0 -0.16 15 15
TNF 0.02 0.02 -10000 0 -0.12 11 11
PKC zeta/PAR4 0.034 0.012 -10000 0 -0.11 4 4
mol:PHOSPHOCHOLINE -0.008 0.016 0.092 5 -10000 0 5
NF kappa B1/RelA/I kappa B alpha 0.044 0.059 -10000 0 -0.096 72 72
AIFM1 -0.005 0.036 0.13 1 -0.12 44 45
BCL2 0.016 0.031 -10000 0 -0.12 27 27
Signaling events mediated by HDAC Class III

Figure S100.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S100.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.022 0.01 -10000 0 -0.12 2 2
HDAC4 0.023 0 -10000 0 -10000 0 0
induction of apoptosis 0 0 -10000 0 -10000 0 0
regulation of S phase of mitotic cell cycle -0.008 0.002 -10000 0 -10000 0 0
CDKN1A 0.034 0.04 -10000 0 -10000 0 0
KAT2B 0 0 -10000 0 -10000 0 0
BAX 0.023 0 -10000 0 -10000 0 0
FOXO3 0.003 0.05 0.26 19 -10000 0 19
FOXO1 0.023 0.009 -10000 0 -0.12 2 2
FOXO4 0.009 0.064 -10000 0 -0.22 34 34
response to UV 0 0 -10000 0 -10000 0 0
XRCC6 0.022 0.004 -10000 0 -10000 0 0
TAT 0.023 0.009 -10000 0 -0.12 2 2
mol:Lysophosphatidic acid 0 0 -10000 0 -10000 0 0
MYOD1 0.011 0.009 -10000 0 -0.077 6 6
PPARGC1A 0.014 0.035 -10000 0 -0.12 35 35
FHL2 0.02 0.02 -10000 0 -0.12 11 11
response to nutrient levels 0 0 -10000 0 -10000 0 0
KU70/SIRT1 0.022 0.045 -10000 0 -0.18 25 25
HIST2H4A 0.008 0.002 -10000 0 -10000 0 0
SIRT1/FOXO3a 0.014 0.037 0.2 19 -0.089 5 24
SIRT1 0.019 0.004 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
SIRT1/MEF2D/HDAC4 0.042 0.021 -10000 0 -0.11 10 10
SIRT1/Histone H1b 0.005 0.071 -10000 0 -0.17 69 69
apoptosis -0.036 0.039 0.14 25 -10000 0 25
SIRT1/PGC1A 0.021 0.029 -10000 0 -0.12 10 10
p53/SIRT1 -0.035 0.081 -10000 0 -0.15 173 173
SIRT1/FOXO4 0.017 0.058 -10000 0 -0.19 34 34
FOXO1/FHL2/SIRT1 0.037 0.026 -10000 0 -0.1 14 14
HIST1H1E -0.005 0.079 -10000 0 -0.2 69 69
SIRT1/p300 0.022 0.04 -10000 0 -0.14 32 32
muscle cell differentiation -0.014 0.02 0.12 11 -10000 0 11
TP53 0.007 0.029 -10000 0 -0.13 22 22
KU70/SIRT1/BAX 0.036 0.039 -10000 0 -0.14 25 25
CREBBP 0.021 0.015 -10000 0 -0.12 6 6
MEF2D 0.023 0 -10000 0 -10000 0 0
HIV-1 Tat/SIRT1 0.028 0.024 -10000 0 -0.14 10 10
ACSS2 0.018 0.01 -10000 0 -0.074 6 6
SIRT1/PCAF/MYOD 0.014 0.02 -10000 0 -0.12 11 11
Signaling events regulated by Ret tyrosine kinase

Figure S101.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S101.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.008 0.098 -9999 0 -0.39 31 31
Crk/p130 Cas/Paxillin -0.007 0.025 -9999 0 -0.15 7 7
JUN 0.012 0.06 -9999 0 -0.21 22 22
HRAS 0.023 0.006 -9999 0 -0.12 1 1
RET51/GFRalpha1/GDNF/GRB10 0.045 0.039 -9999 0 -0.1 11 11
RAP1A 0.021 0.012 -9999 0 -0.12 3 3
FRS2 0.019 0.024 -9999 0 -0.12 15 15
RAP1A/GDP 0.009 0.034 -9999 0 -0.14 28 28
RET51/GFRalpha1/GDNF/DOK1 0.045 0.039 -9999 0 -0.11 9 9
EntrezGene:5979 0 0 -9999 0 -10000 0 0
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.021 0.016 -9999 0 -0.12 7 7
RET9/GFRalpha1/GDNF/Enigma 0.034 0.032 -9999 0 -0.11 7 7
RHOA 0.023 0.006 -9999 0 -0.12 1 1
RAP1A/GTP 0.039 0.042 -9999 0 -0.092 30 30
GRB7 0.018 0.026 -9999 0 -0.12 18 18
RET51/GFRalpha1/GDNF 0.046 0.037 -9999 0 -0.097 8 8
MAPKKK cascade 0.037 0.037 -9999 0 -0.18 5 5
BCAR1 0.022 0.011 -9999 0 -0.12 3 3
RET9/GFRalpha1/GDNF/IRS1 0.033 0.033 -9999 0 -0.1 10 10
lamellipodium assembly 0.025 0.043 -9999 0 -0.17 7 7
RET51/GFRalpha1/GDNF/SHC 0.047 0.035 -9999 0 -0.096 5 5
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
RET9/GFRalpha1/GDNF/SHC 0.036 0.027 -9999 0 -0.099 3 3
RET9/GFRalpha1/GDNF/Shank3 0.036 0.027 -9999 0 -0.1 3 3
MAPK3 0.022 0.033 -9999 0 -0.087 30 30
DOK1 0.021 0.016 -9999 0 -0.12 7 7
DOK6 0.023 0.009 -9999 0 -0.12 2 2
PXN 0.022 0.014 -9999 0 -0.12 5 5
neurite development 0.028 0.039 -9999 0 -0.17 10 10
DOK5 -0.008 0.054 -9999 0 -0.12 102 102
GFRA1 0.01 0.041 -9999 0 -0.12 50 50
MAPK8 0.014 0.061 -9999 0 -0.15 57 57
HRAS/GTP 0.042 0.041 -9999 0 -0.15 9 9
tube development 0.038 0.03 -9999 0 -0.12 6 6
MAPK1 0.021 0.033 -9999 0 -0.087 30 30
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 0.018 0.055 -9999 0 -0.17 32 32
Rac1/GDP 0.016 0.015 -9999 0 -0.15 5 5
SRC 0.023 0.009 -9999 0 -0.12 2 2
PDLIM7 0.02 0.021 -9999 0 -0.12 12 12
RET51/GFRalpha1/GDNF/Dok6 0.056 0.036 -9999 0 -0.097 5 5
SHC1 0.023 0.001 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok4 0.047 0.035 -9999 0 -0.098 7 7
RET51/GFRalpha1/GDNF/Dok5 -0.003 0.072 -9999 0 -0.1 144 144
PRKCA 0.011 0.037 -9999 0 -0.12 40 40
HRAS/GDP 0.017 0.008 -9999 0 -0.11 2 2
CREB1 0.021 0.071 -9999 0 -0.24 28 28
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 0.024 0.034 -9999 0 -0.14 17 17
RET51/GFRalpha1/GDNF/Grb7 0.041 0.044 -9999 0 -0.11 18 18
mol:GDP 0 0 -9999 0 -10000 0 0
RET 0.019 0.026 -9999 0 -0.12 18 18
DOK4 0.022 0.012 -9999 0 -0.12 4 4
JNK cascade 0.01 0.063 -9999 0 -0.2 28 28
RET9/GFRalpha1/GDNF/FRS2 0.031 0.036 -9999 0 -0.1 17 17
SHANK3 0.023 0.006 -9999 0 -0.12 1 1
RASA1 0.021 0.012 -9999 0 -0.12 3 3
NCK1 0.02 0.019 -9999 0 -0.12 9 9
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 0.019 0.048 -9999 0 -0.15 31 31
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 0.023 0.055 -9999 0 -0.17 32 32
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK 0.014 0.065 -9999 0 -0.16 60 60
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 0.024 0.049 -9999 0 -0.15 31 31
PI3K 0.035 0.052 -9999 0 -0.19 11 11
SOS1 0.017 0.027 -9999 0 -0.12 20 20
RET9/GFRalpha1/GDNF/Shank3/Grb2 0.045 0.032 -9999 0 -0.12 6 6
GRB10 0.022 0.014 -9999 0 -0.12 5 5
activation of MAPKK activity 0.022 0.056 -9999 0 -0.29 9 9
RET51/GFRalpha1/GDNF/FRS2 0.042 0.043 -9999 0 -0.097 19 19
GAB1 0.02 0.021 -9999 0 -0.12 12 12
IRS1 0.019 0.023 -9999 0 -0.12 14 14
IRS2 0.021 0.016 -9999 0 -0.12 7 7
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 0.03 0.036 -9999 0 -0.21 2 2
RET51/GFRalpha1/GDNF/PKC alpha 0.03 0.053 -9999 0 -0.097 46 46
GRB2 0.023 0.006 -9999 0 -0.12 1 1
PRKACA 0.021 0.017 -9999 0 -0.12 8 8
GDNF 0.023 0.009 -9999 0 -0.12 2 2
RAC1 0.023 0.002 -9999 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 0.044 0.039 -9999 0 -0.096 13 13
Rac1/GTP 0.032 0.05 -9999 0 -0.2 7 7
RET9/GFRalpha1/GDNF 0.023 0.026 -9999 0 -0.059 52 52
GFRalpha1/GDNF 0.025 0.032 -9999 0 -0.074 52 52
Signaling events mediated by HDAC Class I

Figure S102.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S102.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NF kappa B/RelA 0.032 0.075 -10000 0 -0.2 35 35
Ran/GTP/Exportin 1/HDAC1 -0.012 0.04 -10000 0 -0.12 54 54
NF kappa B1 p50/RelA/I kappa B alpha 0.019 0.091 -10000 0 -0.26 40 40
SUMO1 0.023 0.009 -10000 0 -0.12 2 2
ZFPM1 0.022 0.011 -10000 0 -0.12 3 3
NPC/RanGAP1/SUMO1/Ubc9 0.015 0.037 -10000 0 -0.14 30 30
FKBP3 0.021 0.013 -10000 0 -0.12 4 4
Histones 0.04 0.067 -10000 0 -0.2 22 22
YY1/LSF 0.017 0.063 -10000 0 -0.21 34 34
SMG5 0.022 0.011 -10000 0 -0.12 3 3
RAN 0.023 0.002 -10000 0 -10000 0 0
I kappa B alpha/HDAC3 0.016 0.066 -10000 0 -0.17 49 49
I kappa B alpha/HDAC1 0.011 0.084 -10000 0 -0.24 48 48
SAP18 0.023 0.003 -10000 0 -10000 0 0
RELA 0.017 0.076 -10000 0 -0.22 36 36
HDAC1/Smad7 0.034 0.042 -10000 0 -0.11 39 39
RANGAP1 0.023 0.006 -10000 0 -0.12 1 1
HDAC3/TR2 0.031 0.046 -10000 0 -0.24 11 11
NuRD/MBD3 Complex 0.013 0.099 -10000 0 -0.32 32 32
NF kappa B1 p50/RelA 0.022 0.079 -10000 0 -0.21 44 44
EntrezGene:23225 0 0 -10000 0 -10000 0 0
GATA2 0.02 0.022 -10000 0 -0.12 13 13
GATA1 0.023 0.006 -10000 0 -0.12 1 1
Mad/Max 0.033 0.012 -10000 0 -0.071 8 8
NuRD/MBD3 Complex/GATA1/Fog1 0.025 0.094 -10000 0 -0.29 32 32
RBBP7 0.022 0.011 -10000 0 -0.12 3 3
NPC 0.009 0.023 -10000 0 -0.096 27 27
RBBP4 0.021 0.014 -10000 0 -0.12 5 5
MAX 0.023 0 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
FBXW11 0.023 0.003 -10000 0 -10000 0 0
NFKBIA 0.004 0.083 -10000 0 -0.26 43 43
KAT2B 0 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
SIN3/HDAC complex 0.015 0.082 -10000 0 -0.3 22 22
SIN3 complex 0.052 0.032 -10000 0 -0.098 20 20
SMURF1 0.023 0.009 -10000 0 -0.12 2 2
CHD3 0.021 0.016 -10000 0 -0.12 7 7
SAP30 0.023 0 -10000 0 -10000 0 0
EntrezGene:23636 0 0 -10000 0 -10000 0 0
NCOR1 0.022 0.009 -10000 0 -0.12 2 2
YY1/HDAC3 0.023 0.065 -10000 0 -0.25 19 19
YY1/HDAC2 0.018 0.059 -10000 0 -0.19 35 35
YY1/HDAC1 0.017 0.059 -10000 0 -0.2 34 34
NuRD/MBD2 Complex (MeCP1) 0.013 0.098 -10000 0 -0.31 32 32
PPARG 0.021 0.062 -10000 0 -0.2 35 35
HDAC8/hEST1B 0.037 0.039 -10000 0 -0.12 28 28
UBE2I 0.023 0.001 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.023 0.003 -10000 0 -10000 0 0
TNFRSF1A 0.021 0.016 -10000 0 -0.12 7 7
HDAC3/SMRT (N-CoR2) 0.031 0.046 -10000 0 -0.25 10 10
MBD3L2 0.022 0.011 -10000 0 -0.12 3 3
ubiquitin-dependent protein catabolic process 0.034 0.041 -10000 0 -0.11 39 39
CREBBP 0.021 0.015 -10000 0 -0.12 6 6
NuRD/MBD3/MBD3L2 Complex 0.023 0.095 -10000 0 -0.3 32 32
HDAC1 0.019 0.02 -10000 0 -0.12 10 10
HDAC3 0.023 0.044 -10000 0 -0.26 9 9
HDAC2 0.02 0.021 -10000 0 -0.12 12 12
YY1 0.008 0.064 -10000 0 -0.22 34 34
HDAC8 0.021 0.013 -10000 0 -0.12 4 4
SMAD7 0.023 0.003 -10000 0 -10000 0 0
NCOR2 0.019 0.023 -10000 0 -0.12 15 15
MXD1 0.021 0.017 -10000 0 -0.12 8 8
STAT3 0.006 0.078 -10000 0 -0.23 48 48
NFKB1 0.021 0.013 -10000 0 -0.12 4 4
EntrezGene:8021 0 0 -10000 0 -10000 0 0
RANBP2 0.022 0.01 -10000 0 -0.12 2 2
YY1/LSF/HDAC1 0.019 0.072 -10000 0 -0.19 41 41
YY1/SAP30/HDAC1 0.025 0.062 -10000 0 -0.17 35 35
EP300 0.022 0.01 -10000 0 -0.12 2 2
STAT3 (dimer non-phopshorylated) 0.006 0.078 -10000 0 -0.23 48 48
proteasomal ubiquitin-dependent protein catabolic process 0.004 0.082 -10000 0 -0.26 43 43
histone deacetylation 0.013 0.097 -10000 0 -0.31 32 32
STAT3 (dimer non-phopshorylated)/HDAC3 0.02 0.077 -10000 0 -0.26 24 24
nuclear export -0.036 0.038 0.12 28 -10000 0 28
PRKACA 0.021 0.017 -10000 0 -0.12 8 8
GATAD2B 0.022 0.009 -10000 0 -0.12 2 2
GATAD2A 0.02 0.022 -10000 0 -0.12 13 13
GATA2/HDAC3 0.032 0.047 -10000 0 -0.25 10 10
GATA1/HDAC1 0.023 0.042 -10000 0 -0.12 40 40
GATA1/HDAC3 0.033 0.044 -10000 0 -0.24 10 10
CHD4 0.022 0.009 -10000 0 -0.12 2 2
TNF-alpha/TNFR1A 0.025 0.036 -10000 0 -0.11 37 37
SIN3/HDAC complex/Mad/Max 0.022 0.077 -10000 0 -0.27 22 22
NuRD Complex 0.024 0.095 -10000 0 -0.3 32 32
positive regulation of chromatin silencing 0.038 0.065 -10000 0 -0.2 22 22
SIN3B 0.022 0.015 -10000 0 -0.12 6 6
MTA2 0.023 0.002 -10000 0 -10000 0 0
SIN3A 0.022 0.014 -10000 0 -0.12 5 5
XPO1 0.022 0.01 -10000 0 -0.12 2 2
SUMO1/HDAC1 0.029 0.048 -10000 0 -0.19 13 13
HDAC complex 0.034 0.064 -10000 0 -0.12 66 66
GATA1/Fog1 0.034 0.01 -10000 0 -0.15 1 1
FKBP25/HDAC1/HDAC2 0.027 0.054 -10000 0 -0.12 54 54
TNF 0.02 0.02 -10000 0 -0.12 11 11
negative regulation of cell growth 0.022 0.077 -10000 0 -0.27 22 22
NuRD/MBD2/PRMT5 Complex 0.013 0.098 -10000 0 -0.31 32 32
Ran/GTP/Exportin 1 0.034 0.049 -10000 0 -0.15 30 30
NF kappa B/RelA/I kappa B alpha 0.018 0.08 -10000 0 -0.28 30 30
SIN3/HDAC complex/NCoR1 0.019 0.079 -10000 0 -0.26 28 28
TFCP2 0.021 0.014 -10000 0 -0.12 5 5
NR2C1 0.022 0.01 -10000 0 -0.12 2 2
MBD3 0.023 0.009 -10000 0 -0.12 2 2
MBD2 0.023 0 -10000 0 -10000 0 0
Syndecan-3-mediated signaling events

Figure S103.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S103.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.022 0.011 -9999 0 -0.12 3 3
Syndecan-3/Src/Cortactin -0.001 0.076 -9999 0 -0.3 12 12
Syndecan-3/Neurocan 0.02 0.052 -9999 0 -0.47 5 5
POMC 0.022 0.011 -9999 0 -0.12 3 3
EGFR 0.015 0.03 -9999 0 -0.12 25 25
Syndecan-3/EGFR 0.016 0.054 -9999 0 -0.38 7 7
AGRP 0.023 0 -9999 0 -10000 0 0
NCSTN 0.022 0.012 -9999 0 -0.12 4 4
PSENEN 0.016 0.03 -9999 0 -0.12 24 24
RP11-540L11.1 0 0 -9999 0 -10000 0 0
APH1B 0.014 0.032 -9999 0 -0.12 29 29
APH1A 0.023 0.009 -9999 0 -0.12 2 2
NCAN 0.022 0.011 -9999 0 -0.12 3 3
long-term memory 0.017 0.065 -9999 0 -0.3 11 11
Syndecan-3/IL8 0.011 0.056 -9999 0 -0.43 6 6
PSEN1 0.022 0.008 -9999 0 -0.12 1 1
Src/Cortactin 0.03 0.027 -9999 0 -0.12 17 17
FYN 0.011 0.037 -9999 0 -0.12 40 40
limb bud formation 0.006 0.052 -9999 0 -0.49 5 5
MC4R 0 0 -9999 0 -10000 0 0
SRC 0.023 0.009 -9999 0 -0.12 2 2
PTN -0.009 0.055 -9999 0 -0.12 106 106
FGFR/FGF/Syndecan-3 0.006 0.052 -9999 0 -0.49 5 5
neuron projection morphogenesis -0.006 0.068 -9999 0 -0.3 11 11
Syndecan-3/AgRP 0.021 0.051 -9999 0 -0.47 5 5
Syndecan-3/AgRP/MC4R 0.019 0.049 -9999 0 -0.45 5 5
Fyn/Cortactin 0.011 0.056 -9999 0 -0.11 93 93
SDC3 0.006 0.052 -9999 0 -0.5 5 5
GO:0007205 0 0 -9999 0 -10000 0 0
positive regulation of leukocyte migration 0.011 0.055 -9999 0 -0.42 6 6
IL8 0.004 0.047 -9999 0 -0.12 69 69
Syndecan-3/Fyn/Cortactin 0.018 0.066 -9999 0 -0.31 11 11
Syndecan-3/CASK 0.005 0.049 -9999 0 -0.47 5 5
alpha-MSH/MC4R 0.017 0.007 -9999 0 -0.077 3 3
Gamma Secretase 0.034 0.067 -9999 0 -0.097 89 89
Signaling mediated by p38-alpha and p38-beta

Figure S104.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S104.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 0.005 0.12 -9999 0 -0.82 9 9
MKNK1 0.023 0.006 -9999 0 -0.12 1 1
MAPK14 0.015 0.049 -9999 0 -0.2 15 15
ATF2/c-Jun -0.006 0.11 -9999 0 -0.33 51 51
MAPK11 0.015 0.049 -9999 0 -0.21 14 14
MITF 0.018 0.062 -9999 0 -0.24 19 19
MAPKAPK5 0.02 0.058 -9999 0 -0.23 19 19
KRT8 0.016 0.065 -9999 0 -0.24 25 25
MAPKAPK3 0.022 0.012 -9999 0 -0.12 4 4
MAPKAPK2 0.023 0.009 -9999 0 -0.12 2 2
p38alpha-beta/CK2 0.019 0.072 -9999 0 -0.26 18 18
CEBPB 0.016 0.063 -9999 0 -0.24 20 20
SLC9A1 0.019 0.059 -9999 0 -0.23 20 20
mol:GDP 0 0 -9999 0 -10000 0 0
ATF2 0.016 0.07 -9999 0 -0.27 18 18
p38alpha-beta/MNK1 0.033 0.063 -9999 0 -0.27 11 11
JUN -0.008 0.11 -9999 0 -0.33 51 51
PPARGC1A 0.016 0.06 -9999 0 -0.29 13 13
USF1 0.019 0.059 -9999 0 -0.23 21 21
RAB5/GDP/GDI1 0.018 0.052 -9999 0 -0.17 27 27
NOS2 0.011 0.056 -9999 0 -0.24 18 18
DDIT3 0.015 0.06 -9999 0 -0.23 21 21
RAB5A 0.023 0.006 -9999 0 -0.12 1 1
HSPB1 0.019 0.045 -9999 0 -0.24 11 11
p38alpha-beta/HBP1 0.025 0.069 -9999 0 -0.24 16 16
CREB1 0.019 0.071 -9999 0 -0.3 21 21
RAB5/GDP 0.016 0.014 -9999 0 -0.13 5 5
EIF4E 0.02 0.049 -9999 0 -0.23 11 11
RPS6KA4 0.02 0.057 -9999 0 -0.28 13 13
PLA2G4A 0 0.06 -9999 0 -0.23 18 18
GDI1 0.017 0.062 -9999 0 -0.23 24 24
TP53 0.005 0.066 -9999 0 -0.28 19 19
RPS6KA5 0.018 0.059 -9999 0 -0.22 22 22
ESR1 0.01 0.076 -9999 0 -0.29 27 27
HBP1 0.022 0.005 -9999 0 -10000 0 0
MEF2C 0.016 0.068 -9999 0 -0.24 24 24
MEF2A 0.019 0.061 -9999 0 -0.24 20 20
EIF4EBP1 0.019 0.068 -9999 0 -0.28 21 21
KRT19 0.009 0.075 -9999 0 -0.25 30 30
ELK4 0.021 0.056 -9999 0 -0.23 18 18
ATF6 0.018 0.064 -9999 0 -0.26 19 19
ATF1 0.019 0.07 -9999 0 -0.3 20 20
p38alpha-beta/MAPKAPK2 0.033 0.061 -9999 0 -0.27 10 10
p38alpha-beta/MAPKAPK3 0.033 0.061 -9999 0 -0.27 10 10
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S105.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S105.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A 0.016 0.032 -9999 0 -0.12 28 28
oxygen homeostasis 0 0 -9999 0 -10000 0 0
TCEB2 0.023 0.006 -9999 0 -0.12 1 1
TCEB1 0.022 0.011 -9999 0 -0.12 3 3
HIF1A/p53 0.002 0.061 -9999 0 -0.2 32 32
HIF1A 0.007 0.047 -9999 0 -0.19 22 22
COPS5 0.019 0.022 -9999 0 -0.12 12 12
VHL/Elongin B/Elongin C/RBX1/CUL2 0.053 0.049 -9999 0 -0.17 8 8
FIH (dimer) 0.023 0.006 -9999 0 -0.12 1 1
CDKN2A 0.014 0.023 -9999 0 -0.12 12 12
ARNT/IPAS 0.027 0.028 -9999 0 -0.079 36 36
HIF1AN 0.023 0.006 -9999 0 -0.12 1 1
GNB2L1 0.023 0.003 -9999 0 -10000 0 0
HIF1A/ARNT 0.014 0.055 -9999 0 -0.18 23 23
CUL2 0.022 0.011 -9999 0 -0.12 3 3
OS9 0.022 0.009 -9999 0 -0.12 2 2
RACK1/Elongin B/Elongin C 0.043 0.024 -9999 0 -0.11 13 13
response to hypoxia 0 0 -9999 0 -10000 0 0
HIF1A/Hsp90 0.014 0.056 -9999 0 -0.19 24 24
PHD1-3/OS9 0.014 0.066 -9999 0 -0.097 112 112
HIF1A/RACK1/Elongin B/Elongin C 0.035 0.057 -9999 0 -0.18 21 21
VHL 0.021 0.016 -9999 0 -0.12 7 7
HSP90AA1 0.023 0.003 -9999 0 -10000 0 0
HIF1A/JAB1 0.011 0.057 -9999 0 -0.19 25 25
EGLN3 -0.002 0.051 -9999 0 -0.12 84 84
EGLN2 0.023 0.009 -9999 0 -0.12 2 2
EGLN1 0.023 0.009 -9999 0 -0.12 2 2
TP53 0.011 0.029 -9999 0 -0.12 22 22
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A 0.027 0.091 -9999 0 -0.52 14 14
ARNT 0.022 0.012 -9999 0 -0.12 4 4
ARD1A 0.018 0.025 -9999 0 -0.12 17 17
RBX1 0.022 0.011 -9999 0 -0.12 3 3
HIF1A/p19ARF 0.004 0.063 -9999 0 -0.21 29 29
Class IB PI3K non-lipid kinase events

Figure S106.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S106.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
cAMP biosynthetic process -0.019 0.025 0.12 17 -10000 0 17
PI3K Class IB/PDE3B 0.019 0.025 -10000 0 -0.12 17 17
PDE3B 0.019 0.025 -10000 0 -0.12 17 17
Arf6 trafficking events

Figure S107.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S107.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SLC2A4 0.023 0.006 -10000 0 -0.12 1 1
CLTC 0.005 0.082 -10000 0 -0.35 18 18
calcium ion-dependent exocytosis 0.01 0.043 -10000 0 -0.15 22 22
Dynamin 2/GTP 0.014 0.044 -10000 0 -0.11 53 53
EXOC4 0.022 0.007 -10000 0 -0.12 1 1
CD59 0.009 0.061 -10000 0 -0.35 12 12
CPE 0.009 0.028 -10000 0 -0.066 58 58
CTNNB1 0.022 0.008 -10000 0 -0.12 1 1
membrane fusion 0.015 0.036 -10000 0 -0.15 22 22
CTNND1 0.012 0.041 -10000 0 -0.099 52 52
DNM2 0.02 0.022 -10000 0 -0.12 13 13
mol:PI-4-5-P2 0.015 0.048 -10000 0 -0.26 13 13
TSHR 0.013 0.026 -10000 0 -0.069 49 49
INS 0.018 0.017 -10000 0 -10000 0 0
BIN1 0.022 0.012 -10000 0 -0.12 4 4
mol:Choline 0.015 0.036 -10000 0 -0.15 22 22
growth hormone secretagogue receptor activity 0 0 -10000 0 -10000 0 0
mol:GDP 0.014 0.022 -10000 0 -0.072 30 30
membrane depolarization 0 0 -10000 0 -10000 0 0
ARF6 0.023 0.003 -10000 0 -10000 0 0
mol:Ca2+ 0.014 0.043 -10000 0 -0.1 53 53
JUP 0.006 0.066 -10000 0 -0.36 13 13
ASAP2/amphiphysin II 0.027 0.02 -10000 0 -0.089 16 16
ARF6/GTP 0.015 0.021 -10000 0 -0.15 9 9
CDH1 0.005 0.069 -10000 0 -0.35 14 14
clathrin-independent pinocytosis 0.015 0.021 -10000 0 -0.15 9 9
MAPK8IP3 0.023 0.006 -10000 0 -0.12 1 1
positive regulation of endocytosis 0.015 0.021 -10000 0 -0.15 9 9
EXOC2 0.022 0.013 -10000 0 -0.12 4 4
substrate adhesion-dependent cell spreading 0.011 0.1 -10000 0 -0.39 27 27
insulin receptor binding 0 0 -10000 0 -10000 0 0
SPAG9 0.021 0.015 -10000 0 -0.12 6 6
regulation of calcium-dependent cell-cell adhesion -0.014 0.079 0.27 22 -10000 0 22
positive regulation of phagocytosis 0.018 0.016 -10000 0 -0.11 8 8
ARF6/GTP/JIP3 0.029 0.019 -10000 0 -0.11 10 10
ACAP1 0.014 0.032 -10000 0 -0.13 22 22
mol:GTP 0 0 -10000 0 -10000 0 0
CHRM2 0.01 0.06 -10000 0 -0.37 11 11
clathrin heavy chain/ACAP1 0.011 0.066 -10000 0 -0.27 20 20
JIP4/KLC1 0.033 0.039 -10000 0 -0.11 37 37
EXOC1 0.021 0.012 -10000 0 -0.12 3 3
exocyst 0.011 0.11 -10000 0 -0.4 27 27
RALA/GTP 0.014 0.021 -10000 0 -0.13 11 11
ARF6/GTP/ARF6/GTP/JIP4/Dynactin Complex 0.025 0.029 -10000 0 -0.1 27 27
receptor recycling 0.015 0.021 -10000 0 -0.15 9 9
CTNNA1 0.012 0.04 -10000 0 -0.098 52 52
NME1 0.014 0.022 -10000 0 -0.072 30 30
clathrin coat assembly 0.005 0.081 -10000 0 -0.34 18 18
IL2RA 0.01 0.06 -10000 0 -0.36 11 11
VAMP3 0.019 0.016 -10000 0 -0.12 8 8
GLUT4/clathrin heavy chain/ACAP1 0.019 0.065 -10000 0 -0.28 16 16
EXOC6 0.021 0.012 -10000 0 -0.12 3 3
PLD1 0.002 0.057 -10000 0 -0.19 40 40
PLD2 0.018 0.028 -10000 0 -0.19 6 6
EXOC5 0.022 0.011 -10000 0 -0.12 3 3
PIP5K1C 0.015 0.048 -10000 0 -0.26 13 13
SDC1 0.009 0.061 -10000 0 -0.35 12 12
ARF6/GDP 0.012 0.041 -10000 0 -0.098 63 63
EXOC7 0.023 0.001 -10000 0 -10000 0 0
E-cadherin/beta catenin 0.016 0.082 -10000 0 -0.28 22 22
mol:Phosphatidic acid 0.015 0.036 -10000 0 -0.15 22 22
endocytosis -0.025 0.02 0.088 16 -10000 0 16
SCAMP2 0.023 0.009 -10000 0 -0.12 2 2
ADRB2 0.009 0.078 -10000 0 -0.33 18 18
EXOC3 0.023 0.009 -10000 0 -0.12 2 2
ASAP2 0 0 -10000 0 -10000 0 0
Dynamin 2/GDP 0.016 0.044 -10000 0 -0.1 53 53
KLC1 0.021 0.013 -10000 0 -0.12 4 4
AVPR2 0.008 0.079 -10000 0 -0.34 18 18
RALA 0.022 0.009 -10000 0 -0.12 2 2
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.015 0.087 -10000 0 -0.25 32 32
Class I PI3K signaling events mediated by Akt

Figure S108.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S108.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.02 0.016 -10000 0 -0.071 16 16
BAD/BCL-XL/YWHAZ 0.039 0.031 -10000 0 -0.096 22 22
CDKN1B 0.013 0.076 -10000 0 -0.34 22 22
CDKN1A 0.017 0.075 -10000 0 -0.34 22 22
FRAP1 0.022 0.013 -10000 0 -0.12 4 4
PRKDC 0.021 0.015 -10000 0 -0.12 6 6
FOXO3 0.016 0.076 -10000 0 -0.33 23 23
AKT1 0.014 0.077 -10000 0 -0.35 22 22
BAD 0.022 0.011 -10000 0 -0.12 3 3
AKT3 -0.006 0.055 -10000 0 -0.2 32 32
mol:GTP 0 0 -10000 0 -10000 0 0
FOXO4 0.018 0.074 -10000 0 -0.33 22 22
AKT1/ASK1 0.019 0.077 -10000 0 -0.33 22 22
BAD/YWHAZ 0.043 0.025 -10000 0 -0.11 11 11
RICTOR 0.02 0.017 -10000 0 -0.12 7 7
RAF1 0.023 0.003 -10000 0 -10000 0 0
JNK cascade -0.018 0.075 0.32 22 -10000 0 22
TSC1 0.017 0.074 -10000 0 -0.33 22 22
YWHAZ 0.023 0.003 -10000 0 -10000 0 0
AKT1/RAF1 0.026 0.079 -10000 0 -0.34 23 23
EP300 0.022 0.01 -10000 0 -0.12 2 2
mol:GDP 0.014 0.077 -10000 0 -0.35 22 22
mol:PI-3-4-5-P3 0 0 -10000 0 -10000 0 0
TSC2 0.016 0.074 -10000 0 -0.33 22 22
YWHAQ 0.023 0.003 -10000 0 -10000 0 0
TBC1D4 0.018 0.014 -10000 0 -0.04 28 28
MAP3K5 0.018 0.025 -10000 0 -0.12 17 17
MAPKAP1 0.023 0.002 -10000 0 -10000 0 0
negative regulation of cell cycle -0.018 0.071 0.23 23 -10000 0 23
YWHAH 0.021 0.014 -10000 0 -0.12 5 5
AKT1S1 0.017 0.074 -10000 0 -0.32 23 23
CASP9 0.016 0.075 -10000 0 -0.34 22 22
YWHAB 0.023 0.007 -10000 0 -0.12 1 1
p27Kip1/KPNA1 0.021 0.081 -10000 0 -0.32 25 25
GBL 0.023 0.009 -10000 0 -0.12 2 2
PDK1/Src/Hsp90 0.041 0.032 -10000 0 -0.12 19 19
YWHAE 0.022 0.014 -10000 0 -0.12 5 5
SRC 0.023 0.009 -10000 0 -0.12 2 2
AKT2/p21CIP1 0.022 0.07 -10000 0 -0.29 23 23
KIAA1303 0.023 0.009 -10000 0 -0.12 2 2
mTOR/RHEB/GTP/Raptor/GBL 0.026 0.072 -10000 0 -0.34 17 17
CHUK 0.014 0.078 -10000 0 -0.34 23 23
BAD/BCL-XL 0.035 0.077 -10000 0 -0.32 22 22
mTORC2 0.047 0.043 -10000 0 -0.1 38 38
AKT2 0.014 0.029 -10000 0 -0.2 8 8
FOXO1-3a-4/14-3-3 family 0.024 0.088 -10000 0 -0.26 32 32
PDPK1 0.023 0.007 -10000 0 -0.12 1 1
MDM2 0.015 0.078 -10000 0 -0.35 22 22
MAPKKK cascade -0.026 0.077 0.33 23 -10000 0 23
MDM2/Cbp/p300 0.032 0.087 -10000 0 -0.33 23 23
TSC1/TSC2 0.018 0.073 -10000 0 -0.32 22 22
proteasomal ubiquitin-dependent protein catabolic process 0.03 0.083 -10000 0 -0.32 23 23
glucose import 0.018 0.023 -10000 0 -0.14 8 8
mTOR/RHEB/GDP/Raptor/GBL/PRAS40 0.027 0.071 -10000 0 -0.25 21 21
response to stress 0 0 -10000 0 -10000 0 0
SLC2A4 0.02 0.012 -10000 0 -0.031 29 29
GSK3A 0.016 0.076 -10000 0 -0.34 22 22
FOXO1 0.017 0.074 -10000 0 -0.33 22 22
GSK3B 0.017 0.076 -10000 0 -0.34 22 22
SFN 0.014 0.032 -10000 0 -0.12 29 29
G1/S transition of mitotic cell cycle 0.019 0.075 -10000 0 -0.33 22 22
p27Kip1/14-3-3 family 0.029 0.078 -10000 0 -0.33 17 17
PRKACA 0.021 0.017 -10000 0 -0.12 8 8
KPNA1 0.023 0.003 -10000 0 -10000 0 0
HSP90AA1 0.023 0.003 -10000 0 -10000 0 0
YWHAG 0.02 0.022 -10000 0 -0.12 13 13
RHEB 0.019 0.022 -10000 0 -0.12 13 13
CREBBP 0.021 0.015 -10000 0 -0.12 6 6
Role of Calcineurin-dependent NFAT signaling in lymphocytes

Figure S109.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S109.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.021 0.017 -10000 0 -0.12 8 8
NFATC1 0.03 0.065 -10000 0 -0.25 14 14
NFATC2 0.02 0.048 -10000 0 -0.18 15 15
NFATC3 0.024 0.022 -10000 0 -0.24 2 2
YWHAE 0.022 0.014 -10000 0 -0.12 5 5
Calcineurin A alpha-beta B1/CABIN1 -0.006 0.08 -10000 0 -0.22 37 37
Exportin 1/Ran/NUP214 0.037 0.039 -10000 0 -0.11 34 34
mol:DAG 0 0.001 -10000 0 -10000 0 0
CABIN1/MEF2D/CaM/Ca2+/CAMK IV 0.015 0.079 -10000 0 -0.22 27 27
BCL2/BAX 0.029 0.025 -10000 0 -0.076 29 29
CaM/Ca2+/Calcineurin A alpha-beta B1 0.013 0.021 -10000 0 -0.12 12 12
CaM/Ca2+ 0.013 0.021 -10000 0 -0.12 12 12
BAX 0.023 0 -10000 0 -10000 0 0
MAPK14 0.022 0.007 -10000 0 -0.12 1 1
BAD 0.022 0.011 -10000 0 -0.12 3 3
CABIN1/MEF2D 0.006 0.08 -10000 0 -0.21 37 37
Calcineurin A alpha-beta B1/BCL2 0.016 0.031 -10000 0 -0.12 27 27
FKBP8 0.016 0.031 -10000 0 -0.12 27 27
activation-induced cell death of T cells -0.006 0.079 0.2 37 -10000 0 37
KPNB1 0.022 0.009 -10000 0 -0.12 2 2
KPNA2 0.017 0.024 -10000 0 -0.12 15 15
XPO1 0.022 0.01 -10000 0 -0.12 2 2
SFN 0.014 0.032 -10000 0 -0.12 29 29
MAP3K8 0.022 0.009 -10000 0 -0.12 2 2
NFAT4/CK1 alpha 0.03 0.038 -10000 0 -0.15 13 13
MEF2D/NFAT1/Cbp/p300 0.04 0.079 -10000 0 -0.16 43 43
CABIN1 -0.006 0.081 -10000 0 -0.22 37 37
CALM1 0.021 0.014 -10000 0 -0.12 5 5
RAN 0.023 0.002 -10000 0 -10000 0 0
MAP3K1 0.021 0.015 -10000 0 -0.12 6 6
CAMK4 0.016 0.031 -10000 0 -0.12 27 27
mol:Ca2+ 0 0.003 -10000 0 -10000 0 0
MAPK3 0.022 0.014 -10000 0 -0.12 5 5
YWHAH 0.021 0.014 -10000 0 -0.12 5 5
Calcineurin A alpha-beta B1/AKAP79/PKA 0.032 0.017 -10000 0 -0.082 12 12
YWHAB 0.023 0.007 -10000 0 -0.12 1 1
MAPK8 0.021 0.015 -10000 0 -0.12 6 6
MAPK9 0.021 0.012 -10000 0 -0.12 3 3
YWHAG 0.02 0.022 -10000 0 -0.12 13 13
FKBP1A 0.022 0.012 -10000 0 -0.12 4 4
NFAT1-c-4/YWHAQ 0.048 0.071 -10000 0 -0.27 12 12
PRKCH 0.019 0.024 -10000 0 -0.12 15 15
CABIN1/Cbp/p300 0.02 0.052 -10000 0 -0.16 41 41
CASP3 0.022 0.009 -10000 0 -0.12 2 2
PIM1 0.02 0.023 -10000 0 -0.12 14 14
Calcineurin A alpha-beta B1/FKBP12/FK506 0.014 0.012 -10000 0 -0.087 7 7
apoptosis 0.019 0.036 0.14 2 -0.21 11 13
14-3-3 family/BAD/CaM/Ca2+/Calcineurin A alpha-beta B1 0.017 0.07 -10000 0 -0.27 15 15
PRKCB 0 0 -10000 0 -10000 0 0
PRKCE 0.021 0.017 -10000 0 -0.12 8 8
JNK2/NFAT4 0.034 0.024 -10000 0 -0.2 3 3
BAD/BCL-XL 0.029 0.028 -10000 0 -0.11 22 22
PRKCD 0.02 0.018 -10000 0 -0.12 8 8
NUP214 0.022 0.007 -10000 0 -0.12 1 1
PRKCZ 0.023 0.001 -10000 0 -10000 0 0
PRKCA 0.011 0.037 -10000 0 -0.12 40 40
PRKCG 0.021 0.016 -10000 0 -0.12 7 7
PRKCQ 0.015 0.03 -10000 0 -0.12 24 24
FKBP38/BCL2 0.023 0.035 -10000 0 -0.08 55 55
EP300 0.022 0.01 -10000 0 -0.12 2 2
PRKCB1 0.014 0.035 -10000 0 -0.12 35 35
CSNK2A1 0.021 0.015 -10000 0 -0.12 6 6
NFATc/JNK1 0.039 0.068 -10000 0 -0.24 18 18
CaM/Ca2+/FKBP38 0.024 0.028 -10000 0 -0.074 39 39
FKBP12/FK506 0.016 0.014 -10000 0 -0.11 7 7
CSNK1A1 0.017 0.017 -10000 0 -0.085 12 12
CaM/Ca2+/CAMK IV 0.023 0.028 -10000 0 -0.1 14 14
NFATc/ERK1 0.04 0.066 -10000 0 -0.24 14 14
CABIN1/YWHAQ/CaM/Ca2+/CAMK IV 0.014 0.08 -10000 0 -0.22 28 28
NR4A1 0.017 0.082 -10000 0 -0.21 36 36
GSK3B 0.022 0.011 -10000 0 -0.12 3 3
positive T cell selection 0.024 0.022 -10000 0 -0.24 2 2
NFAT1/CK1 alpha 0.021 0.044 -10000 0 -0.17 17 17
RCH1/ KPNB1 0.01 0.061 -10000 0 -0.13 82 82
YWHAQ 0.023 0.003 -10000 0 -10000 0 0
PRKACA 0.021 0.017 -10000 0 -0.12 8 8
AKAP5 0.023 0.009 -10000 0 -0.12 2 2
MEF2D 0.023 0.002 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
YWHAZ 0.023 0.003 -10000 0 -10000 0 0
NFATc/p38 alpha 0.041 0.067 -10000 0 -0.24 17 17
CREBBP 0.021 0.016 -10000 0 -0.12 6 6
BCL2 0.016 0.031 -10000 0 -0.12 27 27
Hedgehog signaling events mediated by Gli proteins

Figure S110.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S110.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.019 0.02 -9999 0 -0.12 10 10
HDAC2 0.019 0.021 -9999 0 -0.12 12 12
GNB1/GNG2 0.04 0.034 -9999 0 -0.11 23 23
forebrain development 0.027 0.11 -9999 0 -0.42 21 21
GNAO1 0.011 0.042 -9999 0 -0.12 51 51
SMO/beta Arrestin2 0.035 0.021 -9999 0 -0.097 13 13
SMO 0.024 0.011 -9999 0 -0.12 3 3
ARRB2 0.023 0.014 -9999 0 -0.12 5 5
GLI3/SPOP 0.006 0.11 -9999 0 -0.3 37 37
mol:GTP 0.001 0.001 -9999 0 -10000 0 0
GSK3B 0.022 0.011 -9999 0 -0.12 3 3
GNAI2 0.023 0.011 -9999 0 -0.12 3 3
SIN3/HDAC complex 0.051 0.032 -9999 0 -0.098 20 20
GNAI1 0.013 0.035 -9999 0 -0.12 35 35
XPO1 0.025 0.01 -9999 0 -0.12 2 2
GLI1/Su(fu) 0.034 0.11 -9999 0 -0.38 27 27
SAP30 0.023 0 -9999 0 -10000 0 0
mol:GDP 0.024 0.011 -9999 0 -0.12 3 3
MIM/GLI2A 0.022 0.034 -9999 0 -0.11 31 31
IFT88 0.016 0.03 -9999 0 -0.12 25 25
GNAI3 0.022 0.009 -9999 0 -0.12 1 1
GLI2 0.036 0.043 -9999 0 -0.23 8 8
GLI3 -0.005 0.11 -9999 0 -0.32 36 36
CSNK1D 0.023 0.001 -9999 0 -10000 0 0
CSNK1E 0.022 0.015 -9999 0 -0.12 6 6
SAP18 0.023 0.003 -9999 0 -10000 0 0
embryonic digit morphogenesis 0.016 0.03 -9999 0 -0.12 25 25
GNG2 0.02 0.018 -9999 0 -0.12 9 9
Gi family/GTP 0.009 0.07 -9999 0 -0.14 86 86
SIN3B 0.021 0.015 -9999 0 -0.12 6 6
SIN3A 0.021 0.014 -9999 0 -0.12 5 5
GLI3/Su(fu) 0.015 0.1 -9999 0 -0.33 27 27
GLI2/Su(fu) 0.053 0.045 -9999 0 -0.22 9 9
FOXA2 0.028 0.085 -9999 0 -0.74 5 5
neural tube patterning 0.027 0.11 -9999 0 -0.42 21 21
SPOP 0.022 0.011 -9999 0 -0.12 3 3
Su(fu)/PIAS1 0.036 0.041 -9999 0 -0.2 13 13
GNB1 0.023 0.007 -9999 0 -0.12 1 1
CSNK1G2 0.022 0.011 -9999 0 -0.12 3 3
CSNK1G3 0.022 0.007 -9999 0 -0.12 1 1
MTSS1 0.022 0.034 -9999 0 -0.11 31 31
embryonic limb morphogenesis 0.027 0.11 -9999 0 -0.42 21 21
SUFU 0.026 0.041 -9999 0 -0.22 12 12
LGALS3 0.018 0.023 -9999 0 -0.12 14 14
catabolic process 0.032 0.1 -9999 0 -0.32 25 25
GLI3A/CBP 0.033 0.022 -9999 0 -0.14 7 7
KIF3A 0.019 0.021 -9999 0 -0.12 12 12
GLI1 0.027 0.11 -9999 0 -0.43 21 21
RAB23 0.022 0.011 -9999 0 -0.12 3 3
CSNK1A1 0.022 0.007 -9999 0 -0.12 1 1
IFT172 0.021 0.014 -9999 0 -0.12 5 5
RBBP7 0.021 0.011 -9999 0 -0.12 3 3
Su(fu)/Galectin3 0.031 0.044 -9999 0 -0.19 16 16
GNAZ 0.023 0.011 -9999 0 -0.12 3 3
RBBP4 0.021 0.014 -9999 0 -0.12 5 5
CSNK1G1 0.023 0.009 -9999 0 -0.12 2 2
PIAS1 0.022 0.009 -9999 0 -0.12 2 2
PRKACA 0.021 0.017 -9999 0 -0.12 8 8
GLI2/SPOP 0.045 0.044 -9999 0 -0.23 8 8
STK36 0.022 0.022 -9999 0 -0.12 12 12
Gi family/GNB1/GNG2/GDP 0.009 0.077 -9999 0 -0.22 31 31
PTCH1 0.033 0.11 -9999 0 -0.56 7 7
MIM/GLI1 0.043 0.11 -9999 0 -0.4 23 23
CREBBP 0.033 0.022 -9999 0 -0.14 7 7
Su(fu)/SIN3/HDAC complex 0.02 0.094 -9999 0 -0.31 28 28
S1P1 pathway

Figure S111.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S111.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.029 0.054 -9999 0 -0.15 39 39
PDGFRB 0.01 0.042 -9999 0 -0.12 52 52
SPHK1 0.001 0.015 -9999 0 -10000 0 0
mol:S1P 0.015 0.027 -9999 0 -10000 0 0
S1P1/S1P/Gi 0.023 0.07 -9999 0 -0.28 17 17
GNAO1 0.01 0.042 -9999 0 -0.12 51 51
PDGFB-D/PDGFRB/PLCgamma1 0.009 0.086 -9999 0 -0.26 26 26
PLCG1 0.021 0.07 -9999 0 -0.25 21 21
mol:GTP 0 0 -9999 0 -10000 0 0
PDGFB-D/PDGFRB 0.01 0.042 -9999 0 -0.12 52 52
GNAI2 0.022 0.011 -9999 0 -0.12 3 3
GNAI3 0.022 0.009 -9999 0 -0.12 1 1
GNAI1 0.012 0.035 -9999 0 -0.12 35 35
mol:GDP 0 0 -9999 0 -10000 0 0
EDG1 0.023 0.047 -9999 0 -0.19 9 9
S1P1/S1P 0.025 0.052 -9999 0 -0.22 8 8
negative regulation of cAMP metabolic process 0.023 0.069 -9999 0 -0.27 17 17
MAPK3 0.021 0.09 -9999 0 -0.42 14 14
calcium-dependent phospholipase C activity -0.001 0.001 -9999 0 -10000 0 0
Rac1/GDP 0.016 0.015 -9999 0 -0.15 5 5
RhoA/GDP 0.016 0.016 -9999 0 -0.14 6 6
KDR 0.025 0.022 -9999 0 -0.095 16 16
PLCB2 0.026 0.049 -9999 0 -0.2 8 8
RAC1 0.023 0.002 -9999 0 -10000 0 0
RhoA/GTP 0.021 0.046 -9999 0 -0.19 11 11
receptor internalization 0.024 0.05 -9999 0 -0.2 9 9
PTGS2 0.001 0.14 -9999 0 -0.92 9 9
Rac1/GTP 0.021 0.045 -9999 0 -0.19 9 9
RHOA 0.023 0.006 -9999 0 -0.12 1 1
VEGFA 0.023 0.022 -9999 0 -0.11 13 13
negative regulation of T cell proliferation 0.023 0.069 -9999 0 -0.27 17 17
GO:0007205 0 0 -9999 0 -10000 0 0
GNAZ 0.022 0.011 -9999 0 -0.12 3 3
MAPK1 0.021 0.091 -9999 0 -0.42 14 14
S1P1/S1P/PDGFB-D/PDGFRB 0.028 0.065 -9999 0 -0.24 11 11
ABCC1 0.021 0.018 -9999 0 -0.12 8 8
Calcium signaling in the CD4+ TCR pathway

Figure S112.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S112.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 0.025 0.021 -9999 0 -0.089 14 14
NFATC2 0.024 0.022 -9999 0 -0.084 15 15
NFATC3 0.026 0.02 -9999 0 -0.094 11 11
CD40LG 0.045 0.079 -9999 0 -0.22 13 13
PTGS2 0.037 0.089 -9999 0 -0.22 23 23
JUNB 0.007 0.042 -9999 0 -0.12 52 52
CaM/Ca2+/Calcineurin A alpha-beta B1 0.019 0.021 -9999 0 -0.12 12 12
CaM/Ca2+ 0.019 0.021 -9999 0 -0.12 12 12
CALM1 0.024 0.014 -9999 0 -0.12 5 5
JUN 0.017 0.033 -9999 0 -0.12 30 30
mol:Ca2+ 0.002 0.003 -9999 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.016 0.012 -9999 0 -0.086 7 7
FOSL1 0.021 0.018 -9999 0 -0.12 9 9
CREM 0.021 0.012 -9999 0 -0.12 4 4
Jun/NFAT1-c-4/p21SNFT 0.062 0.06 -9999 0 -0.17 9 9
FOS -0.002 0.053 -9999 0 -0.12 95 95
IFNG 0.041 0.085 -9999 0 -0.24 14 14
AP-1/NFAT1-c-4 0.089 0.12 -9999 0 -0.24 13 13
FASLG 0.044 0.08 -9999 0 -0.22 14 14
NFAT1-c-4/ICER1 0.052 0.038 -9999 0 -0.13 8 8
IL2RA 0.043 0.081 -9999 0 -0.21 16 16
FKBP12/FK506 0.016 0.014 -9999 0 -0.11 7 7
CSF2 0.044 0.079 -9999 0 -0.22 13 13
JunB/Fra1/NFAT1-c-4 0.046 0.06 -9999 0 -0.14 17 17
IL4 0.044 0.079 -9999 0 -0.23 11 11
IL2 0.008 0.015 -9999 0 -10000 0 0
IL3 0.039 0.05 -9999 0 -0.61 3 3
FKBP1A 0.022 0.012 -9999 0 -0.12 4 4
BATF3 0 0 -9999 0 -10000 0 0
mol:FK506 0 0 -9999 0 -10000 0 0
POU2F1 0.031 0.007 -9999 0 -0.12 1 1
VEGFR1 specific signals

Figure S113.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S113.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.026 0.057 -9999 0 -0.28 10 10
VEGFR1 homodimer/NRP1 0.014 0.05 -9999 0 -0.4 5 5
mol:DAG 0.022 0.05 -9999 0 -0.26 10 10
VEGFR1 homodimer/NRP1/VEGFR 121 0.019 0.06 -9999 0 -0.29 10 10
CaM/Ca2+ 0.032 0.053 -9999 0 -0.25 10 10
HIF1A 0.029 0.033 -9999 0 -0.23 7 7
GAB1 0.02 0.021 -9999 0 -0.12 12 12
AKT1 0.014 0.072 -9999 0 -0.24 26 26
PLCG1 0.022 0.05 -9999 0 -0.26 10 10
NOS3 0.029 0.061 -9999 0 -0.26 12 12
CBL 0.023 0.006 -9999 0 -0.12 1 1
mol:NO 0.029 0.059 -9999 0 -0.26 12 12
FLT1 0.027 0.05 -9999 0 -0.47 5 5
PGF 0.021 0.018 -9999 0 -0.12 9 9
VEGFR1 homodimer/NRP2/VEGFR121 0.015 0.077 -9999 0 -0.25 20 20
CALM1 0.022 0.014 -9999 0 -0.12 5 5
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
eNOS/Hsp90 0.039 0.063 -9999 0 -0.25 13 13
endothelial cell proliferation 0.006 0.068 -9999 0 -0.31 12 12
mol:Ca2+ 0.022 0.05 -9999 0 -0.26 10 10
MAPK3 0.016 0.045 -9999 0 -0.24 9 9
MAPK1 0.016 0.046 -9999 0 -0.23 11 11
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
PLGF homodimer 0.021 0.018 -9999 0 -0.12 9 9
PRKACA 0.021 0.017 -9999 0 -0.12 8 8
RP11-342D11.1 0 0 -9999 0 -10000 0 0
CAV1 0.012 0.039 -9999 0 -0.12 43 43
VEGFA homodimer 0.019 0.021 -9999 0 -0.12 11 11
VEGFR1 homodimer/VEGFA homodimer 0.026 0.06 -9999 0 -0.32 10 10
platelet activating factor biosynthetic process 0.017 0.044 -9999 0 -0.22 10 10
PI3K 0.032 0.074 -9999 0 -0.23 22 22
PRKCA 0.016 0.047 -9999 0 -0.23 11 11
PRKCB 0.016 0.045 -9999 0 -0.24 10 10
VEGFR1 homodimer/PLGF homodimer 0.029 0.054 -9999 0 -0.36 6 6
VEGFA 0.019 0.021 -9999 0 -0.12 11 11
VEGFB 0.015 0.033 -9999 0 -0.12 30 30
mol:IP3 0.022 0.05 -9999 0 -0.26 10 10
RASA1 0.02 0.052 -9999 0 -0.24 14 14
NRP2 0.011 0.036 -9999 0 -0.12 38 38
VEGFR1 homodimer 0.027 0.05 -9999 0 -0.47 5 5
VEGFB homodimer 0.015 0.033 -9999 0 -0.12 30 30
NCK1 0.02 0.019 -9999 0 -0.12 9 9
eNOS/Caveolin-1 0.034 0.064 -9999 0 -0.27 11 11
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
mol:PI-3-4-5-P3 0.03 0.073 -9999 0 -0.23 22 22
mol:L-citrulline 0.029 0.059 -9999 0 -0.26 12 12
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP 0.034 0.073 -9999 0 -0.23 18 18
VEGFR1 homodimer/VEGFA homodimer/NCK1 0.024 0.072 -9999 0 -0.26 16 16
CD2AP 0.02 0.017 -9999 0 -0.12 7 7
PI3K/GAB1 0.037 0.077 -9999 0 -0.22 25 25
PDPK1 0.015 0.063 -9999 0 -0.22 24 24
VEGFR1 homodimer/VEGFA homodimer/SHP2 0.028 0.07 -9999 0 -0.25 19 19
mol:NADP 0.029 0.059 -9999 0 -0.26 12 12
HSP90AA1 0.023 0.003 -9999 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.033 0.071 -9999 0 -0.23 18 18
VEGFR1 homodimer/NRP2 0.02 0.061 -9999 0 -0.3 11 11
JNK signaling in the CD4+ TCR pathway

Figure S114.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S114.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 0.036 0.054 -9999 0 -0.1 60 60
MAP4K1 0.02 0.023 -9999 0 -0.12 14 14
MAP3K8 0.023 0.009 -9999 0 -0.12 2 2
PRKCB 0 0 -9999 0 -10000 0 0
DBNL 0.023 0.006 -9999 0 -0.12 1 1
CRKL 0.023 0.009 -9999 0 -0.12 2 2
MAP3K1 0.021 0.053 -9999 0 -0.19 9 9
JUN -0.002 0.093 -9999 0 -0.5 17 17
MAP3K7 0.021 0.051 -9999 0 -0.19 7 7
GRAP2 0.022 0.012 -9999 0 -0.12 4 4
CRK 0.021 0.016 -9999 0 -0.12 7 7
MAP2K4 0.021 0.057 -9999 0 -0.2 13 13
LAT 0.022 0.011 -9999 0 -0.12 3 3
LCP2 0.013 0.033 -9999 0 -0.12 31 31
MAPK8 0.004 0.095 -9999 0 -0.52 17 17
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family 0.031 0.037 -9999 0 -0.2 9 9
LAT/GRAP2/SLP76/HPK1/HIP-55 0.044 0.056 -9999 0 -0.14 11 11
Insulin-mediated glucose transport

Figure S115.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S115.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Insulin responsive Vesicles 0.021 0.074 0.18 5 -0.21 24 29
CaM/Ca2+ 0.014 0.02 -10000 0 -0.12 12 12
AKT1 0.021 0.019 -10000 0 -0.12 10 10
AKT2 0.019 0.025 -10000 0 -0.12 17 17
STXBP4 0.018 0.026 -10000 0 -0.12 19 19
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucose 0.015 0.067 0.18 7 -0.2 20 27
YWHAZ 0.023 0.003 -10000 0 -10000 0 0
CALM1 0.022 0.014 -10000 0 -0.12 5 5
YWHAQ 0.023 0.003 -10000 0 -10000 0 0
TBC1D4 0.02 0.017 -10000 0 -0.071 20 20
mol:Ca2+ 0 0 -10000 0 -10000 0 0
YWHAH 0.021 0.014 -10000 0 -0.12 5 5
YWHAB 0.023 0.007 -10000 0 -0.12 1 1
SNARE/Synip 0.033 0.041 -10000 0 -0.13 19 19
YWHAG 0.02 0.022 -10000 0 -0.12 13 13
ASIP 0.021 0.015 -10000 0 -0.12 6 6
PRKCI 0.016 0.028 -10000 0 -0.12 22 22
AS160/CaM/Ca2+ 0.014 0.02 -10000 0 -0.12 12 12
RHOQ 0.021 0.017 -10000 0 -0.12 8 8
GYS1 0.025 0.017 -10000 0 -0.22 1 1
PRKCZ 0.023 0 -10000 0 -10000 0 0
TRIP10 0.021 0.018 -10000 0 -0.12 9 9
TC10/GTP/CIP4/Exocyst 0.026 0.027 -10000 0 -0.12 14 14
AS160/14-3-3 0.024 0.064 -10000 0 -0.25 19 19
VAMP2 0.015 0.033 -10000 0 -0.12 30 30
SLC2A4 0.015 0.072 0.18 6 -0.22 20 26
STX4 0.022 0.012 -10000 0 -0.12 4 4
GSK3B 0.023 0.03 -10000 0 -0.2 7 7
SFN 0.014 0.032 -10000 0 -0.12 29 29
LNPEP 0.016 0.027 -10000 0 -0.12 20 20
YWHAE 0.022 0.014 -10000 0 -0.12 5 5
Effects of Botulinum toxin

Figure S116.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S116.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A 0.011 0.006 -9999 0 -0.077 3 3
UniProt:P19321 0 0 -9999 0 -10000 0 0
RIMS1/UNC13B 0.032 0.016 -9999 0 -0.085 10 10
STXBP1 0.02 0.02 -9999 0 -0.12 11 11
ACh/CHRNA1 0.013 0.025 -9999 0 -0.063 49 49
RAB3GAP2/RIMS1/UNC13B 0.041 0.029 -9999 0 -0.091 25 25
mol:Ca2+ 0 0 -9999 0 -10000 0 0
UniProt:P30996 0 0 -9999 0 -10000 0 0
UniProt:Q60393 0 0 -9999 0 -10000 0 0
CST086 0 0 -9999 0 -10000 0 0
RIMS1 0.023 0.006 -9999 0 -0.12 1 1
mol:ACh 0.005 0.01 -9999 0 -0.056 6 6
RAB3GAP2 0.022 0.009 -9999 0 -0.12 2 2
STX1A/SNAP25/VAMP2 0.039 0.031 -9999 0 -0.098 9 9
UniProt:P10844 0 0 -9999 0 -10000 0 0
muscle contraction 0.013 0.025 -9999 0 -0.063 49 49
UNC13B 0.021 0.016 -9999 0 -0.12 7 7
CHRNA1 0.011 0.04 -9999 0 -0.12 47 47
UniProt:P10845 0 0 -9999 0 -10000 0 0
ACh/Synaptotagmin 1 0.015 0.023 -9999 0 -0.062 39 39
SNAP25 0.004 0.017 -9999 0 -0.19 1 1
VAMP2 0.004 0.016 -9999 0 -0.18 2 2
SYT1 0.014 0.036 -9999 0 -0.12 36 36
UniProt:Q00496 0 0 -9999 0 -10000 0 0
STXIA/STXBP1 0.024 0.013 -9999 0 -0.057 14 14
STX1A/SNAP25 fragment 1/VAMP2 0.039 0.031 -9999 0 -0.098 9 9
Insulin Pathway

Figure S117.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S117.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP 0.034 0.028 -9999 0 -0.1 11 11
TC10/GTP 0.031 0.024 -9999 0 -0.082 15 15
Insulin Receptor/Insulin/IRS1/Shp2 0.049 0.042 -9999 0 -0.1 29 29
HRAS 0.023 0.006 -9999 0 -0.12 1 1
APS homodimer 0 0 -9999 0 -10000 0 0
GRB14 0.013 0.036 -9999 0 -0.12 38 38
FOXO3 0.009 0.065 -9999 0 -0.6 6 6
AKT1 0.015 0.048 -9999 0 -0.13 28 28
INSR 0.023 0.017 -9999 0 -0.11 9 9
Insulin Receptor/Insulin 0.06 0.028 -9999 0 -0.19 2 2
mol:GTP 0 0 -9999 0 -10000 0 0
GRB10 0.022 0.014 -9999 0 -0.12 5 5
SORBS1 0.02 0.021 -9999 0 -0.12 12 12
CRK 0.021 0.016 -9999 0 -0.12 7 7
PTPN1 0.026 0.021 -9999 0 -0.19 2 2
CAV1 0.02 0.027 -9999 0 -0.091 13 13
CBL/APS/CAP/Crk-II/C3G 0.051 0.024 -9999 0 -0.1 7 7
Insulin Receptor/Insulin/IRS1/NCK2 0.055 0.03 -9999 0 -0.09 13 13
mol:GDP 0 0 -9999 0 -10000 0 0
mol:PI-3-4-5-P3 0.025 0.052 -9999 0 -0.094 69 69
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B 0.038 0.053 -9999 0 -0.3 12 12
RPS6KB1 0.014 0.05 -9999 0 -0.14 32 32
PARD6A 0.023 0.009 -9999 0 -0.12 2 2
CBL 0.023 0.006 -9999 0 -0.12 1 1
tumor necrosis factor-mediated signaling pathway 0 0 -9999 0 -10000 0 0
DOK1 0.009 0.074 -9999 0 -0.68 6 6
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
Insulin Receptor/Insuli/IRS1/GRB2/Shc 0.026 0.056 -9999 0 -0.16 23 23
HRAS/GTP -0.007 0.02 -9999 0 -0.12 6 6
Insulin Receptor 0.023 0.017 -9999 0 -0.11 9 9
Insulin Receptor/Insuli/IRS1/GRB2/SHC 0.063 0.034 -9999 0 -0.13 2 2
PRKCI -0.012 0.13 -9999 0 -0.38 63 63
Insulin Receptor/Insulin/GRB14/PDK1 0.007 0.046 -9999 0 -0.14 25 25
SHC1 0.023 0.001 -9999 0 -10000 0 0
negative regulation of MAPKKK cascade 0.021 0.079 -9999 0 -0.47 9 9
PI3K 0.033 0.057 -9999 0 -0.095 69 69
NCK2 0.023 0.006 -9999 0 -0.12 1 1
RHOQ 0.021 0.017 -9999 0 -0.12 8 8
mol:H2O2 0 0.002 -9999 0 -10000 0 0
HRAS/GDP 0.017 0.008 -9999 0 -0.11 2 2
AKT2 0.015 0.049 -9999 0 -0.13 27 27
PRKCZ 0.028 0.063 -9999 0 -0.36 13 13
SH2B2 0 0 -9999 0 -10000 0 0
SHC/SHIP 0.025 0.02 -9999 0 -0.079 13 13
F2RL2 0.019 0.023 -9999 0 -0.12 15 15
TRIP10 0.021 0.018 -9999 0 -0.12 9 9
Insulin Receptor/Insulin/Shc 0.044 0.02 -9999 0 -0.095 7 7
TC10/GTP/CIP4/Exocyst 0.026 0.027 -9999 0 -0.12 14 14
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0.057 0.046 -9999 0 -0.16 5 5
RAPGEF1 0.023 0 -9999 0 -10000 0 0
RASA1 0.021 0.012 -9999 0 -0.12 3 3
NCK1 0.02 0.019 -9999 0 -0.12 9 9
CBL/APS/CAP/Crk-II 0.04 0.024 -9999 0 -0.11 7 7
TC10/GDP 0.014 0.022 -9999 0 -0.11 16 16
Insulin Receptor/Insulin/SHC/GRB10 0.056 0.029 -9999 0 -0.092 15 15
INPP5D 0.012 0.018 -9999 0 -0.086 12 12
SOS1 0.017 0.027 -9999 0 -0.12 20 20
SGK1 -0.002 0.004 -9999 0 -10000 0 0
mol:cAMP 0 0 -9999 0 -10000 0 0
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
IRS1 0.019 0.023 -9999 0 -0.12 14 14
p62DOK/RasGAP 0.021 0.08 -9999 0 -0.48 9 9
INS 0.024 0.011 -9999 0 -0.12 3 3
mol:PI-3-4-P2 0.011 0.018 -9999 0 -0.085 12 12
GRB2 0.023 0.006 -9999 0 -0.12 1 1
EIF4EBP1 0.015 0.046 -9999 0 -0.12 31 31
PTPRA 0.024 0.012 -9999 0 -0.12 4 4
PIK3CA 0.02 0.017 -9999 0 -0.12 7 7
TC10/GTP/CIP4 0.026 0.027 -9999 0 -0.12 14 14
PDPK1 0.023 0.007 -9999 0 -0.12 1 1
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos 0.027 0.048 -9999 0 -0.22 5 5
Insulin Receptor/Insulin/IRS1 0.04 0.027 -9999 0 -0.094 12 12
Insulin Receptor/Insulin/IRS3 0.034 0.024 -9999 0 -0.13 7 7
Par3/Par6 0.045 0.032 -9999 0 -0.089 18 18
Alternative NF-kappaB pathway

Figure S118.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S118.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer 0.024 0.04 -9999 0 -0.13 35 35
FBXW11 0.023 0.003 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0 0 -9999 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.023 0.003 -9999 0 -10000 0 0
CHUK 0.021 0.013 -9999 0 -0.12 4 4
NF kappa B2 p100/RelB 0.055 0.045 -9999 0 -0.091 44 44
NFKB1 0.021 0.013 -9999 0 -0.12 4 4
MAP3K14 0.023 0.006 -9999 0 -0.12 1 1
NF kappa B1 p50/RelB 0.02 0.048 -9999 0 -0.13 48 48
RELB 0.022 0.011 -9999 0 -0.12 3 3
NFKB2 0.023 0.009 -9999 0 -0.12 2 2
NF kappa B2 p52/RelB 0.029 0.02 -9999 0 -0.1 12 12
regulation of B cell activation 0.028 0.02 -9999 0 -0.1 12 12
Signaling events mediated by HDAC Class II

Figure S119.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S119.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G beta1gamma2/HDAC5 0.052 0.033 -10000 0 -0.098 21 21
HDAC3 0.023 0.002 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 -0.007 0.028 -10000 0 -0.11 36 36
GATA1/HDAC4 0.034 0.004 -10000 0 -0.071 1 1
GATA1/HDAC5 0.034 0.004 -10000 0 -0.071 1 1
GATA2/HDAC5 0.032 0.016 -10000 0 -0.071 13 13
HDAC5/BCL6/BCoR 0.034 0.044 -10000 0 -0.12 41 41
HDAC9 0.015 0.032 -10000 0 -0.12 28 28
Glucocorticoid receptor/Hsp90/HDAC6 0.031 0.047 -10000 0 -0.12 45 45
HDAC4/ANKRA2 0.028 0.031 -10000 0 -0.14 14 14
HDAC5/YWHAB 0.032 0.02 -10000 0 -0.13 8 8
NPC/RanGAP1/SUMO1/Ubc9 0.015 0.037 -10000 0 -0.14 30 30
GATA2 0.02 0.022 -10000 0 -0.12 13 13
HDAC4/RFXANK 0.025 0.037 -10000 0 -0.11 37 37
BCOR 0.023 0.007 -10000 0 -0.12 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
HDAC10 0.023 0 -10000 0 -10000 0 0
HDAC5 0.023 0 -10000 0 -10000 0 0
GNB1/GNG2 0.026 0.035 -10000 0 -0.14 20 20
Histones 0.026 0.035 -10000 0 -0.12 26 26
ADRBK1 0.023 0.001 -10000 0 -10000 0 0
HDAC4 0.023 0 -10000 0 -10000 0 0
XPO1 0.022 0.01 -10000 0 -0.12 2 2
HDAC5/ANKRA2 0.028 0.031 -10000 0 -0.11 26 26
HDAC4/Ubc9 0.034 0.007 -10000 0 -0.14 1 1
HDAC7 0 0 -10000 0 -10000 0 0
HDAC5/14-3-3 E 0.031 0.023 -10000 0 -0.11 13 13
TUBA1B 0.023 0 -10000 0 -10000 0 0
HDAC6 0.019 0.023 -10000 0 -0.12 15 15
HDAC5/RFXANK 0.025 0.037 -10000 0 -0.11 37 37
CAMK4 0.016 0.031 -10000 0 -0.12 27 27
Tubulin/HDAC6 0.043 0.02 -10000 0 -10000 0 0
SUMO1 0.023 0.009 -10000 0 -0.12 2 2
EntrezGene:9972 0 0 -10000 0 -10000 0 0
YWHAB 0.023 0.007 -10000 0 -0.12 1 1
GATA1 0.023 0.006 -10000 0 -0.12 1 1
EntrezGene:8021 0 0 -10000 0 -10000 0 0
YWHAE 0.022 0.014 -10000 0 -0.12 5 5
NR3C1 0.021 0.015 -10000 0 -0.12 5 5
SUMO1/HDAC4 0.036 0.035 -10000 0 -0.17 6 6
SRF 0.018 0.026 -10000 0 -0.12 19 19
HDAC4/YWHAB 0.032 0.02 -10000 0 -0.13 8 8
Tubulin 0.033 0.012 -10000 0 -10000 0 0
HDAC4/14-3-3 E 0.031 0.023 -10000 0 -0.14 8 8
GNB1 0.023 0.007 -10000 0 -0.12 1 1
RANGAP1 0.023 0.006 -10000 0 -0.12 1 1
BCL6/BCoR 0.019 0.05 -10000 0 -0.15 41 41
HDAC4/HDAC3/SMRT (N-CoR2) 0.043 0.022 -10000 0 -0.11 6 6
HDAC4/SRF 0.038 0.03 -10000 0 -0.12 5 5
HDAC4/ER alpha 0.018 0.049 -10000 0 -0.14 43 43
EntrezGene:23225 0 0 -10000 0 -10000 0 0
positive regulation of chromatin silencing 0.026 0.035 -10000 0 -0.12 26 26
cell motility 0.043 0.019 -10000 0 -10000 0 0
EntrezGene:23636 0 0 -10000 0 -10000 0 0
UBE2I 0.023 0.001 -10000 0 -10000 0 0
HDAC7/HDAC3 0.016 0.012 -10000 0 -0.15 3 3
BCL6 0.019 0.02 -10000 0 -0.12 10 10
HDAC4/CaMK II delta B 0.023 0 -10000 0 -10000 0 0
Hsp90/HDAC6 0.028 0.031 -10000 0 -0.1 28 28
ESR1 0.018 0.024 -10000 0 -0.12 15 15
HDAC6/HDAC11 0.029 0.028 -10000 0 -0.095 26 26
Ran/GTP/Exportin 1 0.034 0.049 -10000 0 -0.15 30 30
NPC 0.009 0.023 -10000 0 -0.096 27 27
MEF2C 0.02 0.02 -10000 0 -0.12 11 11
RAN 0.023 0.002 -10000 0 -10000 0 0
HDAC4/MEF2C 0.059 0.037 -10000 0 -0.091 22 22
GNG2 0.02 0.018 -10000 0 -0.12 9 9
NCOR2 0.019 0.023 -10000 0 -0.12 15 15
TUBB2A 0.021 0.017 -10000 0 -0.12 8 8
HDAC11 0.022 0.012 -10000 0 -0.12 4 4
HSP90AA1 0.023 0.003 -10000 0 -10000 0 0
RANBP2 0.022 0.01 -10000 0 -0.12 2 2
ANKRA2 0.02 0.021 -10000 0 -0.12 12 12
RFXANK 0.018 0.024 -10000 0 -0.12 16 16
nuclear import -0.034 0.033 0.16 14 -10000 0 14
Sphingosine 1-phosphate (S1P) pathway

Figure S120.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S120.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.022 0.011 -9999 0 -0.12 3 3
SPHK1 0.022 0.015 -9999 0 -0.12 6 6
GNAI2 0.022 0.011 -9999 0 -0.12 3 3
mol:S1P 0.019 0.029 -9999 0 -0.18 11 11
GNAO1 0.01 0.042 -9999 0 -0.12 51 51
mol:Sphinganine-1-P 0.022 0.012 -9999 0 -0.071 9 9
growth factor activity 0 0 -9999 0 -10000 0 0
S1P/S1P2/G12/G13 0.037 0.033 -9999 0 -0.14 12 12
GNAI3 0.021 0.008 -9999 0 -0.12 1 1
G12/G13 0.03 0.028 -9999 0 -0.14 14 14
S1PR3 0 0 -9999 0 -10000 0 0
S1PR2 0 0 -9999 0 -10000 0 0
EDG1 0.021 0.016 -9999 0 -0.12 7 7
S1P1/S1P 0.028 0.028 -9999 0 -0.14 11 11
S1PR5 0 0 -9999 0 -10000 0 0
S1PR4 0 0 -9999 0 -10000 0 0
GNAI1 0.012 0.035 -9999 0 -0.12 35 35
S1P/S1P5/G12 0.026 0.024 -9999 0 -0.13 11 11
S1P/S1P3/Gq 0.022 0.057 -9999 0 -0.22 26 26
S1P/S1P4/Gi 0.002 0.074 -9999 0 -0.16 86 86
GNAQ 0.021 0.016 -9999 0 -0.12 6 6
GNAZ 0.022 0.011 -9999 0 -0.12 3 3
GNA14 0.02 0.02 -9999 0 -0.12 11 11
GNA15 0.021 0.017 -9999 0 -0.12 8 8
GNA12 0.023 0.001 -9999 0 -10000 0 0
GNA13 0.022 0.009 -9999 0 -0.12 2 2
GNA11 0.022 0.014 -9999 0 -0.12 5 5
ABCC1 0.021 0.017 -9999 0 -0.12 8 8
Sumoylation by RanBP2 regulates transcriptional repression

Figure S121.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S121.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.019 0.02 -9999 0 -0.12 10 10
Ran/GTP/Exportin 1/HDAC4 -0.008 0.033 -9999 0 -0.15 26 26
MDM2/SUMO1 0.032 0.041 -9999 0 -0.18 8 8
HDAC4 0.023 0 -9999 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC1 -0.013 0.043 -9999 0 -0.17 30 30
SUMO1 0.023 0.009 -9999 0 -0.12 2 2
NPC/RanGAP1/SUMO1 0.01 0.036 -9999 0 -0.14 29 29
mol:GTP 0 0 -9999 0 -10000 0 0
XPO1 0.02 0.03 -9999 0 -0.13 17 17
EntrezGene:23636 0 0 -9999 0 -10000 0 0
RAN 0.023 0.002 -9999 0 -10000 0 0
EntrezGene:8021 0 0 -9999 0 -10000 0 0
RANBP2 0.022 0.01 -9999 0 -0.12 2 2
SUMO1/HDAC4 0.036 0.035 -9999 0 -0.17 6 6
SUMO1/HDAC1 0.029 0.048 -9999 0 -0.19 13 13
RANGAP1 0.023 0.006 -9999 0 -0.12 1 1
MDM2/SUMO1/SUMO1 0.047 0.043 -9999 0 -0.11 31 31
NPC/RanGAP1/SUMO1/RanBP2/Ubc9 0.015 0.037 -9999 0 -0.14 30 30
Ran/GTP 0.026 0.036 -9999 0 -0.12 30 30
EntrezGene:23225 0 0 -9999 0 -10000 0 0
MDM2 0.02 0.02 -9999 0 -0.12 11 11
UBE2I 0.023 0.001 -9999 0 -10000 0 0
Ran/GTP/Exportin 1 0.025 0.047 -9999 0 -0.15 30 30
NPC 0.009 0.023 -9999 0 -0.096 27 27
PIAS2 0.021 0.017 -9999 0 -0.12 8 8
PIAS1 0.022 0.009 -9999 0 -0.12 2 2
EntrezGene:9972 0 0 -9999 0 -10000 0 0
Angiopoietin receptor Tie2-mediated signaling

Figure S122.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S122.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 0.022 0.17 -9999 0 -0.68 14 14
NCK1/PAK1/Dok-R -0.028 0.072 -9999 0 -0.32 15 15
NCK1/Dok-R 0.049 0.087 -9999 0 -0.84 2 2
PIK3CA 0.019 0.017 -9999 0 -0.12 7 7
mol:beta2-estradiol -0.008 0.012 -9999 0 -10000 0 0
RELA 0.023 0.009 -9999 0 -0.12 2 2
SHC1 0.024 0.002 -9999 0 -10000 0 0
Rac/GDP 0.016 0.015 -9999 0 -0.15 5 5
F2 0.014 0.02 -9999 0 -0.14 4 4
TNIP2 0.021 0.017 -9999 0 -0.12 8 8
NF kappa B/RelA 0.057 0.087 -9999 0 -0.79 2 2
FN1 -0.013 0.056 -9999 0 -0.12 114 114
PLD2 0.041 0.076 -9999 0 -0.87 2 2
PTPN11 0.022 0.011 -9999 0 -0.12 3 3
GRB14 0.013 0.036 -9999 0 -0.12 38 38
ELK1 0.044 0.074 -9999 0 -0.82 2 2
GRB7 0.018 0.026 -9999 0 -0.12 18 18
PAK1 0.016 0.029 -9999 0 -0.12 23 23
Tie2/Ang1/alpha5/beta1 Integrin 0.013 0.1 -9999 0 -0.82 2 2
CDKN1A 0.027 0.18 -9999 0 -0.61 41 41
ITGA5 0.013 0.036 -9999 0 -0.12 38 38
mol:GTP 0 0 -9999 0 -10000 0 0
RasGAP/Dok-R 0.051 0.084 -9999 0 -0.84 2 2
CRK 0.021 0.016 -9999 0 -0.12 7 7
mol:NO 0.03 0.14 -9999 0 -0.5 17 17
PLG 0.041 0.077 -9999 0 -0.87 2 2
mol:GDP 0 0 -9999 0 -10000 0 0
chemokinesis 0.036 0.14 -9999 0 -0.74 6 6
GRB2 0.023 0.006 -9999 0 -0.12 1 1
PIK3R1 0.015 0.031 -9999 0 -0.12 27 27
ANGPT2 -0.029 0.27 -9999 0 -1 39 39
BMX 0.041 0.077 -9999 0 -0.87 2 2
ANGPT1 0.022 0.048 -9999 0 -10000 0 0
tube development 0.009 0.2 -9999 0 -0.69 41 41
ANGPT4 0.023 0.01 -9999 0 -0.12 2 2
response to hypoxia 0.002 0.008 -9999 0 -0.061 2 2
Tie2/Ang1/GRB14 0.043 0.083 -9999 0 -0.88 2 2
alpha5/beta1 Integrin 0.016 0.048 -9999 0 -0.14 34 34
FGF2 0.023 0.01 -9999 0 -0.12 2 2
STAT5A (dimer) 0.024 0.23 -9999 0 -0.78 41 41
mol:L-citrulline 0.03 0.14 -9999 0 -0.5 17 17
AGTR1 0.021 0.017 -9999 0 -0.12 4 4
MAPK14 0.037 0.12 -9999 0 -1 4 4
Tie2/SHP2 0.036 0.083 -9999 0 -0.67 4 4
TEK 0.033 0.088 -9999 0 -0.84 3 3
RPS6KB1 0.025 0.15 -9999 0 -0.71 9 9
Angiotensin II/AT1 0.016 0.018 -9999 0 -0.079 4 4
Tie2/Ang1/GRB2 0.048 0.081 -9999 0 -0.88 2 2
MAPK3 0.042 0.073 -9999 0 -0.81 2 2
MAPK1 0.041 0.074 -9999 0 -0.81 2 2
Tie2/Ang1/GRB7 0.045 0.083 -9999 0 -0.88 2 2
NFKB1 0.021 0.013 -9999 0 -0.12 4 4
MAPK8 0.039 0.077 -9999 0 -0.87 2 2
PI3K 0.024 0.16 -9999 0 -0.92 6 6
FES 0.045 0.097 -9999 0 -1 2 2
Crk/Dok-R 0.055 0.082 -9999 0 -0.84 2 2
Tie2/Ang1/ABIN2 0.047 0.081 -9999 0 -0.88 2 2
blood circulation 0 0 -9999 0 -10000 0 0
negative regulation of caspase activity 0.024 0.16 -9999 0 -0.62 14 14
STAT5A 0.022 0.013 -9999 0 -0.12 4 4
mol:ROS 0 0 -9999 0 -10000 0 0
PTK2 0.024 0.15 -9999 0 -0.74 7 7
Tie2/Ang2 0.002 0.27 -9999 0 -0.93 41 41
Tie2/Ang1 0.04 0.081 -9999 0 -0.92 2 2
FOXO1 0.02 0.18 -9999 0 -0.6 41 41
ELF1 0.03 0.014 -9999 0 -0.098 3 3
ELF2 0.041 0.078 -9999 0 -0.88 2 2
mol:Choline 0.041 0.075 -9999 0 -0.84 2 2
cell migration -0.02 0.045 -9999 0 -0.19 16 16
FYN 0.003 0.23 -9999 0 -0.79 41 41
DOK2 0.02 0.021 -9999 0 -0.12 12 12
negative regulation of cell cycle 0.029 0.17 -9999 0 -0.55 41 41
ETS1 0.022 0.035 -9999 0 -0.12 27 27
PXN 0.028 0.14 -9999 0 -0.62 7 7
ITGB1 0.021 0.015 -9999 0 -0.12 6 6
NOS3 0.028 0.15 -9999 0 -0.58 14 14
RAC1 0.023 0.002 -9999 0 -10000 0 0
TNF 0.028 0.025 -9999 0 -0.12 11 11
MAPKKK cascade 0.041 0.075 -9999 0 -0.84 2 2
RASA1 0.021 0.012 -9999 0 -0.12 3 3
Tie2/Ang1/Shc 0.049 0.082 -9999 0 -0.88 2 2
NCK1 0.02 0.019 -9999 0 -0.12 9 9
vasculogenesis 0.031 0.13 -9999 0 -0.45 17 17
mol:Phosphatidic acid 0.041 0.075 -9999 0 -0.84 2 2
mol:Angiotensin II -0.001 0.009 -9999 0 -10000 0 0
mol:NADP 0.03 0.14 -9999 0 -0.5 17 17
Rac1/GTP 0.03 0.14 -9999 0 -0.73 6 6
MMP2 0.015 0.083 -9999 0 -0.87 2 2
Aurora C signaling

Figure S123.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S123.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
INCENP 0.023 0.009 -9999 0 -0.12 2 2
Aurora C/Aurora B/INCENP 0.033 0.036 -9999 0 -0.097 32 32
metaphase 0 0 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
H3F3B 0.003 0.069 -9999 0 -0.39 16 16
AURKB 0.017 0.027 -9999 0 -0.12 19 19
AURKC 0.023 0.006 -9999 0 -0.12 1 1
IL27-mediated signaling events

Figure S124.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S124.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.025 0.035 -10000 0 -0.4 2 2
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response -0.002 0.086 0.36 16 -10000 0 16
IL27/IL27R/JAK1 0.029 0.089 -10000 0 -0.95 2 2
TBX21 0 0.077 -10000 0 -0.53 3 3
IL12B 0.024 0.002 -10000 0 -10000 0 0
IL12A 0 0.029 -10000 0 -0.077 70 70
IL6ST 0.016 0.027 -10000 0 -0.12 19 19
IL27RA/JAK1 0.012 0.073 -10000 0 -1.1 2 2
IL27 0.023 0.004 -10000 0 -10000 0 0
TYK2 0.021 0.017 -10000 0 -0.12 7 7
T-helper cell lineage commitment 0.013 0.09 -10000 0 -1.2 2 2
T-helper 2 cell differentiation -0.002 0.086 0.36 16 -10000 0 16
T cell proliferation during immune response -0.002 0.086 0.36 16 -10000 0 16
MAPKKK cascade 0.002 0.086 -10000 0 -0.36 16 16
STAT3 0.022 0.011 -10000 0 -0.12 3 3
STAT2 0.02 0.019 -10000 0 -0.12 9 9
STAT1 0.014 0.031 -10000 0 -0.12 26 26
IL12RB1 0.023 0.006 -10000 0 -0.12 1 1
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 0 0.08 -10000 0 -0.48 4 4
IL27/IL27R/JAK2/TYK2 0.002 0.086 -10000 0 -0.37 16 16
positive regulation of T cell mediated cytotoxicity 0.002 0.086 -10000 0 -0.36 16 16
STAT1 (dimer) 0.015 0.11 -10000 0 -0.74 3 3
JAK2 0.016 0.025 -10000 0 -0.12 16 16
JAK1 0.022 0.01 -10000 0 -0.12 2 2
STAT2 (dimer) 0.004 0.094 -10000 0 -0.36 17 17
T cell proliferation 0 0.084 -10000 0 -0.34 17 17
IL12/IL12R/TYK2/JAK2 0.026 0.066 -10000 0 -0.72 1 1
IL17A 0.013 0.09 -10000 0 -1.2 2 2
mast cell activation -0.002 0.086 0.36 16 -10000 0 16
IFNG 0.003 0.021 -10000 0 -0.07 4 4
T cell differentiation -0.001 0.003 -10000 0 -0.02 3 3
STAT3 (dimer) 0.004 0.094 -10000 0 -0.36 16 16
STAT5A (dimer) 0.006 0.091 -10000 0 -0.35 16 16
STAT4 (dimer) 0.006 0.091 -10000 0 -0.35 16 16
STAT4 0.02 0.02 -10000 0 -0.12 11 11
T cell activation -0.006 0.011 0.12 2 -10000 0 2
IL27R/JAK2/TYK2 0.009 0.094 -10000 0 -0.98 2 2
GATA3 0.014 0.029 -10000 0 -10000 0 0
IL18 0 0.028 -10000 0 -0.077 66 66
positive regulation of mast cell cytokine production 0.004 0.092 -10000 0 -0.36 16 16
IL27/EBI3 0.034 0.009 -10000 0 -10000 0 0
IL27RA -0.001 0.076 -10000 0 -1.1 2 2
IL6 0.012 0.054 -10000 0 -0.33 3 3
STAT5A 0.022 0.013 -10000 0 -0.12 4 4
monocyte differentiation 0 0.001 -10000 0 -10000 0 0
IL2 0.005 0.041 0.46 2 -10000 0 2
IL1B 0.003 0.024 -10000 0 -0.077 45 45
EBI3 0.023 0.008 -10000 0 -0.12 1 1
TNF 0.01 0.012 -10000 0 -0.077 11 11
Regulation of cytoplasmic and nuclear SMAD2/3 signaling

Figure S125.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S125.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SMAD4 0.022 0.007 -10000 0 -0.12 1 1
SMAD2 0.015 0.036 0.19 2 -0.16 8 10
SMAD3 0.027 0.046 -10000 0 -0.29 4 4
SMAD3/SMAD4 -0.013 0.16 -10000 0 -0.37 81 81
SMAD4/Ubc9/PIASy 0.043 0.027 -10000 0 -0.12 15 15
SMAD2/SMAD2/SMAD4 0.034 0.063 -10000 0 -0.17 18 18
PPM1A 0.023 0.001 -10000 0 -10000 0 0
CALM1 0.022 0.014 -10000 0 -0.12 5 5
SMAD2/SMAD4 0.027 0.032 0.16 2 -0.14 8 10
MAP3K1 0.021 0.015 -10000 0 -0.12 6 6
TRAP-1/SMAD4 0.025 0.041 -10000 0 -0.14 30 30
MAPK3 0.022 0.014 -10000 0 -0.12 5 5
MAPK1 0.021 0.016 -10000 0 -0.12 7 7
NUP214 0.023 0.007 -10000 0 -0.12 1 1
CTDSP1 0.022 0.011 -10000 0 -0.12 3 3
CTDSP2 0.022 0.01 -10000 0 -0.12 2 2
CTDSPL 0.023 0.006 -10000 0 -0.12 1 1
KPNB1 0.022 0.009 -10000 0 -0.12 2 2
TGFBRAP1 0.022 0.007 -10000 0 -0.12 1 1
UBE2I 0.023 0.001 -10000 0 -10000 0 0
NUP153 0.02 0.019 -10000 0 -0.12 9 9
KPNA2 0.017 0.024 -10000 0 -0.12 15 15
PIAS4 0.023 0 -10000 0 -10000 0 0
Glypican 2 network

Figure S126.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S126.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK 0.021 0.014 -9999 0 -0.12 5 5
GPC2 0.023 0.009 -9999 0 -0.12 2 2
GPC2/Midkine 0.029 0.031 -9999 0 -0.14 16 16
neuron projection morphogenesis 0.029 0.031 -9999 0 -0.14 16 16
Arf1 pathway

Figure S127.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S127.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
coatomer protein complex 0.019 0.009 -10000 0 -10000 0 0
EntrezGene:79658 0 0 -10000 0 -10000 0 0
ARF1/GDP/Membrin/GBF1/p115/Brefeldin A 0.008 0.035 -10000 0 -0.14 14 14
AP2 0.025 0.04 -10000 0 -0.13 33 33
mol:DAG 0 0 -10000 0 -10000 0 0
Arfaptin 2/Rac/GTP 0.03 0.016 -10000 0 -0.089 10 10
CLTB 0.022 0.014 -10000 0 -0.12 5 5
coatomer protein complex/ARF1/GTP/ER cargo protein 0.02 0.034 -10000 0 -0.16 16 16
CD4 0.016 0.028 -10000 0 -0.12 21 21
CLTA 0.023 0.006 -10000 0 -0.12 1 1
mol:GTP 0 0.002 -10000 0 -10000 0 0
ARFGAP1 0.012 0 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.009 0.009 -10000 0 -0.047 5 5
ARF1/GTP 0.011 0.015 -10000 0 -0.12 2 2
coatomer protein complex/ARF1/GTP/ARF-GAP1/ER cargo protein 0.02 0.026 -10000 0 -0.15 11 11
mol:Choline 0.009 0.008 -10000 0 -0.046 5 5
mol:GDP 0 0 -10000 0 -10000 0 0
ARF1 0.017 0.028 -10000 0 -0.12 21 21
DDEF1 0.008 0.012 -10000 0 -0.2 1 1
ARF1/GDP 0.009 0.005 0.047 1 -0.063 1 2
AP2M1 0.022 0.005 -10000 0 -10000 0 0
EntrezGene:1313 0 0 -10000 0 -10000 0 0
actin filament polymerization 0.013 0.019 -10000 0 -0.11 7 7
Rac/GTP 0.016 0.016 -10000 0 -0.15 5 5
ARF1/GTP/GGA3/ARF-GAP1 0.032 0.019 -10000 0 -0.091 3 3
ARFIP2 0.021 0.014 -10000 0 -0.12 5 5
COPA 0.023 0.007 -10000 0 -0.12 1 1
RAC1 0.023 0.002 -10000 0 -10000 0 0
ARF1/GTP/coatomer protein complex 0.018 0.035 -10000 0 -0.21 11 11
ARF1/GTP/ARHGAP10 0.011 0.016 -10000 0 -0.066 23 23
GGA3 0.022 0.015 -10000 0 -0.12 6 6
ARF1/GTP/Membrin 0.019 0.018 -10000 0 -0.18 2 2
AP2A1 0.021 0.017 -10000 0 -0.12 8 8
coatomer protein complex/ARF1/GTP/ARF-GAP1 0.021 0.033 -10000 0 -0.17 13 13
ARF1/GDP/Membrin 0.021 0.019 -10000 0 -0.29 1 1
Arfaptin 2/Rac/GDP 0.029 0.016 -10000 0 -0.087 10 10
CYTH2 0 0.002 -10000 0 -10000 0 0
ARF1/GTP/GGA3 0.026 0.021 -10000 0 -0.062 30 30
mol:ATP 0 0 -10000 0 -10000 0 0
Rac/GDP 0.016 0.015 -10000 0 -0.15 5 5
mol:Brefeldin A 0 0 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex/Coatomer protein complex/ARF1/GTP 0.006 0.077 -10000 0 -0.26 22 22
PLD2 0.009 0.008 -10000 0 -0.046 5 5
ARF-GAP1/v-SNARE 0.012 0 -10000 0 -10000 0 0
PIP5K1A 0.009 0.009 -10000 0 -0.047 5 5
ARF1/GTP/Membrin/GBF1/p115 0.011 0.028 -10000 0 -0.1 14 14
mol:Phosphatic acid 0 0 -10000 0 -10000 0 0
mol:Phosphatidic acid 0.009 0.008 -10000 0 -0.046 5 5
KDEL Receptor/Ligand/ARF-GAP1 0.012 0 -10000 0 -10000 0 0
GOSR2 0.015 0.016 -10000 0 -0.36 1 1
USO1 -0.01 0.093 -10000 0 -0.36 37 37
GBF1 0.001 0.07 -10000 0 -0.36 21 21
ARF1/GTP/Arfaptin 2 0.027 0.021 -10000 0 -0.062 27 27
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex 0.02 0.062 -10000 0 -0.13 74 74
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S128.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S128.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 0.016 0.057 -10000 0 -0.24 7 7
CRKL 0.014 0.059 -10000 0 -0.27 6 6
HRAS 0.032 0.067 -10000 0 -0.26 7 7
mol:PIP3 0.004 0.067 0.22 5 -0.26 7 12
SPRED1 0.019 0.016 -10000 0 -0.12 6 6
SPRED2 0.022 0.014 -10000 0 -0.12 5 5
GAB1 0.011 0.061 -10000 0 -0.29 6 6
FOXO3 0.019 0.063 -10000 0 -0.28 8 8
AKT1 0.017 0.064 -10000 0 -0.3 7 7
BAD 0.021 0.061 -10000 0 -0.3 6 6
megakaryocyte differentiation 0.013 0.059 -10000 0 -0.3 5 5
GSK3B 0.02 0.062 -10000 0 -0.33 5 5
RAF1 0.031 0.06 -10000 0 -0.24 7 7
SHC1 0.023 0.001 -10000 0 -10000 0 0
STAT3 0.011 0.062 -10000 0 -0.26 9 9
STAT1 0.013 0.12 -10000 0 -0.59 9 9
HRAS/SPRED1 0.031 0.067 -10000 0 -0.24 8 8
cell proliferation 0.012 0.06 -10000 0 -0.3 6 6
PIK3CA 0.02 0.017 -10000 0 -0.12 7 7
TEC 0.01 0.038 -10000 0 -0.12 43 43
RPS6KB1 0.01 0.077 -10000 0 -0.27 18 18
HRAS/SPRED2 0.037 0.063 -10000 0 -0.22 8 8
LYN/TEC/p62DOK 0.013 0.085 -10000 0 -0.26 17 17
MAPK3 0.03 0.052 -10000 0 -0.26 4 4
STAP1 0.012 0.06 -10000 0 -0.3 5 5
GRAP2 0.022 0.012 -10000 0 -0.12 4 4
JAK2 0.005 0.12 -10000 0 -0.51 12 12
STAT1 (dimer) 0.008 0.13 -10000 0 -0.58 9 9
mol:Gleevec -0.001 0.003 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 0.031 0.074 -10000 0 -0.28 7 7
actin filament polymerization 0.009 0.059 -10000 0 -0.3 5 5
LYN 0.021 0.013 -10000 0 -0.12 4 4
STAP1/STAT5A (dimer) 0.013 0.09 -10000 0 -0.38 9 9
PIK3R1 0.015 0.031 -10000 0 -0.12 27 27
CBL/CRKL/GRB2 0.034 0.063 -10000 0 -0.34 3 3
PI3K 0.017 0.089 -10000 0 -0.27 21 21
PTEN 0.022 0.008 -10000 0 -0.12 1 1
SCF/KIT/EPO/EPOR 0.032 0.13 -10000 0 -1.3 2 2
MAPK8 0.012 0.061 -10000 0 -0.31 6 6
STAT3 (dimer) 0.012 0.061 -10000 0 -0.26 9 9
positive regulation of transcription 0.028 0.045 0.14 1 -0.21 4 5
mol:GDP 0.031 0.072 -10000 0 -0.25 9 9
PIK3C2B 0.011 0.061 -10000 0 -0.28 6 6
CBL/CRKL 0.025 0.061 -10000 0 -0.28 5 5
FER 0.012 0.06 -10000 0 -0.3 5 5
SH2B3 0.013 0.06 -10000 0 -0.3 5 5
PDPK1 0.007 0.066 0.21 4 -0.23 11 15
SNAI2 0.002 0.065 -10000 0 -0.3 8 8
positive regulation of cell proliferation 0.008 0.11 -10000 0 -0.43 12 12
KITLG 0.02 0.029 -10000 0 -0.12 21 21
cell motility 0.008 0.11 -10000 0 -0.43 12 12
PTPN6 0.021 0.01 -10000 0 -0.12 2 2
EPOR 0.015 0.13 -10000 0 -0.55 22 22
STAT5A (dimer) 0.011 0.094 -10000 0 -0.36 13 13
SOCS1 0.016 0.031 -10000 0 -0.12 27 27
cell migration -0.013 0.059 0.3 5 -10000 0 5
SOS1 0.017 0.027 -10000 0 -0.12 20 20
EPO 0.024 0.008 -10000 0 -0.13 1 1
VAV1 0.02 0.02 -10000 0 -0.12 10 10
GRB10 0.012 0.062 -10000 0 -0.28 8 8
PTPN11 0.021 0.012 -10000 0 -0.12 3 3
SCF/KIT 0.009 0.062 -10000 0 -0.32 5 5
GO:0007205 -0.001 0.004 -10000 0 -10000 0 0
MAP2K1 0.03 0.051 -10000 0 -0.2 6 6
CBL 0.023 0.006 -10000 0 -0.12 1 1
KIT 0.007 0.12 -10000 0 -0.63 6 6
MAP2K2 0.028 0.053 -10000 0 -0.18 8 8
SHC/Grb2/SOS1 0.033 0.071 -10000 0 -0.27 7 7
STAT5A 0.01 0.096 -10000 0 -0.37 13 13
GRB2 0.023 0.006 -10000 0 -0.12 1 1
response to radiation 0.002 0.064 -10000 0 -0.3 8 8
SHC/GRAP2 0.034 0.011 -10000 0 -0.14 1 1
PTPRO 0.013 0.06 -10000 0 -0.3 5 5
SH2B2 0.008 0.059 -10000 0 -0.31 5 5
DOK1 0.021 0.016 -10000 0 -0.12 7 7
MATK 0.013 0.06 -10000 0 -0.3 5 5
CREBBP 0.036 0.031 -10000 0 -0.12 9 9
BCL2 0.009 0.15 -10000 0 -0.62 23 23
Visual signal transduction: Rods

Figure S129.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S129.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.023 0.009 -9999 0 -0.12 2 2
GNAT1/GTP 0.017 0.006 -9999 0 -0.077 2 2
Metarhodopsin II/Arrestin 0.031 0.007 -9999 0 -10000 0 0
PDE6G/GNAT1/GTP 0.025 0.024 -9999 0 -0.061 38 38
mol:GTP 0 0 -9999 0 -10000 0 0
absorption of light 0 0 -9999 0 -10000 0 0
GNAT1 0.023 0.009 -9999 0 -0.12 2 2
GRK1 0 0 -9999 0 -10000 0 0
CNG Channel 0.039 0.024 -9999 0 -0.11 3 3
mol:Na + 0.052 0.02 -9999 0 -0.31 1 1
mol:ADP 0 0 -9999 0 -10000 0 0
RGS9-1/Gbeta5/R9AP 0.042 0.023 -9999 0 -0.11 2 2
mol:GDP 0 0 -9999 0 -10000 0 0
cGMP/CNG Channel 0.065 0.021 -9999 0 -0.32 1 1
CNGB1 0.023 0.006 -9999 0 -0.12 1 1
RDH5 0.011 0.041 -9999 0 -0.12 48 48
SAG 0.022 0.011 -9999 0 -0.12 3 3
mol:Ca2+ 0.04 0.018 -9999 0 -0.3 1 1
Na + (4 Units) 0.042 0.018 -9999 0 -0.29 1 1
RGS9 0.017 0.029 -9999 0 -0.12 23 23
GNB1/GNGT1 0.03 0.027 -9999 0 -0.1 20 20
GNAT1/GDP 0.05 0.022 -9999 0 -0.089 2 2
GUCY2D 0.022 0.011 -9999 0 -0.12 3 3
GNGT1 0.02 0.023 -9999 0 -0.12 14 14
GUCY2F 0.023 0.006 -9999 0 -0.12 1 1
GNB5 0.023 0.009 -9999 0 -0.12 2 2
mol:GMP (4 units) 0.031 0.023 -9999 0 -0.1 4 4
mol:11-cis-retinal 0.011 0.04 -9999 0 -0.12 48 48
mol:cGMP 0.057 0.019 -9999 0 -0.12 4 4
GNB1 0.023 0.007 -9999 0 -0.12 1 1
Rhodopsin 0.023 0.035 -9999 0 -0.08 57 57
SLC24A1 0.023 0.009 -9999 0 -0.12 2 2
CNGA1 0.022 0.014 -9999 0 -0.12 5 5
Metarhodopsin II 0.015 0.003 -9999 0 -0.055 1 1
mol:Ca ++ 0 0 -9999 0 -10000 0 0
GC1/GCAP Family 0.058 0.019 -9999 0 -0.12 4 4
RGS9BP 0.022 0.011 -9999 0 -0.12 3 3
Metarhodopsin II/Transducin 0.025 0.022 -9999 0 -0.15 7 7
GCAP Family/Ca ++ 0.043 0.015 -9999 0 -0.12 4 4
PDE6A/B 0.033 0.014 -9999 0 -0.071 10 10
mol:Pi 0.042 0.022 -9999 0 -0.11 2 2
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
Transducin 0.041 0.023 -9999 0 -0.11 8 8
PDE6B 0.022 0.015 -9999 0 -0.12 6 6
PDE6A 0.022 0.012 -9999 0 -0.12 4 4
PDE6G 0.014 0.035 -9999 0 -0.12 35 35
RHO 0.023 0.006 -9999 0 -0.12 1 1
PDE6 0.056 0.035 -9999 0 -0.15 2 2
GUCA1A 0.022 0.011 -9999 0 -0.12 3 3
GC2/GCAP Family 0.058 0.018 -9999 0 -0.12 4 4
GUCA1C 0.022 0.012 -9999 0 -0.12 4 4
GUCA1B 0.023 0.006 -9999 0 -0.12 1 1
Rapid glucocorticoid signaling

Figure S130.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S130.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Gs family/GDP/Gbeta gamma 0.034 0.029 -10000 0 -0.093 20 20
MAPK9 0 0.045 -10000 0 -0.21 25 25
adrenocorticotropin secretion 0.011 0.006 -10000 0 -0.077 3 3
GNB1/GNG2 0.025 0.029 -10000 0 -0.12 20 20
GNB1 0.023 0.007 -10000 0 -0.12 1 1
regulation of calcium ion transport via voltage-gated calcium channel activity 0 0 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
MAPK14 0.006 0.03 -10000 0 -0.21 11 11
Gs family/GTP 0.014 0.009 -10000 0 -0.055 9 9
EntrezGene:2778 0 0 -10000 0 -10000 0 0
vasopressin secretion 0 0 -10000 0 -10000 0 0
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
glutamate secretion 0 0.002 0.017 9 -10000 0 9
GNAL 0.021 0.018 -10000 0 -0.12 9 9
GNG2 0.02 0.018 -10000 0 -0.12 9 9
CRH 0.022 0.011 -10000 0 -0.12 3 3
mol:cortisol 0 0 -10000 0 -10000 0 0
MAPK8 0.003 0.038 -10000 0 -0.21 17 17
MAPK11 0.01 0 -10000 0 -10000 0 0
Visual signal transduction: Cones

Figure S131.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S131.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.04 0.013 -9999 0 -0.09 2 2
RGS9BP 0.022 0.011 -9999 0 -0.12 3 3
mol:GTP 0 0 -9999 0 -10000 0 0
GRK1 0 0 -9999 0 -10000 0 0
mol:Na + 0.031 0.004 -9999 0 -10000 0 0
mol:ADP 0.011 0.004 -9999 0 -0.077 1 1
GNAT2 0.023 0 -9999 0 -10000 0 0
RGS9-1/Gbeta5/R9AP 0.042 0.023 -9999 0 -0.11 2 2
mol:GDP 0 0 -9999 0 -10000 0 0
PDE6H/GNAT2/GTP 0.031 0.004 -9999 0 -0.057 1 1
GRK7 0.023 0.006 -9999 0 -0.12 1 1
CNGB3 0.023 0.006 -9999 0 -0.12 1 1
Cone Metarhodopsin II/X-Arrestin 0.017 0.004 -9999 0 -0.077 1 1
mol:Ca2+ 0.025 0.008 -9999 0 -0.1 1 1
Cone PDE6 0.064 0.024 -9999 0 -0.11 2 2
Cone Metarhodopsin II 0.015 0.003 -9999 0 -0.055 1 1
Na + (4 Units) 0.043 0.01 -9999 0 -0.1 1 1
GNAT2/GDP 0.05 0.021 -9999 0 -0.089 2 2
GNB5 0.023 0.009 -9999 0 -0.12 2 2
mol:GMP (4 units) 0.026 0.005 -9999 0 -0.1 1 1
Cone Transducin 0.043 0.014 -9999 0 -0.097 2 2
SLC24A2 0.022 0.014 -9999 0 -0.12 5 5
GNB3/GNGT2 0.032 0.016 -9999 0 -0.14 2 2
GNB3 0.022 0.011 -9999 0 -0.12 3 3
GNAT2/GTP 0.017 0 -9999 0 -10000 0 0
CNGA3 0.023 0 -9999 0 -10000 0 0
ARR3 0.023 0.006 -9999 0 -0.12 1 1
absorption of light 0 0 -9999 0 -10000 0 0
cGMP/Cone CNG Channel 0.031 0.004 -9999 0 -10000 0 0
mol:Pi 0.042 0.022 -9999 0 -0.11 2 2
Cone CNG Channel 0.057 0.008 -9999 0 -0.14 1 1
mol:all-trans-retinal 0 0 -9999 0 -10000 0 0
mol:K + 0.022 0.014 -9999 0 -0.12 5 5
RGS9 0.017 0.029 -9999 0 -0.12 23 23
PDE6C 0.023 0.006 -9999 0 -0.12 1 1
GNGT2 0.022 0.014 -9999 0 -0.12 5 5
mol:cGMP (4 units) 0 0 -9999 0 -10000 0 0
PDE6H 0.023 0.006 -9999 0 -0.12 1 1
Methods & Data
Input

  • Expression Data Normalization = Tumor samples were used to median center the expression data used in this analysis.

  • Expression File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_MergeDataFilesPipeline/OV/856530/1.GDAC_MergeDataFiles.Finished/OV.exon__huex_1_0_st_v2__lbl_gov__Level_3__quantile_normalization_gene__data.data.txt

  • Copy Number File Used = Copy number data was not used in this analysis.

Data Sets and Pathway Interactions

Both copy number and expression data are incorporated into PARADIGM's inference. Whenever normal tissue controls are available for analysis in the expression data, each patient's gene-value is normalized by subtracting the gene's median level observed in the normal control. Copy number data is also normalized to reflect the difference in copy number between a gene's levels detected in tumor versus control (e.g. blood normal). The collection of pathways used by PARADIGM includes those from NCI-PID on September 15, 2009 containing 131 pathways, 11,563 interactions, and 7,204 entities. All gene identifiers were translated into HUGO standard identifiers wherever possible. We refer to molecular entities as "concepts," which include gene products such as proteins and miRNAs, small molecules, protein complexes, and abstract concepts. Each concept is represented as "node" in PARADIGM's graphical model. The abstract concepts correspond to general cellular processes (such as "apoptosis" or "DNA damage response") and families of genes that share functional activity such as the RAS family of signal transducers. Various types of concept-concept interactions are included in the pathways including protein-protein interactions, transcriptional regulatory interactions, and protein modifications such as phosphorylation and ubiquitinylation interactions.

Pathway Inference Method

The PARADIGM algorithm (described in PMID: 20529912) assigns an integrated pathway level (IPL) reflecting the activity of a concept determined through a belief propagation strategy. The belief propagation is given the copy number and gene expression measurements of all of the genes and iteratively updates hidden states reflecting the activities of all of the genes in a pathway so as to maximize the likelihood of the observed data given the interactions in the pathway. In the end, the inferred level of a concept reflects both the data observed for the concept and the neighborhood of activity surrounding the concept.

Determining significantly altered levels

The significance of the IPL obtained for each concept in each patient sample is assessed using a permutation analysis. Importantly, the permutation analysis preserves data tuples so as to preserve any implicit correlations between the different data modalities. For example, genes that are deleted have concomitantly lower expression levels. Preserving the copy number and expression pairs therefore retains this data property. The simulation therefore makes "null samples" by permuting data tuples across all of the genes in the genome so that each gene in a null sample is associated with a random tuple of another gene with equal probability. This approach has the added benefit of preserving the pathway structure so that every observed IPL can be compared to a distribution of random IPLs derived from exactly the same interaction context. PARADIGM inferences are then obtained for 1000 "null" patients and serve as a background distribution to contrast the observed IPLs against. Pathway concepts are excluded from further analysis if they did not obtain a minimum IPL of 0.5 in any patient sample both observed or simulated.

An IPL I(i,j) for concept i in sample j, is considered to be deviated if its absolute level is two standard deviations from the average level observed for concept i in the 1000 null samples. The degree to which a concept has significantly altered levels across a patient cohort is summarized in the proportion of deviated samples (PDS) score. For example, a protein with a PDS of 0.10 reflects that the protein's level of activity was inferred to be significantly higher or lower in tumors compared to normal in 10% of the patient samples. An average PDS for a pathway is also reported by computing the mean PDS over all concepts in the pathway.

Download Results

This is an experimental feature. Location of data archives could not be determined.

References
[2] Charles J. Vaske, Stephen C. Benz, J. Zachary Sanborn, Dent Earl, Christopher Szeto, Jingchun Zhu, David Haussler, and Joshua M. Stuart, Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM, Bioinformatics 12(26):237-245 (2010)
Meta

  • Maintainer = TCGA GDAC Team

Copyright © 2011 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle